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GABA is important for proper functioning of the CNS 
 
Present in ~30% of nerve terminals (Bloom and Iversen, 1971), -aminobutyric 
acid (GABA) is the most abundant inhibitory neurotransmitter in the central nervous 
system (CNS) (Curtis and Crawford, 1969; Hebb, 1970).  Although GABA has also been 
detected in the pancreas, lung, kidney, and uterus (Hedblom and Kirkness, 1997; Wendt 
et al., 2004; Sarang et al., 2008; Jin et al., 2008) and in several stem cell lineages 
(Andang et al., 2008), its levels are highest in the brain and spinal cord (Awapara et al., 
1950; Roberts and Frankel, 1950), where it plays an important role in sensory-motor 
integration (Middleton et al., 2008), learning and memory (Liu et al., 2007; McNally et 
al., 2008), maintenance of circadian rhythms and sleep (Liu and Reppert, 2000; Gillespie 
et al., 1997; Mintz et al., 2002; Steriade, 2005; Agosto et al., 2008), regulation of reward 
pathways (Johnson and North, 1992; Steffensen et al., 1998), mediation and perception of 
pain (Jasmin et al., 2003; Enna and McCarson, 2006), and even neuronal proliferation, 
migration, and differentiation (Owens and Kriegstein, 2002; McClellan et al., 2008).  It is 
therefore not surprising that impaired GABA signaling has been implicated in a wide 
variety of neurological and psychiatric disorders including epilepsy, anxiety, insomnia, 
neuropathic pain, spasticity, schizophrenia, autism, depression, and drug addiction 
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(Malan et al., 2002; Wong et al., 2003; Rudolph and Möhler, 2004; Cryan and 
Kaupmann, 2005; Akbarian and Huang, 2006; Krystal et al., 2006; Enoch, 2008; Maguire 
and Mody, 2008).  Although many of these disorders are undoubtedly polygenic, the 
recent discovery of inherited epilepsy syndromes caused by point mutations or 
polymorphisms in genes encoding GABA receptors (Macdonald et al., 2006) highlights 
the vulnerability of neuronal circuitry to loss of GABAergic inhibition and underscores 
the need to better understand this important neurotransmitter system. 
 
Synthesis and degradation of GABA 
 
GABA is synthesized from glutamate in presynaptic nerve terminals by the 
pyridoxal phosphate-requiring enzyme L-glutamic acid decarboxylase (GAD).  (Notably, 
this reaction converts the predominant excitatory neurotransmitter into the predominant 
inhibitory one.)  There are two isoforms of GAD (GAD65 and GAD67; Erlander et al., 
1991), each having different kinetic properties and subcellular localizations (Esclapez et 
al., 1994; Kanaani et al., 1999; Battaglioli et al., 2003).  Once synthesized, GABA is 
packaged into presynaptic vesicles by the vesicular GABA transporter (VGAT) 
(Chaudhry et al., 1998).  Following exocytic release into the synaptic cleft, GABA is 
cleared rapidly (in less than 1 ms; Clements, 1996; Glavinovic, 1999) by a combination 
of diffusion and reuptake, the latter being mediated by GABA transporters (GATs) 
expressed on the surface of presynaptic neurons and neighboring glia (Minelli et al., 
1995).  Interestingly, despite the classical view that individual synapses release a single 
type of neurotransmitter (Dale, 1935), several studies have shown that GABA can be co-
released with other neurotransmitters such as glycine (Jonas et al., 1998), ATP (Jo and 
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Schlichter, 1999), glutamate (Gutierrez, 2005), and dopamine (Maher and Westbrook, 
2008). 
Once cleared from synapses, GABA is either repackaged into presynaptic vesicles 
by VGAT or converted back to glutamate by the “GABA shunt”, a series of enzymatic 
reactions occurring in glia (Martin, 1993).  The first step requires the mitochondrial 
enzyme GABA transaminase (GABA-T), which converts GABA to succinic 
semialdehyde (SSA).  SSA is then converted by SSA dehydrogenase (SSADH) to 
succinate, which enters the Krebs cycle and is converted eventually to α-ketoglutarate.  
Glutamate is then regenerated from α-ketoglutarate during the process of GABA 
deamination by GABA-T, thereby ensuring that GABA catabolism is directly coupled 
with regeneration of its precursor.  Glutamate, however, cannot be converted to GABA in 
glia due to their lack of GAD expression (Wuenschell et al., 1986).  It is therefore 
converted by glutamine synthetase to glutamine, which is pumped out of glia and into the 
extracellular space by sodium-coupled neutral amino acid transporters (SNAT3/5) 
(Mackenzie and Erickson, 2003).  From there, glutamine is pumped back into neurons by 
members of the same transporter family (SNAT1/2), where it is reconverted to glutamate 
by the enzyme glutaminase and thus available again for GABA synthesis (Mackenzie and 
Erickson, 2003). 
 
Types of GABA receptors 
 
GABAergic synaptic transmission is mediated by three receptor classes.  The 
most widely expressed are the GABAA receptors (Laurie et al., 1992; Wisden et al., 
1992), a large family of ligand-gated chloride channels responsible for the effects of 
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benzodiazepines (BDZs), barbiturates, anesthetics, neurosteroids, and ethanol (Olsen and 
Macdonald, 1992; Macdonald and Olsen, 1994; Rabow et al., 1995).  In most adult 
neurons, GABAA receptor activation decreases the likelihood of neuronal firing by 
promoting membrane hyperpolarization.  This occurs because the chloride reversal 
potential is typically lower than the resting membrane potential, reflecting the relatively 
low concentration of intracellular chloride due to expression of the potassium-chloride 
exporter, KCC2 (Rivera et al., 1999).  Notably, lack of KCC2 expression is responsible 
for GABAA receptor activation causing membrane depolarization (i.e., excitation) during 
development, as this permits chloride to accumulate intracellularly and, consequently, 
efflux upon GABAA receptor channel opening (Ben-Ari, 2002; Stein and Nicoll, 2003).  
Although most GABAA receptors are expressed postsynaptically, where they give rise to 
fast inhibitory postsynaptic currents (IPSCs), they can also be found presynaptically, 
where they serve to inhibit neurotransmitter release (Kullmann et al., 2005). 
In contrast, GABAB receptors are metabotropic G-protein-coupled receptors 
(GPCRs) that exert slow inhibitory effects either by activating outwardly rectifying 
voltage-gated potassium channels (Wagner and Dekin, 1993) or by inhibiting voltage-
gated calcium channels (Mintz and Bean 1993).  These effects are blocked by pertussis 
toxin, indicating that receptor coupling to its effector channels is mediated by Giα- or Goα-
type G proteins (Bowery et al., 2002).  Like GABAA receptors, GABAB receptors are 
expressed both pre- and postsynaptically, where they decrease the likelihood of 
neurotransmitter release and neuronal firing, respectively.  However, unlike GABAA 
receptors, which are expressed at high levels throughout the brain, GABAB receptors 
have a more limited distribution.  They are most highly expressed in cerebral cortex, 
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thalamus, cerebellum, interpeduncular nucleus, and spinal cord (Wilkin et al., 1981; 
Bowery et al., 1987; Chu et al., 1990).  GABAB receptors are targeted by several 
clinically relevant compounds, including baclofen, an anti-spasticity agent (Bowery et al., 
1980), and γ-hydroxybutyrate (GHB), an endogenous metabolite of GABA and common 
drug of abuse (Schweitzer et al., 2004). 
A third type of GABA receptor, termed the GABAC receptor, has been identified 
in the retina and brainstem (Enz and Cutting, 1998; Bormann, 2000; Milligan et al., 
2004).  However, its classification as a separate entity from the GABAA receptor remains 
a matter of debate (Barnard et al., 1998; Zhang et al., 2001).  Although GABAA and 
GABAC receptors have slightly different functional and pharmacological properties, they 
are both nevertheless ligand-gated chloride channels assembled from the same family of 
homologous subunits (Collingridge et al., 2008).  Indeed, it should be emphasized that if 
differences in receptor function and pharmacology were sufficient for independent 
classification, then the GABAA receptor family would need to be further subdivided into 
perhaps as many as 30 different receptor classes (see below).  Moreover, although 
GABAC receptors were originally thought to assemble from a different subunit subtype 
than GABAA receptors, recent studies have found that hybrid GABAA/C receptors can 
form and that they have unique biophysical and pharmacological properties (Qian and 
Ripps, 1999; Pan et al., 2001; Ekema et al., 2002; Milligan et al., 2004; Qian and Pan, 
2002; Pan and Qian, 2004). 
Classification issues aside, it is generally agreed that GABAA receptors mediate 
the majority of GABAergic signaling and are thus most important for maintaining 
inhibitory tone in the mammalian brain.  Pharmacological blockade of GABAA receptors 
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rapidly induces seizures in animals (Kapur et al., 1997; Poulter et al., 1999) and 
epileptiform activity in neuronal slice preparations (De Deyn, et al., 1990; Schneiderman, 
1997).  Conversely, enhancement of GABAA receptor function leads to sedation and, 
ultimately, coma.  Targeting GABAA receptors has thus been an effective approach for 
treating neuropsychiatric disorders characterized by neuronal hyperexcitability (e.g., 
epilepsy, anxiety, and insomnia).  The properties of GABAA receptors will therefore be 
the focus of this dissertation. 
 
Molecular biology of GABAA receptors 
 
Like other members of the Cys-loop superfamily of LGICs, which includes the 
nicotinic acetylcholine receptor (nAChR; Noda et al., 1983), the 5-hydroxytryptamine 
type 3 serotonin receptor (5-HT3R; Maricq et al., 1991), the zinc-activated channel (ZAC; 
Davies et al., 2003), and the glycine receptor (GlyR; Langosch et al., 1988), GABAA 
receptors are assembled as heteropentamers from a large family of homologous subunits 
(Schofield et al., 1987; Mamalaki et al., 1989; Nayeem et al., 1994; Knight et al., 1998; 
Barrera et al., 2008).  Molecular cloning studies have identified eight subunit families (α, 
β, γ, δ, ε, θ, π, and ρ), thus providing enormous potential for receptor heterogeneity.  
Some of these subunit families are comprised of multiple subtypes (α1-6, β1-3, γ1-3, ρ1-
3), splice variants (e.g., β2S and β2L; β3-v1 and β3-v2; 2S and 2L), and alternatively 
edited transcripts (e.g., α3I and α3M), further increasing the potential for heterogeneity 
(Schofield et al., 1987; Levitan et al., 1988; Pritchett et al., 1989; Shivers et al., 1989; 
Ymer et al., 1989a; Ymer et al., 1989b; Whiting et al., 1990; Herb et al., 1992; Kirkness 
and Fraser, 1993; Davies et al., 1997; Hedblom and Kirkness, 1997; Bonnert et al., 1999; 
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Simon et al., 2004; Ohlson et al., 2007).  Sequence homology is ~60–80 % among 
members of the same GABAA receptor family, ~20-40 % among members of different 
families, and ~10-20 % among members of the GABAA receptor and other Cys-loop 
receptor families (Olsen and Tobin, 1990). 
Most genes encoding human GABAA receptor subunits are found in tight clusters 
comprising 1 or 2 α subunits, 1 β subunit, and 1 γ subunit gene (in the order β-α-[α]-γ).  
Chromosome 4 contains α2, α4, β1, and γ1 subunit genes; chromosome 5 contains α1, α6, 
β2, and γ2 subunit genes; and chromosome 15 contains α5, β3, and γ3 subunit genes 
(Buckle et al., 1989; Wilcox et al., 1992; Russek and Farb, 1994; Hicks et al., 1994; 
McLean et al., 1995; Glatt et al., 1997; Simon et al., 2004).  The gene encoding the α3 
subunit is found on the X chromosome near the genes encoding θ and ε subunits (Bell et 
al., 1989; Wilke et al., 1997), which are most homologous to β and γ subunits, 
respectively (Wilke et al., 1997; Bonnert et al., 1999).  Thus, it is believed that the 
incredible diversity of GABAA receptor subunits arose following duplication of a 
progenitor α-β-γ cluster (Hicks et al., 1994; Russek and Farb, 1994; Greger et al., 1995; 
McLean et al., 1995; Wilke et al., 1997; Darlison et al., 2005).  The exceptions are the 
relatively isolated genes encoding the δ (chromosome 1; Sommer et al., 1990), π 
(chromosome 5; Bailey et al., 1999a), and ρ (chromosomes 3 and 6; Cutting et al., 1992; 
Bailey et al., 1999b; Simon et al., 2004) subunits, which given their lower degree of 
homology to other subunit subtypes, likely resulted from earlier gene duplication and 
transposition (Simon et al., 2004). 
Although the functional significance of gene clustering remains uncertain, it may 
be important for coordinating transcription, and consequently, for limiting receptor 
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heterogeneity (Russek and Farb, 1994; McLean et al., 1995; Wilke et al., 1997; Darlison 
et al., 2005).  Indeed, it is remarkable that the most abundant GABAA receptor isoforms 
in the cortex (α1β2γ2; McKernan and Whiting, 1996; Pirker et al., 2000) and cerebellum 
(α6β2γ2; McKernan and Whiting, 1996; Pirker et al., 2000) are composed of subunits 
encoded by genes clustered on chromosome 5, and similarly, that brain regions known to 
express the α3 subunit also express the ε and θ subunits, which form the X chromosome 
cluster (Fritschy et al., 1992; Moragues et al., 2000; Moragues et al., 2002).  Additional 
support for this hypothesis comes from the observation that genomic disruption of α6 
subunit expression leads to decreased transcript levels for co-clustered subunits (Uusi-
Oukari et al., 2000).  There are, however, many examples of receptor isoforms (see 
below) comprised of subunits encoded by non-clustered genes (McKernan and Whiting, 
1996), reflecting the fact that individual neurons can simultaneously express as many as 
10 different subunit subtypes (Brooks-Kayal et al., 2001). 
 
Assembly of GABAA receptors 
 
GABAA receptors, like other Cys-loop receptors, are assembled in a complex, 
multi-step process that occurs in the endoplasmic reticulum (ER).  Assembly is thought to 
be slow and relatively inefficient (Green and Millar, 1995), relying heavily on luminal 
and cytoplasmic molecular chaperones (Bollan et al., 2003; Wanamaker and Green, 2007; 
Sarto-Jackson and Sieghart, 2008).  Luminal chaperones include calnexin, which 
recognizes immature glycans (Helenius and Aebi, 2004); immunoglobulin heavy-chain-
binding protein (BiP), which recognizes exposed hydrophobic residues (Gething, 1999); 
and protein disulfide isomerase, which catalyzes the formation of appropriate disulfide 
9 
 
bonds (Maattanen et al., 2006).  Working together, these proteins facilitate the folding 
and oligomerization of GABAA receptor subunits and provide a stringent quality control 
system (Ellgaard and Frickel, 2003; Bollan et al., 2003).  Although less is known about 
the role of cytoplasmic chaperones in GABAA receptor assembly, their involvement has 
been inferred based on the known interaction between α4β2 nAChRs and 14-3-3η 
(Jeanclos et al., 2001; Exley et al., 2006), a member of a large family of cytoplasmic 
regulatory, scaffolding, and adaptor proteins (Wang and Shakes, 1996). 
In addition to these cellular requirements, there are also specific subunit 
requirements for GABAA receptor assembly that serve to limit receptor heterogeneity 
(Angelotti et al., 1993).  Although most subunit combinations appear capable of 
oligomerization (Connolly et al., 1996), sucrose density centrifugation studies indicate 
that only a small subset can form pentamers, a prerequisite for receptor function and 
surface expression (lower molecular weight oligomers are retained in the ER and 
degraded) (Gorrie et al., 1997; Connolly et al., 1996; Connolly et al., 1999; Taylor et al., 
2000; Klausberger et al., 2001; Bollan et al., 2003; Lo et al., 2008; Sarto-Jackson and 
Sieghart, 2008).  For example, when recombinant α1, β2, or 2 subunits were expressed 
individually in heterologous cells, primarily monomers and dimers were formed (Gorrie 
et al., 1997; Connolly et al., 1999; Taylor et al., 1999; Lo et al., 2008; Sarto-Jackson and 
Sieghart, 2008).  Similarly, co-expression of either α1 or β3 subunits with 2 subunits 
yielded primarily dimers and trimers (Tretter et al., 1997; Sarto-Jackson and Sieghart, 
2008).  In contrast, co-expression of α1 and β2/3 subunits formed pentamers, as did co-
expression of α1, β2/3, and 2 subunits (Gorrie et al., 1997; Tretter et al., 1997; Connolly 
et al., 1999; Taylor et al., 2000; Klausberger et al., 2001; Lo et al., 2008; Sarto-Jackson 
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and Sieghart, 2008).  Thus, the presence of both α and β subunits is required for 
pentameric assembly (Angelotti et al., 1993).  Known exceptions are the β3 and ρ1 
subunits, which efficiently form homopentameric receptors when expressed individually 
(Taylor et al., 1999; Pan et al., 2006). 
Interestingly, ternary receptors appear to assemble with higher efficiency than 
binary receptors, suggesting the existence of an assembly hierarchy within the subunit 
family that further limits receptor heterogeneity.  For example, co-expression of α and β 
subunits with either , δ, ε, or π subunits yields a relatively homogeneous receptor 
population with kinetic properties distinct from receptors formed following co-expression 
of only α and β subunits (Angelotti and Macdonald, 1993; Saxena and Macdonald, 1994; 
Fisher and Macdonald, 1997; Haas and Macdonald, 1999; Neelands et al., 1999; 
Neelands and Macdonald, 1999; Lagrange et al., 2007).  Similarly, despite the functional 
and pharmacological signature of αβ receptors having been identified in a subset of 
hippocampal neurons (Mortensen and Smart, 2006), the overwhelming majority of native 
receptors are thought to be composed of ternary subunit combinations (McKernan and 
Whiting, 1996; Olsen and Sieghart, 2008).  The most widely expressed are  and  
receptors, though ε, θ, and π receptors may be important in certain brain regions 
(see below).  The 122 isoform is the most abundant, accounting for ~40% of all 
GABAA receptors (McKernan and Whiting, 1996; Olsen and Sieghart, 2008). 
For β receptors, a subunit stoichiometry of 2:2β:1 (Chang et al., 1996; 
Tretter et al., 1997; Farrar et al., 1999) and a subunit arrangement of -β--β- 
(counterclockwise when viewed top-down from the synaptic cleft; Baumann et al., 2001; 
Baumann et al., 2002; Baur et al., 2006) was proposed.  Atomic force microscopy studies 
11 
 
suggested a similar stoichiometry and arrangement for β receptors, with the  subunit 
taking the place of the  subunit in the pentamer (i.e., δ-β--β-; Barrera et al., 2008).  It 
should be noted, however, that there is evidence for alternate patterns of assembly.  For 
example, multiple  subunit subtypes have been identified in a subset of native (Quirk et 
al., 1994; Khan et al., 1994; Benke et al., 1996) and recombinant (Backus et al., 1993) 
receptors.  Although it is unclear if multiple  subunits can also be incorporated in the 
same pentamer, recent evidence using concatenated subunits suggests that at least two 
additional arrangements are possible: δ--β-β- (GABA-gated) and δ--β--β (THDOC-
gated) (Kaur et al., 2009).  The  subunit, which is highly homologous to the γ subunit 
(Wilke et al., 1997), appears particularly promiscuous (at least when expressed in 
heterologous systems), as it can form not only αβε receptors with multiple 
stoichiometries (2:2β:1ε and 2:1β:2ε), but can also co-assemble with α, β, and γ 
subunits to form αβγε receptors (Neelands et al., 1999; Davies et al., 2001; Wagner et al., 
2005; Jones and Henderson, 2007; Bollan et al., 2008).  The θ and π subunits, which are 
most homologous to β and δ subunits, respectively (Simon et al., 2004), exhibit similar 
promiscuity (again, when expressed in heterologous systems), having been shown to 
assemble as both ternary (αβθ and αβπ) and quaternary (αβγθ and αβγπ) receptors 
(Bonnert et al., 1999; Neelands and Macdonald, 1999). 
 
Spatial and temporal regulation of GABAA receptor expression 
 
Expression of GABAA receptors is tightly regulated both spatially and temporally, 
with individual subunits having distinct, but often overlapping, distributions.  Based on in 
situ hybridization (Zhang et al., 1991; Laurie et al., 1992a, 1992b; Wisden et al., 1992) 
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and immunohistochemical (Fritschy et al., 1994; Fritschy and Mohler, 1995; Pirker et al., 
2000) studies, α1 subunits appear to be widely expressed in the adult, but not the 
developing, brain.  In contrast, α2 subunits are widely expressed during development 
(though not in cerebellum) but are limited to cortex, hippocampus, basal ganglia, 
amygdala, certain thalamic nuclei, and hypothalamus in the adult.  α3 subunits have a 
similar spatiotemporal pattern, with high expression in most brain areas during 
development but limited expression in the adult, when it is found mainly in cortex and 
certain thalamic nuclei (most notably in the nucleus reticularis).  Of note, α2 and α3 
subunits are the predominant α subtypes in brainstem and spinal cord.  α4 subunits have 
little expression during development; in the adult, their highest levels are found in cortex, 
hippocampus, and thalamus.  α5 and α6 subunits have the most restricted distributions of 
all α subtypes, being localized mainly to hippocampus and cerebellum, respectively.  α5 
subunits, however, are expressed highly during development (except in cerebellum, 
where α3 subunits predominate).  Among β subunits, β2 subunits are most widely 
expressed in the adult, except in hippocampus, where β1 and β3 subunits predominate 
(particularly in the dentate gyrus).  Conversely, β3 subunits are most widely expressed 
during development, though β2 subunits are also expressed in cortex.  γ2 subunits are the 
most widely expressed of the γ subunits, both in developing and adult brain.  γ1 subunits 
are expressed in basal ganglia, forebrain, amygdala, and cerebellum, whereas γ3 subunits 
are expressed in cortex, basal ganglia, and certain thalamic nuclei (Herb et al., 1992).  δ 
subunits are virtually absent during early development, but in the adult, are found in 
cortex, hippocampus, basal ganglia, thalamus, and cerebellum.  Expression of ε subunits 
was initially undetectable in whole brain mRNA (Wilke et al., 1997), but upon closer 
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evaluation, was identified in amygdala, thalamus, and the subthalamic nucleus (Davies et 
al., 1997).  θ subunits are found at low levels in cortex, intermediate levels in 
hypothalamus, and high levels in amygdala, hippocampus, and brainstem (Bonnert et al., 
1999).  Although π subunits are found mainly in peripheral tissues, low levels have been 
identified in hippocampus and temporal cortex (Hedblom and Kirkness, 1997).  ρ 
subunits are expressed in retina on bipolar cells (Enz et al., 1996), cerebellum during 
development, and adult brainstem and spinal cord (Boue-Grabot et al., 1998; López-
Chavez et al., 2005; Mejía et al., 2008). 
Using information provided by mRNA co-localization studies, testable 
hypotheses were generated regarding possible subunit combinations that might exist in 
vivo (as opposed to what subunits could theoretically assemble in vitro).  For example, 
transcripts encoding α1, β2, and γ2 subunits were co-expressed throughout the brain, 
while transcripts encoding α4, β2, and δ subunits were co-expressed in thalamus and 
hippocampus, suggesting they had a high probability of co-assembly in those areas.  
However, many brain regions were found to simultaneously express a variety of subunit 
subtypes (dentate gyrus, for example, expresses α1-5, β1-3, γ1-3, and δ subunits; Wisden 
et al., 1992), making the potential for receptor heterogeneity tremendous.  As a result, 
early estimates put the total number of different isoforms in the adult brain at nearly 800 
(Barnard et al., 1998)!  To address this issue more directly, immunoprecipitation and 
immunoaffinity chromatography studies were performed using subunit-specific 
antibodies (Quirk et al., 1995; Jechlinger et al., 1998; Sur et al., 1999; Sieghart and 
Sperk, 2002).  These studies, combined with detailed electrophysiological and 
pharmacological profiling of native receptors demonstrated that receptor heterogeneity in 
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vivo is surprisingly limited (Sieghart and Sperk, 2002; Olsen and Sieghart, 2008).  In 
total, only 11 receptor isoforms (α1β2γ2, α2β2γ2, α3β2γ2, α4β2γ2, α4β2δ, α4β3δ, 
α5βxγ2, α6βxγ2, α6β2δ, α6β3δ, and ρx) were identified “unequivocally” (Olsen and 
Sieghart, 2008).  An additional 8 isoforms (α1β3γ2, α1βxδ, α5β3γ2, αxβ1γ, αxβ1δ, αxβx, 
α1α6βxγ, and α1α6βxδx) were thought to exist with “high probability”, and the existence 
of an additional 9 isoforms (αxβxγ1, αxβxγ3, αxβxε, αxβxθ,  αxβxπ, αxαyβxγ2, ρ1, ρ2, 
and ρ3) were considered “tentative” (Olsen and Sieghart, 2008).  Note that some of the 
listed isoforms contain multiple α subunit subtypes, which confer unique functional and 
pharmacological properties upon receptors (Duggan et al., 1991; Lüddens and Wisden, 
1991; Lüddens et al., 1991).  The same is thought to be true for β subunit subtypes, but 
evidence for this is more equivocal (Li and De Blas, 1997; Olsen and Sieghart, 2008). 
Of these isoforms, α1βxγ2, α1βxδ, α2βxγ2, α3βxγ2, and α4βxδ isoforms are the 
predominant cortical receptors; α1βxγ2, α4βxγ2, and α4βxδ isoforms are the predominant 
thalamic receptors (α3βxγ2 is also important in the nucleus reticularis); α1βxγ2, α2βxγ2, 
and α5βxγ2 isoforms are the predominant hypothalamic receptors; α1βxγ2, α1βxδ, 
α2βxγ2, α4βxδ, and α5β3γ2 isoforms are the predominant hippocampal receptors; and 
α1βxγ2, α1βxδ, α1α6βxγ2, α1α6βxδ, α6βxγ2, and α6βxδ isoforms are the predominant 
cerebellar receptors (Wisden et al., 1992; McKernan and Whiting, 1996; Pirker et al., 
2000; Brickley et al., 2001; Caraiscos et al., 2004; Farrant and Nusser, 2005; Glykys and 
Mody, 2007).  Interestingly, subunit composition is an important determinant of receptor 
subcellular localization.  For example, receptors containing γ subunits are typically found 
in synapses, while those containing δ subunits are typically found in peri- and/or 
extrasynaptic compartments (Nusser et al., 1998; Brickley et al., 2001; Farrant and 
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Nusser, 2005).  The known exceptions are α4 and α5 subunit-containing αβγ receptors, 
which are thought to be primarily peri- and extrasynaptic (Caraiscos et al., 2004; Glykys 
and Mody, 2007).  Similarly, receptors assembled without γ and δ subunits (i.e., αβ 
receptors) are localized extrasynaptically (Mortensen and Smart, 2006).  Interestingly, β 
subunit subtype was recently shown to be an important determinant of subcellular 
localization in dentate gyrus (Herd et al., 2008). 
 
Structure of GABAA receptors 
 
Although a crystal structure of the GABAA receptor is unavailable, several 
experimental approaches have provided important insight into its tertiary and quaternary 
structure.  These include imaging by electron and atomic force microscopy (Nayeem et 
al., 1994; Barrera et al., 2008), scanning for accessibility of substituted cysteine residues 
(Akabas, 2004), and homology modeling based on high resolution structures of the 
Torpedo marmorata nAChR (Unwin, 1993; Miyazawa et al., 2003; Unwin, 2005) and its 
soluble molluscan cousin, the acetylcholine binding protein (AChBP; Brejc et al., 2001) 
(Cromer et al., 2002; Ernst et al., 2003; Trudell and Bertaccini, 2004; O’Mara et al., 
2005; Campagna-Slater and Weaver, 2007).  The recent crystallization of the nAChR 
extracellular domain (Dellisanti et al., 2007) and a prokaryotic Cys-loop receptor (Hilf 
and Dutzler, 2008) has also provided important validation for the predicted GABAA 
receptor structure. 
Hydropathy analysis suggests that individual GABAA receptor subunits are 
composed of a large (~200 amino acids) extracellular N-terminal domain, followed by 
four α-helical transmembrane domains (M1, M2, M3, and M4) that are connected by 
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cytoplasmic (M1-M2 and M3-M4) and extracellular (M2-M3) linkers (Olsen and Tobin, 
1990; Macdonald and Olsen, 1994; Smith and Olsen, 1995).  When viewed from the 
synaptic cleft (i.e., perpendicular to the plasma membrane), assembled GABAA receptors 
have a circular structure (~80 Å in diameter), with individual subunits arranged pseudo-
symmetrically around a central ion-conducting pore (~20 Å in diameter).  When viewed 
from their side (i.e., parallel to the plasma membrane), GABAA receptors are inverted 
wedge-shaped structures (~160 Å in length).  The ion pore runs the length of the receptor 
and is divided into four sections.  Most extracellular is a large funnel shaped vestibule 
(~50 Å in length).  Just exterior to the plasma membrane, the vestibule connects to a 
smaller oval chamber (~20 Å in length), which is connected in turn to a long 
transmembrane channel (~50 Å in length).  The latter contains the narrowest point of the 
pore (~4 Å in the closed conformation and ~6 Å in the open conformation; Bormann et 
al., 1987; Fatima-Shad and Barry, 1993; O’Mara et al., 2005) and determines ion 
selectivity (Cl
- Br- SCN- F-; Bormann et al., 1987).  There may also be an additional 
vestibule located in the intracellular domain that contains lateral windows for ion 
movement (Unwin, 2005; Hales et al., 2006). 
The extracellular domain is composed of two sets of β-sheets joined by a highly 
conserved disulphide bridge (the Cys-loop), for which the receptor superfamily is named 
(Unwin, 2005).  These β-sheets contain seven major “loops” that are important for 
agonist binding, three on each side of the extracellular domain.  The “principal” side of 
the extracellular domain (also referred to as the “+” side) is composed of the A, B, and C 
loops, whereas the “complementary” side (the “-“ side) is composed of the D, E, F, and G 
loops (Ernst et al., 2003).  GABA binding occurs at the interface between the principal 
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side of the β subunit and the complementary side of the α subunit.  In contrast, BDZs 
bind at the interface between the principal side of the α subunit and the complementary 
side of the γ subunit (assuming the γ-β-α-β-α arrangement is correct, this predicts that 
each αβγ receptor has two GABA binding sites and one BDZ binding site).  Interestingly, 
the BDZ and GABA binding sites are highly homologous, suggesting that the BDZ 
binding site evolved from a former GABA binding site (Galzi and Changeux, 1994).  An 
endogenous ligand for the BDZ binding site, however, has yet to be identified.  Of note, 
in addition to containing binding sites for a variety of agonists, antagonists, and allosteric 
modulators (Macdonald and Olsen, 1994; Olsen et al., 2004), the extracellular subunit 
domain is the primary determinant of receptor assembly (Hackam et al., 1997; Hackam et 
al., 1998; Enz and Cutting, 1999; Taylor et al., 1999; Klausberger et al., 2000; Taylor et 
al., 2000). 
The M1 domain contains residues important for determining receptor kinetic 
properties and sensitivity to allosteric modulators such as BDZs and neurosteroids 
(Bianchi et al., 2001; Bianchi and Macdonald, 2002; Engblom et al., 2002; Jones-Davis et 
al., 2005; Keramidas et al., 2006; Akk et al., 2008).  The M2 domain lines the 
transmembrane portion of the pore, determines ion selectivity and channel conductance, 
and contains the channel gate (Giraudat et al., 1986; Imoto et al., 1986, 1988; Akabas
 
et 
al., 1994; Xu and Akabas, 1996; Serafini et al., 2000; Wilkins et al., 2002; Keramidas et 
al., 2004; Gonzales, et al., 2008).  A leucine residue at the 9’ position is highly conserved 
among members of the Cys-loop family and has therefore been the focus of active 
investigation.  This residue is thought to line the narrowest part of the pore, and 
consequently, mutation of this residue has profound effects on channel function (Chang 
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and Weiss, 1998; Bianchi and Macdonald, 2001; Scheller and Forman, 2002; Bianchi et 
al., 2007).  The M3 and M4 domains are packed somewhat loosely with respect to the M1 
and M2 domains, creating cavities where allosteric modulators such volatile and 
intravenous anesthetics bind (Schofield and Harrison, 2005; Richardson et al., 2007).  
The lipid-facing M4 domain is farthest from the channel pore and is thought mainly to 
provide subunit stability in the plasma membrane.  In nAChRs, for example, the M4 
domain can be replaced by an unrelated transmembrane domain without abolishing 
channel function, whereas replacement of any other transmembrane domain renders 
channels non-functional (Tobimatsu et al., 1987). 
The amino acid linkers connecting the transmembrane domains are also important 
determinants of receptor function.  The intracellular M1-M2 linker extends the channel 
pore and contributes to charge selectivity (Jensen et al., 2002; Filippova et al., 2004; 
Wotring and Weiss, 2008).  The extracellular M2-M3 linker is responsible for 
transducing ligand binding in the N-terminal domain to channel gating in the 
transmembrane domain.  Based on charge swapping mutations, this appears to involve a 
salt bridge between loop 2 (and possibly, loop 7) in the N-terminal domain and a highly 
conserved lysine residue in the M2-M3 linker (Kash et al., 2003).  Of note, mutation of 
this conserved residue in the γ2 subunit of the GABAA receptor (K289M) has been 
associated with generalized epilepsy with febrile seizures plus (Baulac et al., 2001), and 
mutations of the same residue in the α1 subunit of the GlyR (K276E and K276Q) have 
been associated with hyperekplexia (Langosch et al., 1994; Harvey et al., 2008).  In each 
case, mutation of the conserved lysine substantially inhibited channel function (Bianchi 
& Macdonald, 2002), consistent with a role for this domain in transducing binding to 
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gating.  Interestingly, the mechanisms underlying the coupling of binding and gating 
appear to be highly conserved within the Cys-loop superfamily.  Functional chimeras 
have been generated between nAChR subunit extracellular domains and 5-HT3R subunit 
transmembrane domains and, similarly, between GABAA receptors and GlyRs (Eisele et 
al., 1993; Mihic et al., 1997).  These chimeric receptors are gated by ligands specific for 
the extracellular domain, but have functional properties that depend on the identity of the 
transmembrane domain.  The large intracellular M3-M4 linker (~100-200 amino acids) is 
also thought to play a role in channel function, having recently been shown in 5-HT3Rs 
and nAChRs to contain a motif (the “MA” stretch) that is an important determinant of 
single-channel conductance (Kelley et al., 2003; Peters et al., 2005; Hales et al., 2006). 
The M3-M4 linker, however, has a variety of other functions.  Indeed, this 
domain serves as the primary interface between the GABAA receptor and the intracellular 
milieu.  It contains phosphorylation sites for PKA, PKC, and PTK (Brandon et al., 2002; 
Kittler and Moss, 2003; Jacob et al., 2008), and protein binding domains that are 
important for receptor clustering, sorting, targeting, and trafficking (Kittler and Moss, 
2003; Chen and Olsen, 2007; Jacob et al., 2008).  Known interacting proteins include 
AP2, which promotes endocytosis by recruiting receptors into clathrin-coated pits (Kittler 
et al., 2005; Smith, et al., 2008); GRIF1, which regulates kinesin-mediated vesicular 
transport (Beck et al., 2002; Brickley et al., 2005); gephyrin, which clusters and stabilizes 
receptors in synapses (Essrich et al., 1998; Kneussel et al., 2000; Tretter et al., 2008); 
BIG2, which facilitates vesicular transport (Charych et al., 2004); GABARAP, which 
promotes receptor trafficking from the Golgi to the cell surface (Wang et al., 1999; Chen 
et al., 2000); PRIPs, which modulate phosphatase activity (Kanematsu et al., 2002, 2007); 
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and PLIC1, which stabilizes receptors on the cell surface by preventing ubiquitination-
mediated degradation (Bedford et al., 2001).  The M3-M4 linker is also thought to 
mediate the direct interaction between GABAA receptors and other neurotransmitter 
receptors such as the GABAB, D5, and P2X receptors (Liu et al., 2000; Balasubramanian 
et al., 2004; Boué-Grabot et al., 2004).  In addition, recent evidence suggests that motifs 
in the M3-M4 linker are required for complete pentameric assembly (Lo et al., 2008). 
 
Biophysical and kinetic properties of GABAA receptor channels 
 
GABAA receptor channels are relatively impermeant to cations (permeability ratio 
of K+ to Cl- < 0.05) but highly permeable to anions such as Cl
-
 and HCO3
-
 (Bormann et 
al., 1987).  The channel is considerably more permeable to Cl
-
 than to HCO3
-
 (Cl
-
:HCO3
-
 
permeability is ~5:1), and consequently, the majority of charge transfer that follows 
channel activation in vivo is Cl
-
 mediated.  However, HCO3
- 
may play an important role 
when the Cl
-
 gradient is collapsed (Grover et al., 1993; Perkins and Wong, 1997; Dallwig 
et al., 1999; Kim et al., 2009), as may be the case in immature neurons and in a subset of 
mature neurons.  Interestingly, GABA-mediated HCO3
-
 efflux has been shown to trigger 
Ca
2+
 influx (Kulik et al., 2000; Chavas et al., 2004), which may underlie the ability of 
GABA to serve as a trophic
 
signal in maturing networks (Ben-Ari, 2002; Owens and 
Kriegstein, 2002). 
The canonical α1βxγ2 GABAA receptor opens to a main conductance level of 26-
30 pS and to several less frequent sub-conductance levels (Macdonald et al., 1989; 
Twyman et al., 1990; Newland et al., 1991; Fisher and Macdonald, 1997; Haas and 
Macdonald, 1999; Burkat et al., 2001).  The channel is almost exclusively chloride 
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selective with a permeability ratio of potassium to chloride ions less than 0.05 (Bormann 
et al., 1987).  To fully activate the receptor, binding of two molecules of GABA (to 
independent sites) is required.  Once bound with GABA, the channel exhibits complex 
patterns of activity.  Detailed kinetic analysis of native (Macdonald et al., 1989; Twyman 
et al., 1990; Newland et al., 1991) and recombinant (Fisher & Macdonald, 1997; Haas & 
Macdonald, 1999; Burkat et al., 2001) receptors demonstrated the existence of three open 
states and at least five closed states (based on exponential fitting of open and closed time 
distributions).  When activated by a saturating concentration of GABA (1 mM), open 
times of 0.3, 2.0, and 3.5 ms (referred to as O1, O2, and O3) were observed with relative 
amplitudes of 24, 48, and 28 %, respectively, the overall mean open time being 2.1 ms 
(Haas and Macdonald, 1999).  The overall mean closed time was 21.0 ms (with 
individual components ranging from 0.2 to 990 ms in duration), thus yielding an open 
probability of ~0.1 when activated by 1 mM GABA (note that this may be an 
overestimation, as recordings are rarely obtained from patches containing a “single” 
channel). 
Channel openings tended to occur in bursts (a series of openings separated by 
brief closures), of which there were at least three types, each containing a single type of 
opening (i.e., either O1 or O2 or O3).  This indicated that receptors could not transition 
directly from one open state to another.  Interestingly, activating receptors with 
progressively lower GABA concentrations increased the relative contribution of O1 
openings at the expense of both O2 and O3 openings, without altering individual open 
times (though the overall mean open time was decreased since the lifetime of O1 is 
short).  Considering that receptors have negligible spontaneous activity, these data have 
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been interpreted to mean that O1 and O2/O3 represent receptor sojourns in mono- and di-
liganded open states, respectively (Twyman et al., 1990).  What remains unclear, 
however, is why O1 openings were detectable at all in the context of a saturating GABA 
concentration, as this should have effectively driven receptor occupancy in mono-
liganded states near zero.  One possibility is that two O1 states exist with similar mean 
open times, one mono-liganded and the other di-liganded.  In other words, there may 
actually be four open states, two of which are simply indistinguishable with classical 
exponential fitting of open time distributions (Lagrange et al., 2007). 
Given the complex channel activity observed at the microscopic level, it is not 
surprising that GABAA receptor macroscopic current properties (i.e., the ensemble 
response of hundreds or thousands of channels) are also quite complex (Haas and 
Macdonald, 1999; Bianchi and Macdonald, 2001; Mozrzymas et al., 2003; Lagrange et 
al., 2007).  Rapid application of a saturating GABA concentration to excised outside-out 
patches from hippocampal neurons or HEK293T cells transiently expressing α1βxγ2 
receptors gives rise to large amplitude currents that activate in the sub-millisecond time 
domain.  In the context of prolonged agonist exposure, these currents undergo extensive 
multi-phasic desensitization, typically with three to four time constants ranging from <10 
ms to >1000 ms (Celentano and Wong, 1994; Haas and Macdonald, 1999; Bianchi and 
Macdonald, 2002;  Lagrange et al., 2007).  This phenomenon (also referred to as current 
“sag”) is not caused by receptor internalization or loss of the chloride gradient, but rather, 
is an intrinsic property of the channel, reflecting the progressive accumulation of 
receptors in long-lived non-conducting (desensitized) states (Celentano and Wong, 1994; 
Bianchi and Macdonald, 2002).  Interestingly, desensitization has a steep concentration-
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dependence (Haas and Macdonald, 1999; Bianchi et al., 2007).  Although this has been 
suggested to reflect a concentration-dependent entry rate into the microscopic 
desensitized state, multiple modeling studies have demonstrated that this gating structure 
is not actually required (Haas and Macdonald, 1999; Bianchi et al., 2007).  Instead, the 
loss of desensitization associated with application of low concentrations of GABA is 
most likely caused by failure to synchronously activate receptors, which masks the 
otherwise concentration-independent process (much like slow application of agonist; 
Jones and Westbrook, 1995; Bianchi and Macdonald, 2002).  Evidence for this comes 
from detailed kinetic analysis of macroscopic desensitization, which shows that while the 
relative contribution of each desensitization time constant changes with GABA 
concentration, the actual time constants do not (Haas and Macdonald, 1999). 
Following GABA washout, currents typically deactivate bi-phasically (Jones and 
Westbrook, 1995; Haas and Macdonald, 1999), though multi-phasic deactivation has 
been described (Lagrange et al., 2007).  The time course of deactivation depends strongly 
on the duration of GABA exposure prior to washout, with longer applications being 
associated with slower deactivation (Jones and Westbrook, 1995; Haas and Macdonald, 
1999; Bianchi et al., 2007; Botzolakis et al., 2008).  This reflects the inability of GABA 
to unbind from receptors in desensitized states (note that GABA is also “trapped” on 
receptors in open and pre-open states; Bianchi et al., 2002), which represent an increasing 
fraction of receptors with longer GABA applications (Bianchi et al., 2007).  Although 
desensitized states are functionally identical to other closed states, their long lifetimes 
provide channels with the opportunity to re-open long after GABA washout, the 
macroscopic correlate of which is prolonged deactivation (Jones and Westbrook, 1995, 
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1996).  As a result, the phenomena of desensitization and deactivation are commonly 
referred to as being “coupled” (Jones and Westbrook, 1995; Bianchi et al., 2001). 
Both the macroscopic and microscopic kinetic properties of GABAA receptors are 
highly influenced by subunit composition, thus providing a mechanism for neurons to 
fine tune their sensitivity to GABA (Angelotti and Macdonald, 1993; Saxena and 
Macdonald, 1994; Burgard et al., 1996; Fisher and Macdonald, 1997a, 1997b; Fisher et 
al., 1997; Neelands et al., 1999; Neelands and Macdonald, 1999; Haas and Macdonald, 
1999; Bianchi et al., 2002; Feng and Macdonald, 1994; Feng et al., 2004; Barberis et al., 
2007; Bianchi et al., 2007; Lagrange et al., 2007; Picton and Fisher, 2007; Rula et al., 
2008).  For example, in contrast to αβγ receptors, αβδ receptors have only two open 
states, both of which are relatively short-lived (0.3 and 1.0 ms).  The shorter of these 
accounts for 80% of all openings, yielding an overall mean open time of only 0.4 ms 
(Fisher and Macdonald, 1997; Haas and Macdonald, 1999).  In addition, αβδ receptors 
have a longer mean closed time (~36 ms), reflecting their increased likelihood of entering 
long-lived closed states.  This, combined with their decreased mean open time, makes 
their overall open probability when activated by 1 mM GABA much lower than that of 
αβγ receptors (~0.02 vs. ~0.1, respectively).  Consequently, macroscopic currents evoked 
from αβδ receptors have kinetic properties that are different from those evoked from αβγ 
receptors.  Indeed, αβδ receptor currents are typically small, slowly activating, minimally 
desensitizing, and rapidly deactivating (Saxena and Macdonald, 1996; Fisher and 
Macdonald, 1997; Haas and Macdonald, 1999; Bianchi and Macdonald, 2002).  
Interestingly, while comparing αβδ and αβγ macroscopic currents provides support for 
the idea that desensitization and deactivation are coupled phenomena, at the microscopic 
25 
 
level, αβδ receptors actually appear to have similar, if not increased, access to long-lived 
closed states (Fisher and Macdonald, 1997; Haas and Macdonald, 1999).  This suggests 
that macroscopic desensitization may not simply reflect receptor accumulation in any 
particular state or set of states, but rather, may depend on a more complex interplay 
between all rate constants in the gating scheme (Mozrzymas et al., 2003; Bianchi et al., 
2007).  Similarly, although deactivation may be influenced by receptor trapping in 
desensitized states, other rate constants (such as the unbinding rate) undoubtedly also 
contribute to its time course. 
A variety of mathematical approaches have been used to describe the behavior of 
ion channels; however, it is generally agreed that Markov models comprising multiple, 
reversibly connected states, each corresponding to a distinct receptor conformation (i.e., 
open or closed), provide the best fits of channel data (Korn and Horn, 1988; McManus et 
al., 1988; Sansom et al., 1989).  Although applying Markov models to ion channels 
involves several assumptions (primarily, that state transitions are probabilistic and 
independent of previous channel activity), thus far, they have proven extremely useful for 
describing the behavior not only of GABAA receptors (Twyman and Macdonald, 1989; 
Weiss and Magleby, 1989; Celentano and Wong, 1994; Jones and Westbrook, 1995; 
Haas and Macdonald, 1999; Lagrange et al., 2007), but also of numerous other ligand- 
and voltage-gated channels (Horn and Vandenberg, 1984; Zagotta et al.,
 
1994; Schoppa 
and Sigworth, 1998; Rothberg and Magleby, 2000; Sigg and Bezanilla,
 
2003; Burzomato 
et al., 2004; Chakrapani et al., 2004; Lape et al., 2008).  Indeed, Markov models have 
provided an important conceptual framework for interpreting the effects of disease-
causing mutations and a variety of modulators (Twyman and Macdonald, 1992; Twyman 
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et al., 1989a, 1989b, 1992; Bianchi and Macdonald, 2001; Feng et al., 2004; Mercik et 
al., 2006; Mozrzymas et al., 2007; Plested et al., 2007).  However, for models to have any 
practical utility, they must account for both microscopic and macroscopic channel 
behavior (that being said, simple models are often quite valuable for systematically 
exploring the relationship between microscopic rate constants and macroscopic 
phenomena, and for that purpose, will be relied upon as much as comprehensive models 
in this dissertation).  Considering that receptor responses under both microscopic and 
macroscopic conditions are critical, as neither can independently provide enough 
information for a unique reaction scheme to be generated with certainty.  Macroscopic 
currents, for example, constrain gating schemes by providing non-equilibrium kinetic 
data, which is typically unavailable from near-equilibrium single-channel studies.  Single 
channel data, in contrast, provides direct information regarding channel open and closed 
states, including the number of each, their connectivity, and in the case of the open states, 
their approximate lifetimes.  The first comprehensive model was developed by Haas and 
Macdonald (1999) and was based on an earlier model by Twyman et al. (1990) that 
described the behavior of single channels.  This model contained two GABA binding 
steps and a total of 16 states - 3 open and 13 closed.  Three of closed states were given 
the special designation of “desensitized” states, as they allowed for the macroscopic 
phenomenon of desensitization to occur.  Although this model has been updated recently 
to take into account several additional macroscopic and microscopic observations, its 
core gating structure has not changed in almost a decade (Lagrange et al., 2007). 
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Pharmacological properties of GABAA receptors 
 
GABAA receptors have a rich pharmacology (for a review, see Macdonald and 
Olsen, 1994, or Johnston, 1996).  In addition to GABA, a number of GABA analogues 
can directly activate the receptor, including the plant alkaloid muscimol and its 
conformationally restricted analogue tetrahydroisoxazolopyridinol (THIP).  Endogenous 
agonists include taurine and β-alanine, both of which are found at relatively high 
concentrations in the brain (Lerma et al., 1986).  Interestingly, although each of these 
agonists has a different microscopic affinity for GABA (muscimol > GABA > β-alanine 
 THIP), when used at EC-equivalent concentrations, all give rise to similar microscopic 
and macroscopic currents (Jones et al., 1998; Bianchi et al., 2007).  GABAA receptor 
currents can be competitively antagonized by the convulsant drug, bicuculline, and by the 
pyridazinyl derivative of GABA, gabazine (SR95531).  Of note, bicuculline can also 
block spontaneously active GABAA receptors (Bianchi and Macdonald, 2002), indicating 
it should also be classified as an inverse GABAA receptor agonist along with -carbolines 
such as DMCM.  Non-competitive antagonists include the convulsants picrotoxin, TBPS, 
pentylenetetrazole, and penicillin, the latter being a classic open channel blocker of 
GABAA receptors (Twyman et al., 1989; Feng et al., 2009).  The anticonvulsant 
barbiturates and BDZs allosterically enhance GABAA receptor currents, but through 
different binding sites and by different mechanisms (Twyman et al., 1989).  Barbiturates 
increase the fraction of long (O3) openings at the expense of short (O1 and O2) openings, 
thus increasing channel mean open time.  In contrast, BDZs increase the microscopic 
affinity of GABA for the receptor without altering channel mean open time, thus 
increasing channel opening frequency (at sub-saturating concentrations of GABA) 
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(Bianchi et al., 2009).  The BDZ binding site is targeted by several agents, including the 
inverse agonist -carbolines, the imidazolpyridines (zolpidem, alpidem), the BDZ inverse 
agonist Ro 15-4513, and the BDZ antagonist, flumazenil.  Other positive allosteric 
modulators include ethanol, neurosteroids (THDOC and allopregnanolone), and several 
volatile and intravenous anesthetics (halothane, diethylether, enflurane, isoflurane, 
alphaxalone, ketamine, and propofol).  Negative allosteric modulators include 
pregnenolone sulfate, zinc, and furosemide.  In addition, there are several classes of 
allosteric modulators with mixed effects (i.e., positive and negative modulation 
depending on GABA concentration and context of receptor activation).  These include 
the insecticides dieldrin and lindane, the anti-helminthic ivermectin, lanthanum, and pH. 
The pharmacological properties of GABAA receptors, much like their kinetic 
properties, are highly sensitive to subunit composition (for a review, see Hevers and 
Lüddens, 1998).  For example, BDZ modulation requires the presence of a γ subunit; 
however, only α(1, 2, 3, or 5) receptor isoforms are BDZ sensitive.  Conversely, α(1, 2, 
3, or 5) receptor isoforms are less sensitive to furosemide, while those containing α4 
and α6 subunits are highly sensitive.  Zolpidem has highest affinity for α1 subtype-
containing receptors, low affinity for α2 and α3 subtype-containing receptors, and almost 
no affinity for α5 subtype-containing receptors.  Receptors containing 2 or 3 subtypes 
are highly sensitive to loreclezole, whereas those containing the 1 subtype are relatively 
insensitive.  Inclusion of a γ subunit dramatically reduces receptor sensitivity to zinc and 
neurosteroids.  Receptor incorporation of  subunits increases receptor sensitivity to 
neurosteroids and ethanol.  In some cases, subunit composition determines the polarity of 
modulation (i.e., enhancement vs. inhibition).  For example, while Ro 15-4513 is an 
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inverse agonist at the BDZ binding site for α(1, 2, 3, or 5) receptor isoforms, it is an 
agonist of α4 and α6 subtype-containing receptors.  Similarly, while lanthanum enhances 
α1 receptor currents, it blocks α6 receptor currents. 
 
Modes of GABAergic inhibition 
 
GABAA receptors mediate two modes of inhibitory neurotransmission.  The first, 
termed “phasic” inhibition, involves the transient activation of postsynaptic GABAA 
receptors by nearly saturating concentrations of GABA released from presynaptic 
vesicles.  This process gives rise to inhibitory postsynaptic currents (IPSCs) that activate 
rapidly (rise times of ~1 ms or less) but decay slowly (time constants of 10s to 100s of 
ms) (Maconochie et al., 1994; Jones and Westbrook, 1995).  In the experimental setting, 
several types of IPSCs can be recorded, each having slightly different kinetic properties 
(Otis and Mody, 1992a, 1992b; Otis et al., 1994; Kirmse et al., 2006; Liang et al., 2006).  
These include “miniature” IPSCs (mIPSCs), “spontaneous” IPSCs (sIPSCs), and 
“evoked” IPSCs (eIPSCs).  mIPSCs are triggered by the spontaneous release of GABA 
from a single synaptic vesicle (i.e., action potential independent).  In contrast, sIPSCs are 
triggered by spontaneously occurring action potentials in presynaptic terminals and 
typically involve release of GABA from multiple synaptic vesicles.  eIPSCs are triggered 
following experimentally induced action potentials, and like sIPSCs, involve release of 
GABA from multiple synaptic vesicles.  The properties of IPSCs are highly variable, 
depending on brain region, developmental stage, and neuron type (Vicini et al., 2001; 
Mozrzymas, 2004).  While both pre- and postsynaptic factors influence IPSC shape, it is 
generally accepted that postsynaptic factors are the primary determinants.  Indeed, the 
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GABA transient is thought to reach nearly saturating concentrations in <100 s and 
decay in <1 ms due to a combination of diffusion and reuptake (Clements, 1996; 
Glavinovic, 1999; Ventriglia and Di, 2003).  Thus, IPSC duration significantly outlasts 
the presence of GABA in the synaptic cleft, suggesting that IPSCs are shaped primarily 
by the intrinsic properties of postsynaptic receptors.  In support of this hypothesis, 
application of ultra-brief pulses of nearly saturating GABA to membrane patches excised 
from mammalian cell lines expressing recombinant GABAA receptors gives rise to 
currents with kinetic properties that resemble IPSCs (Jones and Westbrook, 1995; Haas 
and Macdonald, 1999).  Currents evoked from receptors containing the  subunit are most 
similar to IPSCs, as they activate rapidly and deactivate slowly (Jones and Westbrook, 
1995; Haas and Macdonald, 1999; Lagrange et al., 2007).  This should not imply, 
however, that presynaptic factors cannot also influence IPSC shape.  Several studies 
suggest that the GABA transient may actually decay with a time constant as brief as 100 
s (Mozrzymas, 2004).  Kinetic modeling studies predict that such ultra-brief exposures 
prevent postsynaptic receptors from reaching maximal activation, thus leading to smaller 
amplitude and more rapidly deactivating IPSCs (Mozrzymas, 2004; Lagrange et al., 
2007).  In addition, while the concentration of GABA in synapses is generally thought to 
be nearly saturating (~1 mM) (Edwards et al., 1990; Otis and Mody, 1992; Jones and 
Westbrook, 1995; Strecker et al., 1999), the observation that diazepam can increase IPSC 
amplitudes in some brain regions suggests this may not always be the case (i.e., if GABA 
is truly saturating in the synapse, then increasing receptor affinity for GABA with a BDZ 
should not affect IPSC amplitude, as the postsynaptic receptors are already fully-
liganded) (Frerking et al., 1995; Defazio and Hablitz, 1998; Hill et al., 1998).  Activating 
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receptors with sub-saturating concentrations of GABA can significantly impact IPSC 
kinetics, as the time courses of GABAA receptor activation and deactivation are both 
highly sensitive to GABA concentration (slower and faster, respectively) (Bianchi et al., 
2007; Lagrange et al., 2007). 
In addition to mediating fast synaptic inhibition, there is now compelling evidence 
that GABAA receptors are also involved in slower forms of nonsynaptic inhibition, a 
phenomenon termed “tonic” inhibition (Farrant and Nusser, 2005).  This is mediated by 
peri- and extrasynaptic GABAA receptors that are persistently activated by sub-saturating 
concentrations of ambient GABA.  While the sources and precise concentration of 
ambient GABA are still uncertain (unlike other neurotransmitters such as dopamine and 
serotonin, the GABA concentration cannot be measured directly), it is generally believed 
to arise from a combination of synaptic overflow and non-vesicular release, and to reach 
concentrations of ~1 M (Attwell et al., 1993; Nusser et al., 1998; Zoli et al., 1999; Bach-
y-Rita, 2001; Farrant and Nusser, 2005).  Interestingly, the contribution of the tonic 
current to overall inhibitory tone may actually be greater than the summed charge transfer 
of phasic currents (Brickley et al., 1996; Hamann et al., 2002).  It should also be noted 
that tonic and phasic inhibition are differentially modulated by various pharmacological 
agents (Feng and Macdonald, 2004; Feng et al., 2004; Feng et al., 2008) and that they 
play distinct roles in the pathogenesis of neurological disorders such as epilepsy (Dibbens 
et al., 2004; Feng et al., 2006; Eugène et al., 2007).  This reflects the fact that tonic 
currents are mediated by a different subset of receptor isoforms, which have kinetic 
properties distinct from those mediating phasic currents.  4x and 6x receptor 
isoforms are thought to be the primary mediators of tonic inhibition (Brickley et al., 
32 
 
2001; Farrant and Nusser, 2005), though 1x and 5x2 receptors may also play an 
important role in the hippocampus (Glykys et al., 2008).  Indeed, properties conferred by 
the  subunit are consistent with a role in tonic inhibition; β receptors desensitize 
much slower and less extensively than β receptors and have a lower GABA EC50, ideal 
for receptors that must respond to very low concentrations of GABA for extended periods 
of time (Saxena and Macdonald, 1996; Haas and Macdonald, 1999; Lagrange et al., 
2007). 
 
Involvement of GABAA receptors in epilepsy 
 
Epilepsy is associated with abnormal hypersynchronous activation of large 
neuronal populations.  Although the mechanistic bases for partial and generalized forms 
of epilepsy are uncertain, there is considerable evidence that impaired GABAergic 
inhibition underlies several types of epilepsy.  Indeed, pharmacological blockade of 
GABAergic inhibition with GABAA receptor antagonists such as penicillin, picrotoxin, or 
bicuculline produces paroxysmal bursting in isolated neurons and partial seizures in 
experimental animals (Schwartzkroin & Prince, 1980).  Similar experiments have shown 
that GABAA receptor blockade produces paroxysmal depolarization shifts (PDSs), which 
are the interictal manifestations of epileptiform events.  This local paroxysmal bursting 
can spread to involve large areas of hippocampus or generalize to cortex when inhibition 
is further weakened and when other synchronizing factors occur, such as altered 
extracellular concentrations of potassium and calcium (Korn et al., 1987; Traynelis and 
Dingledine, 1988). 
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However, conclusive evidence that loss of GABAergic inhibition was involved in 
the pathogenesis of human epilepsy syndromes did not come until the recent discovery of 
mutations in genes encoding GABAA receptor subunits that were associated with 
idiopathic generalized epilepsies (Macdonald et al., 2006).  The first  subunit mutation 
to be reported was the 1 subunit mutation, A322D, in a family with juvenile myoclonic 
epilepsy (JME).  Mutant receptors had substantially reduced maximal currents and 
increased GABA EC50 (Cossette et al., 2002).  This was caused by reduced levels of 
GABAA receptor surface expression, which resulted from ER retention and accelerated 
proteosomal and lysosomal degradation of subunits following failure of the M3 domain 
to insert properly in the plasma membrane (Gallagher et al., 2004, 2005, 2007; Bradley et 
al., 2008).  Another 1 subunit mutation, a single base-pair deletion predicted to produce 
a frameshift and a premature translation-termination codon, 975delC, S326fs328X, was 
recently identified as a de novo mutation in an individual with childhood absence 
epilepsy (CAE) (Maljevic et al., 2006).  Little is known regarding the mechanisms by 
which this mutation causes disease, except that current was not detectable when the 
mutant subunit was co-expressed with 2 and 2 subunits.  Whether this was caused by 
impaired channel function or trafficking, however, remains unknown.  Three β3 subunit 
mutations, β3(S15F), β3(P11S), and β3(G32R), were also reported recently in families 
with CAE (Tanaka et al., 2008).  These mutations were found to decrease the amplitude 
of GABA-evoked currents, a finding likely attributable to altered channel trafficking 
since mutant subunits has altered glycosylation in the absence of altered total protein 
expression.  In the  subunit, two epilepsy susceptibility variants, E177A and R220H, 
were discovered in small GEFS+ families (Dibbens et al., 2004).  When co-expressed 
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with 1 and 2 subunits, these variants reduced single channel mean open time and the 
levels of GABAA receptor surface expression, thus substantially decreasing whole cell 
current amplitudes (Feng et al., 2006). 
Interestingly, more mutations have been identified in the 2 subunit than in all 
other subunit subtypes combined.  A family with generalized epilepsy with febrile 
seizures plus (GEFS+) was found to have a 2 subunit mutation, K289M, located in the 
extracellular M2-M3 linker (Baulac et al., 2001), a region implicated in transduction of 
ligand binding to channel gating (Kash et al., 2003).  Consistent with the known 
importance of this protein domain to channel function, recordings from HEK293T cells 
expressing 122(K289M) receptors were found to have defective channel gating 
(shortened mean open times) and accelerated deactivation (Bianchi et al., 2002).  A 
family with CAE and febrile seizures had a 2 subunit mutation, R43Q, located in the N-
terminal extracellular domain in the BDZ binding domain (Wallace et al., 2001).  This 
mutation reduced peak current amplitudes without altering channel kinetics (Bianchi et 
al., 2002).  The basis for the reduced current was reduced surface expression due to 
retention of the receptor in the ER (Kang and Macdonald, 2004; Sancar and Czajkowski, 
2004), possibly due to disruption of inter-subunit contacts at the - subunit interface 
(Hales et al., 2005).  However, it has been reported that 2(R43Q) subunits may assemble 
with 3 subunits (Frugier et al., 2007), suggesting the effects of the mutation may depend 
on the specific  subunit subtype involved.  The 2 subunit mutation, R139G, altered 
BDZ sensitivity and accelerated desensitization (Audenaert et al., 2006).  A 2 subunit 
mutation, Q351X, which introduced a PTC in the M3-M4 linker was identified in a 
family with GEFS+ (Harkin et al., 2002).  Mutant receptors had no GABA sensitivity 
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when expressed in oocytes, probably due to ER retention.  A 2 subunit splice donor site 
mutation, IVS6+2T-G, was identified in a family with CAE and febrile seizures 
(Kananura et al., 2002).  The effect of this mutation is unknown but was predicted to lead 
to nonfunctional receptors.  A 2 subunit, mutation Q1X, that introduced a PTC (Q1X) 
between the signal peptide and the mature peptide was identified in a family with severe 
myoclonic epilepsy of infancy (Hirose et al., 2004).  The functional consequence of the 
mutation is unknown but may be haploinsufficiency, since the mutation would likely 
trigger nonsense mediated mRNA decay, thus preventing production of even a signal 
peptide. 
 
Rationale for experimental chapters 
 
One of the greatest challenges in science is extracting microscopic mechanisms 
from data sets containing primarily macroscopic observations.  Indeed, while there are 
myriad experimental techniques for monitoring the functional properties of biological 
machinery, few techniques provide direct information regarding the behavior of 
individual molecules.  Scientists are therefore forced to deduce how molecules behave 
(or, in the case of disease, how the behavior of molecules is altered) at the microscopic 
level by carefully constructing experiments at the macroscopic level.  This typically 
involves perturbing the system with multiple experimental protocols, each designed to 
eliminate one or more possible explanations, and then using the combined results to 
constrain mechanistic hypotheses.  Perhaps the best-known illustration of the potential 
power of this experimental approach is the popular childhood road-trip game “20 
questions”, which challenges one player to guess what object another has in mind simply 
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by asking a series of twenty “yes” or “no” questions.  While this may initially seem 
difficult (if not impossible) given the seemingly countless named objects in the known 
universe, the binary nature of the questions allows for as many as 2
20
 different objects to 
be unambiguously identified, a number nearly double the total number of characters 
(including spaces) in this entire dissertation.  However, what has challenged scientists, 
quite simply, is knowing what questions to ask.  While even a child can list the defining 
features of dogs (e.g., four legs, tails, barking, etc.), and thus, can rule out dogs 
immediately when the answer to the question “does it have a shell?” is “yes”, scientists 
are often unaware of the microscopic determinants of many macroscopic phenomena, or 
if they do know, do not enough about the system to meaningfully combine the 
macroscopic observations to discriminate among possible microscopic mechanisms. 
Nowhere is this challenge more relevant than in the field of ion channel research, 
where despite the availability of a Nobel Prize-winning technique that allows the 
behavior of individual channels to be monitored (i.e., single-channel recording), the 
mechanistic bases for a variety of macroscopic phenomena remain unclear.  For example, 
what determines the extent and time course of receptor current desensitization?  Why 
does desensitization often appear “uncoupled” from deactivation (i.e., more 
desensitization in the context of accelerated deactivation, or vice versa)?  What is the 
kinetic basis for repeated pulse inhibition?  Worse yet, the literature is replete with 
conclusions regarding the microscopic effects of disease-causing mutations or potential 
therapeutic compounds based on isolated macroscopic observations, ignoring the work of 
many investigators that has illustrated the complex relationship between microscopic rate 
constants and certain macroscopic current properties.  Colquhoun (1998), for example, 
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demonstrated that changes in EC50 (and, by extension, binding affinity) should never, 
under any circumstances, be used to draw conclusions regarding the microscopic affinity 
of the channel for an agonist or allosteric modulator, as changes in efficacy can shift EC50 
just as easily as changes in affinity (and importantly, without any appreciable change in 
the apparent maximal open probability).  Nevertheless, despite this cautionary note, 
changes in a variety of macroscopic properties are often attributed incorrectly to changes 
in individual rate constants.  Altered rise time is often attributed to changes in the channel 
opening rate; altered desensitization is often attributed to changes in the stability of 
desensitized states; and altered deactivation is often attributed to changes in the 
unbinding rate. 
However, one could argue that the hands of investigators are effectively tied; that 
while Colquhoun and others may have illustrated the difficulties faced in bridging the gap 
between macroscopic and microscopic channel properties, they have failed to provide 
investigators with the ability to unambiguously discriminate among microscopic 
mechanisms.  For example, a valid experimental algorithm has yet to be proposed for 
discriminating changes in the entry or exit rates from desensitized states from changes in 
the rates connecting other non-conducting states (or even the channel opening rate).  
While tempting to suggest that investigators resort to single-channel analysis, it should be 
noted that this is much easier said than done, as patches rarely, if ever, include only a 
single channel, and even when they do, distinguishing changes in the entry and exit rates 
from desensitized states from changes in other rate constants requires assumption of a 
kinetic model (for a discussion, see Shelley and Magleby, 2008).  Indeed, these rates 
cannot simply be extracted from exponential fitting of closed time distributions, as 
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decreased desensitized state stability can be caused either by a decreased entry rate into 
the desensitized state or an increased rate into another state (open or closed).  Moreover, 
the very nature of desensitized states substantially decreases the practical utility of single-
channel analysis, as they are by definition long-lived (dwell times can be 1000 ms or 
greater), meaning that there will not only be far fewer events available for analysis per 
recording, but also that their lifetimes will be underestimated by the presence of multiple 
channels in the patch. 
The first goal of this dissertation was therefore to determine the kinetic basis for 
several GABAA receptor macroscopic current properties including the non-equilibrium 
phenomena of desensitization and deactivation.  This was accomplished with two 
approaches.  The first involved a combination of kinetic modeling using Markov models 
of GABAA receptor function and mathematical analysis of the differential equations 
governing the behavior of these models.  The second involved comparing the predictions 
of these theoretical studies with electrophysiological data acquired from receptors that a) 
had different kinetic properties, b) were activated by different agonists or allosteric 
modulators, or c) were activated under different experimental conditions (e.g., short vs. 
long pulses of GABA, high vs. low GABA).  Once the kinetic bases for these 
macroscopic phenomena were determined, an experimental algorithm for interpreting 
changes in macroscopic currents in terms of microscopic mechanisms was generated, the 
first of its kind.  This algorithm was then applied to answer several long-standing 
questions in the field of GABAA receptor research.  These included determining how 
desensitized states were arranged with respect to other states in the gating scheme; 
determining why receptor isoforms with access to long-lived non-conducting states failed 
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to exhibit macroscopic desensitization; determining the kinetic basis for the phenomenon 
of desensitization-deactivation uncoupling; determining the specific rate constant targeted 
by the most widely prescribed class of GABAA receptor modulator, the benzodiazepines; 
and determining the kinetic basis for the seemingly paradoxical effects of open channel 
block on macroscopic currents.  In addition, the kinetic lessons learned from these studies 
allowed the comprehensive GABAA receptor gating scheme generated by Haas and 
Macdonald (1999) to be expanded, such that it accounted for several additional 
microscopic and macroscopic experimental observations. 
Having identified the kinetic determinants of macroscopic desensitization and 
deactivation, the physiological relevance of these phenomena (and by extension, their 
kinetic determinants) was then explored.  While deactivation is known to determine the 
decay of IPSCs, the relevance of desensitization to GABAergic synaptic transmission 
remains unclear.  Indeed, some investigators have gone so far as to state that 
desensitization is more of an experimental nuisance than a physiologically interesting 
phenomenon, as agonist is not present in vivo at saturating concentrations for extended 
durations.  Others have disagreed, arguing that desensitization is important not only for 
shaping the decay of individual IPSCs (Jones and Westbrook, 1995, 1996; Haas and 
Macdonald, 1999), but also for shaping the pattern of IPSCs during high-frequency 
stimulation (Overstreet et al., 2000; Bianchi and Macdonald, 2002).  To explore this 
important issue further, a combination of theoretical modeling and electrophysiological 
recording studies were again performed.  Taken together, the results suggested that 
desensitization was indeed likely to have physiological significance, as it was both 
necessary and sufficient for currents to undergo repeated pulse inhibition (defined as the 
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loss of current amplitude during high-frequency stimulation).  In fact, desensitization was 
found to represent an important boundary condition for the time course of repeated pulse 
inhibition, and also for the time course of IPSC decay.  The results also suggested that 
desensitization may have physiological relevance to peri- and extrasynaptic inhibitory 
neurotransmission, as the underlying desensitized states effectively “buffered” open state 
fractional occupancy, protecting it from fluctuations in the concentration of ambient 
GABA or negative modulators of GABAA receptor function.  In other words, 
desensitized states appeared to offer stability to tonic currents at the expense of efficacy. 
It should be noted that many of the aforementioned experiments could not have 
been performed without an ultra-fast drug application system, as resolving the fastest 
phases of desensitization required resolution of the true peak current amplitude, which is 
achieved by many receptor isoforms in the sub-millisecond time domain.  However, 
investigating the physiological significance of desensitization required that the drug 
application system not only be capable of applying GABA to receptor-containing 
membrane preparations rapidly, but also that it be able to terminate the GABA pulse after 
synaptically relevant durations.  Moreover, these experiments required that the drug 
application system be capable of delivering synaptically relevant pulses at extremely high 
frequencies, as many GABAergic neurons are known to reach extremely high firing rates 
for short periods of time.  Unfortunately, the latter two criteria were not met by our 
existing drug application system, necessitating the development of a novel approach to 
solution switching.  This was accomplished using PDMS microfluidics.  This system, the 
first of its kind, allowed GABA to be applied rapidly (solution exchange times < 100 s), 
briefly (total exposure times < 400 s), and at high frequencies (up to 80 Hz).  
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GLOSSARY 
Activation: the process by which a macroscopic current reaches its peak 
following application of an agonist; typically quantified as the 10-90% rise time, but can 
also be fit to a sum of exponentials; determined by a complex relationship between all 
rate constants in the gating scheme, and therefore, does not simply equal the microscopic 
rate constant of channel opening (β) 
Affinity: the ratio of the microscopic binding rate (Kon) to the microscopic 
unbinding rate (Koff) (i.e., increasing affinity increases the fraction of receptors that are 
bound with GABA); commonly reported as the Ka, which is actually the inverse of 
affinity, such that high Ka means an agonist is relatively low affinity (and vice versa) 
Deactivation: the return of a macroscopic current to baseline following agonist 
washout; typically quantified by fitting to a sum of exponentials and calculating a 
weighted time constant; correlates with the average time channels are bound with GABA 
(see Appendix II), which is influenced by every rate constant in the gating scheme except 
that of agonist binding; sometimes referred to as the “washout” current 
Desensitization: the loss of macroscopic current in the continued presence of 
agonist; also referred to as “sag” or “decay”; typically quantified either by fitting to a 
sum of exponentials or by calculating the amount of current lost relative to peak (referred 
to as the extent of desensitization); note that the time course of macroscopic 
desensitization does not equal the microscopic entry rate into the desensitized state, and 
similarly, the extent of macroscopic desensitization does not equal the fractional 
occupancy of receptors in the microscopic desensitized state 
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Dwell Time: the average lifetime of a receptor in an individual state; equal to the 
reciprocal sum of the exit rates from that state 
Efficacy: classically defined as the ratio of the microscopic channel opening rate 
(β) to the microscopic channel closing rate (α); however, often used inappropriately in the 
macroscopic sense to describe the peak open probability; typical indices include mean 
open duration, burst duration, and open time per burst 
Fractional Occupancy: the fraction of all receptors in a given state; 
mathematically the same as the probability that an individual receptor occupies a given 
state at any moment in time (see Appendix I) 
Gating: generic term that describes the microscopic process of receptor transition 
among ligand-bound states 
Macroscopic: involving many receptors; the “population” or “ensemble” 
response 
Microscopic: involving a single receptor; note that while macroscopic currents 
can reach equilibrium, microscopic or “single channel” currents are never at equilibrium 
Rate: a term used to describe the time course of a macroscopic current property 
Rate Constant: a microscopic term used to describe the probability per unit time 
that a receptor transitions from one state to another 
Stability: the ratio of the entry rate to the exit rate of a given state; the same as 
efficacy for open states 
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GABAA RECEPTOR DESENSITIZATION AND DEACTIVATION 
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ABSTRACT 
The time course of inhibitory postsynaptic currents (IPSCs) reflects GABAA 
receptor deactivation, the process of current relaxation following transient activation.  
Fast desensitization has been demonstrated to prolong deactivation, and these processes 
have been described as being “coupled”.  However, the relationship between 
desensitization and deactivation remains poorly understood.  We investigated the 
“uncoupling” of GABAA receptor macroscopic desensitization and deactivation using 
experimental conditions that affected these two processes differently.  Changing agonist 
affinity preferentially altered deactivation, changing agonist concentration preferentially 
altered macroscopic desensitization, and a pore-domain mutation prolonged deactivation 
despite blocking fast desensitization.  To gain insight into the mechanistic basis for 
coupling and uncoupling, simulations were used to systematically evaluate the interplay 
between agonist affinity, gating efficacy, and desensitized state stability in shaping 
macroscopic desensitization and deactivation.  We found that the influence of individual 
kinetic transitions on macroscopic currents depended not only on model connectivity, but 
also on the relationship among transitions within a given model.  In addition, changing 
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single rate constants differentially affected macroscopic desensitization and deactivation, 
thus providing parsimonious kinetic explanations for experimentally observed 
uncoupling.  Finally, these findings permitted development of an algorithmic framework 
for kinetic interpretation of experimental manipulations that alter macroscopic current 
properties. 
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INTRODUCTION 
Transient synaptic release of GABA onto clusters of post-synaptic αβγ GABAA 
receptors represents a major mechanism of inhibition in the brain.  The time course of 
GABAA receptor synaptic currents influences the complex behavior of inhibitory circuits, 
and many clinically useful drugs that potentiate GABAA receptor function act by 
prolonging IPSCs.  Because IPSC duration depends primarily on post-synaptic GABAA 
receptor properties, the kinetic principles governing channel behavior have been the focus 
of active experimental investigation (Twyman and Macdonald, 1990; Jones and 
Westbrook, 1995; Galarreta and Hestrin, 1997; Haas and Macdonald, 1999; Bai et al, 
1999; Mozrzymas et al., 2003).  In particular, GABAA receptor deactivation, the process 
by which activated receptors relax toward the resting state, shapes the decay rate (and 
thus charge transfer) of IPSCs.  This process can be studied experimentally by activating 
GABAA receptors with brief pulses of high concentration GABA and taking the ensuing 
deactivation time course as a model of synaptic currents. 
Early work by Jones and Westbrook (1995, 1996) demonstrated that the fast 
phase of macroscopic desensitization played an important physiological role in 
augmenting IPSC duration, as the underlying desensitized state provided a surrogate high 
affinity conformation that prolonged the time during which an activated receptor could 
re-open.  The importance of fast desensitization in shaping IPSCs has been validated by 
subsequent studies (Galarreta and Hestrin, 1997; Mozrzymas et al., 2003), and extended 
to include possible roles for slower phases of desensitization (Overstreet et al., 2000; 
Bianchi and Macdonald, 2002).  This phenomenon of desensitization-deactivation 
“coupling”, defined as increased macroscopic desensitization in the context of prolonged 
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deactivation (or decreased macroscopic desensitization in the context of accelerated 
deactivation), has been observed with changes in subunit composition (Haas and 
Macdonald, 1999; Bianchi et al., 2001; Lagrange et al., 2007), allosteric modulators 
(Bianchi et al., 2002; Feng and Macdonald, 2004), post-translational modifications 
(Hinkle and Macdonald, 2003), and disease-related mutations (Buhr et al., 2002). 
While it is clear that desensitized states prolong the time course of deactivation, 
other receptor conformations (both conducting and non-conducting) are predicted to 
serve similar roles.  Indeed, for Markovian models of ligand-gated ion channels, every 
agonist bound state delays unbinding in non-cyclic kinetic schemes (for example, 
Twyman et al., 1990; Celentano and Wong; 1994; Jones and Westbrook, 1995; Haas and 
Macdonald, 1999).  This delay is unrelated to microscopic affinity (which also affects 
unbinding); occupancy of any kinetic state not associated with a binding/unbinding step 
is said to “trap” agonist (Bianchi and Macdonald, 2001a).  The functional consequence of 
trapping is that additional transitions among open and closed states occur prior to agonist 
unbinding, the macroscopic correlate of which is a prolonged time course of deactivation.  
Although cyclic models have been proposed for cys-loop receptors (for example, 
Grosman and Auerbach, 2001; Scheller and Forman, 2002; Chang et al., 2002) and are 
not predicted to exhibit trapping per se, open and desensitized states will nonetheless 
prolong deactivation if they are high affinity states (low unbinding rate constants). 
How other receptor conformations influence macroscopic desensitization, 
however, has received less attention (Mozrzymas et al., 2003).  In many experimental 
circumstances, desensitization and deactivation appeared to be “uncoupled” (Bianchi et 
al., 2001b; Scheller and Forman, 2002; Fisher 2004; Mercik et al., 2006; Barberis et al., 
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2007), such that decreased extents of macroscopic desensitization were associated with 
prolonged time courses of deactivation (or increased extents of macroscopic 
desensitization with accelerated deactivation time courses).  This suggested that the 
kinetic determinants of macroscopic desensitization were distinct from those of 
deactivation, despite the known sensitivity of both processes to all rate constants in the 
gating scheme (Mozrzymas et al., 2003).  To explore the kinetic basis for coupling and 
uncoupling (purely phenomenological descriptions of macroscopic currents), we focused 
on experimental manipulations that affected desensitization and deactivation differently: 
GABAA receptor agonists of different affinity, a range of concentrations of GABA 
application, and a pore-domain mutation that blocked fast desensitization.  In addition, 
using kinetic simulations, we investigated the relative roles of agonist affinity, efficacy, 
desensitized state stability, and model connectivity in shaping macroscopic current 
properties.  Analysis of simulated currents generated from a spectrum of rate constants 
and gating schemes provided mechanistic insight into experimental observations of 
coupling and uncoupling, and established a preliminary framework for interpretation of 
changes in macroscopic current properties due to the effects of mutations or allosteric 
modulators. 
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MATERIALS AND METHODS 
 
Cell culture and expression of recombinant GABAA receptors 
 
The cDNAs encoding rat α1, α6, β1, β3, γ2L, δ, and α1(L245S) GABAA receptor 
subunits were subcloned into the pCMVNeo vector.  Human embryonic kidney cells 
(HEK293T; a gift from P. Connely, COR Therapeutics, San Francisco, CA) were 
maintained in DMEM supplemented with 10% fetal bovine serum and 
penicillin/streptomycin at 37C in 5% CO2 / 95% air.  Experiments shown in Figure 2 
were conducted using mouse L929 fibroblasts.  Cells were transfected with 4 g of each 
subunit plasmid and 1-2 g of pHOOK (Invitrogen, Carlsbad, CA) for immunomagnetic 
bead selection of transfected cells using a modified calcium phosphate technique (Fisher 
et al., 1997).  The next day, cells were replated and recordings were made at room 
temperature 18-30 hours later. 
 
Electrophysiology 
 
On recording days, transfected fibroblasts were bathed in an external solution 
consisting of (in mM): NaCl 142; KCl 8; MgCl2 6; CaCl2 1; HEPES 10; glucose 10 (pH 
adjusted to 7.4 with NaOH, ~330 mOsm).  For whole cell studies, thin-walled 
borosilicate glass electrodes (World Precision Instruments, Pittsburgh, PA, USA) were 
pulled with a P-2000 laser puller (Sutter Instrument Co., San Rafael, CA, USA) and heat-
polished to resistances of 0.5-1.5 M.  The internal solution consisted of (in mM): KCl 
153; MgCl2 1; MgATP 2; HEPES 10; EGTA 5 (pH adjusted to 7.3 with KOH prior to 
ATP addition, ~300 mOsm).  ATP was added on the day of recording.  This combination 
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of internal and external solutions produced a chloride equilibrium potential near 0 mV.  
For excised patch experiments, thick-walled borosilicate glass was used with resistances 
of 5-15 M after heat-polishing.  Electrodes used for single channel recordings were 
coated with Q-Dope.  Cells and patches were voltage-clamped using an Axon 200A or 
200B amplifier (Axon Instruments, Foster City, CA).  GABA was applied (via gravity) 
with a rapid perfusion system consisting of pulled multi-barrel square glass connected to 
a Warner Perfusion Fast-Step (Warner Instrument Corp., Hamden, CT), or “theta” glass 
mounted on a piezo-electric translator (Burleigh Instruments, Victor, NY).  The solution 
exchange time for excised patch experiments was 400 s or less, as determined after each 
recording by blowing off the patch and then stepping a dilute external solution across the 
open electrode tip.  For whole cell experiments, solution flow rates were decreased by 
lowering the height of the source solutions so that open tip exchange times were ~ 1 ms, 
although slower exchange probably occurred around intact cells.  All chemicals were 
from Sigma-Aldrich. 
 
Analysis of currents 
 
Currents were low-pass filtered at 2 kHz by the internal 4 pole Bessel filter of the 
amplifier, digitized at 10-20 kHz, and analyzed using the pCLAMP8 or 9 software suite 
(Axon Instruments, Foster City, CA).  For experiments using outside out patches, 
multiple applications were made at 30-90 second intervals and averaged prior to kinetic 
analysis.  The desensitization and deactivation time courses were fit using the Levenberg-
Marquardt least squares method with multiple component exponential functions of the 
form ane
(-t/n), where n is the number of exponential components, a is the relative 
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(fractional) amplitude of the component at time = 0, t is time, and  is the time constant.  
The number of components was incremented until additional components did not 
significantly improve the fit as determined by an F-test performed on residuals.  Fitting 
the decay during 400 ms and 6 second applications sometimes revealed 3 or 4 
exponential components, respectively.  To simplify comparisons, no more than 2 or 3 
components, respectively, were considered for analysis.  A weighted summation of 
biphasic deactivation time courses (af * f + as * s) was used.  Three component fits were 
not considered.  Single channel recordings were obtained after 3-4 minutes of incubation 
in 1 mM GABA.  Currents were idealized using a 50% threshold method with the 
Fetchan program of the pClamp suite, and binned histograms were fitted with multiple 
exponential functions using Interval5 software (Dr. B. Pallotta, University of North 
Carolina, Chapel Hill).  Only main conductance state openings (approximately 2 pA at –
75 mV) were included in the analysis.  However, brief openings that reached threshold 
were accepted in the idealization.  All patches contained more than one channel as 
indicated by overlapped openings.  Although these openings were ignored in the 
idealization, the presence of multiple openings complicates the analysis of closed times 
(artificially shortened), opening frequency (artificially increased), and open probability 
(artificially increased).  Numerical data were expressed as mean  SEM.  Statistical 
significance, using Student’s t test (paired or unpaired as appropriate) was taken as p< 
0.05. 
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Simulations 
 
Kinetic modeling was carried out with Berkeley Madonna 3.1 
(www.berkeleymadonna.com), a differential equation solver, using the fourth order 
Runge-Kutta method with a time interval of 10-100 s. 
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RESULTS 
 
Agonists with different affinities for the GABAA receptor altered deactivation without 
altering macroscopic desensitization 
 
We tested the hypothesis that deactivation could be altered independent of 
macroscopic desensitization using ligands with higher (muscimol) or lower (THIP) 
affinity than GABA for GABAA receptors.  Since muscimol (Twyman and Macdonald, 
unpublished observation) and THIP (Mortensen et al., 2004) evoked single channel 
currents similar to those evoked by GABA, we predicted that macroscopic desensitization 
would be similar for all three agonists when applied at nearly-saturating concentrations, 
as activated receptors would transition within the same di-liganded portion of the receptor 
gating scheme.  In contrast, we expected that deactivation would be markedly different 
for each of the three agonists, as the unbinding rate plays an important role in 
determining how quickly activated receptors return to the resting state (Jones et al, 1998, 
Li and Pearce, 2000). 
Macroscopic desensitization of α1β1γ2L receptor currents was investigated in 
response to rapid application of EC-equivalent concentrations of each agonist, 
approximated from whole cell concentration-response curves generated using a Y-tube 
perfusion system (not shown).  Outside-out patches were obtained from transfected L929 
fibroblasts, and agonists were applied rapidly with the concentration-jump technique (see 
methods).  GABA- and THIP-evoked currents desensitized to similar extents during 400 
ms applications (66.1 + 6.1 %; n = 6, for 100 M GABA; 59.6 + 5.0 %; n = 11, for 10 
mM THIP) (Figure 1A1, 1B1).  Also, 8 of 11 patches exposed to THIP exhibited a 
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biphasic desensitization time course that included a fast (~20 ms or less) phase.  The rate 
and extent of the fast phase of desensitization was similar between the biphasic currents  
evoked by GABA (12.1 + 3.1 ms; 51.1 + 6.7 %; n = 6 ) and THIP (11.2 + 2.2 ms; 49.7 + 
6.0 %; n = 11).  Currents evoked by muscimol (30 M) activated more slowly (5.7 + 0.9 
ms; n = 4) than those evoked by THIP (2.2 + 0.4 ms; n = 11) or GABA (1.8 + 0.2 ms; n = 
6) currents (not shown).  However, the extent of desensitization (53.2 + 4.9 %; n = 4) and 
the rate and relative proportion of fast desensitization (17.4 + 5.6 ms; 44.5 + 4.5 %; n = 
4) of biphasic currents activated by muscimol were not different than those observed for 
GABA or THIP (Figure 1C1). 
In contrast, the deactivation time course depended strongly on agonist affinity 
(Figure 1A1, 1B1, 1C1).  To further explore this difference, brief (5 ms) applications of 
each agonist were applied (Figure 1A2, 1B2, 1C2).  For muscimol, some of these 
applications were made using a longer duration (30 ms) to ensure that peak current was 
obtained.  Since the resulting deactivation time courses were similar between these two 
conditions, the results were pooled.  The weighted time constants of current deactivation 
were 10.5 + 0.9 ms (n = 5) for THIP, 61.3 + 6.8 ms (n = 5) for GABA, and 198.1 + 48.0 
ms (n = 6) for muscimol (Figure 1D).  Whereas brief GABA- and muscimol-evoked 
currents decayed bi-phasically, in 4 of 5 THIP-evoked currents, the decay was dominated 
by a fast phase (>95%).  These results were similar to those of Jones et al. (1998), who 
reported that currents evoked by muscimol and the low affinity agonist β-alanine had 
longer and shorter deactivation time courses, respectively, than those evoked by GABA, 
despite identical desensitization kinetics. 
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Figure 1.  Macroscopic desensitization and deactivation of α1β1γ2L GABAA receptor 
currents evoked by different agonists 
  
Currents were obtained from outside-out membrane patches using concentration jumps of 
400 or 5 ms duration into equivalent concentrations of GABA (A1, A2), THIP (B1, B2), 
or Muscimol (C1, C2).  The currents displayed were obtained from different patches.  
The horizontal scale bar in panel A1 applies to panels A-C.  The agonist pulse duration is 
shown by a filled bar above each trace.  Quantification of macroscopic desensitization is 
given in the text.  D.  Weighted time constants of deactivation following brief pulses of 1 
mM THIP (T; gray bar), 100 M GABA (G; filled bar), and 30 M Muscimol (M; open 
bar).  E.  Deactivation currents from patches containing α1β3δ (top trace) and α6β3δ 
receptors (bottom trace) following a 5 ms pulse of 1 mM GABA (filled bar).  The 
horizontal scale bar applies to both traces. 
92 
 
This apparent uncoupling of desensitization and deactivation demonstrated that 
the unbinding rate constant could dominate the deactivation time course, even in the 
presence of fast desensitization.  To explore this observation, deactivation time courses 
were measured following activation of different receptor isoforms by the same agonist 
(note that changes in agonist affinity can also be related to subunit composition).  While 
kinetic models of α6 subunit-containing αβδ receptors are unavailable, their low GABA 
EC50 compared to α1 subunit-containing receptors has been attributed to increased 
affinity (Saxena and Macdonald, 1996; Fisher et al., 1997; Fisher 2004).  When excised 
patches containing α1β3δ or α6β3δ receptors were exposed to brief (5 ms) pulses of 
GABA (1 mM), those containing the α6 subunit had markedly slower deactivation 
(Figure 1E).  Neither receptor isoform, however, exhibited fast desensitization (Bianchi et 
al., 2002).  Taken together, these data suggested that fast desensitization was neither 
necessary nor sufficient for prolonged deactivation.  In addition, the data also raised the 
more general questions: under what conditions could other rate constants in the gating 
scheme dominate the deactivation time course, and in what context would this also be 
manifested as desensitization-deactivation uncoupling? 
 
Different agonist concentrations altered macroscopic desensitization without affecting 
deactivation 
 
One interpretation of the apparent increase in macroscopic desensitization 
observed with increasing agonist concentrations (Figure 2A) is that desensitized states are 
preferentially accessed during activation with high agonist concentrations.  However, the 
slow activation observed with low agonist concentrations may mask the manifestation of 
an inherently concentration-independent desensitization process (Celentano and Wong, 
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1994), similar to slow agonist perfusion (Bianchi and Macdonald, 2002).  Indeed, “pre-
desensitization” has been shown using pre-incubations of low GABA concentrations 
prior to test jumps into a saturating GABA concentration (Overstreet et al., 2001; 
Lagrange et al., 2007).  If desensitized states were accessible at low GABA  
concentrations, similar deactivation time courses would be predicted over a broad range 
of GABA concentrations despite variable macroscopic desensitization (i.e., uncoupling).  
In contrast, if desensitized state accessibility decreased with lower GABA concentrations, 
the observed loss of macroscopic desensitization would be associated with an accelerated 
deactivation time course (i.e., coupling). 
Macroscopic desensitization was measured during 4-6 second applications of 
different GABA concentrations to cells expressing α1β3γ2L receptors (Figure 2A).  
Although the extent of desensitization varied from 0% to 80% over this concentration 
range (Figure 2B), deactivation time courses were indistinguishable at concentrations 
from 1 mM (near-saturating) to 1 M (approximately EC10) (Figure 2C, D), providing an 
additional experimental example of desensitization-deactivation uncoupling.  The 
deactivation time course was significantly faster only following the 300 nM GABA 
applications (Figure 2D), possibly caused by a significant mono-liganded component at 
this low concentration.  Similar results were obtained in excised patches, eliminating the 
possibility that our findings were an artifact of the slower solution exchange 
characteristic of whole-cell recording (not shown).  This suggested that the underlying 
kinetic processes shaping deactivation were unchanged over a wide range of GABA  
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Figure 2.  Macroscopic desensitization and deactivation of α1β3γ2L receptor currents 
evoked by different GABA concentrations 
 
A.  Representative traces from a single cell exposed to increasing concentrations of 
GABA were labeled with concentration in M.  The 30 M trace was staggered 
horizontally for clarity.  B.  The extent of macroscopic desensitization, measured as % 
current loss during the GABA pulse, was plotted for each concentration.  C.  Deactivation 
currents expanded from the traces shown in panel A.  The traces were staggered 
horizontally to illustrate their similar time courses.  D. The weighted deactivation time 
constant was shown for 8 concentrations of GABA (4-6 second applications each).  Only 
the deactivation following the 300 nM concentration was significantly faster than the 
others. 
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concentrations, and thus, that accessibility of desensitized states was not compromised.  
As in the previous section, this demonstrated that prolonged deactivation was possible 
even in the absence of fast macroscopic desensitization, and provided an additional 
example of uncoupling. 
 
A channel mutation blocked macroscopic desensitization without accelerating 
deactivation 
 
Mutations of the conserved pore-lining TM2 9’leucine in the cys-loop family of 
receptors to the polar residues serine or threonine have been shown to alter macroscopic 
current properties via an increase in single channel mean open time (Revah et al, 1991; 
Yakel et al, 1993; Filatov and White, 1995; Thompson et al, 1999).  Specifically, during 
rapid kinetic studies of the α1(L9’T)β2γ2L receptor mutation, the extent of macroscopic 
desensitization was found to decrease despite a prolonged deactivation time course 
(Scheller and Forman, 2002).  To better understand the mechanistic basis for this 
desensitization-deactivation uncoupling, we analyzed the kinetic properties of a similar 
mutation in the GABAA receptor α1 subunit. 
α1(L9’S)β3γ2L receptors exhibited a left-shifted whole cell GABA EC50 of ~300 
nM (Figure 3A), as well as bicuculline-sensitive spontaneous activity (not shown), 
consistent with previous studies (Labarca et al, 1995; Chang and Weiss, 1999; Thompson 
et al, 1999, Bianchi and Macdonald, 2001b; Scheller and Forman, 2002).  During a 6 
second application of GABA to excised outside-out patches, macroscopic desensitization 
of α1(L9’S)β3γ2L currents was slower and less extensive than that of α1β3γ2L currents 
(Figure 3B).  In contrast to α1β3γ2L currents, which desensitized with three exponential  
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Figure 3.  Characterization of α1(L9’S)β3γ2L GABAA receptor currents 
 
A.  Concentration-response curves obtained for α1β3γ2L (filled circles) and 
α1(L9’S)β3γ2L (gray triangles) receptors.  Representative current traces from individual 
cells are shown at concentrations of 3, 10, and 100 M for α1β3γ2L receptors, and 0.03, 
0.1, and 10 M for α1(L9’S)β3γ2L receptors.  Vertical scale bars are 1.0 nA and 50 pA 
for α1β3γ2L and α1(L9’S)β3γ2L receptors, respectively.  Horizontal scale bars are 3 s for 
both isoforms.  B.  Currents evoked by 6 s applications of 1 mM GABA to outside out 
patches containing α1β3γ2L (black trace) and α1(L9’S)β3γ2L (gray trace) receptors.  
Traces were normalized to peak and slightly staggered horizontally for comparison.  C. 
Scatter plot of the time constants obtained from exponential fitting of the desensitization 
time course.  Three time constants were required to fit the time course of α1β3γ2L 
receptor desensitization (filled symbols), while α1(L9’S)β3γ2L receptor desensitization 
was mono-exponential (gray symbols).  Note the logarithmic axis.  D, E. α1β3γ2L (black 
traces) and α1(L9’S)β3γ2L (gray traces) receptor currents were evoked by 400 ms (Panel 
D) and 5 ms (Panel E) concentration jumps into 1 mM GABA.  F.  Activation rates (left), 
as indicated by the 10-90% rise time observed for 400 ms concentration jumps, were 
shown for both isoforms.  The extent of macroscopic desensitization was plotted as the 
loss of current during the 400 ms application (right).  G. The weighted deactivation time 
constant was shown for α1β3γ2L (solid bars) and α1(L9’S)β3γ2L (gray bars) receptor 
currents following 5 ms (left) and 400 ms (right) application durations.  Filled squares in 
Panel D indicate isoform color for bar graphs in Panels F and G. 
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components (Figure 3C, filled symbols), α1(L9’S)β3γ2L currents desensitized with a 
single exponential component (Figure 3C, open squares), similar to the results of Scheller 
and Forman (2002).  The single α1(L9’S)β3γ2L desensitization time constant (2098 + 
435 ms; n = 4) was not different from the longest wild-type desensitization time constant 
(3; 2395 + 184 ms; n = 9), but its relative contribution was increased from 37.0 + 3.0 % 
to 57.5 + 6.3 %. 
Shorter duration pulses of GABA (1 mM) were used to investigate the effects of 
the α1(L9’S) subunit mutation on deactivation (Figure 3D, 400 ms; Figure 4E, 5 ms).  
The 10-90% rise times were significantly increased by the α1(L9’S) subunit mutation 
from 0.71 + 0.07 ms to 1.51 + 0.19 ms (Figure 3F, left).  For 400 ms pulses, the extent of 
desensitization was minimal for α1(L9’S)β3γ2L compared to wild-type receptors (Figure 
3F, right), while the deactivation time courses of α1β3γ2L (238.7 + 14.7 ms, n = 6) and 
α1(L9’S)β3γ2L (181.8 + 21.9 ms, n = 9) currents were similar.  Consistent with prior 
reports, this uncoupling manifested as the loss of fast desensitization without accelerated 
deactivation time course.  After 5 ms pulses, deactivation was faster than after 400 ms 
pulses for both mutant and wild-type receptors, although the time course was 
significantly longer for the mutant (114.0 + 9.4 ms) in comparison to wild-type (68.4 + 
10.9 ms) receptors (Figure 3G).  Thus, with longer GABA exposure, prolongation of 
deactivation for the wild-type current (~300% increase) was greater than for the mutant 
current (~40% increase) (Figure 3G). 
The dependence of the deactivation time course on the duration of GABA 
exposure has been suggested to reflect increasing occupancy of desensitized states (Jones 
and Westbrook, 1995).  Thus, the failure to observe such an increase with the α1(L9’S) 
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mutation, particularly given the absence of fast macroscopic desensitization, could 
indicate failure to access desensitized state(s).  However, this would be expected to 
accelerate deactivation, while in this case, deactivation was prolonged following synaptic 
pulse durations.  We hypothesized that increased efficacy could account for the 
constellation of findings, as this would be consistent with prolonged deactivation after 
brief pulses, decreased macroscopic desensitization, and a left-shifted GABA EC50.  
Moreover, since deactivation following prolonged agonist exposure is dominated by the 
ability of long-lived desensitized states to delay agonist unbinding, this would also be 
consistent with a similar deactivation time course following long applications. 
 
Changes in gating efficacy accounted for slow deactivation despite reduced 
desensitization of α1(L9’S)β3γ2L receptor currents 
 
Although it has been proposed that increased spontaneous channel activity reflects 
increased efficacy of liganded gating (Grosman and Auerbach, 2000; Scheller and 
Forman, 2002), spontaneous openings may involve a different reaction pathway than the 
gating of liganded receptors, thus necessitating single channel analysis.  To test the 
hypothesis that prolonged deactivation after brief pulses (despite absent fast 
desensitization) in α1(L9’S) mutants was due to increased gating efficacy, we obtained 
single channel recordings from α1β3γ2L and α1(L9’S)β3γ2L receptor channels (Figure 
4A and 4B).  Both mean open time (2.5 versus 1.8 ms) and burst duration (18.6 versus 
3.7 ms) were significantly increased by the mutation.  Open duration histograms for 
α1β3γ2L and α1(L9’S)β3γ2L receptor single channel currents were both fitted best by 
three exponential functions (Figure 4C and 4D).  The increase in mean open and burst  
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Figure 4.  Single channel analysis of α1(L9’S)β3γ2L receptors 
 
A.  Representative α1β3γ2L receptor single channel events recorded from an outside-out 
patch voltage clamped at –75 mV are shown.  A portion of the continuous trace (open 
bar) is expanded below.  Channel openings are visible as downward deflections from the 
baseline current.  B.  Continuous trace showing α1(L9’S)β3γ2L receptor single channel 
events for comparison.  C, D.  Open time histograms for WT (Panel C) and L9’S mutant 
(Panel D) single channel recordings.  Open durations were fitted best with three 
exponential functions in each case (overlapping curves in each plot).  The sum of the 
three exponentials was shown as the top curve in each plot. 
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durations were accounted for in part by longer time constants associated with the two 
longest open components (O2 and O3).  Opening frequency, open probability, and closed 
time distributions were not investigated, since the patches used for analysis contained 
multiple channels (overlapped openings).  While development of an exhaustive kinetic 
scheme of the mutated receptors was not possible with this limited data set, the results 
suggested that increased efficacy could explain prolonged deactivation despite reduced 
macroscopic desensitization, and supported the idea that multiple rate constants in the 
gating scheme (not just the agonist binding and unbinding rates) could mediate 
desensitization-deactivation uncoupling. 
 
Kinetic modeling explored the role of microscopic kinetic parameters on macroscopic 
desensitization and deactivation 
 
Although comprehensive kinetic models have been developed that account for 
both the microscopic and macroscopic properties of GABAA receptors (Haas and 
Macdonald, 1999; Figure 5A), simple models are often sufficient to illustrate the salient 
features of GABA-evoked currents such as rapid activation, extensive macroscopic 
desensitization, and prolonged deactivation.  In addition, with fewer free parameters, they 
facilitate systematic exploration of relationships between individual rate constants and 
macroscopic current properties.  Historically, two simple models have been commonly 
used to describe the behavior of ligand-gated ion channels.  Katz and colleagues 
described cholinergic responses with a linear scheme of binding, isomerisation to the 
open state, and subsequent entry into the desensitized state (Katz and Thesleff, 1957; 
Figure 5B).  Jones and Westbrook (1995) explained GABAA receptor desensitization  
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Figure 5.  Kinetic models of ligand-gated ion channel function 
 
A.  Comprehensive kinetic scheme for the α1β3γ2L receptor isoform taken from Haas 
and Macdonald (1999).  For simplicity, the two distal “intraburst” closed states connected 
to each open state were omitted from the display.  Closed (C), open (O), and desensitized 
(Df, “fast”; Di, “intermediate”; Ds, “slow”) states were reversibly interconnected.  The 
microscopic transitions associated with agonist binding were labeled kon and koff for 
association and dissociation rate constants, respectively.  Each agonist binding step was 
taken to be equivalent and independent in this scheme (the first binding and unbinding 
rates were therefore multiplied by 2).  [G], concentration of GABA.  B.  4-state kinetic 
model, in linear arrangement.  A single binding step connects C1 and C2.  The O state is 
accessed from C2, and is arranged in series with the D state D.  C.  4-state kinetic model, 
in branched arrangement.  D and O states are arranged in parallel, each being directly 
accessible following sojourns in the ligand-bound closed state.  All rate constants referred 
to in the text and in subsequent figures have units of s
-1
, except for the binding rate, kon, 
which is multiplied by the concentration of ligand, and thus has units of s
-1 
M
-1
. 
 
 
 
using a branched arrangement of states, which at high agonist concentration, reduces to 
the scheme shown in Figure 5C.  In both cases, the single non-conducting state not 
associated with a binding step was designated the desensitized (D) state.  This was 
supported by the fact that no combination of rate constants supported macroscopic 
desensitization in the absence of this state (Appendix IV). 
To gain insight into the mechanistic basis for coupling and uncoupling, 
simulations were conducted to explore the effects of agonist affinity, agonist 
concentration, open state efficacy, and desensitized state stability (defined as the ratio of 
the entry rate, δ, to the exit rate, ρ) on macroscopic desensitization and deactivation.  
While the comprehensive α1β3γ2L receptor model was used to recapitulate our 
experimental findings, the simple 4-state models were used to systematically evaluate the 
impact of each kinetic parameter on macroscopic currents.  By co-varying rate constants, 
the kinetic conditions for which deactivation was either coupled to or uncoupled from 
macroscopic desensitization were determined.  In this manner, we elucidated patterns 
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relevant to the experimental setting, where neither the kinetic model nor the relevant 
underlying transitions are typically known. 
 
The relationships among agonist unbinding, macroscopic desensitization, and 
deactivation 
 
Our experimental observations using agonists of different affinity suggested that 
unbinding, the terminating step in the relaxation of activated receptors to the resting state, 
could have a dominant influence on deactivation independent of the rate or extent of 
macroscopic desensitization.  This form of desensitization-deactivation uncoupling was 
further examined using the comprehensive α1β3γ2L receptor model (Figure 5A) (Haas 
and Macdonald, 1999).  For a 30-fold increase (Figure 6A1) or decrease (Figure 6A2) in 
koff, the peak current amplitude and shape of macroscopic desensitization were nearly 
overlapping during activation by a near-saturating GABA concentration, while 
deactivation differed markedly (current with the “wild-type” koff is marked with an 
asterisk).  Additional increases in koff resulted in decreased peak amplitude, attributable to 
substantial shifts in GABA EC50 that rendered 1 mM GABA sub-saturating and thus 
slowed macroscopic activation (which also resulted in decreased apparent 
desensitization; not shown).  The same phenomena were also observed for alterations in 
koff using the 4-state branched and linear models (not shown).  These results confirmed 
that deactivation could be markedly altered by changes in unbinding that produced little 
effect on macroscopic desensitization, similar to our experimental observations with 
currents evoked by agonists of different affinity (Figure 1; Jones et al., 1998). 
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Figure 6.  Predicted effects of altering microscopic unbinding on macroscopic 
desensitization and deactivation 
 
A.  Simulated responses to 400 ms applications of near-saturating GABA (1 mM) were 
overlapped for various values of koff using the comprehensive α1β3γ2L receptor model 
(Figure 5A).  In the left panel, koff = 5100, 1700, 510, and 170 s
-1
.  In the right panel, koff 
= 170, 51, 17, and 5.1 s
-1
.  Currents were not normalized.  Insets show the first 10 ms of 
the overlapped traces to illustrate the effect of altering koff on activation rate and peak 
current amplitude.  * indicates “wild-type” deactivation, where koff = 170 s
-1
.  B.  
Simulated current responses to 5 ms applications of GABA (1 mM) for wild type (*) and 
either increasing (B1; koff varied from 170 to 170,000 s
-1
) or decreasing (B2; koff varied 
from 170 to 0 s
-1
) unbinding rates.  For the two fastest koff traces, the GABA 
concentration was raised to 20 mM to overcome the extremely low affinity.  C.  In the 
left panel, simulated responses of the α1β3γ2L model to 5 or 1000 ms pulses (black lines, 
open circles) were overlaid with a simulated response to a 5 ms pulse when koff was set to 
zero (gray line, filled circle).  In the right panel, the response of the same model, but 
without D states, to a 1 second application of 1 mM GABA (black line, open circle) is 
overlaid with a 5 ms application for which koff was set to zero (gray line, filled circle).  
The small amount of macroscopic desensitization that persisted even in the absence of 
desensitized states was due to C4 serving as a “branched” D state relative to O2. 
 
 
 
Macroscopic desensitization sets a boundary condition for deactivation time course 
 
To investigate the relationship between koff and deactivation under synaptic 
conditions, currents evoked by brief GABA pulses were simulated using the α1β3γ2L 
model in the context of increasing (Figure 6B1) or decreasing (Figure 6B2) koff.  The 
resulting deactivation currents were multi-phasic, with the fast phase demonstrating less 
sensitivity to changes in koff than the slower phases (Figure 6B1, 6B2).  Overall, both 
slow and fast phases of deactivation became faster with increasing koff until approaching 
a limit at higher koff values (Figure 6B1).  Similarly, with decreasing koff, both slow and 
fast phases of deactivation became slower until approaching a limit at lower koff values 
(Figure 6B2).  The observation of a fast limit under conditions of extremely rapid 
unbinding was not surprising, since open receptors must close before unbinding, in which 
case, open durations (or in the case of more complex models, burst/cluster durations) 
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become rate limiting.  The basis for the slow limit, however, was less clear.  Given that 
the slowly desensitizing α6β3δ isoform also deactivated slowly (Figure 1E), we 
hypothesized that macroscopic desensitization served to limit the deactivation time 
course.  Although this initially seemed counterintuitive, additional simulations revealed a 
simple kinetic basis for this phenomenon. 
The simulated response to a 5 ms pulse of 1 mM GABA using the kinetic scheme 
of Figure 5A and the default value for koff (Figure 6C1, left open circle) was compared to 
the response of the same brief pulse in the extreme case when koff was set to zero (Figure 
6C1, filled circle).  As expected, when unbinding could not occur, the deactivation time 
course was markedly prolonged.  Interestingly, when the response to a 1 second 
application of 1 mM GABA was overlaid on these responses (Figure 6C1, right open 
circle), it was found to follow a time course identical to that of deactivation following the 
5 ms pulse when koff was set to zero (Figure 6C1, filled circle).  The overlap between 
deactivation following the 5 ms pulse (where unbinding was impossible) and 
macroscopic desensitization during the 1 second pulse (where unbinding was possible, 
but functionally irrelevant given the near-saturating agonist concentration) occurred 
simply because receptors were fully liganded in both conditions, and as a result, behaved 
in the same manner.  Similar constraints on the deactivation time course by macroscopic 
desensitization were also evident with the 4-state models (not shown). 
The idea that the time course of deactivation could not be slower than 
macroscopic desensitization was illustrated further by repeating the simulations of Figure 
6C1 in the absence of all three D states.  We compared the currents generated by a 1 
second pulse of 1 mM GABA using the default value for koff (Figure 6C2, open circle) 
107 
 
with a 5 ms pulse where koff was set to zero (Figure 6C2, filled circle).  Again, 
deactivation following the brief pulse followed the same time course as that of 
macroscopic desensitization during the 1 second pulse.  However, compared to 
deactivation in the context of all three D states, the overall time course was markedly 
prolonged (compare Figure 6C1 to Figure 6C2; filled circles).  Thus, when unbinding 
was impossible, desensitization-deactivation uncoupling always occurred, as decreased 
macroscopic desensitization allowed for prolonged deactivation, while increased 
macroscopic desensitization forced deactivation to accelerate. 
It should be noted that the constraint imposed by macroscopic desensitization on 
deactivation actually depended on the duration of agonist application.  For example, the 
constraint imposed on the fast phase of deactivation was limited to brief applications, 
because macroscopic desensitization manifested a fast phase selectively in this time 
domain.  In other words, only if an agonist pulse terminated prior to the onset of a given 
phase of macroscopic desensitization could that phase constrain deactivation.  Thus, 
while deactivation following brief pulses was constrained by all phases of macroscopic 
desensitization, deactivation following prolonged pulses, where macroscopic fast 
desensitization had already occurred, was only constrained by slower phases of 
desensitization. 
Although the extreme case of irreversible binding was used to illustrate the 
complex interplay between macroscopic desensitization and deactivation, the 
interpretations are applicable to the continuum of rate constants likely to occur 
biologically.  The implication of fast macroscopic desensitization in shaping the fast 
phase of deactivation is of particular physiological relevance since rapid desensitization 
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has been widely observed in native and recombinant GABAA receptor currents 
(Celentano and Wong, 1994; Jones and Westbrook, 1995; Tia et al., 1997, Haas and 
Macdonald, 1999; Li and Pearce, 2000; Burkat et al., 2001; Mozrzymas et al., 2003; 
Scheller and Forman, 2002; Yang et al., 2002).  In summary, the simulations suggested 
that the effect of agonist affinity on deactivation was not actually independent of 
macroscopic desensitization.  Instead, agonist affinity determined the “position” of 
deactivation between two limits: a fast limit dictated by channel gating, and a slow one 
imparted by the shape of macroscopic desensitization. 
 
The relationships among agonist concentration, macroscopic desensitization, and 
deactivation 
 
Higher concentrations of GABA evoke faster and more extensively desensitizing 
currents (Figure 2A), but it is important to distinguish between two possible explanations 
for this phenomenon: increased D state occupancy, or improved resolution of the 
concentration-independent desensitization process.  While the experimental observation 
of similar deactivation time courses for currents evoked by concentrations above ~EC20 
(3 μM) suggested that relative occupancy of microscopic states was similar over this 
range of concentrations, we further explored this hypothesis using kinetic simulations.  
Using the α1β3γ2L model (Figure 5A), currents evoked by four different agonist 
concentrations were simulated (Figure 7A).  Total D state occupancy (sum of Df + Di + 
Ds) is represented in the upward traces, while total O state occupancy (sum of O1 + O2 + 
O3) is represented in the downward traces (i.e., the currents).  When the current evoked 
by 10 M GABA (~EC30) was compared with the current evoked by 1 mM GABA  
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Figure 7.  Predicted concentration dependence of macroscopic desensitization and 
deactivation 
 
A.  The sum of desensitized state (upward traces) and open state (downward traces) 
occupancies are shown for 4 agonist concentrations (1, 3, 10, and 1000 M) using the 
comprehensive α1β3γ2L receptor model from Figure 5A.  The top of the upward traces 
and the bottom of the downward traces corresponds to 1000 M.  The calibration bars 
apply to both sets of traces.  The vertical calibration represents a probability of receptor 
occupancy of 0.2.  Note that the currents (downward traces) and the D state probability 
curves (upward traces) represent the combined occupancy of all 3 O and D states, 
respectively.  B.  Weighted deactivation time constant of simulated currents generated 
with the α1β3γ2L model over a range of GABA concentrations applied for 400 ms.  For 
each concentration, simulations were generated using the “wild-type” rate constants 
(open circles), setting the entry rate into Df to zero (filled circles), setting the entry rates 
into both Di and Ds to zero (gray circles), and setting entry rates into all 3 desensitized 
states to zero (x).  The labels to the right of the circles indicated the desensitized states 
that remained accessible for a set of simulations.  The longer deactivation predicted by 
the model relative to the experimental data may be attributed to a long time constant that 
is unlikely to be resolved experimentally because its small amplitude would be difficult 
to distinguish from baseline noise. 
110 
 
(~EC100), marked differences were observed in the extent of macroscopic desensitization, 
though the fractional occupancy of D states was similar (Figure 7A).  This clearly 
demonstrated that increasing concentrations of GABA did not produce increasing extents 
of macroscopic desensitization due to increased accessibility of D states.  Equilibrium 
occupancy of O states was also similar in this concentration range, indicating that 
increasing the GABA concentration did not substantially affect the equilibrium 
occupancy of fully-liganded receptors.  Consistent with this result, simulated deactivation 
was faster only following applications of very low GABA concentrations (Figure 7B).  
Interestingly, the simulated current generated by 0.3 M GABA (Figure 7A, smallest 
current) was associated with several-fold higher probability of D state occupancy (Figure 
7A, smallest of the upward traces) than of O state occupancy, despite the extent of 
macroscopic desensitization being <1%.  Taken together, these findings demonstrated 
that the extent of macroscopic desensitization was a poor predictor of desensitized state 
occupancy. 
To investigate the kinetic basis for this concentration relationship, we measured 
deactivation over this concentration range for simulations in which one or more D states 
were eliminated.  Eliminating Df accelerated deactivation similarly at each concentration 
(Figure 7B, filled circles) relative to the intact scheme (Figure 7B, open circles), 
suggesting that this state contributed to deactivation similarly at all tested concentrations.  
Eliminating the two slower D states, however, accelerated deactivation and blunted the 
concentration-dependence (Figure 7B, gray circles), suggesting that receptors activated 
by very low agonist concentrations were unable to achieve sufficient occupancy of these 
slowly equilibrating states.  Because low concentrations forced receptors to spend more 
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time in mono- and unliganded states, receptors had fewer opportunities to enter slowly 
equilibrating D states (which were only accessible to di-liganded receptors).  In support 
of this slow equilibration idea, increasing the application duration (>25 seconds) for low 
concentrations (300 nM and 1 M GABA) allowed receptors time to equilibrate among 
slower D states, significantly prolonging the time course of deactivation (not shown).  In 
other words, increasing the fractional occupancy of slowly equilibrating D states (Di and 
Ds) could be accomplished either by increasing the concentration of agonist for a given 
duration application, or by increasing the application duration for low concentrations. 
 
The relationship between macroscopic desensitization and the stability of open and 
desensitized states 
 
Although macroscopic desensitization is not possible without D states, extracting 
microscopic information about D states from current traces remains a significant 
challenge, as other states are known to contribute to macroscopic current shape 
(Mozrzymas et al., 2003; Celentano and Hawkes, 2004; Appendix III).  We therefore 
examined the extent of macroscopic desensitization (percent of current lost) for branched 
and linear 4-state models (Figure 5), over a range of entry and exit rate constants from O 
and D states spanning two orders of magnitude (60 s
-1
 to 6000 s
-1
).  Plotting the extent of 
macroscopic desensitization (on the ordinate) against each pair of rate constants yielded a 
“landscape” illustrating the dependence of macroscopic desensitization on the relative 
stability (defined as the ratio of the entry rate to the exit rate) of O (/) and D (/) 
states (Figure 8).  For example, in Figures 8A and 8B, the extent of macroscopic 
desensitization of the branched model was evaluated over a range of β and α values (right  
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Figure 8.  Dependence of the extent of macroscopic desensitization on the stability of 
open and desensitized states for branched and linear kinetic schemes 
 
Landscape plots illustrate the extent of macroscopic desensitization (Z axis) for branched 
(A-D) and linear (E-H) kinetic schemes over a range of β/α and δ/ρ combinations.  The Z 
axis labels of panel A apply to all 8 plots.  Each grid shows the 81 combinations of rate 
constants used to generate the simulated currents (not shown), the values of which are 
indicated in the four corners of each plot by variable letter sizes.  Large letters correspond 
to 6000 s
-1
, small letters correspond to 60 s
-1
, and the rate constant values in between 
were 3000, 2000, 1000, 600, 300, 200 and 100
 
s
-1
 (not labeled).  The top 4 landscapes 
were generated using the branched 4-state model (Figure 5C), and the bottom 4 were 
generated using the linear 4-state model (Figure 5B).  For all panels, kon = 10
6 
s
-1
M
-1
, koff 
= 300 s
-1
, and the GABA concentration was 1 mM.  For panels in which the O state 
transitions were varied (A, B, E, F), the D state rate constants were δ = 1.0 and ρ = 0.1 for 
“high D stability” panels, and δ = 0.6 and ρ = 0.6 for “low D stability” panels.  For panels 
in which the D state transitions were varied, the O state rate constants were β = 3.0; and α 
= 0.6 for “high efficacy” panels and β = 0.3; and α = 2.0 for “low efficacy” panels.  Note 
that in simulations of the linear kinetic scheme, efficacy was actually changing in the δ x 
ρ grids because open duration was determined by the reciprocal sum of the two “closing” 
rate constants: α and δ. 
 
 
 
and left corners represented the highest and lowest O state stabilities, respectively), in the 
context of either more (panel A) or less (panel B) D state stability.  Note that for these 
simplified schemes, the percent of current lost was considered a suitable index of 
macroscopic desensitization, as faster time constants correlated in most cases with more 
extensive desensitization (not shown). 
When efficacy (O state stability; β/α) was varied in the branched model, the 
extent of macroscopic desensitization was greatest for high values of α (brief openings), 
and least when α was low (long openings) (Figure 8A, B).  Increasing β (higher opening 
frequency) reduced the extent of macroscopic desensitization, while decreasing β (lower 
opening frequency) increased the extent.  Although varying β had much less of an effect 
than varying α, these landscape patterns were consistent with the idea that increasing 
efficacy caused the branched model to shift towards a C-C-O arrangement, which cannot 
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macroscopically desensitize (Appendix IV).  When D state stability was varied in the 
branched model, the extent of macroscopic desensitization was greatest for high values of  
δ and low values of ρ (Figures 8C, 8D).  Overall, the high efficacy condition (Figure 8C) 
displayed less macroscopic desensitization than the low efficacy condition (Figure 8D), 
again reflecting the inability of C-C-O arrangements to macroscopically desensitize.  
Note, however, that high values of δ were not always associated with macroscopic 
desensitization, even for low efficacy receptors (Figure 8D).  Indeed, macroscopic 
desensitization was only possible when α was greater than ρ (Appendix IV).  When this 
condition was violated, neither increasing δ nor decreasing β restored macroscopic 
desensitization, even when this drove D state fractional occupancy above 90% (not 
shown). 
Varying efficacy in the linear model produced patterns of macroscopic 
desensitization distinct from those of the branched model (Figures 8E, 8F).  The extent of 
macroscopic desensitization was greatest when efficacy was highest and was more 
sensitive to changing β than α.  In addition, while both models predicted extensive 
macroscopic desensitization for high values of δ and low values of ρ (Figures 8C, 8D, 
8G, 8H), high efficacy receptors in the linear model were more susceptible to changes in 
D state stability than low efficacy receptors (Figures 8G, 8H).  Interestingly, the rate 
constant relationships that determined whether macroscopic desensitization occurred 
were also different.  Unlike the branched model, macroscopic desensitization was 
possible in the linear model only when β was greater than ρ (Appendix IV).  When this 
condition was violated, altering other rate constants could not restore macroscopic 
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desensitization, even when this yielded D state fractional occupancies above 90% (not 
shown). 
These results demonstrated that tremendous variation in macroscopic 
desensitization could arise despite constant D state stability (note the constant δ/ρ ratio 
along the diagonal between the nearest and furthest corners of Figure 8D).  Conversely, 
the landscapes demonstrated regions of negligible macroscopic desensitization despite 
marked changes D state stability.  Thus, current shape was a poor predictor of D state 
fractional occupancy, suggesting that failure to observe macroscopic desensitization 
should not, by itself, be considered evidence against the presence of D states.  Although 
macroscopic currents are shaped by all rate constants in the gating scheme (Mozrzymas 
et al., 2003; Appendix III), these results also suggested that only certain rate constants 
determine whether macroscopic desensitization can occur (Appendix IV). 
 
The relationship between deactivation and the stability of open and desensitized states 
 
Similar to the approach taken in the previous section to determine the relationship 
between individual rate constants and the extent of macroscopic desensitization, 
landscape plots were generated from weighted deactivation time courses following 
simulated 100 ms agonist pulses for branched (Figures 9A-D) and linear (Figures 9E-H)  
schemes.  For the branched model, increasing efficacy prolonged deactivation while 
decreasing efficacy accelerated deactivation, in the context of both high (Figure 9A) and 
low (Figure 9B) D state stabilities.  These deactivation landscapes, however, trended in 
the opposite direction compared to their corresponding desensitization landscapes  
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Figure 9.  Dependence of deactivation time course on the stability of the open and 
desensitized states for branched and linear schemes 
 
Landscape plots illustrate the weighted deactivation time constant (Z axis) for branched 
(A-D) and linear (E-H) kinetic schemes over a range of β/α and δ/ combinations.  The Z 
axis labels in panel A apply to all 8 panels.  See the legend of Figure 8 for plot 
descriptions and rate constants. 
 
 
 
 (compare Figures 9A, 9B to Figures 8A, 8B), thus revealing a pattern of uncoupling: 
regions with the slowest deactivation showed the least macroscopic desensitization, while 
those with the fastest deactivation showed the most macroscopic desensitization.  Figures 
9C and 9D illustrated branched model deactivation when D state stability was varied in 
the context of high and low efficacy.  Deactivation was slowest for the most stable D 
state conditions and fastest for the least stable D state conditions for both high and low 
efficacy conditions, matching the relationship between deactivation and efficacy (Figures 
9A and 9B).  These deactivation landscapes trended in the same direction as their 
corresponding desensitization landscapes (compare Figures 9C, 9D to Figures 8C, 8D), 
thus illustrating desensitization-deactivation coupling.  Note, however, that deactivation 
varied substantially even for regions that lacked macroscopic desensitization. 
Similar to the branched model, increasing and decreasing O or D state stabilities 
in the linear model corresponded to longer and shorter deactivation time courses, 
respectively (Figures 9E-9H).  This suggested that unlike macroscopic desensitization, 
the effect of stabilizing O and D states on deactivation was independent of model 
connectivity, consistent with the idea that weighted deactivation time courses simply 
reflect the mean time receptors are agonist bound, which increases when O and/or D  
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Figure 10.  The interplay between agonist affinity, gating efficacy, desensitized state 
stability, and model connectivity on current deactivation 
 
Simulated responses of linear and branched kinetic models (Figure 5B, C) to 5 ms pulses 
of nearly-saturating GABA concentrations (1 mM to 20 mM; higher concentrations were 
required when koff was high) in the context of different O and D state stabilities.  Within 
each panel, koff was varied from 10 s
-1
 to 100,000 s
-1
.   All other rate constants were 
identical to those used in Figures 8 and 9.  Horizontal scale bar applies to all traces.  
Open circles in each panel indicate traces corresponding to the slowest unbinding rate. 
 
 
 
states are stabilized (Appendix II).  Exceptions to this relationship between time bound 
and deactivation include irreversible microscopic desensitization, and small amplitude 
components not resolvable through baseline noise (neither case is considered here). 
There were, however, notable quantitative differences between branched and 
linear deactivation landscapes.  Compared to the branched model (Figures 9A-D to 
Figures 9E-H), stabilizing O and/or D states in the linear model resulted in slower 
deactivation (Figures 9E-H, right corners).  This was related to O and D states being 
directly interconnected, which allowed transitions without any chance of unbinding.    It 
should also be noted that while deactivation was typically biphasic for both models, the 
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magnitude and relative contribution of each phase depended greatly on state connectivity.  
This was particularly evident for deactivation following brief pulses, whose time course 
was constrained by macroscopic desensitization (Figure 6).  For example, while 
deactivation in the linear model had the most prominent fast phase when efficacy was 
high (which corresponded to extensive macroscopic desensitization; Figure 8), the 
opposite was true for the branched model (Figure 10). 
Interestingly, all deactivation landscapes obtained with the linear model trended 
in the same direction as their corresponding desensitization landscapes, suggesting that 
linear arrangements primarily supported desensitization-deactivation coupling (compare 
Figures 9E-H with Figures 8E-H).  As with the branched model, however, changes in 
deactivation were observed even when corresponding grid positions lacked macroscopic 
desensitization, providing additional landscape regions of apparent uncoupling.  These 
results suggested that neither coupling nor uncoupling was the rule per se for GABAA 
receptors.  Instead, it appeared that both phenomena were theoretically possible for any 
given kinetic scheme, the result of desensitization and deactivation having markedly 
different kinetic determinants. 
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DISCUSSION 
 
Coupling and uncoupling of macroscopic desensitization and deactivation 
 
It is common practice to use the term “coupled” to describe correlated 
observations, such as that of fast desensitization with slow deactivation.  We described 
several experimental conditions that differed from the typical correlation of fast 
desensitization with slow deactivation, or of slow desensitization with fast deactivation.  
Such “uncoupling” resulted from macroscopic desensitization and deactivation being 
differentially sensitive to changes in certain rate constants, and consequently, able to vary 
independently.  We found the kinetic determinants of macroscopic desensitization to be 
complex, depending not only on the relationship between subsets of rate constants, but 
also on the specific connectivity of states (Appendix IV). 
While we limited our simulations to non-cyclic gating schemes, coupling and 
uncoupling are also theoretically possible for schemes containing cyclic features 
(Scheller and Forman, 2002), as macroscopic desensitization and deactivation have 
different kinetic determinants under these circumstances as well.  We did not, however, 
systematically evaluate the behavior of cyclic schemes, as they introduced a higher level 
of kinetic complexity to the simulations (for example, maintaining microscopic 
reversibility precluded alterations of individual rate constants).  In addition, our prior data 
suggested that unbinding does not occur from fully-liganded open or pre-open states 
(Bianchi and Macdonald, 2001a), which argues against the presence of cyclic features. 
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The relationship between macroscopic current shape and microscopic rate constants 
 
Our simulations emphasized that macroscopic phenomena could not be attributed 
to individual states or rate constants; rather, they were shaped by all transitions within a 
given scheme, as well as the connectivity of states (Mozrzymas et al., 2003; Appendix 
III).  As a result, the terminology used to describe an experimental observation may 
inappropriately suggest relevance to a microscopic process.  For this reason, Colquhoun 
(1998) has argued against using “affinity” or even “apparent affinity” interchangeably 
with EC50.  Similarly, the phenomenological description of fading current during 
continued agonist application as “desensitization” implies relevance to microscopic D 
states; however, simulations indicated that macroscopic desensitization provides little or 
no information about the fractional occupancy or stability of D states.  Even  “flat” 
currents do not preclude existence of D states; indeed, the fractional occupancy of D 
states can actually exceed that of O states (Figure 7).  Moreover, describing macroscopic 
desensitization requires observation of an initial peak amplitude, which may imply that 
microscopic desensitization is a kinetic process mechanistically preceded by channel 
opening (Colquhoun and Hawkes, 1995).  Our simulations, however, demonstrated that D 
states may achieve substantial occupancy before currents reach peak, and therefore, 
before any loss of macroscopic current can be measured. 
 
The influence of agonist affinity on desensitization and deactivation 
 
Both the extent and time course of macroscopic desensitization were relatively 
insensitive to changes in agonist affinity in the setting of a near-saturating GABA 
concentration.  This occurred because the effective binding rate (kon x [GABA]) was 
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orders of magnitude higher than the unbinding rate (koff), and as a result, changes in 
affinity could not affect the relative distribution of receptors in the gating scheme (which 
were essentially fully-liganded).  In contrast, deactivation was highly sensitive to agonist 
affinity, as the unbinding rate was an important determinant of the rate at which receptors 
returned to the resting state.  While this represented one example of apparent uncoupling 
between desensitization and deactivation, it should be noted that altering affinity in the 
context of sub-saturating agonist concentrations causes desensitization-deactivation 
coupling.  Under these conditions, increasing agonist affinity not only prolongs 
deactivation, but also increases the extent of macroscopic desensitization (as if a higher 
concentration of agonist was applied; see Figure 7). 
Although the unbinding rate played a dominant role in shaping deactivation under 
certain circumstances, it was clear that multiple microscopic parameters contributed to 
the deactivation time course, including the unbinding rate constant, the entry and exit 
rates from O and D states, and the gating scheme connectivity.  Interestingly, 
macroscopic desensitization constrained the effect of agonist affinity on deactivation by 
providing a slow limit to its time course.  This constraint had particular relevance to brief 
(such as synaptic) pulses, where the fast phase of deactivation could not be slower than 
the fast phase of macroscopic desensitization.  An unexpected consequence of this 
finding was that deactivation of currents lacking fast macroscopic desensitization should 
theoretically be unconstrained (Figures 2E and 6D), a concept that may be important for 
understanding the kinetic basis for prolonged deactivation in the slowly desensitizing but 
high affinity α4βδ and α6βδ isoforms.  Thus, not only can prolonged deactivation occur 
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without macroscopic desensitization, but the presence of fast macroscopic desensitization 
may actually accelerate early phases of deactivation. 
 
The influence of gating efficacy on macroscopic desensitization and deactivation 
 
Whether unbinding from the O state is assumed to be impossible (non-cyclic 
schemes) or less probable than unbinding from other states (cyclic schemes), increasing 
efficacy in branched arrangements is predicted to prolong deactivation (Figure 9A, 9B).  
Since increased O state occupancy shifts the gating scheme towards the C-C-O 
arrangement (which cannot macroscopically desensitize; Appendix IV), this reduces the 
extent of macroscopic desensitization (Figure 8A, 8B), thereby providing an example of 
uncoupling.  In the linear model, however, the concept of efficacy is more complex.  
Increasing efficacy can technically occur in two ways (since there are two routes for 
channel closure): increasing β/α or decreasing δ/ρ.  Increasing β/α prolongs deactivation 
because of increased time spent in both O and D states.  Increasing efficacy via 
decreasing δ/ρ, however, increases O state occupancy while decreasing D state 
occupancy.  In our simulations, the changes in D state occupancy dominated, likely due 
to the more distal positioning of the D state relative to the unbinding step.  Thus, unlike 
in the branched model, increasing efficacy in the linear scheme can either prolong (via 
β/α) or accelerate (via δ/ρ) deactivation.  Either way, altered efficacy in the linear scheme 
is always associated with coupling.  If efficacy is increased via increasing β/α, 
deactivation is prolonged and the extent of macroscopic desensitization is increased 
(Figures 8E, 8F, 9E, 9F).  If efficacy is increased via decreasing δ/ρ, deactivation is  
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Figure 11.  Predicted effects of increased efficacy on macroscopic current properties 
using a comprehensive model of GABAA receptor function 
 
Using the α1β3γ2L receptor kinetic model (Figure 5A), the effect of increasing efficacy 
(via decreasing the exit rate from the O2 state) was evaluated on current rise time 
(“Rise10-90”), extent and time course of macroscopic desensitization (“Desensitization”), 
and weighted deactivation time course (“Deact τw”).  “τn“ and “An“ indicate the time 
constant and relative contribution of each exponential component to the time course of 
macroscopic desensitization, respectively.  “C” indicates the fraction of current remaining 
at the end of the GABA pulse.  Values for deactivation reflect exponential fitting of 
curents for 10 s following pulse termination (not shown).  A, B.  Simulated responses to 
prolonged (4 s) and brief (5 ms) applications of 1 mM GABA to wild-type receptors 
(WT).  C, D.  Simulated responses to prolonged (4 s) and brief (5 ms) applications of 1 
mM GABA to higher efficacy receptors, achieved by decreasing the exit rate from O2 
(α2/10).  Note that decreasing α2 ten-fold increases the mean dwell time in O2 less than 
two-fold, the result of multiple routes existing for channel closure. 
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accelerated and the extent of macroscopic desensitization is decreased (Figures 8G, 8H, 
9G, 9H).  Therefore, uncoupling in the context of altered efficacy necessitates a branched 
arrangement. 
Several experimental observations argue against a purely linear kinetic 
arrangement for GABAA receptors.  Barbiturates prolong IPSC duration via increased 
gating efficacy (Twyman, et al., 1989) while decreasing the extent of macroscopic 
desensitization (Feng, et al., 2004), consistent with a branched arrangement.  Increased 
efficacy in the context of uncoupling due to mutations in the pore-domain supports this 
idea (Figures 3 and 4).  Although altered efficacy may be only one of several kinetic 
alterations caused by the α1(L9’S) mutation, preliminary simulations using the 
comprehensive α1β3γ2L model (Figure 5), whose O and D states are in branched 
arrangement, confirm that increasing efficacy can recapitulate the decreased macroscopic 
desensitization, prolonged deactivation following brief but not long applications, and 
slower rise time (Figure 11). 
 
Predictive microscopic kinetic value of observed changes in macroscopic 
desensitization and deactivation 
 
Although the complex kinetic basis underlying current shape essentially precludes 
direct extraction of microscopic parameters, the differential sensitivities of macroscopic 
desensitization and deactivation to various kinetic parameters can help distinguish 
between model arrangements and guide mechanistic interpretations (Figure 12).  For 
example, given an experimental observation of decreased macroscopic desensitization 
(from a mutation or allosteric modulator), changes in deactivation could be used to  
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Figure 12.  Flowchart for interpreting changes in GABAA receptor current kinetics 
 
The flowchart depicts an algorithmic approach for interpreting the effect of a kinetic 
perturbation (due to a mutation or allosteric modulator) on GABAA receptor macroscopic 
currents.  By analyzing macroscopic current properties (“Des”, extent of desensitization; 
“Deact ”, weighted deactivation time constant) and single channel kinetic properties, 
both the relevant microscopic transition (β/α, δ/, kon/koff) and the arrangement of O and 
D states (branched or linear) can be determined assuming a simple 4-state kinetic scheme.  
The abbreviations “ Des”, “ Des”, and “= Des” refer to increased, decreased, and 
unchanged extents of macroscopic desensitization, respectively, when receptors are 
activated by a nearly-saturating GABA concentration.  “ Deact ” and “ Deact ” refer 
to prolonged and shortened time courses of deactivation, respectively.  * indicates that for 
linear models, changes in either β/α or δ/ will change efficacy, since receptors can open 
and close via two independent pathways. 
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constrain the number of potentially responsible microscopic transitions.  If deactivation 
was prolonged (uncoupling), this would be consistent with increased efficacy in a 
branched model, a prediction testable using single channel recording.  However, if 
deactivation was accelerated (coupling), this could result from destabilization of the D 
state in either kinetic scheme or from decreased efficacy in the linear scheme.  
Comparing peak current amplitudes would then be useful, since destabilization of the D 
state and decreased efficacy should have opposite effects (increased and decreased peak 
current amplitudes, respectively).  If peak current amplitude was increased, single 
channel studies could then be employed to distinguish between D state destabilization in 
branched and linear schemes.  If the D state was destabilized in the branched model, then 
efficacy should be unchanged.  If, however, the D state was destabilized in the linear 
model, then efficacy would be expected to increase. 
Single channel studies might also be helpful for distinguishing branched and 
linear arrangements in the special case of unchanged desensitization but altered 
deactivation, an example of uncoupling presumably reflecting altered microscopic 
affinity.  In this case, evaluation of the concentration sensitivity of the closed time 
distribution can expose different arrangements of D states.  Only linear arrangements can 
yield a fixed (concentration-independent) time constant, since only then do a subset of all 
closures correspond with certainty to sojourns in a single closed state (Colquhoun and 
Hawkes, 1982).  In contrast, branched D states are directly connected with the pre-open 
state, which is directly connected with the unbound state.  Thus, individual closures may 
include transitions among all three closed states, causing the time constants to depend on 
a complex relationship between all rate constants connecting these states.  Since one of 
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these rates (the effective binding rate) depends on the agonist concentration, all time 
constants will be concentration sensitive, even though entry and exit rates from the D 
state are not themselves concentration dependent.  It should be noted that while this 
approach is valid in theory, in practice, even branched arrangements can appear to have 
fixed time constants when D states are very long-lived.  Nonetheless, if all time constants 
in the closed time distribution vary with concentration, then it can be concluded that all 
non-conducting states in the gating scheme are connected. 
Despite the mentioned limitations, the goal of this algorithmic approach was to 
collapse the spectrum of potential explanations for a given macroscopic observation into 
a smaller and potentially testable set of hypotheses.  Although the observations outlined 
here represent characterization of simplified models that likely underestimate the 
complexity of GABAA receptor kinetics, it is clear that even in these simplified cases, 
macroscopic current interpretation can be complex or even counterintuitive.  The 
likelihood that GABAA receptors obey even more complex kinetic rules emphasizes the 
necessity for establishing more quantitative frameworks to transition from macroscopic 
observations to microscopic models. 
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CHAPTER III 
 
 
 
BENZODIAZEPINE MODULATION OF GABAA RECEPTOR 
OPENING FREQUENCY DEPENDS ON ACTIVATION CONTEXT: 
A PATCH CLAMP AND SIMULATION STUDY 
 
 
 
Emmanuel J. Botzolakis, Matt T. Bianchi, Andre H. Lagrange, and Robert L. Macdonald 
 
ABSTRACT 
Benzodiazepines (BDZs) are GABAA receptor modulators with anxiolytic, 
hypnotic, and anti-convulsant properties.  BDZs are understood to potentiate GABAA 
receptor function by increasing channel opening frequency, in contrast to barbiturates, 
which increase channel open duration.  However, the in vitro evidence demonstrating 
increased opening frequency involved prolonged exposure to sub-saturating GABA 
concentrations, conditions most similar to those found in extrasynaptic areas.  In contrast, 
synaptic GABAA receptors are transiently activated by high GABA concentrations.  To 
determine if BDZ modulation of single-channel opening frequency would be different for 
BDZ-sensitive receptors activated under synaptic versus extrasynaptic conditions, a 
combination of patch-clamp recording and kinetic modeling was used.  Consistent with 
the original experimental findings, BDZs were found to increase receptor affinity for 
GABA by decreasing the unbinding rate.  While this mechanism was predicted to 
increase opening frequency under extrasynaptic conditions, simulations predicted that the 
same mechanism under synaptic conditions would increase the number, but not the 
frequency, of single-channel openings.  Thus, a single mechanism (slower GABA 
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unbinding) can produce differential changes in opening frequency under synaptic versus 
extrasynaptic conditions.  The functional impact of BDZs on GABAA receptors therefore 
depends upon the physiological context of receptor activation. 
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INTRODUCTION 
As the predominant source of fast synaptic inhibition in the brain, GABAA 
receptors have been the focus of emerging hypotheses not only of seizure 
pathophysiology, but also of anticonvulsant drug pharmacology.  However, their role as 
the therapeutic target of benzodiazepines (BDZs) remained controversial for some time.  
While BDZs were observed to enhance GABAA receptor currents during intracellular 
recording from cultured neurons (Choh, et al., 1977; Macdonald and Barker, 1978), 
others studies suggested that BDZs were antagonists of GABAA receptors (Gahwiler, 
1976; Mathers, 1987), and still others indicated actions at glycine receptors (Young, et 
al., 1974).  Not until the development of single-channel recording (Colquhoun, 1991) was 
direct evidence presented that BDZs enhanced GABAA receptor responses (Rogers, et al., 
1994; Twyman, et al., 1989).  Specifically, BDZs were reported to increase single-
channel opening frequency without altering mean open duration, an effect attributed to an 
increased affinity of GABA for the receptor (Rogers, et al., 1994).  Barbiturates, in 
contrast, were reported to increase the duration of openings without increasing their 
frequency (Macdonald, et al., 1989; Twyman, et al., 1989). 
However, the in vitro electrophysiological evidence demonstrating BDZ-mediated 
increased opening frequency involved conditions most similar to those occurring in 
extrasynaptic areas, where receptors are persistently activated by sub-saturating 
concentrations of ambient GABA (~1 µM or less) (Farrant and Nusser, 2005).  Under 
these conditions, binding of GABA to the receptor is infrequent, and because GABA is 
always present, receptors are free to repeatedly bind and unbind GABA.  Synaptic 
receptors, in contrast, are transiently activated (~1 ms) by saturating concentrations of 
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GABA (~1 mM) (Jones and Westbrook, 1996), such that receptors are predominantly 
GABA-bound, and the majority of channel activity (which can last 10s-100s of 
milliseconds) occurs without the prospect of rebinding.  Given that BDZs were reported 
to increase the affinity of GABA for the receptor, a mechanism that favors GABA-bound 
receptor conformations, this suggests that the effects of BDZs on opening frequency 
would be different for receptors activated under synaptic versus extrasynaptic conditions.  
Although extrasynaptic receptors are enriched for BDZ-insensitive receptor isoforms 
(i.e., those containing the  subunit), BDZ-sensitive receptor isoforms (i.e., those 
containing the  subunit) occur commonly in extrasynaptic locations as well (Glykys, et 
al., 2008; Glykys and Mody, 2007), and in some cases, are actually more abundant than 
BDZ-insensitive receptors (Farrant and Nusser, 2005).  Therefore, the potential context-
dependence of BDZ modulation of GABAA receptor function remains an important 
mechanistic issue. 
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MATERIALS AND METHODS 
 
Cell culture and electrophysiology 
 
HEK293T cells were maintained in FBS-supplemented DMEM (Invitrogen, 
Grand Island, NY) and co-transfected with rat α1, β3, and γ2L GABAA receptor subunit 
cDNAs using Fugene 6 (Roche Diagnostics, Indianapolis, IN).  Co-transfection of cDNA 
encoding the pHook surface antibody allowed for immunomagnetic selection of 
positively-transfected cells.  Electrophysiological recordings were performed the day 
after selection, as described previously (Bianchi and Macdonald, 2001).  Briefly, patched 
cells were gently lifted from the culture dish and exposed to drug-containing solution via 
a rapid solution switching system (Hinkle, et al., 2003).  Solution exchange times were 
consistently < 400 μs when measured at the open patch electrode, but were slightly 
slower around the lifted cell.  Currents were recorded using an Axopatch 200A amplifier 
(Molecular Devices, Foster City, CA), low-pass filtered at 2 kHz, and digitized with the 
Digidata 1322A data acquisition system (Molecular Devices).  Diazepam was pre-applied 
for 1.0 sec prior to co-application with GABA.  Consecutive applications were separated 
by at least 45 sec to allow for complete GABA and diazepam unbinding.  GABA and 
diazepam were obtained from Sigma-Aldrich (St. Louis, MO). 
 
Kinetic Simulations 
 
Simulations of macroscopic currents (100s of receptors) were conducted using 
Berkeley Madonna (www.berkeleymadonna.com) software that solves the probability 
that a receptor will occupy any state of a kinetic model as a function of time.  QUB 
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(www.qub.buffalo.edu) software was used for single channel simulations such that 
resting (Cu), bound closed (Cb and D), and bound open (O) states could be distinguished 
via assigning different (arbitrary) current levels (Cu = 0 units, Cb and D = -2 units, and O 
= -6 units, respectively) to each state.  For equilibrium (“extrasynaptic”) simulations, 10 
ms after the start of the trial, 1 M GABA was applied for 1990 ms.  10 such trials 
constituted a batch.  For phasic (“synaptic”) simulations, 10 ms after the start of a trial, 1 
mM GABA was applied for 1 ms.  Channel openings were then observed for 490 ms.  50 
such trials were analyzed per batch, and batches were averaged for analysis.  GraphPad 
Prism (www.graphpad.com) was used for statistical analysis.  All data were plotted as 
mean + SEM, and statistical significance was taken as p < 0.05 using ANOVA followed 
by Tukey post-hoc analysis. 
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RESULTS 
 
GABAA receptor macroscopic current properties were predicted to have different 
sensitivities to changes in GABA affinity 
 
BDZs have been shown to enhance GABAA receptor currents by increasing the 
affinity of GABA for the receptor (defined as the ratio of the binding to the unbinding 
rate) (Twyman, et al., 1989), causing a “left shift” of the GABA concentration-response 
curve (Ghansah and Weiss, 1999).  This mechanism predicts that BDZs should increase 
peak current amplitude only when receptors are activated by sub-saturating 
concentrations of GABA.  Once receptors are activated by a saturating GABA 
concentration, no further increase in peak current should be possible through increasing 
agonist binding affinity (Ghansah and Weiss, 1999).  Furthermore, desensitization (the 
loss of current in the continued presence of agonist) should not be affected by BDZs 
during application of a saturating concentration of GABA, again because binding sites 
are already saturated (Bianchi, et al., 2007).  In contrast, the sensitivity of deactivation 
(the process by which currents return to baseline following GABA washout) to BDZs 
should depend on whether BDZs increased affinity by increasing the binding rate or 
decreasing the unbinding rate.  Since deactivation occurs in the absence of free GABA, 
its time course should be insensitive to changes in the binding rate (defined as the product 
of the “true” binding rate and the GABA concentration, which equals zero during 
deactivation).  In contrast, deactivation should be highly sensitive to slower unbinding, 
which increases the average time receptors spend GABA-bound, thus allowing for 
additional openings. 
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Figure 1.  Simplified 4-state kinetic model of GABAA receptor function. 
 
The model contains a single unbound closed state (Cu).  Agonist binding initiates the 
transition from Cu to the bound closed state (Cb).  This state can reversibly transition into 
either the open (O) or the desensitized (D) state.  Note that the binding rate is the product 
of Kon and the GABA concentration, which have units of M
-1
s
-1
 and M, respectively.  The 
remaining rate constants have units of s
-1
.  Model rate constants are:  Kon = 5 x 10
6
; Koff = 
1000; O+ = 800; O- = 500; D+ = 800; D- = 100. 
 
 
These predictions were tested using a simple kinetic model of GABAA receptor 
function, previously shown to be useful for investigating the relationship between 
microscopic and macroscopic current kinetics (Figure 1) (Bianchi, et al., 2007)  While 
this simplified model does not capture the rich kinetic behavior of GABAA receptors 
(Haas and Macdonald, 1999), it provides qualitative representation of the salient features 
of GABAA receptor currents (fast activation, fast desensitization, and relatively slow 
deactivation).  In this model, receptors can occupy one of 4 states: a resting closed state 
(closed-unbound, Cu), a GABA-bound closed state (closed-bound, Cb), a GABA-bound 
open state (open, O), and an additional GABA-bound closed state that permits 
desensitization to occur (desensitized, D).  As predicted, increasing affinity by increasing 
Kon (Figure 2A) or decreasing Koff (Figure 2B) increased peak amplitude when
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Figure 2.  The effect of increasing GABA affinity by increasing Kon or decreasing Koff on 
macroscopic current properties. 
 
Increasing receptor affinity for GABA can be accomplished either by increasing Kon (left 
column) or decreasing Koff (right column).  A. Increasing GABA affinity by increasing 
Kon increased current amplitudes in the context of a sub-saturating (1 μM; ~EC2) GABA 
concentration (Panel A1), but had no appreciable effect on currents evoked by a 
saturating (3 mM; ~EC99) GABA concentration, either after long (Panel A2) or short 
(Panel A3) duration GABA applications.  The asterisk (*) indicates the baseline current 
(Kon = 5x10
6
), and currents evoked in the context of progressively higher values of Kon 
(2.5x10
7
 and 1x10
8
) were superimposed.  B. Increasing GABA affinity by decreasing Koff 
also increased current amplitudes in the context of a sub-saturating GABA concentration 
(Panel B1) but not in the context of a saturating GABA concentration (Panels B2, B3).  
However, deactivation was substantially prolonged with decreasing Koff at all GABA 
concentrations, independent of the application duration.  The asterisk (*) indicates the 
baseline current (Koff = 1000), and currents evoked in the context of progressively lower 
values of Kon (200 and 50) were superimposed.  Currents are downward-going by 
convention. 
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currents were evoked by a sub-saturating GABA concentration (Figure 2A1, 2B1), but 
neither did so when currents were evoked by a saturating GABA concentration (Figure 
2A2, 2B2).  Desensitization occurring in the presence of a saturating GABA 
concentration was also not affected by increased affinity, either by increasing Kon or 
decreasing Koff (Figure 2A2, 2B2).  Deactivation, in contrast, was highly sensitive to 
increases in affinity, even in the context of saturating GABA, but only by decreasing Koff.  
This was true for deactivation following prolonged exposures to GABA (Figure 2A2, 
2B2) and also for deactivation following “synaptic” (1 ms) pulses (Figure 2A3, 2B3).  
Similar results were obtained using comprehensive models containing multiple open, 
closed, and desensitized states (Haas and Macdonald, 1999; Lagrange, et al., 2007). 
 
BDZs enhanced GABAA receptor currents by decreasing the GABA unbinding rate 
 
Although single-channel studies have suggested that BDZs enhance GABAA 
receptor currents by increasing GABA affinity, it remains unclear whether this is 
mediated by an increased rate of GABA binding or a decreased rate of GABA unbinding 
(Lavoie and Twyman, 1996).  Therefore, guided by the kinetic simulations in the 
previous section, we re-evaluated BDZ-mediated increase in GABA affinity using 
electrophysiolgy.  Whole-cell patch-clamp recordings were obtained from HEK293T 
cells transiently expressing 132L GABAA receptors (Figure 3).  GABA was applied 
with or without 1 μM diazepam (DZP) using a rapid solution exchange system.  DZP was 
pre-applied for 1 sec to allow for equilibration (the slight baseline shift with BDZ pre-
application may reflect a low-affinity direct activation mechanism) (Bianchi and 
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Figure 3.  Modulation of GABAA receptor currents by diazepam. 
 
A, Currents evoked from cells expressing 132L GABAA receptors by a sub-saturating 
GABA concentration (1 µM; black line) were enhanced by concurrent application of 
diazepam (1 µM; gray line).  B, Similar experimental protocol as in Panel A, using a 
saturating GABA concentration (3 mM).  Note that the current amplitude and shape of 
desensitization (i.e., during the GABA application; black bar above traces) were 
unchanged by diazepam.  In contrast, current deactivation (i.e., after the GABA 
application) was prolonged by diazepam.  C, Diazepam prolonged deactivation after a 
brief (5 ms, “synaptic”) pulse of saturating GABA. 
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Macdonald, 2001).  Consistent with BDZs increasing the affinity of GABA for the 
receptor, DZP co-application increased the peak amplitude and desensitization of currents 
evoked by a sub-saturating concentration of GABA (1 µM, ~EC25) (Figure 3A), but had 
no effect on the amplitude or desensitization of currents evoked by a saturating 
concentration of GABA (3 mM, ~EC99) (Figure 3B).  Deactivation, however, was always 
prolonged in the presence of DZP, for both low and high GABA concentrations (Figure 
3A, B), and for brief (5 ms) synaptic-like pulses of GABA (Figure 3C).  Taken together, 
these findings suggested that BDZs increased GABA affinity by decreasing the GABA 
unbinding rate, Koff.  Although we cannot exclude a mixed mechanism that involves both 
Kon and Koff, the data are incompatible with BDZs modulating Kon alone. 
 
Decreasing the GABA unbinding rate is predicted to increase opening frequency of 
GABAA receptors activated under tonic “extrasynaptic” conditions 
 
Single-channel opening frequency is defined as the number of openings per unit 
time.  Since individual openings must be flanked by closures, opening frequency is 
determined by the average time channels spend open and by the average time channels 
spend closed (this determines the average interval between openings).  However, when 
channels are capable of accessing multiple closed states, as in the kinetic model shown in 
Figure 1, the overall average closed time depends not only on the average lifetime of each 
individual closed state (which equals the reciprocal sum of the exit rates from each state), 
but also on the weighted likelihood of reaching each closed state (which is determined by 
a more complex relationship between rates) (Colquhoun and Hawkes, 1982).  For 
receptors activated under extrasynaptic conditions (i.e., prolonged exposure to a sub-
saturating concentration of GABA), the average lifetime of the Cu state is relatively long
145 
 
 
Figure 4.  Simulated single-channel activity under “extrasynaptic” conditions 
 
A. Simulated single-channel activity in response to continuous exposure to 1 M GABA 
when Koff is 600 s
-1
 (top trace) and when Koff is 200 s
-1
 (bottom trace).  The current levels 
designate receptor presence in the Cu (level 1), Cb or D (level 2), and O (level 3) states.  
Decreasing Koff (which increases GABA affinity) leads to an increase in the frequency of 
openings (currents reaching the 3
rd
 current level), and less time spent in the resting 
unbound state (the baseline current level).  The horizontal time bar applies to both traces.  
B. Overall opening frequency, including time spent in the unbound state, increased as Koff 
decreased, with significant differences in comparison of every pair of columns.  C. 
Opening frequency, restricted to the time during which the channel was GABA-bound, 
did not increase as Koff was decreased.  In this and subsequent panels, the column labels 
indicate the value of Koff in units of s
-1
. 
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(since the effective binding rate is determined by the product of Kon and the GABA 
concentration), and therefore, contributes substantially to the average closed time.  By 
decreasing Koff, BDZs decrease the likelihood that receptors enter this long-lived state, 
thus decreasing the average closed time.  In other words, with slower unbinding, the
average length of channel closure becomes dominated by the time spent in two closed 
states (Cb and D) as opposed to three (Cu, Cb, and D).  Thus, BDZs are predicted to 
decrease the interval between openings and, therefore, increase opening frequency. 
To evaluate this phenomenon explicitly, single-channel activity was simulated 
using the simple kinetic model (Figure 1) under extrasynaptic conditions: a low 
concentration of GABA (1 M) applied for an extended period of time (2000 ms) (Figure 
4).  Increasing BDZ concentration was simulated by varying Koff from 1000 s
-1
 (baseline) 
to progressively lower values (600, 200, and 50 s
-1).  The “ECX” notation denotes the 
GABA concentration producing X percent of maximal current amplitude.  Based on 
simulated concentration-response curves (not shown), 1 M GABA was approximately 
EC2 when Koff was 1000, EC15 when Koff was 600, EC25 when Koff was 200, and EC35 
when Koff was 50 s
-1
.  The use of a simplified model and a single concentration of BDZ 
precluded direct comparison of the magnitude of BDZ modulation with that seen in the 
patch clamp experiments, although this would not alter the interpretations of our 
simulation data.   
Unlike “real” single-channel recordings, where one cannot explicitly distinguish 
different states with the same conductance (such as different closed states), the 
simulations allowed us to unambiguously determine the receptor occupation of each state 
by assigning them different current levels (Figure 4A; see Methods).  We were 
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specifically interested in distinguishing the unbound state (Cu, level 1) from the GABA-
bound non-conducting states (Cb and D, level 2), and also from the single GABA-bound 
conducting state (O, level 3).  As expected, the transition profile in the presence of BDZ 
(lower trace) consisted of less time in the unbound closed state (level 1) and more time in 
the bound closed (level 2) and open (level 3) states than did the transition profile in the 
absence of BDZ (top trace).  Note that in both cases channels spent only a fraction of the 
total GABA-bound time in the open state; the remainder of bound time was spent in Cb 
and D.  Since decreasing the unbinding rate did not affect channel mean open time (not 
shown), this shift of receptor occupancy towards the GABA-bound conformations 
increased overall channel opening frequency (Figure 4B). 
However, when analysis was restricted to the time when receptors were GABA-
bound (something that can only be accomplished in silico), opening frequency was not 
found to increase (Figure 4C).  This critical difference reflects the fact that the increase in 
overall frequency (which is what was measured in the previously reported experiments 
using prolonged exposure to low GABA concentrations) was mediated entirely by 
decreased occupancy of the unbound closed state (Cu).  Therefore, when we eliminated 
this state from our calculations, the effect on opening frequency disappeared.  In other 
words, the observed frequency change simply reflected the ability of receptors to bind 
and rebind GABA in the experimental conditions, as opposed to a fundamental change in 
receptor kinetics. 
Interestingly, opening frequency actually tended to decrease with lower values of 
Koff.  Although seemingly counterintuitive, this reflected the fact that decreasing the 
unbinding rate actually increased the average lifetime of the Cb state, which partly 
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determined the GABA-bound closed time.  The magnitude of this decrease in frequency 
was small simply because the average lifetime of the Cb state was short compared to that 
of the D state, which dominated the GABA-bound closed time. 
 
Decreasing the GABA unbinding rate is predicted to increase the number, but not the 
frequency, of single-channel openings under phasic “synaptic” conditions 
 
Synaptic receptors are activated under markedly different conditions from those 
traditionally used to evaluate the effects of BDZs on single-channels, suggesting that 
BDZs will have a different effect on their opening frequency.  Indeed, if receptors are 
fully-saturated by vesicular release of GABA, then receptor occupancy in Cu approaches 
zero.  This limits the ability of BDZs to affect opening frequency, as decreasing the 
unbinding rate cannot further increase the fraction of receptors that are GABA-bound (a 
“ceiling” effect).  Importantly, this inability to affect opening frequency is independent of 
the duration of the GABA transient: as long as the GABA concentration is high, the Cu 
species is negligible, and thus frequency will not be increased whether the GABA 
transient is 1 ms (as in our simulations) or 5 ms (as in our experiments).  Although our 
simulations and experiments do not address the potential contributions of altered 
diffusion and/or transporter function on the time-course of the GABA transient, it should 
be noted that even if receptors are not saturated, once GABA is cleared from the synaptic 
cleft, all subsequent openings shaping the synaptic current necessarily reflect transitions 
among GABA-bound states (i.e., Cb, D, and O).  Our results, however, demonstrated that 
decreasing the unbinding rate cannot increase opening frequency when channel activity 
does not involve the Cu state (Figure 4), suggesting that BDZs would not increase 
opening frequency under synaptic conditions. 
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Figure 5.  Simulated single-channel activity under “synaptic” conditions 
 
A. Simulated single-channel activity in response to a 1 ms pulse of 1 mM GABA when 
Koff is 600 s
-1
 (top trace), 200 s
-1
 (middle trace), and 50 s
-1
 (bottom trace).  The current 
levels designate receptor presence in the Cu (level 1), Cb or D (level 2), and O (level 3) 
states.  B. Mean open duration (ms) was not significantly altered by changes in Koff.  In 
this and subsequent panels, the column labels indicate the value of Koff in units of s
-1
.  C. 
Mean opening frequency, measured while channels were bound by GABA, was not 
significantly altered by changes in Koff.  D. The time spent in the bound states increased 
as Koff decreased, with significant differences in every pair-wise column comparison 
except between Koff = 1000 and Koff = 600.  E. The mean number of openings per trial 
pulse of GABA increased as Koff decreased, with significant differences in comparison of 
every pair of columns except between Koff = 1000 and Koff = 600. 
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To test this hypothesis, single-channel responses to 1 ms pulses of 1 mM GABA 
were simulated (Figure 5).  As in the previous section, Koff was set to 1000 s
-1
 in the 
baseline condition, and increasing BDZ concentrations were simulated using 
progressively lower Koff values (600, 200, and 50 s
-1
) (Figure 5A).  Unbinding (entry into  
Cu) was considered a terminal event for calculations of opening frequency, since we 
assumed that rebinding was negligible under synaptic conditions.  Opening frequency 
was therefore defined as the number of openings divided by the time spent GABA-bound.  
Note that being able to determine precisely the moment of unbinding overcomes a critical 
limitation for testing this hypothesis experimentally, where unbinding is not associated 
with a change in channel conductance and thus cannot be measured or inferred.  In other 
words, with “real” experiments, one cannot justify how long to “watch” for openings 
after a GABA pulse is delivered, yet this duration specifies the denominator for 
calculations of opening frequency.  As expected, neither the open durations (Figure 5B) 
nor the opening frequency (Figure 5C) were increased by decreasing the unbinding rate.  
However, slower unbinding increased the average time receptors spent GABA-bound 
(Figure 5D), which increased the total number of openings (Figure 5E).  Thus, under 
synaptic conditions, BDZs are predicted to increase the number of channel openings 
without increasing opening frequency. 
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DISCUSSION 
 
The unique conditions of synaptic transmission prevent BDZs from increasing single-
channel opening frequency 
 
Electrophysiological studies have demonstrated that BDZs increase single-
channel opening frequency by increasing GABA affinity (Rogers, et al., 1994; Twyman, 
et al., 1989).  However, these experiments were performed using low concentrations of 
GABA, which allowed channels to spend considerable time in the unbound closed state 
(Cu), and prolonged exposure to GABA, which allowed channels to repeatedly access this 
state (i.e., bind and unbind GABA).  In this context, which resembles extrasynaptic 
transmission in vivo, BDZs were able to increase opening frequency by decreasing the 
contribution of the Cu state to the overall average closed time.  This state, however, plays 
a minimal role in opening frequency when receptors are activated under synaptic 
conditions for two main reasons.  First, receptor occupancy in Cu rapidly approaches zero 
with the high concentrations of GABA reached in synapses.  Second, the high rate at 
which free GABA is cleared from the synaptic cleft renders rebinding (and therefore, the 
contribution of the Cu state to the average closed interval) minimal under synaptic 
conditions, even if synaptic GABAA receptors are not saturated (Perrais and Ropert, 
1999; Poncer, et al., 1996).  Thus, BDZs are not predicted to increase the single-channel 
opening frequency of synaptic GABAA receptors. 
 
BDZs enhance synaptic currents by increasing the number of single-channel openings 
 
If BDZs cannot increase single-channel opening frequency of receptors activated 
under synaptic conditions, what then explains their ability to enhance synaptic currents 
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(Nusser and Mody, 2002)?  Our simulations demonstrated that by delaying GABA 
unbinding, BDZs increase the average time receptors are GABA-bound, thus increasing 
the total number of channel openings following a brief pulse of GABA.  Indeed, once a 
receptor enters the Cb state, the likelihood of unbinding GABA versus continuing to 
transition among GABA-bound states is determined by the ratio of the unbinding rate 
(Koff) to the sum of the alternatives (entry into O and D).  Thus, by decreasing Koff, BDZs 
extend the window of time during which individual receptors can transition among 
GABA-bound states, prolonging synaptic currents.  Unlike stabilizing desensitized states, 
which also prolongs synaptic currents by increasing the average time receptors are 
GABA-bound (Bianchi, et al., 2007; Jones and Westbrook, 1995), delaying unbinding by 
decreasing Koff necessarily increases synaptic charge transfer.  This is because decreasing 
Koff increases the number of channels available for opening at each moment in time after 
the GABA pulse (i.e., the “population” opening frequency increases), which increases the 
total number of openings. 
 
BDZs are predicted to increase single-channel opening frequency of extrasynaptic 
GABAA receptors 
 
Increasing evidence suggests that extrasynaptic GABAA receptors make important 
contributions to inhibitory signaling (Kullmann, et al., 2005).  In contrast to synaptic 
signaling that is brief, point-to-point, and involves high neurotransmitter concentrations, 
extrasynaptic communication involves low and slowly changing concentrations of 
neurotransmitters diffusing over larger distances than the synaptic cleft (Kullmann, et al., 
2005).  Although the physiological relevance of extrasynaptic transmission remains 
poorly understood, the effects of BDZs observed on single-channel currents evoked under 
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equilibrium conditions may prove relevant for understanding how this subset of GABAA 
receptors are modulated by BDZs.  While the majority of extrasynaptic receptors include 
the δ subunit, which renders them insensitive to BDZs (McKernan and Whiting, 1996; 
Mehta and Ticku, 1999), γ subunit-containing receptors sensitive to the effects of BDZs 
have also been found outside synapses in a number of brain regions including the 
hippocampus (Glykys and Mody, 2007).  Our simulations predicted that BDZs would in 
fact increase single-channel opening frequency of BDZ-sensitive extrasynaptic receptors.  
Although the relative importance of synaptic and extrasynaptic GABAA receptors to 
neurological diseases such as epilepsy remains uncertain, the dependence of BDZ 
modulation on activation context may have important relevance for anticonvulsant 
treatment.  For example, BDZs may prolong synaptic currents in situations in which they 
are pathologically brief such as the 2 subunit mutation, K289M, associated with 
generalized epilepsy with febrile seizures plus (Bianchi, et al., 2002).  It is conceivable 
that extrasynaptic receptors (which may depend upon ambient rather than synaptic 
GABA) can be modulated by BDZs independent of synaptic inhibition or when synaptic 
inhibition is pathologically compromised. 
 
Single-channel opening frequency is sensitive to multiple kinetic mechanisms 
 
Although single-channel opening frequency is a relatively straightforward 
experimental measurement, there are in fact a variety of “mechanisms” that influence 
opening frequency.  For example, just as decreasing Koff can increase opening frequency 
by decreasing the average channel closed time (under extrasynaptic conditions), 
frequency can also be increased by decreasing the entry rate or increasing the exit rate 
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from the desensitized state.  Interestingly, opening frequency can also be increased by 
decreasing the time spent in the open state (by increasing the exit rate O
-
), as this will 
decrease the length of each open-closed cycle.  However, increasing opening frequency 
in this manner will actually decrease overall channel open probability.  Thus, changes in 
opening frequency alone can neither specify a kinetic mechanism nor provide 
information regarding channel effectiveness (the open duration must also be known).  
This distinction between observation (opening frequency) and mechanism (increased 
affinity via Koff) forms the basis for our demonstration of “context-dependent” BDZ 
modulation of GABAA receptor opening frequency.  Thus, a single mechanism (increased 
affinity via decreasing Koff) yields different functional impacts on opening frequency 
(and macroscopic current properties) depending on the context in which receptors are 
activated.  Despite this kinetic difference, GABAA receptor function is enhanced by 
BDZs in both synaptic and extrasynaptic contexts.  Although detailed kinetic models of 
most GABAA receptor isoforms have not been established, the mechanistic arguments of 
this study are likely to apply in general to BDZ-sensitive isoforms, because they hold for 
any model in which binding precedes transitions to open, pre-open and desensitized 
states, regardless of their number or connectivity. 
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CHAPTER IV 
 
 
 
CONTEXT-DEPENDENT MODULATION OF SYNAPTIC AND 
EXTRASYNAPTIC GABAA RECEPTORS BY PENICILLIN: 
IMPLICATIONS FOR PHASIC AND TONIC INHIBITION 
 
 
 
Emmanuel J. Botzolakis, Hua-Jun Feng, and Robert L. Macdonald 
 
ABSTRACT 
GABAA receptors mediate two modes of inhibitory neurotransmission, each 
involving different subsets of receptor isoforms and different contexts of receptor 
activation.  While “phasic” inhibition results from transient activation of synaptic 
receptors by nearly-saturating concentrations of GABA, “tonic” inhibition results from 
persistent activation of extrasynaptic receptors by sub-saturating concentrations of 
ambient GABA.  Penicillin, an open-channel blocker of GABAA receptors, selectively 
inhibits hippocampal phasic currents.  To distinguish between isoform-specific and 
context-dependent modulation as possible explanations for this selectivity, the effects of 
penicillin were evaluated on the properties of recombinant GABAA receptor isoforms 
expressed in HEK293T cells.  When co-applied with saturating GABA, penicillin 
decreased peak currents, altered desensitization, and prolonged deactivation of both 
synaptic and extrasynaptic isoforms.  However, when activated in their respective 
physiological contexts, synaptic and extrasynaptic isoforms had markedly different 
sensitivities to penicillin.  Currents evoked from synaptic isoforms under phasic 
conditions were substantially inhibited, while those evoked from extrasynaptic isoforms 
159 
 
under tonic conditions were minimally affected.  Although this behavior was unexpected 
for an open-channel blocker, kinetic simulations using simple models of channel function 
provided intuitive explanations for each of the experimental findings and exposed a 
previously unrecognized similarity between the roles of blocked and desensitized states 
in shaping macroscopic currents.  We therefore concluded that the reported inability of 
penicillin to modulate tonic currents could not simply be attributed to insensitivity of 
extrasynaptic receptors, but rather, reflected an inability to modulate these receptors in 
their specific context of activation.  
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INTRODUCTION 
GABAA receptors are heteropentameric ligand-gated chloride channels 
responsible for the majority of fast inhibitory neurotransmission in the mammalian brain 
(Olsen and Macdonald, 2002; Luscher and Keller, 2004).  Seven subunit families (, , , 
, , , and ) are known to exist (Olsen and Macdonald, 2002; Luscher and Keller, 
2004), with  and  isoforms representing the majority of neuronal GABAA 
receptors (McKernan and Whiting, 1996).  In general,  receptors are targeted to 
synapses (though some γ subunit-containing receptors may also be found 
extrasynaptically), while  receptors are targeted to extra- or perisynaptic areas 
(Essrich et al., 1998; Nusser et al., 1998; Wei et al., 2003; Semyanov et al., 2004; Sun et 
al., 2004). 
Following vesicular release, a nearly-saturating concentration of GABA activates 
synaptic receptors before being rapidly cleared by diffusion and reuptake.  This transient 
activation, thought to occur in the sub-millisecond time scale (Mozrzymas, 2004), gives 
rise to inhibitory post-synaptic currents (IPSCs) and is termed “phasic” inhibition.  
Increasing evidence, however, suggests that GABA may escape from synapses, allowing 
for activation of extrasynaptic receptors (Glykys and Mody, 2007).  The persistent 
increase in chloride conductance resulting from prolonged exposure to sub-saturating 
concentrations of ambient GABA gives rise to “tonic” inhibition and represents an 
important alternate mode of GABAergic transmission, one thought to be less spatially 
and temporally constrained (Mody and Pearce, 2004; Farrant and Nusser, 2005).  
Understanding how pharmacological agents differentially modulate these two modes of 
neuronal inhibition is of increasing interest, as they may play distinct roles in the 
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pathogenesis of epilepsy and other neurological disorders (Macdonald et al., 2006; Peng 
et al., 2004). 
Penicillin is a known convulsant that reduces GABA-evoked currents (Macdonald 
and Barker, 1977; Horne et al., 1992; Katayama et al., 1992; Tsuda et al., 1994; 
Behrends, 2000; Sugimoto et al., 2002) and blocks spontaneous activity of GABAA 
receptors (Krishek et al., 1996; Tierney et al., 1996; Lindquist et al., 2004).  This negative 
modulation is thought to be mediated by open-channel block, as single channel studies 
have reported reduced open duration with increased channel opening frequency and burst 
length (Chow and Mathers, 1986; Twyman et al., 1992).  Interestingly, evidence from 
electrophysiological studies in hippocampal neurons indicated that penicillin selectively 
inhibited phasic currents (Yeung et al., 2003).  Given that different receptor isoforms are 
thought to mediate phasic and tonic inhibition (Farrant and Nusser, 2005), and subunit 
composition is known to influence receptor pharmacology (Wohlfarth et al., 2002; Feng 
and Macdonald, 2004; Feng et al., 2004), one parsimonious explanation for this 
observation is that extrasynaptic isoforms are simply insensitive to penicillin (i.e., 
isoform-specific modulation). 
Alternatively, it is possible that penicillin modulates both synaptic and 
extrasynaptic isoforms, but that its effects are highly dependent on the “context” of 
receptor activation (i.e., context-dependent modulation).  Unlike tonic currents, which are 
mediated by receptors activated under conditions of near-equilibrium by low 
concentrations of GABA, phasic currents are mediated by receptors activated under 
conditions of extreme non-equilibrium by high concentrations of GABA.  As a result, the 
distribution of receptors among available states in the gating scheme is likely to be 
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markedly different for conditions of phasic and tonic activation, and depending on the 
relationship between the kinetics of open-channel block and those of receptor gating, 
could give the appearance of selectivity for phasic, but not tonic, currents (e.g., if the 
blocking rate was high but the overall blocker affinity was low).  Indeed, sensitivity to 
the context of receptor activation, both in terms of exposure duration and agonist 
concentration, has previously been described for positive and negative GABAA receptor 
modulators (Barberis et al., 2002; Bianchi and Macdonald, 2003; Feng et al., 2004) and 
also for open-channel blockers of NMDA-type glutamate receptors (Lipton, 2006). 
To distinguish between isoform-specific and context-dependent modulation as 
potential mechanisms underlying the selective modulation of phasic currents, the effects 
of penicillin were evaluated on currents evoked from recombinant synaptic and 
extrasynaptic GABAA receptor isoforms expressed in HEK293T cells.  In addition, 
simulations using simple models of GABAA receptor function explored the relationship 
between the microscopic kinetics of open-channel block and the macroscopic properties 
of currents evoked under phasic or tonic conditions.  Both the simulations and the 
experimental results demonstrated that open-channel blockers can have seemingly 
counterintuitive effects on macroscopic current properties, and interestingly, that these 
effects are highly dependent on the context of receptor activation.  
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MATERIALS AND METHODS 
 
Cell culture and expression of recombinant GABAA receptors 
 
Human embryonic kidney (HEK293T) cells were cultured in Dulbecco’s 
Modified Eagle Medium (Invitrogen, Grand Island, NY, USA) supplemented with 10% 
fetal bovine serum (Invitrogen), 100 i.u./ml penicillin, and 100 g/ml streptomycin (Life 
Technologies, Grand Island, NY, USA) and maintained at 37C in humidified 5% CO2 / 
95% air.  Cells were seeded at moderate density in 60-mm culture dishes (Corning 
Glassworks, Corning, NY, USA) and transfected 24 hr later with 2 g per cDNA 
encoding rat  (1, 4, 5, or 6), 3, and either 2L or  GABAA receptor subunits 
using a modified calcium phosphate precipitation method (Feng et al., 2004).  Two g of 
pHOOK (Invitrogen, Carlsbad, CA, USA), which encodes for the surface antibody sFv, 
were co-transfected for immunomagnetic selection 24 hrs later (Greenfield et al., 1997).  
Following selection, cells were re-plated in 35-mm culture dishes and currents were 
recorded 24 hr later using standard patch clamp techniques.  Collagen-coated dishes were 
used for macropatch recordings. 
 
Electrophysiology  
 
Patch clamp recordings were obtained at room temperature with cells bathed in an 
external solution composed of (in mM) 142 NaCl, 1 CaCl2, 6 MgCl2, 8 KCl, 10 glucose, 
and 10 HEPES (pH 7.4).  Recording electrodes were pulled using a P-87 Flaming Brown 
Micropipette Puller (Sutter Instruments, San Rafael, CA, USA), fire polished on an MF-9 
microforge (Narishige, Tokyo, Japan), and filled with an internal solution consisting of 
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(in mM) 153 KCl, 1 MgCl2, 10 HEPES, 2 MgATP, and 5 EGTA (pH 7.3).  Open tip 
resistances of the recording electrodes were typically 1.0–1.6 M.  Whole-cell or 
macropatch currents were recorded using an Axopatch 200A amplifier (Molecular 
Devices, Foster City, CA, USA), low-pass filtered at 2 kHz using the internal 4-Pole 
Bessel filter of the amplifier, digitized with the Digidata 1322A data acquisition system 
(Molecular Devices), and stored for offline analysis.  Both GABA and penicillin G 
(benzylpenicillin, sodium salt) were purchased from Sigma-Aldrich (St. Louis, MO, 
USA) and prepared as stock solutions.  Working solutions were made on the day of the 
experiment by diluting stock solutions with external solution.  Drugs were gravity-fed 
using 4-barrel square glass tubing connected to a Perfusion Fast-Step system (Warner 
Instruments, Hamden, CT, USA).  The 10-90% rise times of open electrode tip liquid 
junction currents were consistently <2.0 ms.  Penicillin was pre-applied for 1.5 sec prior 
to co-application with GABA.  4 sec pulses of 1 mM GABA were used to evaluate 
macroscopic current kinetics, 5 ms pulses of 1 mM GABA were used to mimic phasic 
activation, and 30 sec pulses of 1 μM GABA were used to mimic tonic activation.  
Consecutive drug applications were separated by at least 45 sec in external solution to 
allow for complete GABA and penicillin unbinding. 
 
Data analysis and simulations 
 
Data were analyzed offline using Clampfit 8.1 (Molecular Devices).  The extent 
of current inhibition by penicillin (% of GABA current) was determined by dividing the 
current evoked during co-application of GABA and penicillin by the current evoked by 
GABA alone.  The extent of desensitization was determined by dividing the amount of 
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current lost (residual current subtracted from peak current) by peak current.  The time 
course of deactivation was fit using the standard Levenberg-Marquardt method to the 
form ane
(-t/n), where n is the number of the exponential components, a is the relative 
amplitude, t is time, and  is the time constant.  A weighted  in the form of (a1τ1 + a2τ2) / 
(a1 + a2) was calculated for comparison of deactivation time courses.  The net charge 
transfer of a pulse was defined as the area between the adjusted baseline and the current.  
Data were reported as mean  SEM.  A paired Student’s t test was performed to compare 
individual current features before and after penicillin co-application.  An unpaired 
Student’s t test was used to compare current features.  Statistical significance was taken 
as p<0.05. 
Kinetic simulations were carried out using Berkeley Madonna 3.1 
(www.berkeleymadonna.com), a differential equation solving program, using the fourth 
order Runge-Kutta method with a time interval of 10 s.  Analyses of simulated currents 
were identical to those of real currents. 
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RESULTS 
 
Penicillin altered the kinetic properties of synaptic and extrasynaptic GABAA receptor 
isoform currents 
 
To explore the effects of penicillin on the macroscopic current properties of 
synaptic and extrasynaptic GABAA receptors, a saturating concentration of GABA (1 
mM) was co-applied with penicillin (1 mM) for 4 sec using rapid solution exchange to 
lifted HEK293T cells transiently transfected with  (1, 4, 5, or 6), 3, and either 
2L or  subunits.  These eight subunit combinations were chosen as a representative 
sample of receptor isoforms thought to be expressed in synaptic or extrasynaptic areas 
(Wisden et al., 1992; Saxena and Macdonald, 1994; McKernan and Whiting, 1996; Sur et 
al., 1999; Brunig et al., 2002; Poltl et al., 2003; Caraiscos et al., 2004; Peng et al., 2004; 
Glykys et al., 2007).  For the purposes of this study, only α1βγ and α6βγ subunit 
combinations were considered “synaptic”; the remaining subunit combinations were 
considered “extrasynaptic”.  Note that although the α4βγ isoform has been detected in 
synapses under certain conditions (Hsu et al., 2003; Liang et al., 2006; Zhang et al., 
2007), its role in normal synaptic physiology remains unclear. 
Penicillin altered the kinetic properties of all 2L subunit-containing receptor 
isoform currents (Figure 1A-D).  Peak currents were substantially decreased for each 
isoform (132L: 47.1  8.1% of control, n = 6, p<0.01; 432L: 41.8  3.8% of 
control, n = 12, p<0.001; 532L: 37.7  3.6% of control, n = 8, p<0.01; 632L: 54.3 
 6.7% of control, n = 10, p<0.05) (Figure 1E), as were residual currents (132L: 32.3 
 4.4% of control, p<0.01; 432L: 59.0  4.0% of control, p<0.01; 532L: 44.9   
 
167 
 
 
Figure 1.  Penicillin altered the macroscopic current properties of 2L subunit-
containing GABAA receptors. 
 
A-D, Whole-cell currents were evoked by 1 mM GABA either alone (left) or in the 
presence of 1 mM penicillin G (PG) (right) for 132L, 432L, 532L, and 
632L receptors, respectively.  The solid line above each trace indicates the duration 
of GABA application.  The dashed line denotes the duration of penicillin application.  E, 
Penicillin decreased peak current amplitudes.  F, Penicillin had variable effects on the 
extent of desensitization.  G, Penicillin increased the weighted time constant () of 
deactivation.  Error bars denote SEM.  + The peak current evoked by co-application of 
GABA and penicillin was significantly reduced compared to the GABA control current at 
p<0.05; ++ p<0.01; +++ p<0.001.  * Significantly different from GABA control current 
desensitization or deactivation at p<0.05; ** p<0.01. 
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4.3% of control, p<0.01; 632L: 55.3  5.3% of control, p<0.05).  While the extent of 
desensitization increased for 132L receptors compared to control (55.5  3.3% vs 
68.7  2.6%, p<0.01), it decreased for 432L (63.3  3.1% vs 46.7  4.6%, p<0.01) 
and 532L (51.1  3.7% vs 41.7  5.4%, p<0.01) receptors, and was unchanged for 
632L receptors (57.3  3.9% vs 55.3  3.7%, p>0.05) (Figure 1F).  Interestingly, 
despite the variable effects on desensitization, all 2L subunit-containing receptors had 
prolonged deactivation in the presence of penicillin compared to control currents 
(132L: 345.8  53.2 ms vs 504.6  51.7 ms, p<0.05; 432L: 268.5  34.2 ms vs 
668.2  201.8 ms, p<0.05; 532L: 617.7  92.6 ms vs 755.3  144.7 ms, p<0.05; 
632L: 432.4  32.4 ms vs 946.4  116.8 ms, p<0.01) (Figure 1G) and had rebound 
currents upon penicillin washout (Figure 1A-D). 
Penicillin also altered the kinetic properties of  subunit-containing receptor 
isoform currents (Figure 2A-D).  As with 2L subunit-containing receptors, peak currents 
were reduced (13: 78.3  7.3% of control, n = 9, p<0.05; 43: 54.2  1.2% of 
control, n = 6, p<0.01; 53: 69.6  5.2% of control, n = 5, p = 0.07; 63: 69.3  
4.3% of control, n = 6, p<0.05) (Figure 2E).  Residual currents, however, were only 
decreased for 43 and 63 receptors (13: 95.6  3.0% of control, p>0.05; 
43: 65.8  2.6% of control, p<0.01; 53: 101.7  3.9% of control, p>0.05; 63: 
65.0  4.6% of control, p<0.05).  The higher sensitivity of peak compared to residual 
currents caused the extent of desensitization to decrease for the majority of  subunit-
containing receptors (13: 24.8  6.5% vs 7.4  1.7%, p<0.05; 43: 53.4  2.1% vs  
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Figure 2. Penicillin altered the macroscopic current properties of  subunit-containing 
GABAA receptors. 
 
A-D, Whole-cell currents were evoked by 1 mM GABA either alone (left) or in the 
presence of 1 mM penicillin G (PG) (right) for 13, 43, 53, and 63 
receptors, respectively.  The solid line above each current trace indicates the duration of 
GABA application.  The dashed line denotes the duration of penicillin application.  E, 
Penicillin decreased peak current amplitudes.  F, Penicillin had variable effects on the 
extent of desensitization.  G, Penicillin increased the weighted time constant () of 
deactivation.  Error bars denote SEM.  + Significantly reduced compared to the GABA 
control current at p<0.05; ++ p<0.01.  * Significantly different from GABA control 
current desensitization or deactivation at p<0.05; ** p<0.01. 
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43.5  2.5%, p<0.01; 53: 36.2  4.4% vs 6.8  0.5%, p<0.01), with only 6 subunit- 
containing receptors having a slightly increased extent of desensitization (44.7  3.9% vs 
48.0  4.1%, p<0.05) (Figure 2F).  With the exception of 5 subunit-containing 
receptors, deactivation was prolonged for all  subunit-containing receptors (13: 
125.3  10.5 ms vs 214.5  19.5 ms, p<0.01; 43: 117.8  13.5 ms vs 641.0  112.4 
ms, p<0.01; 53: 345.7  87.4 ms vs 407.9  100.4 ms, p>0.05; 63: 449.1  80.9 
ms vs 975.7  147.7 ms, p<0.05) (Figure 2G).  In addition, all  subunit-containing 
receptors had rebound currents upon penicillin washout (Figure 2A-D).  Note that 53 
receptors were expressed poorly in HEK293T cells, and we thus obtained currents from 
only 5 cells. 
In summary, penicillin reduced peak current amplitudes, prolonged deactivation, 
and induced rebound currents for both synaptic and extrasynaptic GABAA receptor 
isoforms (Table 1), suggesting that the reported inability of penicillin to modulate tonic 
inhibition in previous studies (Yeung et al., 2003) could not simply be attributed to 
insensitivity of extrasynaptic receptors.  However, the finding that the extent of 
desensitization was decreased for most extrasynaptic receptor isoforms (the result of peak 
currents having higher sensitivity than residual currents) suggested that these isoforms 
might simply appear insensitive to penicillin when activated under near-equilibrium 
conditions.  We thus explored the possibility that the “context” of receptor activation was 
responsible for the apparent selectivity of penicillin for phasic currents. 
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Table 1. Summary of the effects of penicillin on the macroscopic current properties of 
synaptic and extrasynaptic GABAA receptor isoforms (4 sec application of 1 mM GABA 
vs co-application of 1 mM GABA and 1 mM penicillin) 
 
                                 Ipeak amplitude               Desensitization               Deactivation                                      
                                                         
132L                                                                                                      
13                                                                                                          
432L                                                                                                      
43                                                                                                          
532L                                                                                                      
53                                NS                                                                     NS 
632L                                                                 NS                                  
63                                                                                                          
 
/, denotes increased or decreased peak current amplitude, extent of desensitization, or 
weighted deactivation time constant; NS, not significantly different from the GABA 
control current. 
 
 
 
Currents evoked from synaptic GABAA receptor isoforms in the context of phasic 
activation were significantly inhibited by penicillin 
 
To investigate its potential effects on phasic inhibition, penicillin (1 mM) was co-
applied with a brief pulse (5 ms) of saturating GABA (1 mM) to the synaptic 132L 
and 632L GABAA receptor isoforms.  These experimental conditions are thought to  
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Figure 3. Penicillin substantially inhibited currents evoked from synaptic GABAA 
receptor isoforms under phasic conditions. 
 
A, B, Macropatch currents were evoked by a brief (5 ms) application of 1 mM GABA 
either alone (left) or in the presence of 1 mM penicillin G (PG) (right) for 132L and 
632L receptors, respectively.  The solid arrow above each current trace indicates the 
brief duration of GABA application.  The dashed line denotes the duration of penicillin 
application.  C, Penicillin decreased peak current amplitudes.  D, Penicillin decreased 
total charge transfer.  Error bars denote SEM.  * Significantly different from GABA 
control current at p<0.05; ** p<0.01; *** p<0.001. 
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mimic those of phasic activation, as the resulting currents have kinetic properties similar 
to those of IPSCs (Jones and Westbrook, 1995).  To further increase the temporal 
resolution of the recordings, they were performed on excised outside-out patches from 
transiently transfected HEK293T cells. 
Compared to currents evoked by brief pulses of GABA alone, co-application of 
GABA with penicillin reduced the peak current amplitude of 132L receptors (62.3  
3.3% of control, n = 5, p<0.01) (Figure 3A, C).  In addition, penicillin accelerated the 
deactivation time course from 64.7  4.6 ms to 25.9  5.4 ms (p<0.001), an unexpected 
finding given that deactivation was significantly prolonged following longer applications 
(Figure 1G).  Combined, these effects caused a substantial decrease in the net charge 
transfer following an individual GABA pulse (23.7  1.8% of control, p<0.05) (Figure 
3D).  Penicillin also reduced the peak current amplitude (41.6  3.9% of control, n = 11, 
p<0.001) (Figure 3B, C) and accelerated deactivation (109.8  13.5 ms vs 72.5  9.5 ms, 
p<0.05) of 632L receptors.  As with 132L receptors, these effects combined to 
substantially decrease the net charge transfer following an individual brief GABA pulse 
(45.1  7.3% of control, p<0.05) (Figure 3D). 
 
Currents evoked from extrasynaptic GABAA receptor isoforms in the context of tonic 
activation were minimally inhibited by penicillin 
 
To investigate its potential effects on tonic inhibition, penicillin (1 mM) was co-
applied with a long pulse (30 sec) of sub-saturating GABA (1 M) to the extrasynaptic 
43, 432L, and 532L receptor isoforms.  This subset of receptor isoforms is 
thought to mediate the majority of the tonic current in hippocampal neurons (Wisden et 
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al., 1992; Caraiscos et al., 2004; Chandra et al., 2006), which was found to be penicillin 
insensitive (Yeung et al., 2003).  Prolonged drug application allowed for currents to reach 
a pseudo-equilibrium, as would be expected for those that mediate tonic inhibition. 
For 43 receptors, the effects of penicillin were surprisingly limited to the peak 
current (Figure 4A).  Indeed, while peak currents were reduced in the presence of 
penicillin (74.8  2.9% of control, n = 10, p<0.01), equilibrium currents were essentially 
unchanged (93.7  4.1% of control, p>0.05).  The higher sensitivity of peak currents 
(peak vs equilibrium, p<0.01) caused the extent of desensitization to decrease from 40.0 
 1.2% to 24.7  2.8% (p<0.01).  Penicillin also preferentially modulated peak currents 
of 432L (Figure 4B; peak: 72.3  3.9% of control, n = 10, p<0.01; equilibrium: 85.0 
 3.0% of control, p<0.01; peak vs equilibrium, p<0.05) and 532L (Figure 4C; peak: 
58.1  4.2% of control, n = 12, p<0.01; equilibrium: 77.8  4.7% of control, p<0.01; peak 
vs equilibrium, p<0.01) receptors.  As a result, the extent of desensitization was 
decreased from 34.9  3.3% to 23.6  2.4% (p<0.001) and from 35.4  3.9% to 14.2  
3.2% (p<0.001) for 432L and 532L receptor currents, respectively. 
Thus, while peak currents were significantly reduced for each of these 
extrasynaptic receptor isoforms, equilibrium currents were less affected (Figure 4D, E).  
Although preferential modulation of peak currents (i.e., decreased extent of 
desensitization) was also observed for these same isoforms in the context of saturating 
GABA (Figure 1F, 2F), the combination of lowering the GABA concentration and 
extending the duration of GABA exposure rendered equilibrium currents even less  
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Figure 4.  Penicillin had minimal effect on currents evoked from extrasynaptic GABAA 
receptor isoforms under tonic conditions. 
 
A-C, Whole-cell currents were evoked by a long pulse (30 sec) of 1 M GABA either 
alone (left) or in the presence of 1 mM penicillin G (PG) for 43, 432L, and 
532L receptors, respectively.  The solid line above each current trace indicates the 
duration of GABA application.  The dashed black line denotes the duration of penicillin 
application.  The dashed gray line indicates the amount of control steady-state current.  
D, Penicillin reduced peak current amplitudes.  E, Penicillin had limited effect on residual 
current amplitudes.  Error bars represent SEM.  ** Significantly different from GABA 
control peak or steady state current amplitude at p<0.01.  
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sensitive to penicillin.  This suggested that the reported selectivity of penicillin for phasic 
currents resulted not from an inability to modulate extrasynaptic receptors, but rather, 
from an inability to modulate these receptors in their native “context” of activation. 
 
Simple kinetic models qualitatively reproduced the effects of open-channel block on 
GABAA receptor macroscopic current properties 
 
The experimental findings in the previous sections suggested that open-channel 
block could have complex effects on macroscopic current properties.  Although penicillin 
decreased peak currents and prolonged deactivation, its effects on the extent of 
desensitization were isoform specific.  Moreover, while currents evoked under synaptic 
conditions were particularly vulnerable to penicillin, currents evoked under extrasynaptic 
conditions were relatively insensitive.  To determine the kinetic basis for these findings, 
the effects of open-channel block were evaluated on macroscopic current properties using 
Markov models of GABAA receptor function. 
Although comprehensive kinetic models have been proposed that account for both 
the microscopic and macroscopic properties of GABAA receptors (Haas and Macdonald, 
1999; Lema and Auerbach, 2006; Lagrange et al., 2007), simple models are often 
sufficient to illustrate the salient features of GABA-evoked currents.  Two such models, 
proven useful for investigating the relationship between macroscopic currents and 
microscopic kinetics, are shown in Figure 5 (panels A1 and B1; Bianchi et al., 2007).  In 
the “linear" model (Figure 5A1), receptors transition into the desensitized (D) state 
directly from the open (O) state, while in the “branched” model (Figure 5B1) transitions 
into the D state proceed from the pre-open state (C2).  Since penicillin is thought to act  
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Figure 5.  The effects of penicillin-mediated open-channel block on macroscopic currents 
were simulated using simple kinetic models of GABAA receptor function. 
 
A1, 4-state kinetic model, with closed (C), open (O), and desensitized (D) states in 
“linear” arrangement, was used to generate simulated GABA currents.  Agonist binding 
occurs between C1 and C2.  Open-channel block was simulated by adding a blocked state 
(B) to the O state (dashed box).  Rate constants were: kon = 7000, koff = 1.0, β = 1.0, α = 
0.3, δ = 0.3, ρ = 0.1, k+ = 550, k- = 0.1.  All rates had units of ms-1, except for the agonist 
binding (kon) and blocker binding (k+) rates, which were multiplied by the concentration 
of GABA [G] and blocker [B], respectively, and thus had units of ms
-1
M
-1
.  B1, 4-state 
kinetic model, with O and D states in “branched” arrangement, was used to generate 
simulated GABA currents.  Rate constants were: kon = 7000, koff = 1.0, β = 1.0, α = 0.6, δ 
= 0.6, ρ = 0.1, k+ = 550, k- = 0.1.  Note that while the original single channel studies 
assigned different blocking and unblocking rates for each O state (Twyman et al., 1992), 
the averaged values of k+ and k- were used here since linear and branched models 
contained a single O state.  The remaining rate constants were chosen to qualitatively 
reproduce the macroscopic current properties of  receptors (Haas and Macdonald, 
1999; Lagrange et al., 2007).  A2, B2, Currents were simulated from linear (Panel A2) 
and branched (Panel B2) models to 100 ms pulses of 1 mM GABA either in the presence 
(dashed traces) or absence (solid traces) of 1 mM penicillin G (PG).  A3, B3, Currents 
were simulated from linear (Panel A3) and branched (Panel B3) models to 100 ms pulses 
of 1 mM GABA and 1 mM penicillin, with washout of penicillin occurring either 
simultaneously or 50 ms after GABA washout.  Note the rebound currents upon penicillin 
washout, which became smaller in amplitude if deactivation was permitted before 
washout.  A4, B4, Currents (scaled to peak) were simulated from linear (Panel A4) and 
branched (Panel B4) models to 100 ms pulses of 1 mM GABA either with (solid traces) 
or without (dashed traces) 1 mM penicillin when the D state entry rate was set to zero. 
 
 
 
via open-channel block (Twyman et al., 1992), its effects were modeled by reversibly 
connecting a non-conducting state to the O state (Figure 5A1, B1; dashed boxes).  
Receptors entered this “blocked” state (B) via a concentration-dependent blocking rate 
(k+) and returned via a concentration-independent unblocking rate (k-), with k- being 
taken as the inverse of the brief closed time associated with penicillin block and k+ being  
chosen to account for the concentration-dependent increase in burst length (Twyman et 
al., 1992). 
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For both kinetic arrangements, simulated co-application of 1 mM GABA with 1 
mM penicillin generated currents with reduced peak amplitudes, increased extents of 
desensitization, prolonged time courses of deactivation, and rebound upon penicillin 
washout, compared to currents evoked by GABA alone (Figure 5A2, B2, A3, B3).  With 
the exception of the extent of desensitization, these results were qualitatively similar to 
our experimental observations, and were consistent with the expected effects of open-
channel block on macroscopic currents.  For example, since penicillin was modeled by 
adding a non-conducting state to the gating scheme, receptor occupancy in all other states 
should have decreased, the result being currents with smaller amplitudes (Figure 5A2, 
B2).  In addition, since GABA unbinding could only occur from C2, addition of the 
blocked state effectively increased receptor mean bound time (Appendix II).  Much like 
desensitized states, this allowed for additional openings prior to GABA unbinding, the 
macroscopic correlate of which is prolonged deactivation (Figure 5A2, B2) (Jones and 
Westbrook, 1995; Bianchi et al., 2007).  The observation of a rebound current upon 
blocker washout was also to be expected, the result of surging open state occupancy 
following blocker unbinding (Figure 5A3, B3). 
 
Blocking and unblocking rates played distinct roles in modulating the extent of 
desensitization 
 
Although the kinetic simulations in the previous section qualitatively reproduced 
many of our experimental observations, it remained unclear how open-channel block 
could support decreased or unchanged extents of desensitization (Figures 1F, 2F).  
Indeed, since the B state was arranged in series with the O state, just as the D state was 
arranged in the linear model, we expected desensitization to increase, as receptors could 
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now close via an additional route.  Support for the idea that the B state was serving as an 
additional D state came from the observation that desensitization was still possible in the 
absence of the D state (Figure 5A4, B4; dashed traces), while no desensitization was 
observed in the absence of both D and B states (Figure 5A4, B4; solid traces). 
To reconcile our experimental findings with the simulations, we systematically 
explored the relationship between the rates of open-channel block and the extent of 
desensitization (Figure 6A1-A4).  Using the default blocking rate (k+ = 550 ms
-1
) and the 
linear model (Figure 5A1), decreasing the unblocking rate (k-) over two orders of 
magnitude progressively increased desensitization (Figure 6A1).  This corresponded to 
increased desensitization for the lowest unblocking rate (k- = 0.01 ms
-1
) compared to the 
GABA control current (dashed line), but slightly decreased desensitization for the highest 
unblocking rate (k- = 1.0 ms
-1
).  This same trend was observed in the context of a higher 
blocking rate (k+ = 5500 ms
-1
), though the effect was substantially more pronounced 
(Figure 6A2).  Interestingly, the unblocking rate supporting decreased desensitization was 
the same for both blocking rates (k- = 1.0 ms
-1
), as were the unblocking rates supporting 
essentially unchanged (k- = 0.3 ms
-1
) or increased (k- = 0.1, 0.03, 0.01 ms
-1
) 
desensitization.  This suggested that blocking and unblocking rates played different roles 
in determining the sensitivity of desensitization to open-channel block: the unblocking 
rate determined the direction of change (increased, decreased, or unchanged) while the 
blocking rate served mainly to modulate the magnitude of the change. 
This idea was supported by the observation that increasing the blocking rate in the 
context of the default unblocking rate (k- = 0.1 ms
-1
) caused only increased  
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Figure 6. The extent of macroscopic desensitization was differentially sensitive to 
blocking and unblocking rate constants. 
 
A, Currents (normalized to peak) were simulated for the linear model to 100 ms co-
applications of 1 mM GABA and 1 mM penicillin G (PG).  In panels A1 and A2, the 
unblocking rate was varied in the context of either the default blocking rate (Panel A1; k+ 
= 550) or a higher blocking rate (Panel A2; k+ = 5500).  In panels A3 and A4, the 
blocking rate was varied in the context of either the default unblocking rate (Panel A3; k- 
= 0.1) or a higher unblocking rate (Panel A4; k- = 1.0).  Horizontal dashed lines indicate 
the residual current remaining in the absence of penicillin.  B1-2, C1-2, The extent of 
desensitization was evaluated for simulated currents evoked by 100 ms pulses of 1 mM 
GABA to linear (Panels B1 and B2) and branched (Panel C1 and C2) models over a 
range of blocking (k+ = 100, 200, 300, 600, 1000, 2000, 3000, 6000, and 10000) and 
unblocking (k- = 0.01, 0.02, 0.03, 0.06, 0.1, 0.2, 0.3, 0.6, 1.0) rates in the presence of 1 
mM penicillin.  In Panels B2 and C2, the D state entry rate was set to zero.  Dashed 
horizontal lines indicate the extent of desensitization in the absence of penicillin for each 
condition. 
 
 
 
desensitization (Figure 6A3), while increasing the blocking rate in the context of a larger 
unblocking rate (k- = 1.0 ms
-1
) caused only decreased desensitization (Figure 6A4).  
Interestingly, differences in blocker affinity were insufficient to explain this behavior, as 
blockers of similar affinity could have different effects on desensitization (compare k+ = 
1000 ms
-1 
in Figure 6A3 to k+ = 10000 ms
-1 
in Figure 6A4, where k- was also 10 fold 
higher), and conversely, those with different affinities could have similar effects 
(compare k- = 0.3 ms
-1 
in Figure 6A1 to k- = 0.3 ms
-1 
in Figure 6A2, where k+ was 10 
fold higher).  Similar patterns were observed with the branched model (not shown), 
suggesting that this effect did not depend on D state connectivity. 
 
Blocked states decreased the extent of macroscopic desensitization by competing with 
existing desensitized states for occupancy 
 
While the simulations demonstrated that both increased and decreased (or even 
unchanged) extents of desensitization were possible with open-channel block, the kinetic 
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basis for this observation remained unclear.  One possibility was that certain 
combinations of blocking and unblocking rates rendered the B state “non-desensitizing” 
(i.e., unable to support macroscopic desensitization despite being arranged like a linear D 
state).  Indeed, previous kinetic studies have demonstrated that O and D states in linear 
arrangement cause macroscopic desensitization only when specific microscopic 
conditions are met (Bianchi et al., 2007; Appendix IV).  Addition of non-desensitizing 
states might therefore decrease desensitization by decreasing the contribution of the 
existing D state to the macroscopic current.  To test this hypothesis, blocking and 
unblocking rates were co-varied, and the extent of desensitization supported by the B 
state alone was compared to that in the presence of both B and D states (Figure 6B1, C1, 
B2, C2). 
Using the default rate constants for linear and branched models, the distinct roles 
played by blocking and unblocking rates in shaping desensitization were again evident 
(Figure 6B1, C1).  However, when blocking and unblocking rates were co-varied in the 
absence of the D state, the curves were markedly different (compare Figure 6B2, C2 to 
Figure 6B1, C1).  Only increases in desensitization were observed, reflecting the fact that 
models lacking a D state (i.e., C-C-O arrangements) could not macroscopically 
desensitize at baseline (Figure 5A4, B4; Appendix IV).  However, not all combinations of 
blocking and unblocking rates supported desensitization.  Desensitization was not 
observed for the highest unblocking rate tested (k- = 1.0 ms
-1
), or for higher unblocking 
rates (not shown), independent of the magnitude of the blocking rate (Figure 6B2, C2; 
bottom curves).  This was true even for blocking rates two orders of magnitude higher 
than those shown, which reduced current amplitudes to less than 1% of control and 
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increased occupancy of the B state above 99% (not shown).  Interestingly, the maximum 
unblocking rate supporting desensitization was determined by the channel opening rate 
().  This relationship was also reported by Bianchi et al (2007) for  and the exit rate 
from the D state () in the linear model, supporting the idea that open-channel block was 
analogous to adding a linear D state to the gating scheme. 
By comparing the results in Panels B1 and C1 with those in Panels B2 and C2 
(Figure 6), the kinetic basis for the ability of open-channel block to both increase and 
decrease desensitization became apparent.  This was best illustrated by the curves 
corresponding to the highest unblocking rate (Figures B1, C1; k- = 1.0 ms
-1
).  When the 
blocking rate was low (k+ = 100 ms
-1
), desensitization was nearly identical to that of the 
control current (dashed line).  This reflected low B state occupancy, as transitions into 
this state were infrequent (due to the low blocking rate), and when they occurred, were 
short-lived (due to the high unblocking rate).  Thus, the models behaved as if the B state 
did not exist.  At the other extreme, however, when the blocking rate was high (k+ = 
10000 ms
-1
), receptors in the O state were more likely to transition into the B than into 
the D state.  In this case, the model behaved as if the D state did not exist, and the extent 
of desensitization was primarily determined by the relationship between entry and exit 
rates from O and B states.  Use of the high unblocking rate (k- = 1.0 ms
-1
), however, 
yielded non-desensitizing currents for all blocking rates (Figure 6B2, C2; bottom curves).  
Thus, increasing the blocking rate shifted the behavior of the kinetic model from that of 
the macroscopically desensitizing C-O-D arrangement towards that of the 
macroscopically non-desensitizing C-O-B arrangement, resulting in less desensitization.  
Conversely, in cases where the C-O-B sub-scheme supported more desensitization than 
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the C-O-D sub-scheme (for example, compare Figure 6B2, C2 when k- = 0.01 ms
-1 
to the 
control extent of desensitization in Figure 6B1, C1), increasing the blocking rate 
increased desensitization (Figure 6B1, C1; top curve).  Indeed, this same effect could be 
appreciated for each unblocking rate, as desensitization was nearly the same with high 
blocking rates regardless of whether the D state was present (compare values at the far 
right of Figures 6B1 and 6B2 to those of Figures 6C1 and 6C2, respectively).  Therefore, 
whether desensitization appeared to increase, decrease, or remain unchanged following 
addition of the blocker depended simply on the relative contributions of the desensitized 
and blocked states to the macroscopic current. 
The observation that different combinations of blocking and unblocking rates 
could support dramatically different extents of desensitization provided a parsimonious 
explanation for the experimentally observed variability in desensitization.  However, it 
should be emphasized that in principle, blocking and unblocking rates could have been 
similar for all isoforms, with variable effects being observed on desensitization due to 
inherent differences in the gating schemes of synaptic and extrasynaptic receptor 
isoforms (Haas and Macdonald, 1999; Lagrange et al., 2007).  Although systematic 
analysis of the interplay between the stability of O, D, and B states was beyond the scope 
of the present study, preliminary simulations demonstrated that the effects of open-
channel block depended on the kinetics of channel gating, as both increased and 
decreased desensitization was possible for any given combination of blocking and 
unblocking rates depending on the relative stabilities of O and D states (Figure 7). 
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Open-channel block can selectively modulate either peak or residual currents. 
The simulations in the previous sections confirmed that open-channel block could 
decrease the extent of desensitization, as observed experimentally for the majority of 
receptor isoforms.  Interestingly, for certain receptor isoforms (e.g., α1β3δ and α5β3δ), 
this decrease was mediated almost entirely by inhibition of peak currents; residual 
currents were essentially unaffected (Figure 2).  To determine the kinetic basis for this 
observation, the sensitivity of peak and residual currents to open-channel block was 
evaluated.  Each set of simulations was performed with the linear model in the context of 
either increased (Figure 8A1, A2) or decreased (Figure 8B1, B2) D state stability 
(defined as δ/ρ), allowing for an expanded view of the kinetic parameter space. 
Interestingly, a striking difference was noted between the relative contribution of 
blocking and unblocking rates to peak and residual currents.  While residual currents 
were sensitive to both rates (Figures 8A2, B2), peak currents were primarily sensitive to 
changes in the blocking rate (Figure 8A1, B1).  Although somewhat counterintuitive, it 
was noted that current rise times (10-90%) were rapid (~1 ms) for both high and low D 
state stability conditions (Figure 8C1, D1; solid traces).  As a result, unblocking rates 
below 1.0 ms
-1
 did not cause further reductions in the peak current, as they supported 
dwell times in the B state of >1 ms, and therefore, permitted channel reopening (on 
average) only after currents reached peak.  Thus, for any given blocking rate, there was a 
limit to the ability of open-channel block to inhibit peak currents, which was determined 
by the relationship between the current rise time in the absence of blocker and the 
unblocking rate.  Support for this idea came from increasing the highest unblocking rate  
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Figure 7. Gating kinetics influenced the sensitivity of macroscopic desensitization to 
open-channel block. 
 
A-D, The extent of desensitization was evaluated for linear (Panels A and C) and 
branched (Panels B and D) models over a range of blocking and unblocking rates in the 
context of either four-fold increased (Panels A and B) or decreased (Panels C and D) D 
state stability (δ/ρ).  Increased stability was achieved by increasing δ and decreasing ρ 
two-fold each, while decreased stability was achieved by decreasing δ and increasing ρ 
two-fold each.  See the legends of Figures 6 and 7 for rate constants and simulation 
conditions.  Dashed horizontal lines indicate the extent of desensitization in the absence 
of penicillin.  E-H, The extent of desensitization was evaluated for linear (Panels E and 
G) and branched (Panels F and H) models over a range of blocking and unblocking rates 
in the context of four-fold increased (Panels E and F) or decreased (Panels G and H) O 
state stability (β/α).  Increased stability was achieved by increasing β and decreasing α 
two-fold each, while decreased stability was achieved by decreasing β and increasing α 
two-fold each.  Note that when the unblocking rate was set to 0.3 ms
-1
, both increased 
(Panels C, D, E, F) and decreased (Panels A, B, G, H) extents of macroscopic 
desensitization were possible, and that the direction of change was not always related to 
the amount of macroscopic desensitization observed at baseline (i.e., both decreased and 
increased extents of desensitization were possible independent of whether control 
desensitization was high (Panels A and E) or low (Panels C and G)). 
 
 
 
by an order of magnitude (so that channel reopening was more likely during current  
activation), which substantially right-shifted the inhibition curve (not shown).  A similar 
right-shift could also be obtained by altering the kinetics of channel gating, such that 
current rise time was substantially increased (by decreasing the channel opening rate; not 
shown). 
In contrast, there was no limit to the ability of open-channel block to inhibit 
residual currents, as an infinitely low unblocking rate would simply cause the blocked 
state to become absorbing, driving open state occupancy to zero (Appendix II).  Under 
certain conditions, this allowed for selective modulation of peak or residual currents.  For 
example, when the blocking rate was low (k+ = 100), peak currents were always ≥ 90%  
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Figure 8. Peak and residual currents had different sensitivities to blocking and 
unblocking rate constants. 
 
A, B, Peak (Panels A1 and B1) and residual (Panels A2 and B2) currents had different 
sensitivities to open-channel block in the context of increased (Panels A1 and A2) or 
decreased (Panels A2 and B2) D state stability.  Increased stability was achieved by 
increasing δ and decreasing ρ two-fold each, while decreased stability was achieved by 
decreasing δ and increasing ρ two-fold each.  C, Currents were simulated with either 100 
ms (Panel C1) or 1 ms (Panel C2) pulses of 1 mM GABA in the presence of 1 mM 
penicillin G (PG) in the context of low blocking (k+ = 100) and low D state stability (δ/ρ 
= 0.75).  D, Currents were simulated with either 50 ms (Panel D1) or 1 ms (Panel D2) 
pulses of 1 mM GABA in the presence of 1 mM penicillin in the context of high blocking 
(k+ = 10000) and high D state stability (δ/ρ = 12).  Responses simulated with 1 mM 
GABA alone are shown in black.  Peak currents were not normalized.  All simulations 
were performed with the linear model (Figure 5A1; see figure legend for rate constants). 
 
 
 
of control, the result of transitions into the B state being infrequent during current 
activation (Figure 8A1, B1).  However, when combined with the lowest unblocking rate 
(k- = 0.01), substantial reductions were observed in the residual current (Figure 8A2, B2).  
This effect was more apparent with low D state stability (Figure 8B2), as this allowed for 
higher B state fractional occupancy with any given combination of blocking and 
unblocking rates (compare Figure 8A2 to Figure 8B2).  Thus, blockers with relatively 
low blocking and unblocking rates would have limited capacity to modulate early phases 
of current activation, giving the appearance of selectivity for currents evoked under tonic 
conditions (Figure 8C1, 8C2). 
Conversely, certain combinations of rate constants preferentially modulated peak 
currents.  For example, when the blocking rate was increased by two orders of magnitude 
(k+ = 10,000), peak currents were reduced to ~20% of control (Figure 8A1, B1).  
However, when combined with the largest unblocking rate (k- = 1.0), residual currents 
were inhibited less than peak currents (Figure 8A2, B2).  This effect was more 
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pronounced under conditions of increased D state stability (Figure 8A2), where ~60% of 
the residual current remained.  In fact, when D state stability was increased by an 
additional order of magnitude, this same combination of blocking and unblocking rates 
had only minimal effect on residual current, despite causing a similar reduction in peak 
current (not shown).  Thus, it appeared that highly stable D states “buffered” O state 
equilibrium occupancy from the effects of open-channel block (Appendix II).  In this 
context, blockers with relatively high blocking and unblocking rates would appear to 
selectively modulate early phases of current activation (Figure 8D1), which would 
substantially reduce phasic currents (Figure 8D2). 
 
Decreasing the GABA concentration further decreased the sensitivity of residual 
currents to open-channel block 
 
The observation that increasing D state stability limited the ability of open-
channel block to modulate residual currents suggested that stabilizing other non-
conducting states might have a similar (and possibly compounding) effect.  Consistent 
with this idea, residual currents evoked by prolonged exposure to sub-saturating GABA 
(to mimic tonic inhibition) were only minimally affected by penicillin (Figure 4), despite 
having clear sensitivity when evoked by nearly-saturating GABA (Figures 1, 2).  This 
was best illustrated by 43 receptors, whose residual currents were inhibited ~40% by 
penicillin when evoked by 1 mM GABA, but <10% when evoked by 1 μM GABA.  
Since decreasing the GABA concentration should increase fractional occupancy of the 
unliganded non-conducting state, we hypothesized that much like stabilizing D state, this 
might also “buffer” O state occupancy from the effects of open-channel block. 
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Figure 9.  Decreasing the GABA concentration decreased the sensitivity of residual 
currents to open-channel block. 
 
A, The equilibrium fractional occupancy of the unbound state (C1) increased as the 
GABA concentration and B state stability (defined as the ratio of the effective blocking 
rate, k+[Blocker], to the unblocking rate, k-) decreased.  B, The ratio of O state 
occupancy to B state occupancy was unchanged across GABA concentrations for any 
given B state stability.  C, The sensitivity of residual currents to open-channel block 
decreased with decreasing GABA concentration and B state stability.  D, Currents were 
simulated with 1 mM GABA (left) and 1 μM GABA (right) either alone (solid traces) or 
in the presence of 1 mM penicillin G (PG; dashed traces) when B state stability was high 
(k+[PG]/k- = 10).  Currents evoked by GABA alone (black traces) were scaled to the 
amplitude of residual currents.  All simulations were performed with the linear model 
(Figure 5A; see legend for rate constants). 
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To test this hypothesis, simulated residual currents evoked by prolonged co-
applications (30 s) of GABA and 1 mM penicillin were evaluated over a range of GABA 
concentrations (Figure 9).  As expected, decreasing the GABA concentration increased 
equilibrium occupancy of C1 (Figure 9A) and decreased occupancy of all other states (not 
shown).  In addition, increasing B state stability left-shifted the concentration-occupancy 
curve.  This likely reflected the decreased GABA EC50 (not shown), as increasing B state 
stability should have the same effect on EC50 as stabilizing any other fully-liganded state 
in the gating scheme (Colquhoun, 1998).  Interestingly, while decreasing the GABA 
concentration did not alter the ratio of O to B state occupancies (Figure 9B), it 
substantially decreased the sensitivity of residual currents to open-channel block (Figure 
9C).  This phenomenon was observed even when B state occupancy was substantially 
higher than O state occupancy (e.g., when k+[B]/k- = 10; Figure 8C, D).  Similar 
behavior was observed using the branched model (Figure 5B1) and previously published 
kinetic models of 132L and 432L receptors (Lagrange et al., 2007) (Figure 10), 
indicating that this effect was independent of the number and connectivity of states in the 
gating scheme. 
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Figure 10. Context-dependent modulation was also observed with a comprehensive 
model of GABAA receptor function. 
 
A, Comprehensive kinetic model of GABAA receptor function for the α1β3γ2L and 
α4β3γ2L receptor isoforms (for rate constants, see Lagrange et al., 2007).  Blocked states 
(B) were connected to each open state using the default blocking (k+) and unblocking (k-
) rates (see Figure 5 legend).  B, Simulated responses to 1 mM GABA either alone 
(black) or in the presence of 1 mM penicillin (PG; grey) for the α1β3γ2L (top) and 
α4β3γ2L (bottom) receptor isoforms.  Note that the reduction of peak and residual 
currents was less than that observed experimentally (see Figure 1), suggesting that 
penicillin had a higher affinity for these isoforms (note that the original single-channel 
studies were performed in spinal cord neurons, which express different receptor isoforms; 
Twyman, et al., 1992).  C, D, Blocking and unblocking rates were optimized for the 
α1β3γ2L (Panel C) and α4β3γ2L (Panel D) receptor isoforms such that peak and residual 
currents were inhibited to the extent observed experimentally.  The control current is 
shown on the far left, followed by currents obtained in the presence of penicillin at each 
step of the optimization process.  Final values are shown at the far right.  Dashed lines 
indicate the amplitude of peak and residual currents for the GABA control.  Note that the 
final values should be taken only as approximations, as they are based entirely on 
macroscopic data and assume the rates of blockade are identical for all O states.  E, 
Simulated responses to brief (1 ms) pulses of 1 mM GABA either alone (black) or in the 
presence of 1 mM penicillin (grey) predict that both α1β3γ2L (left) and α4β3γ2L (right) 
isoforms would be highly sensitive to penicillin when activated under phasic conditions.  
F, Simulated responses of the α4β3γ2L receptor isoform to prolonged application (30 s) 
of either 1 μM (left) or 100 nM (right) GABA either alone (black) or in the presence of 1 
mM penicillin (grey) predicts that this isoform would be minimally sensitive to penicillin 
when activated under tonic conditions.  Similar results were obtained for the α1β3γ2L 
receptor (not shown).  Control currents were scaled to their peaks. 
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DISCUSSION 
 
Penicillin produced context-dependent modulation of GABAA receptor currents 
 
Preferential modulation of phasic or tonic inhibition is generally attributed to 
synaptic and extrasynaptic receptor isoforms having different sensitivities to a given 
pharmacological agent (Nusser and Mody, 2002; Stell and Mody, 2002; Farrant and 
Nusser, 2005).  The observation that penicillin selectively inhibited phasic currents has 
thus been suggested to reflect specificity for synaptic isoforms (Yeung et al., 2003).  
However, we found that penicillin modulated GABA currents evoked from both synaptic 
and extrasynaptic isoforms, indicating that isoform-specificity was insufficient to account 
for the apparent insensitivity of tonic currents.  We therefore explored the possibility that 
the markedly different contexts of receptor activation associated with phasic and tonic 
inhibition were responsible for their different sensitivities to penicillin.  Consistent with 
this hypothesis, we found that currents evoked by prolonged exposure to sub-saturating 
GABA (i.e., tonic activation) were relatively insensitive to penicillin, while those evoked 
by brief pulses of nearly-saturating GABA (i.e., phasic activation) were highly sensitive.  
Although we did not evaluate the effects of penicillin on every known GABAA receptor 
isoform, the results were nonetheless consistent with the idea that the context of receptor 
activation, and not the subset of receptor isoforms present in synaptic and extrasynaptic 
compartments, was responsible for the reported selectivity of penicillin for phasic 
currents. 
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Penicillin had variable effects on GABAA receptor macroscopic current properties 
 
Penicillin has previously been demonstrated to negatively modulate GABAA 
receptor currents (Macdonald and Barker, 1977; Horne et al., 1992; Katayama et al., 
1992; Tsuda et al., 1994; Behrends, 2000; Sugimoto et al., 2002) by an open-channel 
block mechanism (Twyman et al., 1992).  Consistent with these studies, we found that 
penicillin decreased peak current amplitudes for both synaptic and extrasynaptic receptor 
isoforms when evoked by saturating GABA.  This suggested that phasic currents would 
always be inhibited by penicillin, regardless of which subset of receptor isoforms is 
localized to synapses.  Penicillin is therefore likely to have widespread effects on phasic 
inhibition, which may underlie its potent pro-convulsant properties and ability to produce 
epileptiform activity in vitro (Schneiderman et al., 1994; Uysal et al., 1996; 
Schneiderman 1997; Jimenez et al., 2000; Shen and Lai, 2002).  It should be emphasized, 
however, that the widespread sensitivity of GABAA receptor peak currents to penicillin is 
not a fundamental property of open-channel blockade.  Indeed, our simulations 
demonstrated that addition of blocked states can theoretically have minimal effect on 
peak current if, for example, the current rise time is much faster than the blocking rate 
(Figure 8).  In this case, open-channel block would appear selective for tonic, as opposed 
to phasic, inhibition. 
Interestingly, penicillin had variable effects on the extent of desensitization, with 
increased, decreased, and even unchanged extents being observed with different receptor 
isoforms.  Although unexpected for an open-channel block mechanism, particularly since 
the blocked state provided an additional route for channel closure, our simulations 
demonstrated that macroscopic current shape does not specify uniquely the precise 
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arrangement of states in the microscopic gating scheme (Mozrzymas et al., 2003; Bianchi 
et al., 2007).  In other words, the fact that individual receptors must open before 
becoming blocked does not necessarily mean that the resulting macroscopic currents will 
be affected only after they have reached peak.  Much like desensitized states (Bianchi et 
al., 2007), substantial occupancy of blocked states can be achieved even during current 
activation.  As a result, blocked states can influence both peak and residual currents, and 
depending on the relationship between the kinetics of block and those of channel gating, 
can have markedly different effects on each of these current properties, causing the extent 
of desensitization to change.  While the physiological significance of altered 
desensitization remains unclear (since prolonged exposure to high concentrations of 
GABA is not thought to occur in vivo), increasing evidence suggests that the shape of 
desensitization influences the pattern of current responses during repetitive stimulation 
(Bianchi and Macdonald, 2002; Pugh and Raman, 2005; Lagrange et al., 2007). 
Although the effects on desensitization were highly variable, all receptor isoforms 
displayed prolonged deactivation in the presence of penicillin (in the case of decreased 
desensitization, this provided a novel experimental example of desensitization-
deactivation “uncoupling”; Bianchi et al., 2007).  Somewhat paradoxically, however, 
penicillin accelerated deactivation following brief pulses, a finding consistent with the 
reported ability of penicillin to accelerate IPSC decay in hippocampal neurons 
(Mtchedlishvili and Kapur, 2005).  While this behavior was also observed during our 
kinetic simulations (Figure 8C2), it should be emphasized that only the fast phase of 
deactivation was accelerated by open-channel block.  Similar to the effect of stabilizing 
desensitized states (Bianchi et al., 2007), the accelerated fast phase was accompanied by 
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a markedly prolonged slow phase (Figure 8C2; note that traces corresponding to 
deactivation in the presence of blocker did not return to baseline), causing the weighted 
deactivation time course to actually be prolonged (not shown).  Slow phases, however, 
may be difficult to resolve experimentally above background noise if they are relatively 
low amplitude, giving the appearance of accelerated deactivation. 
Thus, while the effects of penicillin on macroscopic current properties were 
complex and often counterintuitive, our simulations using simple models of GABAA 
receptor function demonstrated that these effects were entirely consistent with simple 
open-channel block.  In addition, the simulations exposed a striking similarity between 
the roles played by blocked and desensitized states in shaping the macroscopic current, 
suggesting that open-channel blockers could be useful experimental tools for exploring 
the relationship between microscopic and macroscopic desensitization.  Unlike native 
desensitized states, the entry rate into the blocked state can be precisely controlled simply 
by varying the blocker concentration, the orientation of the blocked state with respect to 
the open state is always known, and the exit rate from the blocked state can be 
unambiguously determined with single channel analysis. 
 
Receptor activation by low concentrations of GABA contributed to the apparent 
insensitivity of tonic currents to penicillin 
 
For an open-channel blocker to alter the extent of desensitization, it must have 
different effects on peak and residual currents.  Implicit in this definition, however, is the 
capacity to differentially modulate phasic and tonic inhibition.  For example, preferential 
inhibition of peak currents predicts that non-equilibrium phases of receptor activation 
will be more sensitive than near-equilibrium phases, meaning that phasic currents should 
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be affected more than tonic currents.  Conversely, preferential inhibition of residual 
currents predicts that near-equilibrium phases of receptor activation will be more 
sensitive than non-equilibrium phases, meaning that tonic currents should be affected 
more than phasic currents.  The observation that the extent of desensitization was 
decreased for most extrasynaptic isoforms (the result of preferential inhibition of peak 
currents) was therefore consistent with the observation that tonic currents were less 
sensitive to penicillin than phasic currents (Yeung et al., 2003).  This, however, could not 
fully explain the apparent insensitivity of tonic currents.  Despite the decreased extent of 
desensitization observed for most extrasynaptic receptor isoforms, residual currents 
activated by a nearly-saturating GABA concentration were still substantially inhibited by 
penicillin (Figures 1, 2), suggesting that tonic currents should have been reduced to some 
degree.  However, only a small reduction was reported in the root-mean-square noise of 
tonic currents; the magnitude of the tonic current itself was unchanged (Yeung et al., 
2003; Mtchedlishvili and Kapur, 2005). 
Interestingly, residual currents were considerably less sensitive to penicillin when 
evoked by sub-saturating GABA (compare residual currents in Figures 1 and 2 to those in 
Figure 4).  While this could potentially have been explained by lower affinity of the 
blocker for mono-liganded compared to di-liganded open states, single channel studies 
have reported that penicillin actually had the highest affinity for the mono-liganded open 
state (Twyman et al., 1992).  An alternative explanation was provided by the simulations, 
where it was observed that decreasing the GABA concentration buffered open state 
occupancy from the effects of open-channel block by stabilizing the unliganded state.  
This phenomenon was independent of the specific connectivity or number of states in the 
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gating scheme, suggesting that tonic currents would be minimally sensitive to penicillin 
regardless of which receptor isoforms comprised the extrasynaptic pool. 
Thus, our results demonstrated that the “context” of receptor activation, both in 
terms of agonist concentration and time course of exposure, was an important 
determinant of the sensitivity of GABAA receptor currents to penicillin.  While it remains 
unclear whether such context-dependent modulation is possible with other known 
GABAA receptor modulators, preliminary simulations suggested that this behavior was 
not unique to open-channel block.  For example, phasic and tonic currents could also 
have markedly different sensitivities to modulators that “block” non-conducting states, 
and even to modulators that stabilize open states (not shown).  The latter are of particular 
interest, as the ability to selectively enhance equilibrium or non-equilibrium currents 
would have important therapeutic implications for disease states caused by impairments 
in tonic or phasic inhibition, respectively.  
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CHAPTER V 
 
 
 
IDENTITY OF THE GABAA RECEPTOR α SUBUNIT INFLUENCES 
MACROSCOPIC CURRENT KINETICS: IMPLICATIONS FOR 
SYNAPTIC AND EXTRASYNAPTIC TRANSMISSION 
 
 
 
Emmanuel J. Botzolakis, Andre H. Lagrange, and Robert L. Macdonald 
 
ABSTRACT 
Up-regulation of the GABAA receptor α4β3γ2L receptor isoform has been
 
shown 
in multiple animal models of chronic epilepsy.  However, little is known about its
 
functional properties, limiting our understanding of its role in normal and abnormal 
neuronal physiology.  We therefore compared the properties of the α4β3γ2L receptor 
isoform to those of the more widely
 
distributed α1β3γ2L receptor isoform using a 
combination of whole cell recording and kinetic modeling.  While peak current 
amplitudes and GABA EC50 values were similar for both isoforms, currents evoked from 
α4β3γ2L receptors had more fast desensitization and deactivated more slowly than those 
evoked from α1β3γ2L receptors.  To determine how these kinetic differences would 
affect GABAA receptor responses under physiologically relevant conditions, a 
comprehensive kinetic model was generated for each isoform and evaluated under 
synaptic and extrasynaptic contexts of activation.  The simulations predicted that currents 
evoked by repetitive, brief GABA applications
 
would be more strongly attenuated for the 
α4β3γ2L receptor.  In addition, they predicted that exposure to prolonged low levels of 
GABA, similar
 
to those that might be present in the extrasynaptic space, would greatly
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suppress the response of α4β3γ2L currents to higher concentrations of GABA.  Thus, 
while similar to α1β3γ2L receptors in their ability to respond to brief and low frequency 
synaptic inputs, α4β3γ2L receptors are less efficacious when exposed to prolonged tonic 
GABA or during
 
repetitive stimulation.  Taken together, these data suggest that
 
enhanced 
desensitization limits the range of GABA applications to which receptors can respond 
maximally. 
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INTRODUCTION 
GABAA receptors are pentameric cys-loop receptors composed primarily
 
of two α 
subunits, two β subunits, and either a γ or a δ subunit selected from six α, three β, three γ, 
and one δ subunit subtype.  The distribution of specific subtypes is highly brain region 
and cell type specific, and varies during development and in
 
certain disease states.  
Interestingly, the pharmacological properties of GABAA receptors are highly dependent 
upon the specific α subunit subtype included.  For example, when assembled with β and γ 
subunits,
 
GABAA receptors containing α1, 2, 3, or 5 subtypes are highly
 
diazepam 
sensitive.  However, α1 subtype-containing receptors are more sensitive to zolpidem than 
receptors containing
 α2 or α3 subtypes, and those containing α5 subtypes are completely 
insensitive to this drug.  In contrast, GABAA receptors containing
 α4 or α6 subtypes are 
insensitive to both diazepam and zolpidem.  Furthermore, the imidazobenzodiazepine Ro 
15-4513, which is
 
an inverse benzodiazepine receptor agonist at GABAA receptors
 
containing α1, α2, α3 or α5 subtypes, actually enhances currents from GABAA receptors 
containing α4 or α6 subtypes. 
Unlike the pharmacological properties of GABAA receptors composed of different 
α subtypes, relatively little is known about their kinetic properties.  This limits our 
understanding of the role played by GABAA receptors in either normal or abnormal 
inhibitory neurotransmission,
 
as receptor kinetics determine the efficiency of both 
synaptic and extrasynaptic signaling.  Indeed, GABAergic inhibitory
 
post-synaptic 
current (IPSC) time courses are determined primarily by the rates
 
of GABAA receptor 
activation and deactivation.  Moreover, while the role of desensitization in synaptic 
transmission not yet clear, there is evidence that the underlying desensitized states delay 
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GABA unbinding, thereby prolonging current deactivation (Jones & Westbrook, 1995).  
In addition, slow desensitization may be important for shaping receptor responses under 
conditions of high frequency stimulation (Bianchi & Macdonald, 2002).  Receptor kinetic 
properties also determine the effectiveness of extrasynaptic GABAergic transmission.  
Although this mode of inhibitory signaling involves near-equilibrium conditions, 
meaning that extrasynaptic GABAA receptors need not be rapidly
 
activating, highly 
desensitizing, or slowly deactivating, these processes may nonetheless be important for 
determining receptor responses to fluctuations in the ambient GABA concentration. 
As a result, altered expression and distribution of different α subunit-containing 
GABAA receptor isoforms could potentially have profound effects on
 
inhibitory 
neurotransmission.  Interestingly, several animal models of epilepsy have demonstrated 
an up-regulation of α4 subtype protein expression (Schwarzer et al. 1997; Sperk et al. 
1998; Brooks-Kayal et al. 1998).  In addition, one model of CNS hyperexcitability, 
chronic intermittent
 
ethanol, shifts the subcellular localization of α4 subtype-containing 
receptors from a perisynaptic to a central
 
synaptic location (Liang et al. 2006).  In both 
cases, however, it remains unclear whether α4 subtype up-regulation contributes to the 
generation of seizures or, alternatively, is a response to the hyperexcitable state.  Indeed, 
without knowing the kinetic properties of α4 subunit-containing receptors, it is 
impossible to even speculate as to whether this change in receptor expression is causative 
or compensatory.  As a first attempt to address this issue, we compared
 
the functional 
properties of recombinant
 α4β3γ2 and α1β3γ2 receptor isoforms using a combination of 
whole-cell patch-clamp recording and kinetic modeling.  
212 
 
MATERIALS AND METHODS 
 
Cell culture and expression of recombinant GABAA receptors 
 
GABAA receptor α1, α4, β3 and γ2L subunit cDNAs were individually
 
subcloned 
into the mammalian expression vector pCMV-neo.  Deletion
 
of an extraneous genomic 
sequence in the 5' untranslated region
 
of the α4 subtype cDNA resulted in improved 
expression, as previously
 
described (Wallner et al. 2003).  All cDNAs were sequenced by
 
the Vanderbilt University Medical Centre sequencing core to
 
confirm that they matched 
the published sequences for mature
 
rat peptides (accession numbers NP_899155, 
NP_542154,
 
P63079 and NP_899156 for the α1, α4, β3, and γ2 proteins, respectively). 
Human embryonic kidney (HEK293T) cells were plated at a density
 
of 200,000 – 
400,000 cells per 60-mm culture dish and maintained
 
in Dulbecco's modified Eagle's 
medium (Invitrogen, Carlsbad,
 
CA, USA) supplemented with 10% fetal bovine serum 
and 100 IU
 
ml
–1
 each of penicillin and streptomycin (Invitrogen)
 
at 37°C in 5% CO2–95% 
O2.  On day one, cells were transfected
 
using a previously established calcium phosphate 
precipitation
 
technique (Angelotti et al. 1993).  A total of 12 µg of GABAA
 
receptor 
subunit-containing DNA, with 4 µg of each
 
subunit plasmid (ratio 1 : 1 : 1) for αβ3γ2L 
receptors.  Two micrograms of pHook-1 (Invitrogen) were also added so that
 
immunomagnetic bead selection could be performed on day two (Greenfield et al. 1997).  
Following selection, the cells were plated on 35-mm dishes,
 
and recordings were made on 
day three, approximately 18–36 h after selection. 
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Electrophysiological recording and drug application  
 
Whole cell voltage-clamp recordings were performed on transfected
 
HEK293T 
cells.  All experiments were performed using at least
 
two separate transfected batches of 
cells on at least two
 
separate days of recording.  Cells were bathed in an external
 
solution 
consisting of (in mM): NaCl 142, CaCl2 1, KCl 8, MgCl2
 
6, glucose 10, HEPES 10 (pH 
7.4, 320–340 mosmol l–1).  All recordings were performed at room temperature.  Glass 
micropipettes were formed from
 
thin-walled borosilicate glass with a filament (World 
Precision
 
Instruments, Sarasota, FL, USA) with a P2000 laser electrode
 
puller (Sutter 
Instruments, San Rafael, CA, USA) and fire polished
 
with a microforge (Narishige, East 
Meadow, NY, USA).  Microelectrodes
 
used for lifted cell recording had resistances of 1–
2
 
MΩ when filled with an internal solution consisting of (in mM): KCl 153, MgCl2 1, 
HEPES 10, EGTA 5, Mg
2+
-ATP 2 (pH 7.3, 300–310 mosmol l–1).  This combination of 
external and internal
 
solutions produced a chloride equilibrium potential (ECl) of
 
approximately 0 mV. 
Membrane voltages were clamped at –20 mV using an Axopatch 200A amplifier 
(Axon Instruments, Union City, CA, USA) amplifier.  GABA was applied to the lifted 
cells via a three-, four-, or
 
six-barrelled square glass (Friedrich and Dimmock, Millville,
 
NJ, USA).  These multi-barrelled pipettes were pulled on a P-87
 
Flaming-Brown (Sutter 
Instruments, San Rafael, CA, USA) electrode
 
puller with custom made platinum–iridium 
filament and
 
sanded to a final diameter of 200–400 µm for each barrel.  The multi-
barrelled pipettes were attached to a Warner
 
SF-77B Perfusion Fast-Step (Warner 
Instrument Corporation, Hamden,
 
CT, USA), allowing for rapid solution changes.  All 
GABA application
 
protocols began with a cell positioned in the flow of external
 
bath 
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solution from which the multi-barrelled array was repositioned
 
such that the unmoved 
cell and electrode were now exposed to
 
GABA.  The drug application was initiated by an 
analog pulse
 
triggered by the pCLAMP 9 software (Axon Instruments) that caused
 
the 
motor of the Warner Fast-Step to reposition the multi-barrelled
 
array from one barrel to 
another (e.g., external solution to
 
GABA).  Exchange times were routinely measured and 
always found
 
to be 0.3–0.7 ms at an open electrode tip by stepping from control to dilute 
external solution.  The exchange around an intact cell was measured
 
in a subset of cells 
by stepping into 10 µM GABA and then
 
another step into 10 µM GABA in external 
solution in which
 
NaCl was replaced by NaSCN.  The resulting current had a 10–90% rise 
time of 0.9 ± 0.1 ms (n = 9; data not shown) using a drug
 
application pipette with 0.35 ms 
open-tip exchange time. 
For generation of concentration–response relationships, peak GABAA receptor 
currents evoked by randomly sequenced concentrations
 
of GABA were recorded with at 
least 45 s of wash between each
 
application.  This time was empirically determined to be 
sufficient
 
for complete recovery from desensitization.  To assess
 
possible changes in the 
transmembrane chloride ion concentration
 
gradient, pCLAMP 9 generated a 500 ms ramp 
voltage step from
 –50 mV to +50 mV.  The current–voltage relationship was determined 
at the beginning and end of each prolonged exposure
 
to 1 µM GABA, as well as at the 
end of the wash in external
 
solution.  The responses during concentration–response 
determinations and pre-application studies were normalized to
 
the current elicited by 1 
mM GABA after a prolonged wash in
 
external solution during each sweep.  Data were 
excluded if there
 
was a greater than 10% rundown of the maximal response between
 
sweeps. 
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Data analysis  
 
Currents were low-pass filtered at 2 kHz, digitized at 5–10 kHz, and analyzed 
using the pCLAMP 9 software suite.  For cells with very small (< 50 pA) currents, rise 
time, desensitization
 
and deactivation were not determined.  Current amplitudes and
 
10–
90% rise times were measured using the Axon Instruments
 
Clampfit 9 software package.  
The desensitization and deactivation
 
time courses of GABAA receptor currents were fitted 
using the
 
Levenberg-Marquardt least squares method with up to six component
 
exponential functions of the form ane
(–t/ n)
 + C,
 
where t is time, n is the best number of 
exponential components,
 
an is the relative amplitude of the nth component, n is the
 
time 
constant of the nth component, and C is the residual current
 
at the end of the GABA 
application.  Additional components were
 
accepted only if they significantly improved 
the fit, as determined
 
by an F-test automatically performed by the analysis software
 
on 
the sum of squared residuals.  The time course of deactivation
 
was summarized as a 
weighted time constant, defined by the following
 
expression: .  GraphPad Prism 4 
(GraphPad Software Inc, San Diego,
 
CA, USA) was used to fit the concentration–
response results
 
to a sigmoidal function using the equation: 
 
( 
 
where I is the peak current at a given GABA
 
concentration, and Imax is the maximal peak 
current.  Numerical
 
data were expressed as means ± SEM.  Statistical
 
analysis was 
performed using GraphPad Prism 4.  Data were compared
 
using a Mann-Whitney test for 
pairs of data, or a Kruskal-Wallis
 
test for comparing three or more groups.  Statistical 
significance
 
was taken as P < 0.05. 
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Kinetic modeling  
 
Using QuB version 1.4 (http://www.qub.buffalo.edu), a modified
 
version of the 
α1β3γ2L GABA receptor model proposed by Haas & Macdonald (1999) was fitted to 
representative α1β3γ2L and α4β3γ2L whole cell currents.  For each GABA concentration 
used in the fitting process, a representative
 
current was generated by averaging the 
responses of three to
 
eight cells whose peak currents were normalized to the 1 mM
 
GABA peak current.  Before using this averaged current for fitting,
 
it was verified against 
the average kinetic properties of individual
 
cells at the same GABA concentration. 
Since mono-liganded states should have negligible occupancy
 
in the presence of 
saturating concentrations of GABA, we first
 
fitted an averaged current elicited by 10 mM 
GABA to a version
 
of the model including only the di-liganded states.  This reduced
 
the 
number of free parameters, thus decreasing the time required
 
for each fitting iteration.  To 
further reduce the number of
 
free parameters, the exit rates from di-liganded open states
 
were fixed so that mean open times would be consistent with
 
previously published single 
channel data for these receptor
 
isoforms (Haas & Macdonald, 1999; Akk et al. 2004).  
Once
 
an adequate fit was obtained (i.e., when the log likelihood ratio
 
changed by less than 
0.5 between iterations), the currents were
 
refitted to a model with scaled rate constants to 
obtain open
 
time distributions consistent with the published single channel
 
data.  Closed 
time distributions were not considered during the
 
fitting process, as the longest 
components tend to be artificially
 
shortened due to the presences of multiple channels in 
most
 
patches.  Nonetheless, it should be noted that the di-liganded
 
portion of our model 
contains five closed states.  This gives
 
rise to a closed time distribution with five 
components, a number
 
consistent with published reports for both receptor isoforms. 
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After fitting the model to currents elicited by 10 mM GABA,
 
all di-liganded rate 
constants were fixed, and mono- and unliganded
 
non-conducting states were added to 
generate two GABA binding
 
steps.  The two GABA binding sites were assumed have 
equal affinity.  To obtain an estimate of the unbinding rates, this model was
 
first fitted to 
the time course of current deactivation following
 
a brief GABA application (5 ms, 1 
mM).  Mono-liganded open and
 
desensitized states were then added, and the model was 
refitted
 
to currents elicited by the lowest GABA concentration that permitted
 
significant 
activation and macroscopic desensitization (3 and
 
10 µM for α4β3γ2 and α1β3γ2 receptor 
isoforms, respectively).  The final kinetic model for each receptor isoform was verified
 
by 
generating theoretical currents with the differential equation
 
solving program Berkeley-
Madonna 8.0 (http://www.berkeleymadonna.com)
 
using the fourth-order Runge-Kutta 
method and time intervals
 
of 10–100 µs. 
  
218 
 
RESULTS 
To investigate the influence of the α4 subunit subtype on the physiological 
properties of αβγ GABAA receptor currents, we used whole-cell voltage
-
clamp recording 
and a rapid drug delivery system to apply GABA
 
to lifted HEK293T cells that had been 
co-transfected with β3, γ2L, and either α1 or α4 subtypes.  We chose the combination of 
α4, β3, and γ2L subunits because rodent brain α4 subtypes co-precipitate with β2/3 
subunits (Bencsits et al. 1999) and are among the subtypes
 
co-expressed in thalamus and 
hippocampus (Pirker et al. 2000).  Moreover, multiple models of epilepsy have found a 
consistent
 
up-regulation of α4 subtype expression in the hippocampal dentate gyrus, 
where β3 is the predominant β subunit subtype.  Furthermore, low levels of endogenous 
β3 subtypes have been detected by RT-PCR in HEK293 cells (Kirkness & Fraser, 1993; 
Davies et al. 2000).  We therefore used the β3 subtype to prevent possible contamination 
with multiple β subtypes.  Although α1β2γ2 receptors are the most abundant native 
receptors in mammalian brain, we used α1β3γ2L receptors to permit comparison of the 
effects of different α subtypes on receptor current kinetic properties, without the possible 
confound
 
of different β subtypes. 
 
α4β3γ2L receptor currents desensitized more rapidly and extensively than α1β3γ2L 
receptor currents 
 
To characterize the effect of α subtypes on current desensitization, α4β3γ2L and 
α1β3γ2L currents were recorded during prolonged (4 second) applications of a high 
concentration of GABA (1 mM).  While α4β3γ2L and α1β3γ2L receptor currents had 
similar peak amplitudes (data not shown), α4β3γ2L currents desensitized more rapidly  
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Figure 1.  Desensitization of 432L currents was faster and more extensive than that 
of 132L currents. 
 
A)  Representative currents illustrated the rapid and extensive desensitization that 
occurred during a 4 sec application of 1 mM GABA.  Peak currents were normalized to 
allow for comparison of their kinetic properties.  B.)  The same currents were presented 
on an expanded time scale.  C.)  Although the desensitization time constants were similar 
for 132L and 432L currents, there was a greater contribution of fast ( <100 ms) 
desensitization in 432L currents.  Moreover, 432L currents had less residual 
current at the end of 4 sec of GABA.  ** p<.01, *** p<.001 132L versus 432L 
currents. 
 
 
 
and extensively than α1β3γ2L currents (Figure 1A and 1B).  All currents were fitted best 
with
 
a three or four component exponential function with time constants that fell into four
 
discrete groups, τ1 (< 15 ms), τ2 (20–100 ms), τ3 (110–800),
 
and τ4 (800–4800 ms) 
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(Figure 1C).  The α4β3γ2L currents had a greater contribution of fast (< 100 ms) 
desensitization than
 α1β3γ2L receptors (Figure 1C), although the actual time constants of 
desensitization were similar for both receptors.  Moreover,
 α4β3γ2L receptors had more 
overall desensitization, as assessed
 
by the residual current at the end of the 4 s GABA 
application. 
The rapidly changing membrane conductance during GABA application
 
introduces a transient series resistance error that cannot be
 
compensated with our 
recording system.  In theory, this could
 
lead to underestimation of the true peak amplitude 
and degree
 
of rapid desensitization.  However, if this were the case, we
 
would expect 
those cells with larger currents to have a smaller
 
fraction of fast desensitization.  Similar 
to previous work from
 
our laboratory (Bianchi & Macdonald, 2002), we found no
 
such 
correlation between current amplitude and desensitization
 
(data not shown).  Moreover, 
since the peak amplitudes of α4β3γ2L and α1β3γ2L receptors were the same, any 
transient series resistance errors
 
should have been the same in both groups. 
 
α4β3γ2L receptor currents deactivated more slowly than α1β3γ2L receptor currents 
 
Synaptic inhibitory neurotransmission involves very brief exposure
 
to high 
concentrations of GABA.  To characterize the response
 
of these receptors to a more 
synaptically relevant application
 
of GABA, cells were exposed to 1 mM GABA for 5 ms, 
the briefest
 
application that we were able to achieve reproducibly with our
 
drug delivery 
system.  Both α4β3γ2L and α1β3γ2L receptor currents decayed slowly after a brief 
exposure to GABA (Figure 2A).  However, α4β3γ2L currents deactivated more slowly,  
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Figure 2.  432L receptor currents deactivated more slowly than those of 132L 
receptors. 
 
A)  432L currents deactivated more slowly after a brief application of saturating 
GABA (1 mM, 5 ms).  B)  Summary of the deactivation kinetics.  The 132L current 
weighted deactivation time constant was 200  24 ms (n = 13) and was largely 
determined by a single time constant (3).  In contrast, 432L current deactivation was 
more complicated and prolonged, with an overall weighted deactivation time constant of 
371  55 ms (n = 18), which was significantly longer than 132L currents (p<.05).  * 
p<.05, ** p<.01, *** p<.0001 132L versus 432L currents 
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with a weighted time constant
 
of 371 ± 54 ms (n = 18) versus 200 ± 24
 
ms (n = 13, P < 
0.05) for α1β3γ2L currents.  Deactivation of α1β3γ2L current was relatively simple, with 
two (1 of 13 cells),
 
three (6 of 13 cells), or four (6 of 13 cells) time constants,
 
but the 
major part of the deactivation was due to a single component
 
(τ3, 100–300 ms).  In 
contrast, α4β3γ2L current deactivation tended to be more complex, requiring three (7 of 
18 cells),
 
four (8 of 18 cells) or five (3 of 18 cells) components to accurately
 
fit the 
deactivation time course.  Furthermore, unlike α1β3γ2L current deactivation, no single 
component dominated the deactivation
 
time course (Figure 2B). 
Interestingly, in most published reports, only
 
one or two component exponential 
functions are generally used
 
to fit IPSC decay.  The basis for this difference is uncertain,
 
but may be due to the fact that our recombinant currents were
 
significantly larger than 
most IPSCs, which may have allowed
 
us to detect greater kinetic complexity than would 
be possible
 
from the smaller IPSC currents.  Different fitting techniques
 
are another 
potential source of confusion when comparing studies
 
among laboratories.  To address 
this issue, all of the currents
 
in these studies were also fitted with a two-component 
exponential
 
function.  Although this approach provided less precise fits
 
of the data, there 
was no change in the overall weighted time
 
constant compared to the more complicated 
fits described above
 
(data not shown). 
 
α4β3γ2L and α1β3γ2L receptors had similar sensitivities to GABA 
 
In addition to the synaptic receptors mediating IPSCs, another
 
population of 
GABAA receptors found outside the synaptic cleft
 
respond to tonic, low levels of GABA  
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Figure 3.  132L and 432L receptor peak currents had similar sensitivities to 
GABA. 
 
The GABA potency, as determined by complete concentration response studies in 
individual neurons showed that the peak current EC50s (12 ± 2 M (n = 9) and 17 ± 4 M 
(n = 12)) were not different for 132L and 432l currents, respectively.  Similar 
results were obtained when the data from all cells were pooled and then fitted as a group 
(EC50 = 14 M (95% CI = 12 – 17 M) and 15 M (95% CI = 14-17 M), for 132L 
and 432l currents, respectively). 
 
 
 
(≤ 1 μM).  Despite the small size of these tonic currents, their longevity allows a large 
overall charge transfer that can significantly alter
 
neuronal excitability.  Effective 
inhibition by extrasynaptic
 
receptors would be best served by highly sensitive GABAA 
receptors
 
that are able to respond during prolonged exposure to low GABA
 
 
concentrations.  Concentration–response curves were generated by applying varying 
GABA concentrations in random order with
 
at least a 45 s wash between applications of 
each concentration
 
(Figure 3).  Since there was substantial cell-to-cell variability
 
in  
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Figure 4.  Desensitization attenuated receptor responses to prolonged GABA 
applications. 
 
A)  Representative 432L currents illustrating the effect of desensitization to 
differentially influence peak and pseudo-steady state currents in a concentration 
dependent manner.  Unlike the peak current, the pseudo-steady state current measured 
after 4 sec of GABA (arrow) was responsive to a very limited range of GABA 
concentrations, with maximal stimulation occurring at approximately 10 M.  B)  
Prolonged GABA application to 132L receptors strongly suppressed the maximal 
GABA response (Imax = 31% of 1mM peak current; 95% CI = 29 – 32%) and also caused 
an apparent leftward shift of the concentration-response curves (EC50 = 3.3 M; 95% CI 
= 2.4 – 4.5 M GABA).  The highly desensitizing 432L receptors had an even more 
limited response to prolonged GABA application (Imax = 15%; 95% CI = 15-16%) (EC50 
= 1.0 M; 95% CI = 0.7 – 1.3 M GABA)  Comparing the response of 132L versus 
432L receptors to 4 sec of 1 mM GABA confirmed that the highly desensitizing 
432L currents were more suppressed during prolonged GABA application (p < 
0.001).  For comparison, peak current concentration response data from Figure 7 were 
replotted here as dashed lines. 
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 current size, a near-maximal (1 mM) GABA concentration was
 
applied intermittently to 
allow normalization of peak currents
 
and to assess current run-down during the 
experiments.  The GABA
 
EC50 values were similar for both α1β3γ2L and α4β3γ2L 
receptors (Figure 3;
 
GABA EC50 values were 14 μM (95% CI = 12–17 μM)
 and 15 μM 
(95% CI = 14–17 μM) for pooled data from α1β3γ2L and α4β3γ2L peak currents, 
respectively). 
Tonic GABA receptor currents measured in neurons are thought
 
to be caused by 
low levels of extrasynaptic GABA that change
 
much more slowly than GABA levels in 
the synaptic cleft.  Therefore,
 
we determined the pseudo-steady-state concentration-
dependent
 
response of α1β3γ2L and α4β3γ2L receptors to prolonged GABA application.  
Various concentrations of GABA were applied for 4 seconds, and the
 
current at the end 
of the GABA application was measured (Figure 4A,
 
arrow).  At GABA concentrations 
above 10 μM, the response to prolonged GABA was lower for α4β3γ2L than for α1β3γ2L 
receptors
 
(Figure 4B).  It is worth noting that the concentration dependence
 
of these 
pseudo-steady-state currents had remarkably limited
 
dynamic ranges.  A maximal 
pseudo-steady-state response was seen
 with 10 μM GABA, although higher 
concentrations were able
 
to accelerate the rates of activation and desensitization (Figure 
4B).  In the range of GABA concentrations likely to be present in
 
the extrasynaptic 
spaces (1–2 μM), the responses of α4β3γ2L and α1β3γ2L receptors were similar. 
 
Development of a comprehensive kinetic model of α4β3γ2L and α1β3γ2L GABAA 
receptor function 
 
To make more quantitative predictions about the potential physiological
 
roles of  
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Figure 5.  Kinetic model for the L and L receptor isoforms. 
 
A)  Modified version of the kinetic model proposed for the 132L receptor isoform by 
Haas & Macdonald (1999) is shown (O, open; C, closed; D, desensitized).  B)  rate 
constants for the 132L and 432L receptor isoforms were determined by fitting the 
time course of macroscopic currents evoked by saturating and sub-saturating GABA 
concentrations to the kinetic model in A after constraints were imposed based on 
published single-channel data (see Methods).  Units for all rate constants are s
-1
 except 
for kon (M
-1 
s
-1
).  C1, D1) the optimized responses of 132L and 432L receptors to 
a 5 ms square pulse of GABA (1 mM; arrow) are superimposed on averaged currents 
evoked under similar conditions.  C2, D2) the optimized responses of the 132L and 
432L receptors to a 4 sec square pulse of a saturating GABA concentration (10 mM; 
filled bars) are superimposed on the averaged data traces used for fitting the di-liganded 
rate constants (see Methods).  C3, D3) the optimized responses of the 132L and 
432L receptors to a 4 sec square pulse of sub-saturating GABA concentrations (10 
and 3 M, respectively; filled bars) are superimposed on the averaged data traces used for 
fitting of the mono-liganded rate constants (see Methods). 
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α1 and α4 subtype-containing GABAA receptors, a kinetic
 
model was generated for these 
receptor isoforms that accounted
 
for not only the observed macroscopic properties 
described above,
 
but also for the previously published single channel properties
 
(Haas & 
Macdonald, 1999; Akk et al. 2004) (Figure 5).  This
 
model was based largely on the 
previous work of Haas & Macdonald (1999),
 
but has been expanded to account for 
several additional microscopic
 
and macroscopic kinetic observations.  Specifically, single 
channel
 
recordings from α1βγ GABAA receptors have consistently demonstrated
 
three 
open states, with the relative contribution of the shortest
 
open state (O1) being 
concentration dependent at GABA concentrations
 below 10 μM (Fisher & Macdonald, 
1997).  Although this
 
suggests the presence of an additional GABA binding step distal
 
to 
O1, a feature found in most of the existing models, it remains
 
unclear why a residual 
component of O1 persists at higher concentrations.  One possible explanation is that two 
open states with similar
 
mean open times exist, one of which is mono-liganded and the
 
other di-liganded.  We have therefore added two additional states
 
to the Haas & 
Macdonald (1999) kinetic model: a di-liganded closed
 
(C3) and a di-liganded open state 
(O2).  The addition of the
 
closed state is intended to preserve the known burst 
characteristics
 
of these receptors such that only one type of opening is observed
 
per burst 
(Twyman et al. 1990).  As with α1βγ receptors, single channel recordings from α4βγ 
receptors also demonstrated the presence
 
of three open states that are concentration 
independent at GABA
 
concentrations above 10 μM (Akk et al. 2004).  We therefore 
applied the same kinetic model to those receptors. 
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Table 1.  Kinetic models accurately predict the single channel and macroscopic current 
responses of α1β3γ2L and α4β3γ2L receptor isoforms to a variety of GABA application  
protocols. 

Parameter 
132L 432L 
Measured Simulated Measured Simulated 
Open Intervals (1 mM GABA)   
1 (ms) 0.30* 0.30 0.35
+
 0.35 
Fraction O1 0.24* 0.24 0.34
+
 0.32 
2 (ms) 1.92* 1.92 1.30
+
 1.30 
Fraction O2 0.48* 0.49 0.63
+
 0.65 
3 (ms) 3.47* 3.47 6.30
+
 6.25 
Fraction O3 0.28* 0.27 0.03
+
 0.03 
Mean Open Time (ms) 2.14* 1.97 1.13
+
 1.16 
Po 0.11* 0.08 0.35
+ 0.06 
Desensitization (4 sec, 1 mM GABA)   
1 (ms) 6 ± 1 3 7 ± 1 7 
Contribution A1 0.18 ± 0.03 0.18 0.25 ± 0.03 0.25 
2 (ms) 56 ± 5 36 58 ± 4 49 
Contribution A2 0.07 ± 0.01 0.10 0.13 ± 0.02 0.16 
3 (ms) 431 ± 45 373 373 ± 41 392 
Contribution A3 0.17 ± 0.03 0.22 0.17 ± 0.02 0.19 
4 (ms) 2652 ± 250 1848 1934 ± 161 1406 
Contribution A4 0.33 ± 0.03 0.32 0.33 ± 0.03 0.30 
Residual Current 0.25 ± 0.02 0.18 0.12 ± 0.02 0.09 
Deactivation (5 ms, 1 mM GABA)   
Weighted (ms) 200 ± 24 214 371 ± 55 359 
EC50   
Peak (M) 14 14 15 15 
4 sec (M) 3.0 1.8 1.0 0.6 
Repetitive Stimulation (5 ms, 1 mM GABA)   
2 pulses – 12.5 Hz (final/initial peak) 0.84 ± 0.02 0.77 0.60 ± 0.05 0.63 
2 pulses – 1 Hz (final/initial peak) 0.89 ± 0.01 0.85 0.68 ± 0.04 0.65 
2 pulses – 0.05 Hz (final/initial peak) 0.99 ± 0.01 0.99 0.92 ± 0.02 0.96 
4 pulses – 10 Hz (final/initial peak) 0.75 ± 0.03 0.62 0.52 ± 0.06 0.46 
 
*Haas & Macdonald, 1999. 
+
 Akk, Bracamontes, & Steinbach, 2004. 
 Note that this value overestimates the true Po as it only reflects intra-cluster Po. 
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For both receptor isoforms, we also modified the arrangement
 
of the desensitized 
states.  We found that an accurate fit of
 
the currents evoked by low concentrations of 
GABA was only possible
 
when a mono-liganded closed state (D1) was added, as has been
 
previously suggested (Jones & Westbrook, 1995; Mozrzymas et al. 2003).  Furthermore, 
we did not find that a D state connected to the
 
terminal pre-open state (C5) significantly 
improved our fits.  Without very long GABA applications (> 10 seconds), however, we 
cannot rule out the possibility that there may be even slower
 
phases of desensitization 
than those described here, which may
 
necessitate additional states.  It should be noted that 
while
 
at least four phases of desensitization were observed in the
 
presence of saturating 
GABA concentrations (see above), the model
 
proposed here includes only two di-
liganded desensitized states.  The cause of this discrepancy is two-fold.  First, it reflects
 
the fact that macroscopic current kinetic properties do not
 
directly correspond to specific 
microscopic rate constants or
 
any precise connectivity between states.  Instead, 
macroscopic
 
current properties represent a complex mixture of all rate constants
 
in the 
underlying kinetic scheme, such that the number of desensitized
 
states need not directly 
correspond to the number of time constants
 
required for fitting of macroscopic 
desensitization.  Indeed,
 
our model with two desensitized states gives rise to currents
 
that 
require four exponential components to adequately fit the
 
time course of macroscopic 
desensitization (Table 1).  Second,
 
it raises the important question: what is a desensitized
 
state?  From the standpoint of charge transfer, desensitized
 
states are simply non-
conducting states.  While it is tempting
 
to propose that the dwell time in a given state  
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Figure 6.  Kinetic model accurately predicts the concentration dependence of L 
and L receptor peak and steady-state responses to GABA. 
 
Using the L and L kinetic models, simulations of receptor activation were 
performed using square 4 sec GABA pulses.  A) peak currents at various GABA 
concentrations are compared to the peak current evoked by a square pulse of 10 mM 
GABA, above which the peak current amplitude did not change.  Although slight 
differences in the shape of the concentration response profiles are evident, the EC50s are 
virtually identical for these two receptor isoforms (1, 14 M; 4, 15 M).  B) as above, 
except that 45 sec square pulses of GABA were used to allow for the occupancies of all 
states in the kinetic model to reach equilibrium.  As with peak currents, the models 
predict that 1 and 4 receptors have similar steady-state current EC50s (1, 1.8 M; 4, 
0.6 M).  Note that peak steady-state current for 4 receptors occurs at ~ 3 M, 
reflecting the lower O state occupancy of di-liganded receptors than of mono-liganded 
receptors for this isoform at very low GABA concentrations. 
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determines if
 it should be designated as „desensitized‟ (as we have chosen to do here in 
the interest of clarity), it should
 
be noted that both the α1 and α4 models continue to 
undergo fast
 
macroscopic desensitization in the absence of these desensitized
 
states (data 
not shown).  This suggests that other non-conducting
 
states such as C4 and C5, while 
much shorter lived, may also
 
play the role of desensitized states. 
Our studies and those of Akk et al. (2004) used slightly different
 
transfection 
techniques and GABA subunit combinations.  Furthermore,
 
without repeating the single 
channel recording of others, we
 
were not able to directly fit our model to actual single 
channel
 
data and cannot exclude the possibility that other gating schemes
 
might describe 
our results equally well.  We have therefore chosen
 
not to make further mechanistic 
arguments about the microscopic
 
kinetic properties of these receptors based on these 
kinetic
 
models.  Rather, we sought to use these models to help predict
 
the responses of 
these receptor isoforms to GABA application
 
protocols that were not experimentally 
testable with our current
 
techniques.  As shown in Figures 5 and 6, and in Table 1, the 
kinetic
 
models accurately fit the experimentally determined single channel,
 
whole cell, 
and pharmacological data quite accurately.  Thus,
 
we used this model to explore the 
responses of α1 and α4 subtype containing receptors to GABA under a variety of 
physiological
 
conditions. 
 
α4β3γ2L and α1β3γ2L GABAA receptors were predicted to respond differently to 
changes in the duration of the synaptic transient 
 
We first used the kinetic models to predict the responses of
 α1 versus α4 subtype-
containing GABAA receptors to brief
 
pulses of saturating GABA, as might be expected in  
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Figure 7.  The kinetic properties of L and L receptor isoforms have a 
unique dependence on the duration of GABA application. 
 
A) Incrementally increasing the GABA pulse (1 mM; arrow) duration to L 
receptors from 0.3 ms (solid line) to 1.0 ms (short dashed line) slightly increased the peak 
current amplitude, with little effect on the subsequent deactivation rate.  Further 
increasing the GABA application duration to 10 ms (long dashed line) did not further 
increase the peak amplitude, but did prolong the deactivation (see inset).  B) Unlike the 
L receptor isoform, increasing the GABA pulse (1 mM; arrow) duration from 0.3 
ms (solid line) to 1.0 ms (short dashed line) elicited 432L currents with both 
increased peak amplitude and prolonged deactivation.  Like 1 containing receptors, a 
further increase in GABA duration to 10 ms (long dashed line) had no further effect on 
peak current but does continues to prolong deactivation.  C) Brief GABA pulse durations 
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Figure 7 (continued) 
 
(< 1 ms) elicit a smaller normalized peak response from L currents than from 
L receptor isoforms, likely a consequence of the slower activation observed with 
L receptors.  D) deactivation is slower for L receptors than for L 
receptors at all GABA pulse durations.  For pulse durations < 1 ms, however, 
deactivation for L receptors remains relatively stable, while deactivation for 
L receptors continues to accelerate.  E) Due to the combination of accelerated 
deactivation and heightened sensitivity of peak current amplitudes to pulses < 1 ms, the 
charge transfer of  L receptors are more sensitive than L receptor to 
changes in synaptically relevant durations of GABA exposure.  Furthermore, for pulses 
longer than 1 ms, conditions analogous to bursts of high frequency neurotransmitter 
release, charge transfer is relatively stable for L receptors while charge transfer 
continues to increase for L receptors. 
 
 
 
synapses.  During extremely brief (100 µs) GABA applications, the
 
peak currents of both 
α1β3γ2L and α4β3γ2L currents were truncated, but this effect was more pronounced for 
α4β3γ2L currents (Figure 7A and 7B), reflecting the slower rise time of this isoform (data 
not shown).  As GABA durations were prolonged within the synaptically relevant
 
range 
(0.1–1.0 ms), there was a gradual increase in peak currents for both isoforms, although 
the α4β3γ2L receptor required longer GABA applications to reach its maximal peak 
current (Figure 7C).  The rate of deactivation after an extremely brief (100 µs)
 
GABA 
application was similar for α1β3γ2L and α4β3γ2L currents (Figure 7D).  However, the 
deactivation rate of α4β3γ2L currents became progressively prolonged with longer 
GABA exposures while deactivation of α1β3γ2L currents was relatively constant 
following synaptically relevant
 
applications of GABA and only became progressively 
prolonged
 
after GABA exposures longer than 1 ms.  Because charge transfer
 
after a single 
synaptic event depends on both peak current and the time course of deactivation, 
inhibition
 
mediated by α1β3γ2L currents depended linearly on the duration of GABA  
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Figure 8.  L and L receptors respond to different frequencies of 
stimulation during repetitive GABA exposure. 
 
A, B) using the kinetic models for the L and L receptors, simulations of 
pulse trains were performed to evaluate the response of these isoforms to repetitive 
stimulation.  1 ms square pulses of 1 mM GABA were applied at the indicated 
frequencies for 10 sec.  For comparison, the responses are superimposed on the response 
to a continuous application of 1 mM GABA (dashed line).  Note that the shape of the 
response to repeated stimulation for both receptor isoforms begins to approach that of the 
continuous application at higher frequencies.  C) the peak current of the final pulse in the 
pulse train is compared to a control 1 mM pulse.  Although the peak response of both 
isoforms is attenuated with high frequency stimulation, L peak currents are more 
sensitive than L peak currents.  D) charge transfer of the final pulse in the pulse 
train is compared to a control 1 mM pulse.  As with peak currents, the charge transfer 
following a GABA pulse applied to L receptors is more sensitive to high 
frequency stimulation than the charge transfer of L receptors.  E) the total charge 
transfer of the 10 sec pulse train is compared at each frequency to the total charge transfer 
of a continuous GABA application.  Compared to L receptors, L receptors 
approach maximal charge transfer at much lower frequencies.  Indeed, the entire 
frequency-response curve is shifted to the left for 4 containing receptors, suggesting that 
these receptors may act as low-pass filters compared to 1 containing receptors. 
 
 
 
 application.  In contrast, since both peak current and
 
deactivation time course of 
α4β3γ2L currents were very sensitive to the duration of GABA, the overall charge 
transfer was strongly
 
shaped by small changes in the duration of synaptically relevant
 
(< 1 
ms) GABA (Figure 7E). 
 
α4β3γ2L and α1β3γ2L GABAA receptors were predicted to respond differently to 
changes in the frequency of neuronal firing 
 
As a next step toward understanding the potential role of α1 versus α4 subtype 
containing receptors in synaptic physiology,
 
we used the models to predict the responses 
of these receptors
 
to repetitive, brief applications of GABA (1 ms, 1 mM) (Figure 8A and 
8B).  The responses of α1β3γ2L and α4β3γ2L receptors to repetitive exposure of brief 
pulses of GABA were associated with a progressively
 
diminished peak current (Figure 
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8C) and charge transfer per pulse
 
(Figure 8D), thereby limiting the overall charge transfer 
that
 
occurred during a long barrage of inhibitory synaptic input,
 
as might occur during a 
seizure.  The overall charge transfer
 
of both α1β3γ2L and α4β3γ2L currents exhibited a 
steep dependence
 
on stimulus frequency, but α4β3γ2L currents were attenuated by 
repetitive stimulation at lower frequencies than α1β3γ2L currents (Figure 8E).  Similar 
results were obtained by modeling repetitive
 
100 µs pulses of GABA (data not shown).  
Thus, assuming
 
equal receptor densities and similar peak current open probabilities,
 
synapses with α4 subtype-containing receptors would have a stronger inhibitory drive at 
low stimulus frequencies than those with
 α1 subtype-containing receptors given their 
longer deactivation
 
time course.  However, α4 subtype containing synapses would also be 
expected to respond to a narrower range of IPSC frequencies
 
compared to α1 subtype-
containing synapses. 
 
α4β3γ2L and α1β3γ2L GABAA receptors were predicted to respond differently to 
changes in the levels of ambient GABA 
 
In normal animals, α4 subtype-containing receptors occupy a primarily 
perisynaptic position on hippocampal
 
dentate granule cells.  These receptors would be 
expected to respond to
 
synaptic overflow of GABA, which may be largely influenced by
 
changes in GABA reuptake.  There is also evidence for synaptic
 
crosstalk among 
synapses that appears to involve overflow from
 
one synapse to another (Overstreet & 
Westbrook, 2003).  Furthermore,
 
there are complex changes in the expression of GABA 
transporters
 
associated with epilepsy (Dalby, 2003) with the potential to
 
modify the basal 
GABA levels in both the synaptic and extrasynaptic
 
spaces.  We therefore sought to  
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Figure 9.  L receptors are more inhibited than L receptors during 
prolonged exposure to low levels of GABA. 
 
A) low concentrations of GABA (dashed lines) ranging from 100 nM to 6 M (100 nM, 
200 nM, 300 nM, 600 nM, 1 M, 2 M, 3 M, and 6 M) were applied to the L 
kinetic model for a minimum of 40 sec prior to being exchanged for 1 mM GABA for the 
remainder of the 80 sec trace (solid lines).  The length of the pre-applications was varied 
for illustrative purposes only, and does not affect the results (equilibrium occupancy is 
reached by all states in the kinetic model before the earliest time point).  The control 1 
mM pulse is indicated with an asterisk.  B) simulations were performed as in A, except 
using the L kinetic model.  C) peak currents evoked by 1 mM GABA following 
pre-application with various GABA concentrations are compared to the control 1 mM 
GABA application.  Following all pre-applied concentrations of GABA, L 
receptor peak current responses to 1 mM GABA were more attenuated compared to those 
from L receptors.  D) after pre-application with 1 M GABA, receptors were 
switched into various concentrations of GABA.  The resulting peak currents were 
compared to peak currents evoked by a control 1 mM application.  At all but the lowest 
GABA concentrations, L receptors responded more weakly compared to 
L receptors. 
 
 
 
explore how these receptors responded
 
following exposure to low levels of GABA.  We 
first used the
 
model to predict the response to a synaptically relevant GABA
 
concentration (1 mM) following prior exposure to low GABA concentrations.  Exposure 
to low levels of tonic GABA greatly attenuated the
 
response to 1 mM GABA (Figure 9).  
For illustrative purposes,
 
the duration of low GABA concentrations was varied to offset
 
the subsequent responses to 1 mM GABA; identical results were
 
obtained with a single 
fixed duration of low GABA.  The responses
 
of α4β3γ2L receptors were particularly 
sensitive to attenuation
 
during application of very low concentrations of GABA (Figure 
9C).  Alternatively, perisynaptic and extrasynaptic GABA receptors
 
may be constantly 
bathed in low levels of GABA but still need
 
to react to small changes in ambient GABA 
in response to changes
 
in nearby neuronal activity.  Consistent with our whole cell
 
current 
data (not shown), prior exposure to a physiologically relevant low
 
GABA concentration 
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(1 μM) strongly suppressed the response to higher concentrations of GABA, with this 
suppression being
 
especially apparent for α4β3γ2L receptors. 
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DISCUSSION 
 
The role of α4 subunit-containing receptor isoforms in normal and abnormal neuronal 
physiology 
 
To date, the α4 subtype has been most extensively studied in the thalamus and 
hippocampus, where it assembles
 
with δ subunits.  The high GABA sensitivity of α4βδ 
receptors allows
 
them to respond to the persistent low levels of GABA present
 
in the 
extrasynaptic space, thereby conveying a long-lasting
 
tonic current with the ability to 
powerfully modify neuronal
 
excitability (Nusser & Mody, 2002;
 
Jia et al. 2005; Cope et 
al. 2005).  In contrast, the physiological significance of α4βγ GABAA receptors remains 
unclear.  Based on immunoprecipitation studies and analysis of benzodiazepine-
insensitive
 
Ro 15-4513 binding of native brain receptors, α4βγ receptors appear to be at 
least as abundant as α4βδ receptors (Benke et al. 1997; Bencsits et al. 1999), suggesting 
they also contribute substantially to inhibitory tone. 
Although the predominant γ subunit-containing isoform in the central nervous 
system is the α1β2γ2 isoform, the α4 subtype is relatively abundant in brain regions 
involved in both partial
 
and generalized epilepsies, including cortex, hippocampus, and
 
thalamus (Pirker et al. 2000).  Furthermore, this subtype may
 
be involved in both synaptic 
and extrasynaptic neurotransmission,
 
depending on the brain region and physiological 
state of the
 
animal (Hsu et al. 2003; Belelli et al. 2005; Cope et al. 2005).  In addition, α4 
subtype up-regulation has been consistently found
 
in multiple models of temporal lobe 
epilepsy, and is correlated with up-regulation of γ2 subunit expression and down-
regulation of δ subunit expression (Peng et al. 2004; Nishimura et al. 2005).  However, it 
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is unclear whether α4 subtype up-regulation contributes to the generation of seizures or, 
alternatively, is a compensatory
 
response to the hyperexcitable state. 
As a first step towards elucidating the role of α4βγ GABAA receptors in both 
normal and abnormal physiology, we used a variety
 
of GABA application protocols to 
perform a direct comparison
 
of the kinetic properties of recombinant α4β3γ2L and 
α1β3γ2L receptors.  We found that α4β3γ2L currents deactivated more slowly than 
α1β3γ2L currents, a kinetic change predicted to increase synaptic charge transfer, and 
consequently, enhance GABAergic inhibition in the normal physiological state.  
However, α4β3γ2L receptors desensitized more rapidly and extensively, had slower 
recovery
 
from desensitization, had greater loss of peak current amplitude
 
in response to 
repetitive stimulation, and had more suppressed
 
responses following exposure to low 
GABA concentrations.  These findings argue against a compensatory role for the 
α4β3γ2L receptor isoform during seizures, as this constellation of kinetic changes would 
be predicted to substantially reduce the magnitude of GABAergic inhibition, which 
would promote neuronal hyperexcitability.  Instead, the results raise the intriguing 
possibility that increasing α4β3γ2L receptor isoform expression may actually be involved 
in the pathogenesis of epilepsy. 
 
The kinetic basis for the different macroscopic current properties of α4β3γ2L and 
α1β3γ2L GABAA receptors 
 
While the structural basis for the altered kinetic properties
 
is currently unknown, it 
is of interest that the single channel
 
properties of α4βγ receptors (Akk et al. 2004) are 
similar to
 
those of α1βγ receptors (Fisher & Macdonald, 1997; Steinbach & Akk, 2001), 
suggesting that the microscopic kinetic processes underlying
 
activation of these two 
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isoforms are analogous.  This suggests that, following agonist
 
binding, α4βγ receptors 
also gain access to multiple open
 
and closed states, many of which are long-lived.  
Progressive
 
accumulation of receptors into long-lived non-conducting states,
 
referred to 
as desensitized states, gives rise to the phenomenon
 
of macroscopic desensitization (Jones 
& Westbrook, 1995;
 
Haas & Macdonald, 1999).  Since these states cannot release
 
bound 
GABA (Bianchi & Macdonald, 2001a), receptors must
 
transition though multiple 
intermediate closed and open GABA-bound
 
states in order to unbind GABA, the 
macroscopic correlate of
 
which is prolonged deactivation (Jones & Westbrook, 1995;
 
Haas & Macdonald, 1999).  Thus, one parsimonious interpretation
 
of our results is that 
α4β3γ2L receptors have an increased steady-state occupancy of desensitized states, which 
would explain both the
 
increase in the extent of macroscopic desensitization and the
 
prolongation of deactivation observed with α4β3γ2L currents (i.e., desensitization-
deactivation coupling; Bianchi et al. 2007).  Consistent with this hypothesis, our 
modeling studies suggested that α4β3γ2L receptors accessed desensitized states with 
higher stability (defined as the ratio of the entry rate () to the exit rate ()) compared to 
those of α1β3γ2L receptors.  Indeed, the combined stabilities of the D2 and D3 states 
(note that D1 is only relevant at sub-saturating GABA concentrations) were much higher 
in the α4β3γ2L receptor kinetic model, and consequently, were associated with lower 
equilibrium occupancies of open states (i.e., less residual current; data not shown). 
It should be emphasized, however, that occupancy of desensitized states does not 
necessarily correlate with either the rate or extent of macroscopic desensitization 
(Bianchi et al. 2007).  Desensitization is highly sensitive to the entry and exit rates from 
all states in the gating scheme, including open states.  In fact, high occupancy 
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desensitized states can, depending on the rate constants and state connectivity, support 
non-desensitizing macroscopic currents.  For example, kinetic schemes whose 
desensitized states are in “branched” arrangement with the open states (as is the case for 
the kinetic models proposed here) can only desensitize when the exit rate from the open 
state is larger than the exit rate from the desensitized state, with more desensitization 
being observed as the ratio of these two rates increases (Bianchi et al. 2007; Appendix 
IV).  Thus, from a kinetic standpoint, the enhanced macroscopic desensitization observed 
for α4β3γ2L receptors cannot simply be attributed to enhanced D state stability.  Instead, 
it is more likely that one of the branched arrangements embedded within the 
comprehensive model contains O and D states with highly disparate exit rates (or, at 
least, more disparate than those found in the α1β3γ2L receptor model).  Consistent with 
this prediction, while the highest occupancy open state (O2) had a similar exit rate in both 
α1β3γ2L and α4β3γ2L receptor models, its partnering desensitized state (D2) had an 
order of magnitude lower exit rate in the α4β3γ2L receptor model. 
 
α4β3γ2L receptors as synaptic GABAA receptors 
 
Since high concentrations of GABA are thought to exist in the
 
synaptic cleft for 
only very brief periods of time (< 1 ms),
 
effective synaptic GABAA receptors should 
activate very quickly
 
and deactivate slowly.  Within individual synapses, however,
 
there 
is significant variability in the peak amplitude and duration
 
of IPSCs that appears to be 
due to fluctuations in both peak
 
GABA concentration and duration (Nusser et al. 2001; 
Mozrzymas, 2004).  Similar to native receptors, the activation rates reported here
 
were 
quite dependent on GABA concentrations (Maconochie et al. 1994)
 
and were consistently 
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slower for α4β3γ2L receptors during all but the highest GABA concentrations.  
Therefore, while the concentration
 
time course of synaptic GABA may contribute to the 
shape of
 
postsynaptic responses, our results suggest it may do so differently
 
in α1β3γ2L 
and α4β3γ2L receptor-containing synapses.  While multiple studies have found increased 
α4 subtype expression in epileptic animals (Schwarzer et al. 1997; Brooks-Kayal et al. 
1998; Sperk et al. 1998),
 
it is currently unclear whether this is associated with an 
increased
 
number of α4 subtype-containing receptors that are actually within the 
synapses.  One model of CNS hyperexcitability, chronic intermittent
 
ethanol, produces 
animals with a lowered seizure threshold and
 
an increased expression of α4 subunits in 
the hippocampus.  In
 
these animals, the subcellular localization of α4 subtype-containing 
receptors shifts from a primarily perisynaptic to a central
 
synaptic location on dentate 
granule cells (Liang et al. 2006).  If the same phenomenon proves true in epileptic 
animals, our
 
results would predict that α4β3γ2L receptor-containing synapses would have 
attenuated peak currents during brief synaptic GABA.  Our results also predict, however, 
that these responses would
 
have prolonged decay times compared to α1β3γ2L currents, 
thus suggesting
 
a possible compensatory role for up-regulation of α4 subtype-containing 
GABAA receptors.  In the hippocampal dentate region of epileptic
 
animals, there is a loss 
of interneurons and an associated reduction
 
in IPSC frequency (Kobayashi & 
Buckmaster, 2003; Cohen et al. 2003;
 
Naylor et al. 2005).  The prolonged responses 
conveyed by α4 subtype-containing synapses may help to normalize the charge transfer 
over time.  However, because of the observed coupling between desensitization
 
and 
deactivation, α4βγ receptors are rendered relatively insensitive to prolonged repetitive 
stimulation, especially at frequencies
 
above 2–5 Hz.  Therefore, α4βγ receptors may serve 
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as low
 
pass frequency filters, which respond best to brief low frequency
 
barrages of 
synaptic activity, but poorly to high frequency
 
bursts of synaptic input.  Similar to our 
findings, studies using
 
brain slices have shown prolonged IPSCs in dentate granule cells
 
during status epilepticus or chronic epilepsy (Cohen et al. 2003;
 
Shao & Dudek, 2005; 
Naylor et al. 2005).  However it is unknown
 
what role, if any, enhanced α4 subtype 
expression plays in altered
 
inhibitory neurotransmission in epileptic rats.  One of the few
 
reports describing the physiological significance of increased
 
4 subtype expression used 
recordings from CA1 pyramidal neurons
 
following neurosteroid withdrawal.  
Pharmacological characterization
 
of the IPSCs and comparison with recombinant 
GABAA receptors
 
suggest that synaptic α1βγ GABAA receptors may be replaced by α4βγ
 
and/or α4βδ receptors (Hsu et al. 2003; Smith & Gong, 2005).  Interestingly, in contrast 
to our studies, the IPSCs in neurosteroid
 
withdrawn neurons are significantly shortened.  
This discrepancy
 
may be related to several technical differences, but one likely
 
explanation is that the different findings are due to differences
 
in the β subtype.  Work in 
other models of epilepsy have also
 
found accelerated IPSC decay in CA1 pyramidal 
neurons (Mangan & Bertram, 1997;
 
Morin et al. 1998), where the predominant β subtype 
is β2.  However, the enhanced α4 subtype expression in epileptic animals is found in the 
dentate gyrus where the β3 subtype is highly expressed.  Consistent with this, preliminary 
work has found that the deactivation
 
of α4β2γ2L currents is very brief compared to 
α4β3γ2L currents (Lagrange & Macdonald, 2005).  Thus, the physiological consequences 
of α4 subtype expression on synaptic transmission may be very different from region to 
region, depending on the
 
other GABAA receptor subtypes that are available for assembly. 
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α4β3γ2L receptors as extrasynaptic GABAA receptors 
 
In addition to brief IPSCs, many neurons also have a long-lasting
 „tonic‟ current 
that is largely conveyed by extrasynaptic
 
GABAA receptors in response to ambient low 
levels of GABA.  Although
 
this tonic current is small in amplitude, its long duration
 
allows the transfer of substantial charge and may play an important
 
role in regulating 
neuronal excitability (Mody, 2001).  The GABAergic
 
tonic current is most commonly 
mediated by αβδ and occasionally by α5βγ receptors (Nusser et al. 1998; Spigelman et al. 
2003; Caraiscos et al. 2004;
 
Cope et al. 2005; Belelli et al. 2005).  Pharmacological 
experiments
 
have suggested that α4βγ receptors may also convey part of the tonic current 
in some brain regions, and that the subcellular
 
distribution of synaptic and extrasynaptic 
α1 and α4 subtypes may be altered in pathological conditions (Liang et al. 2004; Liang et 
al. 2006).  We found that during prolonged GABA application
 
both α1β3γ2L and 
α4β3γ2L receptors responded to a remarkably limited range of GABA concentrations, 
with a maximal response evoked
 by < 10 μM GABA.  Therefore, small changes in 
GABA concentration
 
(on the order of 1–2 μM) would have a relatively large effect on the 
current produced by extrasynaptic α1βγ or α4βγ receptors.  However, persistent low 
levels of GABA renders GABAA
 
receptors largely insensitive to higher GABA 
concentrations
 
(Overstreet et al. 2000), an effect that is much more pronounced
 
with the 
highly desensitizing α4βγ receptors.  As such, it is conceivable that drug treatments that 
increase the levels of extrasynaptic
 
GABA may differentially suppress the ability of 
extrasynaptic
 α4βγ receptors to respond to variations in ambient GABA that may occur 
during status epilepticus (Naylor et al. 2005). 
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Future directions in understanding the response of GABAA receptors to physiological 
contexts of activation 
 
These studies used recombinant GABAA receptor proteins in an
 
immortalized cell 
line to elucidate the kinetic properties of
 
specific GABAA receptor subunit combinations.  
It is possible
 
that modulatory factors, such as protein phosphorylation, neurosteroids,
 
or 
anchoring proteins differentially alter the kinetics of one
 
GABAA receptor isoform, but 
not another.  Moreover, in some brain
 
regions, a given GABAA receptor population may 
be composed of
 
receptors containing multiple α or β subtypes within the same receptor 
(Fritschy et al. 1992; Mertens et al. 1993).  For example,
 
using immunoprecipitation it 
has been shown that α4 subtypes may exist in combination with α1, α2, or α3 subunits 
(Benke et al. 1997).  The kinetic properties of GABAA receptors with a mixture of α 
subunits are currently unpredictable and will need to be specifically
 
tested. 
In summary, α4βγ GABAA receptors produce rapidly desensitizing
 
and slowly 
deactivating currents.  Based on these findings, disease
 
states in which α1βγ receptors are 
replaced by α4βγ receptors would be expected to be associated with impaired inhibitory 
neurotransmission.  These changes would alter both synaptic and extrasynaptic inhibition
 
in a frequency and GABA concentration-dependent fashion.  Since
 
epilepsy is a network 
phenomenon, further experiments in brain
 
slices will be needed to specifically test 
whether altered α4 subtype expression in epilepsy is actually associated with the changes 
in CNS neurotransmission predicted by these studies.  Nonetheless, our results provide a 
basis for testable hypotheses
 
about the role of altered synaptic and extrasynaptic 
inhibitory
 
neurotransmission in epilepsy.  
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ABSTRACT 
Fast synaptic transmission is mediated by post-synaptic ligand-gated ion channels 
(LGICs) transiently activated by neurotransmitter released from pre-synaptic vesicles.  
Although disruption of synaptic transmission has long been implicated in numerous 
Neurological and Psychiatric disorders, effective and practical methods for studying 
LGICs in vitro under synaptically relevant conditions remain unavailable.  Here, we 
describe a novel microfluidic approach to solution-switching that allows for precise 
temporal control over the neurotransmitter transient while substantially increasing 
experimental throughput, flexibility, reproducibility, and cost-effectiveness.  When this 
system was used to apply ultra-brief (~400 µs) GABA pulses to recombinant GABAA 
receptors, members of the Cys-loop family of LGICs, the resulting currents resembled 
hippocampal inhibitory post-synaptic currents and differed from currents evoked by 
longer, conventional pulses, illustrating the importance of evaluating LGICs on a 
synaptic timescale.  This methodology should therefore allow the effects of disease-
causing mutations and allosteric modulators to be evaluated in vitro under 
physiologically relevant conditions.  
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INTRODUCTION 
Ligand-gated ion channels (LGICs) mediate fast synaptic transmission in the 
central and peripheral nervous systems.  They are targeted by numerous clinically 
important drugs and have been implicated in a variety of Neurological and Psychiatric 
disorders (Kullmann and Hanna, 2002; Macdonald et al., 2004; Vincent et al., 2006).  
However, despite decades of research, effective and practical methods for studying 
LGICs in vitro under physiologically relevant conditions remain unavailable 
(Mozrzymas, 2008), largely reflecting the short timescale on which synaptic transmission 
occurs.  Increasing evidence suggests that neurotransmitter levels in the synaptic cleft rise 
extremely rapidly following release from pre-synaptic vesicles, only to be cleared after 
hundreds of microseconds by a combination of diffusion, reuptake, and for some 
neurotransmitters, enzymatic hydrolysis (Holmes, 1995; Clements, 1996; Glavinovic, 
1999; Ventriglia and Di, V, 2003).  Mimicking the synaptic transient in the experimental 
setting thus requires not only that neurotransmitter be applied rapidly, but also that it be 
applied briefly. 
Failure to activate LGICs under synaptically relevant conditions, however, can 
cause the effects of disease-causing mutations and potential therapeutic compounds to be 
obscured or even missed entirely (Mozrzymas et al., 2007).  Indeed, LGIC currents are 
known to be exquisitely sensitive to both the rate and duration of neurotransmitter 
exposure.  For example, because most LGICs activate in the millisecond time domain 
before undergoing rapid and extensive desensitization, slowly changing the concentration 
of neurotransmitter can lead to underestimation of current amplitudes (Jones and 
Westbrook, 1996; Bianchi and Macdonald, 2002).  Conversely, prolonged 
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neurotransmitter applications can lead to overestimation of current amplitudes, 
particularly when intrinsic current rise times are much longer than the synaptic transient 
(Mozrzymas, 2004; Lagrange et al., 2007; Rula et al., 2008).  Prolonged applications can 
also artificially prolong deactivation (the process by which currents return to baseline), 
the result of receptor accumulation in long-lived “desensitized” states from which 
neurotransmitter cannot directly unbind (Jones and Westbrook, 1995; Lagrange et al., 
2007; Rula et al., 2008). 
Currently, solution switching has proven the most effective technique for 
generating brief neurotransmitter pulses (Franke et al., 1987; Jonas, 1995; Clements, 
1997; Hinkle et al., 2003).  In contrast to photoactivation of “caged” neurotransmitter 
(Niu et al., 1996), this method does not require use of expensive reagents or radiation 
sources, is not constrained by the existing library of photoactivatable compounds, and 
most importantly, provides better control over the rate of neurotransmitter application and 
washout.  Solution switching is typically accomplished by reversibly translating parallel 
control and neurotransmitter-containing solution streams generated from an array of glass 
capillary tubing across stationary cells or excised membrane patches.  This approach 
allows neurotransmitter to be applied extremely rapidly to experimental preparations, 
with solution exchange times less than 100 µs having been reported (Mozrzymas et al., 
2007).  Terminating the neurotransmitter pulse after synaptically relevant durations (i.e., 
300-600 µs), however, has yet to be performed reliably (Jonas, 1995; Clements, 1997; 
Hinkle et al., 2003; Mozrzymas et al., 2007; Mozrzymas, 2008). 
To study LGICs under physiologically relevant conditions, we took a microfluidic 
approach to solution switching.  In contrast to existing systems, we fabricated drug 
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application devices from polydimethylsiloxane (PDMS), an inexpensive, durable, and 
biocompatible polymer, using photolithography and replica molding.  This allowed for 
the miniaturization and customization of device features, which dramatically reduced the 
width of individual channels and their septa while increasing experimental flexibility and 
throughput.  By translating ultra-thin fluid streams generated by these devices across 
stationary excised membrane patches with a stepper motor, solution exchange times as 
brief as ~100 s and application durations as brief as ~400 s were achieved 
reproducibly.  When applied to recombinant GABAA receptors, members of the Cys-loop 
family of LGICs, these ultra-brief GABA pulses yielded currents with kinetic properties 
similar to those of hippocampal inhibitory post-synaptic currents (IPSCs) and different 
from currents evoked by conventional, longer pulses.  We thus anticipate that this novel 
approach to solution switching will provide new insights into the role of different 
receptor isoforms, allosteric modulators, and disease-causing mutations in synaptic 
physiology. 
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MATERIALS AND METHODS 
 
Fabrication of microfluidic device molds from SU-8 using photolithography 
 
Device molds were fabricated in a class-100 clean room at the Vanderbilt Institute 
for Integrative Biosystems Research and Education at Vanderbilt University.  SU-8 2050 
(MicroChem, Newton, MA), a negative-tone photoepoxy, was dispensed onto a polished 
silicon wafer (mechanical grade) on a spinner.  To uniformly coat the wafer, the 
rotational speed was ramped at 100 rpm/s to 500 rpm and held for 5 seconds.  To achieve 
a final film thickness of 100 μm, the speed was then increased to 1750 rpm at 300 rpm/s 
and held for 30 seconds.  Next, the coated wafer was soft baked for 5 minutes at 65°C 
and then for an additional 15 minutes at 95°C.  The coated wafer was subsequently 
patterned with a customized chromium mask by contact photolithography using 230 
mJ/cm
2
 of UV radiation (Figure 1a).  The patterned wafer was subjected to a post-
exposure bake of 5 minutes at 65°C followed by 10 minutes at 95°C.  The unexposed SU-
8 was removed from the wafer by incubation in SU-8 Developer (MicroChem, Newton, 
MA) for 30 minutes, leaving behind an SU-8 complementary replica of the microfluidic 
device (Figure 1b).  For prolonged stability, the resulting SU-8 mold was hard baked by 
temperature-ramping from 25°C to 200°C over 30 minutes and allowed to cool at room 
temperature overnight. 
 
Fabrication of microfluidic devices from PDMS using replica molding 
 
Microfluidic devices were fabricated from the SU-8 masters.  Each device 
consisted of two layers of Sylgard 184 PDMS (Dow Corning Corp., Midland, MI), a 
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Figure 1. Overview of PDMS microfluidic device fabrication using photolithography and 
replica molding 
 
a) The SU-8 photoepoxy is patterned with using the chrome mask by contact 
photolithography.  b) Unexposed SU-8 photoepoxy is removed, leaving behind the device 
mold.  c) PDMS is poured over the SU-8 mold to generate the “imprinted” layer.  d) 
After baking, the imprinted layer is peeled away from the SU-8 mold.  e) The imprinted 
layer of PDMS is bonded with an “unimprinted” layer to seal off the channels.  Chrome 
mask, SU-8 photoepoxy, silicon wafer, and PDMS are indicated by the white, black, dark 
grey, and light grey layers, respectively.  The pre-polymer to catalyst ratio is indicated 
within the PDMS layers. 
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silicone-based organic polymer widely used for microfluidic applications.  Although 
PDMS is hydrophobic, unreactive to most reagents, non-toxic, and stable over a wide 
temperature range (McDonald and Whitesides, 2002; Mata et al., 2005), it should be 
noted that the hydrophobic nature of PDMS renders it incompatible with most organic 
solvents, which cause the material to swell.  One PDMS layer was “imprinted” with a 
replica of the device design (i.e., the fluidic channels), and the other was left 
“unimprinted”, serving as a cover for the fluidic channels.  To generate the imprinted 
layer, PDMS was prepared with a 5:1 ratio of pre-polymer to catalyst and poured over the 
SU-8 molds to a thickness of 5 mm (Figure 1c).  The PDMS was degassed in a vacuum 
chamber for 15-30 minutes and allowed to fully cure by incubation at 65°C for 4 hours.  
Once cured, the imprinted PDMS layer was peeled from the SU-8 molds (Figure 1d), and 
the circular solution input ports were cored using a blunt 18-gauge syringe needle.  To 
generate the unimprinted layer, PDMS was prepared with a 20:1 ratio of pre-polymer to 
catalyst and poured to a final thickness of 2 mm in a 10 cm culture dish (Corning 
Glassworks).  The unimprinted PDMS layer was also degassed in a vacuum chamber for 
15-30 minutes, but allowed to only partially cure for 30-45 minutes at 65°.  The 
imprinted layer was then placed on the unimprinted layer (Figure 1e), and the two were 
incubated at 65°C for 3 hours to fully cure and form a monolithic sealed device.  
Completed microfluidic devices were cut out using a surgical scalpel, and polyethylene 
tubing (Becton Dickinson, Sparks, MD) was connected to the solution input ports. 
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Cell culture and expression of recombinant GABAA receptors 
 
Human GABAA receptor α1, β3, and γ2S subunits were individually sub-cloned 
into the pcDNA3.1+ mammalian expression vector (Invitrogen, Grand Island, NY).  The 
coding region of each vector was sequenced by the Vanderbilt University Medical Center 
DNA Sequencing Facility and verified against published sequences (accession numbers 
NM_000806, NM_000814, and NM_000816 for the α1, β3, and γ2S subunits, 
respectively).  HEK293T cells (American Type Culture Collection, Manassas, VA) were 
maintained at 37C in humidified 5% CO2 / 95% air using Dulbecco’s Modified Eagle 
Medium (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen), 100 
i.u./ml penicillin (Invitrogen), and 100 μg/ml streptomycin (Invitrogen).  Cells were 
plated at a density of ~10
6
 cells per 10 cm culture dish (Corning Glassworks, Corning, 
NY) and passaged every 2-4 days using trypsin-EDTA (Invitrogen).  For 
electrophysiological recordings, cells were plated at a density of 4x10
5
 cells per 6 cm 
culture dish (Corning Glassworks) and transfected ~24 hours later with equal amounts (1 
μg/subunit) of α1, β3, and γ2S subunit cDNA.  One μg of pHook-1 cDNA (encoding the 
cell surface antibody sFv) was included so positively transfected cells could be selected 
24 hours later by immunomagnetic bead separation.  All transfections were performed 
using FuGene6 (Roche Diagnostics, Indianapolis, IN) per manufacturer 
recommendations.  The day after transfection, cells were selected and re-plated at low 
density on collagen-coated 35 mm dishes for electrophysiological recording the next day. 
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Electrophysiology 
 
Patch clamp recordings
 
were performed at room temperature from excised 
outside-out membrane patches.  Cells were maintained during recordings in a bath 
solution consisting of (in mM): 142 NaCl,
 
8 KCl, 6 MgCl2, 1 CaCl2, 10 glucose, and 10 
HEPES (pH adjusted to 7.4; 325-330 mOsm).  All chemicals used for solution 
preparation were purchased from Sigma-Aldrich (St. Louis, MO).  Recording pipettes 
were pulled from thin-walled borosilicate capillary glass (Fisher, Pittsburgh, PA) on a 
Sutter P-2000
 
micropipette electrode puller (Sutter Instruments, San Rafael,
 
CA) and fire 
polished with a microforge (Narishige, East Meadow, NY).  When filled with a pipette 
solution consisting of (in mM) 153 KCl, 1 MgCl2, 5 EGTA, 10 HEPES, and 2 MgATP 
(pH adjusted to 7.3; 300-310 mOsm) and submerged in the bath solution, this yielded 
open tip resistances of ~2 MΩ and a chloride equilibrium potential (ECl) of
 
~0 mV.  
Currents were recorded at a holding potential of -20 mV using an Axopatch 200A 
amplifier (Molecular Devices, Foster City, CA), low-pass filtered at 2 kHz (5 kHz for 
open-tip experiments) using a 4-Pole Bessel filter, digitized at 10 kHz (20 kHz for open-
tip experiments) using the Digidata 1322A (Molecular Devices), and stored offline for 
analysis.  All results shown are from a minimum of two days of experiments, each from a 
different batch of transfected cells.  GABA was prepared as a stock solution.  Working 
solutions were made on the day of the experiment by diluting stock solutions with the 
bath solution.  All solutions were brought to room temperature prior to the experiments to 
minimize formation of bubbles in the microfluidic devices. 
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Data analysis 
 
Current kinetic properties were analyzed using Clampfit 9 (Molecular Devices).  
Rise time was defined as the time required for currents to increase from 10% to 90% of 
their peak.  The time course of deactivation was fit using the Levenberg-Marquardt least 
squares method to the form ∑ ane
(-t/n)+ C, where t is time, n is the number of 
components, a is the relative amplitude,  is the time constant, and C is the fraction of 
current remaining, with ∑ an = 1.  Additional components were accepted only if they 
significantly improved the fit, as determined by an F-test automatically performed by the 
analysis software on the sum of squared residuals.  Deactivation was typically biphasic, 
though as many as four components could be resolved with larger amplitude currents.  To 
facilitate comparison, the time course of deactivation was summarized as a weighted time 
constant in the form ∑ ann with ∑ an = 1.  The time course of peak current decay during 
repetitive stimulation was also fit to a sum of exponential functions, though typically, 
only a single component was required.  Solution exchange time was defined as the time 
for an open-tip liquid-junction current to increase from 10% to 90% of its maximum 
value.  Pulse duration was defined as the time an open-tip liquid-junction current spent at 
 90% of its maximum value.  Data were reported as mean  SEM.  A paired Student’s t 
test (one-tailed) was performed to compare the responses of an individual excised patch 
to different experimental protocols.  Statistical significance was taken as p < 0.05. 
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RESULTS 
 
Custom microfluidic devices capable of generating synaptically relevant 
neurotransmitter pulses were fabricated from PDMS 
 
Generating synaptic neurotransmitter pulses with conventional approaches to 
solution switching remains technically challenging, as most commercially available 
translators cannot reverse their motion to terminate the application (i.e., switch back to 
the control solution stream) after only hundreds of microseconds.  High-velocity 
piezoelectric translators are currently used to overcome this limitation; however, they 
often suffer from resonant “ringing” after very brief excursions, which produces 
unwanted fluidic oscillations (Jonas, 1995; Clements, 1997; Mozrzymas et al., 2007); 
they require the use of high voltages, which requires electrical shielding to prevent 
additional noise contributions (Jonas, 1995; Clements, 1997; Heckmann and Pawlu, 
2002); and they have a limited range of motion (typically 20-80 µm), which substantially 
limits the potential complexity of experimental protocols.  Thus, if LGICs are to be 
studied in vitro under physiologically relevant conditions, an alternate approach is 
needed.  One proposed method involves simultaneously delivering three, as opposed to 
two, parallel solution streams to the experimental preparation (Tang, 2001).  Indeed, if 
only the central stream is loaded with neurotransmitter, then switching directly from the 
first to the third stream allows both application and washout of neurotransmitter to occur 
in a single motion.  Ultra-brief pulses could therefore be generated simply by decreasing 
the width of the central solution stream.  However, achieving solution channels less than 
~100 µm wide is not practical with glass capillary tubing, as heating and pulling the glass
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Figure 2. Microfluidic device design and integration for electrophysiological recording 
 
a)  Standard 3-channel design (length not to scale).  Individual channels (black) are 100 
μm wide and separated by 50 μm septa (white) that taper to a final thickness of 10 μm.  
The circular enlargements at the origin of each channel (top) permit solution access via 
polyethylene tubing.  b) Modified 3-channel design for application of synaptically 
relevant agonist pulses. Dimensions are identical to those of the standard 3-channel 
device except for the width of the central channel, which tapers to a final width of 10 μm.  
c) Schematic of the experimental setup.  PDMS devices were connected to a stepper 
motor via an acrylic platform, allowing for translation of parallel solution streams across 
a stationary recording electrode.  d) Top-down view of a modified 3-channel microfluidic 
device (black arrows indicate device septa) and recording electrode (indicated by asterisk, 
*) submerged in bath solution, as typically arranged for electrophysiological recordings.  
Outer and central channels are shown delivering high and low osmolarity solution 
streams, respectively, allowing for visualization of solution interfaces (white arrows).  
Note that channels were ~80 μm high, though they appear smaller due to the image 
perspective. 
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to achieve the necessary dimensions is not only labor intensive, but also causes 
application devices to be inherently fragile and rarely reproducible. 
To overcome this obstacle, custom microfluidic devices were fabricated from 
PDMS using photolithography and replica molding (see Methods).  This approach 
allowed for micro-miniaturization of device features, while substantially improving 
device durability and reproducibility.  The standard design, intended to mimic existing 
glass devices (Hinkle et al., 2003), employed three identical channels, each being 3 cm 
long and 100 μm wide (Figure 2a).  To generate ultra-brief pulses, the standard design 
was modified such that the central channel tapered to a final width of 50, 25, or 10 μm 
(Figure 2b).  All channels originated from circular solution access ports 300 μm in 
diameter (for connecting reagent reservoirs via polyethylene tubing) and were separated 
at their exits by 10 μm septa (to minimize the width of solution interfaces, allowing for 
rapid solution exchange; Figures 3, 4).  Due to current aspect ratio limitations, decreasing 
the widths of channels or their septa below 10 μm was not possible without decreasing 
channel heights, which needed to be at least 50-100 μm to facilitate channel visualization 
and electrode positioning.  To rapidly translate the microfluidic devices during 
electrophysiological recordings, they were secured on an acrylic platform and connected 
to a Warner Instruments SF-77B stepper motor (Figure 2c).  Since this system has a 
reported translational velocity of ~35 μm/ms (http://www.warneronline.com), we 
predicted the microfluidic devices with the narrowest central channels (i.e., 10 and 25 
µm) would be capable of generating synaptically relevant neurotransmitter pulses. 
Device performance was characterized by loading outer and central channels with 
high and low (1:10 dilution) osmolarity solutions, respectively.  This allowed electrode 
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Figure 3. Relationship between solution velocity and solution exchange time 
 
a) Schematic depicting protocol for achieving rapid solution exchange.  The standard 3-
channel device (PDMS septa represented by grey bars; not to scale) is depicted in the 
starting position (left) with the recording pipette positioned in the high solute (HIGH) 
fluid stream.  Repositioning the device orthogonal to its long axis (black arrow) rapidly 
exposes the recording pipette to the adjacent low solute (LOW) fluid stream (right).  b) 
Representative liquid junction currents obtained using the protocol in Panel A at different 
solution velocities.  Solution exchange times for these currents were 108, 294, 614, and 
1074 μs (for velocities of 25, 5, 1.5, and 0.5 cm/s, respectively).  c) Relationship between 
solution velocity and solution exchange time.  The data were fit using a non-linear 
regression (t = 794.6/v; r2 = 0.87). 
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Figure 4.  Solution exchange time depended on septal thickness and fluid velocity 
 
a) Schematic of channel exits in a custom microfluidic device containing six channels 
(white) separated by septa (grey) of increasing thickness.  The numbers in and above the 
device correspond to the width of the channels and septa, respectively, in μm.  b) 
Exchange time as a function of fluid velocity and septal thickness.  The data were fit 
using a linear regression (r
2
 = 0.99 and 0.94 for 1 cm/s and 10 cm/s fluid velocities, 
respectively).  Although not always visible, error bars representing the SEM were 
included for all points. 
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Figure 5. Microfluidic device characterization 
 
a) Schematic depicting protocol for generating brief neurotransmitter pulses.  A modified 
3-channel device (not to scale) is shown in the starting position (left) with the recording 
pipette positioned in the high osmolarity (HIGH) fluid stream.  With a single lateral 
movement of the device (black arrow), the recording pipette is exposed briefly to the low 
osmolarity (LOW) stream and then to the second high osmolarity stream (right).  b) 
Representative open-tip liquid junction currents obtained using the protocol in Panel A 
using devices with different central channel widths.  Pulse durations for these currents 
were 410, 810, and 1620 μs (for the 10, 25, and 50 μm central channels, respectively).  c) 
Relationship between central channel width and pulse duration.  The data were fit using a 
linear regression (see Results; r
2
=0.99).  Although not always visible, error bars 
representing the SEM were included for all points. 
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positioning relative to the channels to be monitored as a function of time, as solutions 
with different osmolarities yield different liquid-junction currents.  Recordings began 
with an “open-tip” electrode positioned in one of the outer high osmolarity solution 
streams 25-50 μm from the channel exits (Figure 2d).  Maintaining a minimum of this 
distance from the channel exits prevented the electrode from passing through the solution 
“dead space” immediately distal to the septa, and instead, allowed it to pass through a 
narrower and more laminar solution interface (Sachs, 1999).  To generate the brief pulse, 
the microfluidic device was translated orthogonally to its long axis with a single motion 
such that after being exposed to the first high osmolarity stream, the electrode was then 
exposed to the low osmolarity stream, and then to the second high osmolarity stream 
(Figure 5a).  With a fluid velocity of ~25 cm/s (the maximum sustainable by excised 
membrane patches; data not shown), solution exchange times were consistently ~100 µs 
(Figure 3) and exposure durations to the low osmolarity solution stream were 391 ± 47, 
799 ± 49, 1783 ± 159, and 3082 ± 259 ms when central channel widths were 10, 25, 50, 
and 100 μm, respectively (n = 5 devices) (Figure 5b, 5c).  These values were unaffected 
by using different osmolarity solutions or by repeatedly translating the devices at rates up 
to 80 Hz (data not shown).  Pulse duration was linearly related to the width of the central 
channel (r
2
 = 0.99), with a slope of 30.2 ± 1.9 μs/μm (Figure 5c).  This corresponded to 
an average translational velocity of ~33 μm/ms, a value only slightly lower than that 
reported by the manufacturer (likely reflecting the larger mass of the acrylic platform and 
PDMS device compared to glass capillary tubing). 
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Currents evoked from GABAA receptors were exquisitely sensitive to the duration of 
GABA application 
 
Although synaptic LGICs are thought to be exposed to neurotransmitter for only 
300-600 μs, pulse lengths of 1 – 10 ms have historically been used to mimic synaptic 
transmission (Colquhoun et al., 1992; Jones and Westbrook, 1995; Lagrange et al., 2007; 
Bianchi et al., 2007; Rula et al., 2008).  To determine if this difference in pulse length 
could alter the kinetic properties of LGICs, we compared the peak amplitude, 
deactivation time course, and sensitivity to high-frequency stimulation of GABAA 
receptor currents evoked by either a “synaptic” 400 μs or a more “conventional” 10 ms 
pulse of 1 mM GABA (a synaptically relevant concentration).  The 400 μs pulse was 
generated by translating the modified 3-channel device (Figure 2b) containing the 10 μm 
central channel using the protocol described in the previous section (Figure 5a), except 
that high and low osmolarity solutions were replaced by control and GABA-containing 
bath solutions, respectively.  The 10 ms pulse was generated by translating the standard 
3-channel device (Figure 2a), again with control and GABA-containing bath solutions in 
place of high and low osmolarity solutions, respectively, using the traditional approach to 
solution switching (i.e., after exposing the recording electrode to the GABA-containing 
stream, it was then re-exposed to the original control stream by translating the 
microfluidic device in the opposite direction).  Experiments were performed on outside-
out membrane patches excised from HEK293T cells expressing the α1β3γ2S receptor, an 
isoform expressed in adult hippocampal synapses (Pirker et al., 2000; Herd et al., 2008).  
To facilitate application of both pulse lengths to the same excised patch, a combination 
device containing both the standard and modified channel designs was used (Figure 6).  
Note that solution exchange times and application durations are known to be similar for 
272 
 
“open-tip” and “patched” recording electrodes (Colquhoun et al., 1992; Mozrzymas et al., 
2003). 
Compared to currents evoked by conventional 10 ms pulses, those evoked by the 
more synaptically relevant 400 μs pulses had smaller peak amplitudes (169.9 ± 55.3 pA 
vs. 225.4 ± 56.4 pA; n = 10; p < 0.01) (Figure 7a, 7b).  This difference could not be 
attributed to differences in the rates of GABA application, as solution exchange times 
were consistently ~100 μs for all application protocols at a fluid velocity of 25 cm/s 
(Figure 3, 5) and were routinely checked before and after recording sessions.  In addition, 
this difference could not be attributed to current “rundown” between applications, as 10 
ms pulses were applied before and after the 400 μs pulse, and the average of those 
 
 
Figure 6. Schematic of a custom microfluidic device that allows for application of 
synaptic (400 μs) and conventional (10 ms) pulse lengths to the same lifted cell or excised 
membrane patch 
 
Channel exits in a custom microfluidic device that incorporates both the standard (Figure 
2a) and modified (Figure 2b) designs are shown.  Channels (white) are separated by 10 
μm septa (grey).  The numbers above the device indicate the width of the channels in μm. 
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responses was used for comparison.  Instead, the smaller peak amplitude of currents 
evoked by synaptic pulses reflected the fact that α1β3γ2S receptors were relatively slow 
to activate (Figure 7c, 7d).  In other words, while 10 ms pulses provided ample time for 
currents to reach their peak amplitude, 400 μs pulses terminated receptor activation, 
causing currents to be truncated.  Indeed, while maximal rise slopes were similar for 400 
μs and 10 ms pulses (Figure 7c), indicating that the kinetics of receptor activation were 
similar following both application protocols, current rise time was substantially shorter 
following the 400 μs pulse (0.61 ± 0.05 vs. 1.33 ± 0.14 ms; n = 10; p < 0.001) (Figure 7c, 
7d).  In fact, the rise time of currents evoked by 400 μs GABA pulses was approximately 
equal to the sum of the pulse duration (~0.4 ms) and the solution exchange time (~0.2 ms; 
i.e., ~0.1 ms  2, since the electrode must enter and exit the GABA stream), consistent 
with the idea that activation of this particular receptor isoform was limited by the 
duration of GABA exposure. 
In addition, activating GABAA receptors with ultra-brief as opposed to 
conventional pulses decreased the weighted time constant of deactivation (10.67 ± 2.44 
ms vs. 17.99 ± 4.58 ms; n = 10; p < 0.01) (Figure 7e, 7f), suggesting that limiting the 
duration of GABA exposure decreased receptor accumulation in long-lived 
conformations, which serve to delay GABA unbinding (Jones and Westbrook, 1995; 
Bianchi et al., 2007).  Deactivation was typically bi-phasic (although as many as four 
components could be resolved with larger currents), and interestingly, while the relative 
amplitudes of fast and slow phases were similar for synaptic and conventional pulses 
(A1: 0.71 ± 0.05 vs. 0.83 ± 0.04; A2: 0.29 ± 0.05 vs. 0.17 ± 0.04; p > 0.05 in both cases), 
synaptic pulses were associated with faster time constants of deactivation (1: 1.83 ± 0.38  
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Figure 7. Effect of pulse duration on α1β3γ2S GABAA receptor current kinetics 
 
a) Representative currents evoked by 400 µs (left) or 10 ms (right) pulses of 1 mM 
GABA applied to the same outside-out patch.  b) The effect of pulse duration on peak 
current amplitude.  c) Comparison of current activation during 400 µs (black) or 10 ms 
(grey) pulses of 1 mM GABA.  d) The effect of pulse duration on current rise time.  e) 
Comparison of current deactivation following 400 µs (black) or 10 ms (grey) pulses of 1 
mM GABA.  Currents were normalized to their amplitudes at the start of GABA 
washout.  f) The effect of pulse duration on the weighted time constant of deactivation.  
Filled bars above currents indicate duration of GABA exposure.  ** p < 0.01; *** p 
<0.001 
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ms vs. 3.32 ± 0.47 ms; 2: 20.88 ± 5.04 ms vs. 55.24 ± 8.66 ms; p < 0.01 in both cases).  
Synaptic pulses also decreased the sensitivity of GABAA receptors to repetitive 
stimulation (Figure 8), which has been demonstrated to progressively decrease peak 
current amplitudes (Jones and Westbrook, 1995; Lagrange et al., 2007; Rula et al., 2008).  
While this was not apparent at low stimulation frequencies (1 Hz; Figure 8a, 8b), where 
the inter-pulse interval was sufficiently long to allow currents evoked by both synaptic 
and conventional pulses to fully deactivate, a substantial reduction was noted in the rate 
at which peak current amplitudes decayed when evoked by high frequency synaptic, as 
opposed to conventional, pulses (20 Hz; Figure 8c, 8d).  Indeed, when the peak amplitude 
of the last current was compared to that of the first current in a 20 Hz pulse train, 62 ± 11 
% of the current amplitude remained when synaptic pulses were used, while only 27 ± 8 
% remained when conventional pulses were used (n = 3; p < 0.05) (Figure 8e, 8f).  As 
with the effect on peak current, these effects of pulse length on deactivation and 
repetitive stimulation could not be attributed to differences in the rate of GABA washout, 
as solution exchange times were similar for all experimental protocols (data not shown). 
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Figure 8. Effect of pulse duration on α1β3γ2S GABAA receptor current responses during 
repetitive stimulation 
 
a-d) Representative current responses from 400 µs (Panels a and c) and 10 ms (Panels b 
and d) pulses of 1 mM GABA applied at frequencies of 1 Hz (Panels a and b) or 20 Hz 
(Panels c and d).  Note that there was no appreciable reduction of peak currents at 1 Hz 
for either pulse length, while there was a gradual reduction of peak current amplitudes at 
20 Hz.  To facilitate comparison of the rates of peak current reduction during repetitive 
stimulation, the maximal responses in Panels a and c were normalized to those of Panels 
b and d.  E) Representative currents evoked by the first (left) and last (right) pulses in the 
20 Hz condition for either 400 µs (black) or 10 ms (grey) pulses.  Currents were 
normalized to the first pulse in the train.  F) Longer GABA pulses are associated with 
more pronounced loss of peak current amplitude during high frequency repetitive 
stimulation.  * p < 0.05 
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DISCUSSION 
The fact that synaptic transmission occurs on a sub-millisecond timescale has 
made studying LGICs in vitro under physiologically relevant conditions technically 
challenging.  Indeed, mimicking the synaptic transient requires that neurotransmitter be 
applied not only extremely rapidly, but also extremely briefly.  Here, we describe the 
design, fabrication, optimization, and implementation of a novel microfluidic solution-
switching system that allows for solution exchange times as brief as ~100 μs and pulse 
durations as brief as ~400 μs, thus fulfilling both of these requirements.  When applied to 
recombinant α1β3γ2S GABAA receptors, an isoform expressed highly in adult 
hippocampal synapses (Pirker et al., 2000; Herd et al., 2008), currents evoked by ultra-
brief pulses of GABA had kinetic properties similar to those of inhibitory post-synaptic 
currents (IPSCs) recorded from adult hippocampal CA1 pyramidal neurons, including 
sub-millisecond rise times and biphasic deactivation time courses with weighted time 
constants of ~10 ms (Cohen et al., 2000).  These kinetic properties, however, were 
substantially altered for currents evoked by longer, conventional pulses of GABA, 
consistent with the predictions of several theoretical modeling studies (Glavinovic, 1999; 
Mozrzymas, 2004; Lagrange et al., 2007).  This raises the possibility that approximating 
synaptic conditions with longer neurotransmitter pulses could obscure the effects of 
disease-causing mutations or potential therapeutic compounds on LGIC currents, 
particularly when there are large differences between the length of application durations 
and intrinsic current rise times (i.e., the time required for currents to reach peak during 
continuous neurotransmitter exposure) (Mozrzymas, 2004; Mozrzymas et al., 2007). 
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The advantages of using PDMS microfluidic devices for studying LGIC currents, 
however, extend beyond their ability to effectively mimic the timescale of synaptic 
transmission.  In contrast to existing rapid application systems, which typically allow for 
the delivery of only a few solution streams (Jonas, 1995; Clements, 1997; Hinkle et al., 
2003), PDMS-based systems can, in principle, deliver tens to hundreds of solutions to 
experimental preparations.  This tremendously increases the throughput of 
electrophysiological studies (see Figure 9 for an example of a 12-channel microfluidic 
device used to determine the concentration response and pharmacological profiles of the 
α4β3γ2L GABAA receptor isoform), and importantly, permits more complex 
experimental protocols to be performed.  For example, different device designs can be 
included on the same microfluidic chip, thereby allowing neurotransmitter to be applied 
for different lengths of time (by varying central channel width; Figure 6) and/or at 
different rates (by varying septum width; Figure 4).  Fabricating microfluidic devices 
from PDMS also makes them more durable and reproducible.  Indeed, there is little risk 
of breaking PDMS devices even when they include micron-scale features, and should this 
occur, the replica molding process ensures that all replacement devices will be nearly 
identical to the original.  Furthermore, taking a microfluidic approach to solution 
switching substantially reduces the cost of electrophysiological experiments, as PDMS-
based devices are cheaper to fabricate, consume less reagent, and with short setup times, 
are less labor intensive. 
The future for this microfluidic approach to solution switching thus appears 
highly promising, and new techniques are poised to further enhance its capabilities.  
Optimized methods for PDMS microfabrication allow for devices with higher aspect 
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Figure 9. Schematic of a microfluidic device that allows for efficient screening of LGIC 
concentration response and pharmacological profiles 
 
a) Channel exits in a custom 12-channel device are shown (numbered above device for 
clarity; not to scale).  Even-numbered channels were loaded with GABA solutions (G) of 
increasing concentration (subscript denotes concentration in μM).  Odd-numbered 
channels were loaded with external bath solution (E).  Shown below the device are the 
corresponding currents (normalized to the 1000 μM trace) evoked from lifted whole cells 
expressing rat α4β3γ2L GABAA receptors.  One-second GABA applications were 
separated by 45-second washes in external solution to allow for complete agonist 
unbinding (omitted traces indicated by //).  Following exposure to the final GABA 
solution (channel 12), neurotransmitter washout was accomplished by stepping the device 
in reverse to channel 11 (indicated by light gray box; far right).  b) As above, except that 
even-numbered channels contained either low (10 μM; lanes 2, 4, and 6) or high (100 
μM; lanes 8, 10, and 12) concentrations of GABA along with either a putative agonist or 
antagonist (PB = pentobarbital; TH = THDOC; PX = picrotoxin; BI = bicuculline; 
subscript denotes concentration in μM).  Agonists (PB and TH) and antagonists (PX and 
BI) were co-applied with 10 μM and 100 μM GABA, respectively.  Dashed lines indicate 
control peak current amplitudes for reference. 
 
 
 
ratios (Liu et al., 2005), meaning that the widths of individual channels and their septa 
could be further decreased.  This, combined with the availability of higher velocity 
stepper translators (Haydon Switch and Instrument Corp., Waterbury, CT), should allow 
for faster solution exchange times and briefer pulse durations.  Moreover, given the 
recent development of microfluidic design elements that allow concentration gradients to 
be generated within individual channels (Chung et al., 2005), modulating the shape of the 
neurotransmitter transient should now be feasible.  In other words, if the central 
neurotransmitter-containing solution stream is replaced with one that contains a 
neurotransmitter gradient, then passing this stream across the recording pipette will 
generate a non-square neurotransmitter waveform.  This will allow the experimental 
neurotransmitter transient not only to be brief, but also to mimic the shape of the synaptic 
neurotransmitter transient, whose decay is better described by an exponential function 
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(Clements, 1996).  We thus anticipate that our novel approach to solution switching will 
allow for LGIC currents to be evaluated in vitro under a wide range of physiologically 
relevant conditions.  
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CHAPTER VII 
 
 
 
THE ROLE OF MACROSCOPIC DESENSITIZATION AND DEACTIVATION 
IN SHAPING GABAA RECEPTOR CURRENTS EVOKED 
BY REPETITIVE STIMULATION 
 
 
 
Emmanuel J. Botzolakis, Matt T. Bianchi, and Robert L. Macdonald 
 
 
 
ABSTRACT 
Repetitive activation of GABAA receptors gives rise to currents with 
progressively smaller peak amplitudes (repetitive pulse inhibition, RPI), a phenomenon 
important for normal signal processing and recently implicated in the pathogenesis of 
temporal lobe epilepsy.  Although RPI is assumed to reflect accumulation and trapping of 
GABAA receptors in long-lived desensitized states, certain receptor isoforms (e.g., αβδ 
receptors) exhibit minimal RPI despite having access to such states.  To better understand 
the kinetic basis for RPI, we evaluated the relationship between desensitization and the 
sensitivity of currents to repetitive activation using a combination of electrophysiological 
studies of recombinant α1β3γ2L receptors expressed in HEK293T cells and Markov 
modeling of GABAA receptor function.  The results demonstrated that while desensitized 
states were necessary for GABAA receptor currents to exhibit RPI, they were not 
sufficient and did not necessarily need to be long-lived.  In contrast, the phenomenon of 
macroscopic desensitization (the loss of current in the continued presence of agonist) was 
both necessary and sufficient for RPI.  Interestingly, this macroscopic current property 
defined a boundary condition for the time course of RPI: increasing the frequency of 
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receptor activation drove the rate and extent of RPI towards the limit set by macroscopic 
desensitization.  Weighted deactivation time course accounted for differences between 
the kinetics of RPI and those of macroscopic desensitization, with faster deactivation 
decreasing and slower deactivation increasing the rate and extent of RPI.  Taken together, 
the results demonstrate that RPI is shaped primarily by macroscopic phenomena, and 
therefore, cannot be attributed to individual microscopic parameters (such as desensitized 
state occupancy).  Moreover, the results suggest that macroscopic desensitization has 
important physiological relevance, as alterations in its kinetic properties are predicted to 
have profound effects on the inhibitory signaling mediated by GABAA receptors under 
conditions of high frequency synaptic transmission. 
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INTRODUCTION 
Sustained neuronal firing leads to a progressive reduction in the amplitude of 
inhibitory post-synaptic currents (IPSCs) (Ben-Ari, et al., 1979, 1981; Connors, et al., 
1982; Wong and Watkins, 1982; Numann and Wong, 1984; McCarren and Alger, 1985; 
Huguenard and Alger, 1986; Deisz and Prince, 1989; Thompson and Gähwiler, 1989; 
Fukuda, et al., 1993; Galarreta and Hestrin, 1998; Varela, et al., 1999), a form of short-
term plasticity that provides synapses with a rapid and powerful mechanism for negative 
feedback.  This phenomenon, commonly referred to as “repetitive pulse inhibition (RPI)” 
(or alternatively, “frequency-dependent” or “use-dependent” depression), is thought to be 
important for normal signal processing (Metherate and Ashe, 1994; Reyes et al., 1998; 
Galaretta and Hestrin, 1998; Varela, et al., 1999; Fortune and Rose, 2001; Grande and 
Spain, 2005) and has been implicated in the pathogenesis of some forms of epilepsy 
(Palma et al., 2002; Roseti et al., 2008; Mazzuferi et al., 2010).  While there is 
considerable evidence that pre-synaptic factors such as depletion of GABA from synaptic 
vesicles, enhanced GABA reuptake, and autoinhibitory feedback via GABAB receptors 
contribute to this phenomenon (Krnjevic, 1984; Varela et al., 1999; McCarren and Alger, 
1985; Deisz and Prince, 1989; Thompson and Gähwiler, 1989; Davies and Collingridge, 
1993; Fukuda, et al., 1993), post-synaptic factors such as dissipation of the chloride 
gradient, internalization of GABAA receptors, and accumulation of GABAA receptors in 
desensitized states are also thought to play an important role (Ben-Ari, et al., 1979, 1981; 
Desarmenien et al., 1980; Wong and Watkins, 1982; Numann and Wong, 1984; 
McCarren and Alger, 1985; Huguenard and Alger, 1986; Thompson and Gähwiler, 1989; 
Galarreta and Hestrin, 1997, 1998). 
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Of the post-synaptic factors, the least understood in terms of its role in shaping 
RPI is GABAA receptor desensitization.  Indeed, while the relationship between 
desensitization and the shape of individual IPSCs has been examined in detail (Jones and 
Westbrook, 1995, 1996; Galarreta and Hestrin, 1997; Haas and Macdonald, 1999; 
Bianchi et al., 2007), how desensitization shapes IPSCs in the setting of repetitive 
stimulation has only started to be explored (Bianchi and Macdonald, 2002; Lagrange et 
al., 2007).  Loss of current in the setting of repetitive activation is traditionally attributed 
to receptor accumulation in desensitized states (Jones and Wesbtrook, 1996), defined as 
long-lived non-conducting states from which agonist cannot directly unbind (Bianchi and 
Macdonald, 2001).  Support for this hypothesis comes from in vitro studies of the 
predominant GABAA receptor isoform in synapses (α1β2/3γ2), which exhibits extensive 
RPI that correlates with receptor accumulation in desensitized states (Jones and 
Westbrook, 1995; Galarreta and Hestrin, 1997; Bianchi and Macdonald, 2002; Lagrange 
et al., 2007).  However, other GABAA receptor isoforms (e.g., α1β2/3δ) access similar 
long-lived non-conducting states and yet exhibit only minimal RPI (Haas and Macdonald, 
1999; Bianchi and Macdonald, 2002).  Moreover, in some cases (e.g., α1β2/3δ and 
α3β2/3γ2), RPI is paradoxically preceded by the phenomenon of repeated pulse 
enhancement (RPE), where current amplitudes become progressively larger with 
repetitive activation.  Thus, accumulation of receptors in desensitized states can actually 
be associated with increased current amplitudes (Bianchi and Macdonald, 2002; Rula et 
al., 2008). 
One possible explanation for the apparent discrepancy between experimentally 
observed RPI (or RPE) and the ability of receptors to access desensitized states is that 
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RPI, like other macroscopic phenomena, cannot simply be attributed to individual 
microscopic parameters.  Despite the common attribution of macroscopic behavior to 
individual rate constants, it is well known that macroscopic current kinetics actually 
reflect a complex interplay between all rate constants in the underlying gating scheme 
(Colquhoun, 1981; Bianchi et al., 2007).  For example, the time course of macroscopic 
desensitization (the loss of current in the continued presence of agonist; also referred to 
as current “sag”) is known to depend on the entry and exit rates not only of desensitized 
states, but also of open states (Bianchi et al., 2007).  Similarly, the time course of 
deactivation (the return of currents to baseline following agonist washout) depends 
primarily on the mean time receptors remain agonist-bound, which is determined not only 
by the agonist unbinding rate(s), but also by every other rate constant connecting agonist-
bound states (Bianchi et al., 2007; Appendix II).  Put another way, while any particular 
change in a microscopic parameter “maps” clearly to a macroscopic current, the reverse 
is not true – changes in macroscopic current properties could have been generated by any 
of a number of microscopic parameters (sometimes referred to as the “inverse problem” 
in engineering). 
To better understand the kinetic basis for RPI, a combination of patch-clamp 
electrophysiology and mathematical modeling was used to evaluate the relationship 
between the shape of currents evoked by trains of saturating GABA pulses and intrinsic 
receptor kinetics.  The results demonstrated that desensitized states were in fact necessary 
for the phenomenon of RPI to be observed, consistent with prior hypotheses linking RPI 
to discreet kinetic states.  However, desensitized states were not sufficient and did not 
necessarily need to be long-lived.  In contrast, the presence of macroscopic 
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desensitization was both necessary and sufficient for RPI to occur (i.e., any Markov 
model that gave rise to a macroscopically desensitizing current also supported RPI).  
Interestingly, macroscopic desensitization was found to represent a boundary condition 
for the time course of RPI.  This suggests that macroscopic desensitization has important 
physiological relevance, despite its experimental “visualization” requiring agonist 
exposure for periods of time orders of magnitude longer than are thought to occur at 
synapses.  
291 
 
MATERIALS AND METHODS 
 
Cell culture and expression of recombinant GABAA receptors 
 
Rat GABAA receptor α1, β3, and γ2L subunits were individually sub-cloned into 
the pcDNA3.1+ mammalian expression vector (Invitrogen, Grand Island, NY).  The 
coding region of each vector was sequenced by the Vanderbilt University Medical Center 
DNA Sequencing Facility and verified against published sequences.  HEK293T cells 
(American Type Culture Collection, Manassas, VA) were maintained at 37C in 
humidified 5% CO2 / 95% air using Dulbecco’s Modified Eagle Medium (Invitrogen) 
supplemented with 10% fetal bovine serum (Invitrogen), 100 i.u./ml penicillin 
(Invitrogen), and 100 μg/ml streptomycin (Invitrogen).  Cells were plated at a density of 
~10
6
 cells per 10 cm culture dish (Corning Glassworks, Corning, NY) and passaged 
every 2-4 days using trypsin-EDTA (Invitrogen).  For electrophysiological recordings, 
cells were plated at a density of 4x10
5
 cells per 6 cm culture dish (Corning Glassworks) 
and transfected ~24 hours later with equal amounts (1 μg/subunit) of α1, β3, and γ2S 
subunit cDNA.  One μg of pHook-1 cDNA (encoding the cell surface antibody sFv) was 
included so positively transfected cells could be selected 24 hours later by 
immunomagnetic bead separation.  All transfections were performed using FuGene6 
(Roche Diagnostics, Indianapolis, IN) per manufacturer recommendations.  The day after 
transfection, cells were selected and re-plated at low density on collagen-coated 35 mm 
dishes for electrophysiological recording the next day. 
 
292 
 
Electrophysiology 
 
Patch clamp recordings
 
were performed at room temperature from excised 
outside-out membrane patches.  Cells were maintained during recordings in a bath 
solution consisting of (in mM): 142 NaCl,
 
8 KCl, 6 MgCl2, 1 CaCl2, 10 glucose, and 10 
HEPES (pH adjusted to 7.4; 325-330 mOsm).  All chemicals used for solution 
preparation were purchased from Sigma-Aldrich (St. Louis, MO).  Recording pipettes 
were pulled from thin-walled borosilicate capillary glass (Fisher, Pittsburgh, PA) on a 
Sutter P-2000
 
micropipette electrode puller (Sutter Instruments, San Rafael,
 
CA) and fire 
polished with a microforge (Narishige, East Meadow, NY).  When filled with a pipette 
solution consisting of (in mM) 153 KCl, 1 MgCl2, 5 EGTA, 10 HEPES, and 2 MgATP 
(pH adjusted to 7.3; 300-310 mOsm) and submerged in the bath solution, this yielded 
open tip resistances of ~2 MΩ and a chloride equilibrium potential (ECl) of
 
~0 mV.  
Currents were recorded at a holding potential of -20 mV using an Axopatch 200B 
amplifier (Molecular Devices, Foster City, CA), low-pass filtered at 2 kHz using a 4-Pole 
Bessel filter, digitized at 10 kHz using the Digidata 1322A (Molecular Devices), and 
stored offline for analysis.  GABA was prepared as a stock solution.  Working solutions 
were made on the day of the experiment by diluting stock solutions with the bath 
solution. 
 
Kinetic Simulations 
 
Kinetic simulations were carried out with Berkeley Madonna 3.1 
(www.berkeleymadonna.com), a differential equation solver, using the fourth order 
Runge-Kutta method with a time interval of 10 µs.  For the branched model, default rates 
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were (s
-1
) Kon = 7 x 10
6
, Koff = 300, β = 1000, α = 300, δ = 100, and ρ = 3.  For the linear 
model, default rates were (s
-1
) Kon = 7 x 10
6
, Koff = 300, β = 1000, α = 300, δ = 100, and ρ 
= 10.  1 ms pulses of 10 mM GABA were used during the pulse-trains unless otherwise 
stated.  Occupancies of open and desensitized states were normalized in Clampfit 9.2 for 
display, and virtual currents were generated by assuming activation of 100 receptors with 
a 26 pS conductance voltage-clamped at -75 mV.  Proof of the kinetic conditions 
supporting macroscopic desensitization for simple Markov models of GABAA receptor 
function are shown Appendix IV and V. 
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RESULTS 
 
 
Repetitive activation of GABAA receptors leads to progressive reduction of peak current 
amplitudes 
 
To illustrate the phenomenon of repeated pulse inhibition (RPI), brief (5 ms) 
pulses of a saturating GABA concentration (1 mM) were applied at increasing 
frequencies (1 – 20 Hz) for 20 seconds to membrane patches excised from HEK293T 
cells expressing recombinant α1β3γ2L GABAA receptors, an isoform commonly found in 
inhibitory synapses (Farrant and Nusser, 2005).  Brief pulses of GABA were generated 
using a rapid solution switching system, as previously described (Hinkle et al., 2003).  Of 
note, while this pulse duration was approximately an order of magnitude longer than the 
synaptic GABA transient in vivo (Clements, 1996; Glavinovic, 1999), experimental data 
(Jones and Westbrook, 1995) and simulations using comprehensive Markov models for 
the α1β3γ2L isoform (Haas and Macdonald, 1999; Lagrange et al., 2007) predicted that 
this would not significantly affect macroscopic current kinetics following single or 
multiple GABA pulses (data not shown). 
The results demonstrated that both the extent (defined as the ratio of peak current 
amplitude evoked by the last GABA pulse to that evoked by the first GABA pulse) and 
the time course (defined as the rate of current amplitude loss) of RPI increased sharply 
with increasing stimulation frequency (Figure 1).  This loss of current amplitude was 
completely reversible with prolonged exposure to control solution (~60 second wash; 
data not shown), suggesting that it did not reflect receptor internalization or loss of the 
chloride gradient, a finding consistent with previous studies (Celentano and Wong, 1994; 
Bianchi and Macdonald, 2002).  Of note, a wash period of 20 seconds was
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Figure 1. Repeated stimulation of 132L GABAA receptors decreases the amplitude of 
currents evoked by brief pulses of GABA. 
the minimum necessary to prevent RPI from occurring in the first place (i.e., RPI was 
observed at frequencies above 0.05 Hz; data not shown).  Interestingly, both the extent 
and the time course of RPI reached a maximum when the stimulation frequency was 20 
Hz.  Indeed, the currents generated with pulse trains at 20 Hz were nearly identical to 
those generated by a single continuous pulse (which is essentially the equivalent of an 
infinitely high stimulation frequency).  The similarity of the currents evoked by high 
frequency stimulation to those evoked by continuous application could not be attributed 
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to malfunction of the drug application system, as open tip recordings of liquid junction 
currents (generated by replacing the GABA-containing solution with diluted control 
solution) demonstrated complete washout between pulses and similar solution exchange 
times at all stimulation frequencies (data not shown). 
 
The relationship between desensitization and repeated pulse inhibition was explored 
using kinetic models of GABAA receptor function 
 
The data shown in the previous section demonstrated that increasing the 
frequency of GABAA receptor activation increased the rate and extent of RPI, and 
ultimately, with progressively higher stimulation frequencies, gave rise to currents that 
closely approximated those generated by a continuous application of GABA.  In other 
words, the shape of currents evoked by continuous application appeared to represent a 
boundary condition for currents generated by repetitive activation, such that current lost 
due to repetitive activation could never exceed current lost in the setting of continuous 
application (i.e., the rate and extent of RPI could never exceed the rate and extent of 
macroscopic desensitization).  We therefore hypothesized that, under conditions where 
currents failed to exhibit macroscopic desensitization, RPI would not be observed, 
independent of the presence or fractional occupancy of microscopic desensitized states 
(note that while desensitized states are necessary, they are not sufficient to cause 
macroscopic desensitization; Bianchi et al., 2007).  If true, this could explain the failure 
of the αβδ isoform to exhibit significant RPI (Bianchi and Macdonald, 2002), despite its 
known ability to access long-lived desensitized states (Haas and Macdonald, 1999). 
To test this hypothesis, we generated simple 4-state Markov models of GABAA 
receptor function.  In the “linear" model (Figure 2, top), receptors transitioned into the
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Figure 2. Requirements for macroscopic desensitization in simple models of GABAA 
receptor function. 
 
 
desensitized (D) state directly from the open (O) state, while in the “branched” model 
(Figure 2, bottom) transitions into the D state occurred via the pre-open state (C2).  
Although comprehensive models that account for both the microscopic and macroscopic 
kinetic properties of GABAA receptors have been proposed (Haas and Macdonald, 1999; 
Lema and Auerbach, 2006; Lagrange et al., 2007), simple models are often sufficient to 
illustrate the salient features of GABA-evoked currents (Jones and Westbrook, 1996; 
Bianchi et al., 2007; Feng et al., 2009).  More importantly, simple models permit the 
microscopic conditions supporting macroscopic desensitization to be solved analytically 
(Figure 2; for proofs see Appendix IV and V).  For example, in the branched model, 
macroscopic desensitization was possible only when the exit rate from the O state (α) was 
larger than the exit rate from the D state (ρ).  In contrast, the linear model only exhibited 
macroscopic desensitization when the entry rate into the O state (β) was larger than the 
exit rate from the D state (ρ). 
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Figure 3. High occupancy microscopic desensitized states were not sufficient for 
macroscopic currents to undergo desensitization. 
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Knowledge of these kinetic relationships allowed for models to be generated with 
high occupancy D states but without the ability to macroscopically desensitize, a situation 
analogous to the previously described αβδ isoform and to the αβγ isoform activated by 
low GABA concentrations (Haas and Macdonald, 1999; Bianchi and Macdonald, 2002).  
This is illustrated in Figure 3 for branched and linear models.  For example, when α was 
set equal to ρ in the branched model (or when β was set equal to ρ in the linear model), 
the fractional occupancy of the O state, p(O), did not overshoot its equilibrium value (the 
equivalent of a macroscopic current without desensitization), despite the fractional 
occupancy of the D state, p(D), approaching an equilibrium value of 0.9.  However, when 
α was much larger than ρ in the branched model (or when β was much larger than ρ in the 
linear model), peak p(O) was much larger than equilibrium p(O) (the equivalent of a 
current with macroscopic desensitization), and yet p(D) again approached an equilibrium 
value of 0.9.  Note that an identical p(D) was possible in each condition despite 
increasing values of α or β (which should have increased and decreased p(D), 
respectively) because changes in α and β were always accompanied by an identical 
change in the partnering rate constant (i.e., if α was increased by an order of magnitude, 
so was β). 
Using these models, we evaluated the relationship between RPI and 
desensitization, both in terms of macroscopic time course and microscopic D state 
kinetics (Figure 4).  In the left column (α >> ρ), the branched model supporting extensive 
macroscopic desensitization was subjected to either brief pulses (1 ms) of saturating 
GABA at frequencies of 10, 30, and 100 Hz or to a continuous application of saturating 
GABA.  In the middle and right columns, the same protocols were applied to the 
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branched models supporting moderate (α > ρ) or absent (α = ρ) macroscopic 
desensitization, respectively.  For each condition, p(D) was shown as an upward trace, 
while the resulting current (which is directly proportional to p(O)) was shown as a 
downward trace.  Although the results are shown only for the branched model, it should 
be emphasized that nearly identical results were obtained for the linear model, indicating 
the results were independent of model connectivity (thought we did not explore cyclic 
models). 
Consistent with our hypothesis, the results demonstrated that RPI was not possible 
for receptors that failed to exhibit macroscopic desensitization, even in the setting of high 
occupancy D states.  Indeed, despite all three variations of the branched model exhibiting 
progressive receptor accumulation in the D state with repetitive activation, the resulting 
macroscopic currents had markedly different kinetic profiles.  For example, while the 
highly desensitizing model (α >> ρ) exhibited rapid and extensive RPI at even the lowest 
tested frequency (10 Hz), the non-desensitizing model (α = ρ) failed to exhibit RPI at 
even the highest tested frequency (100 Hz).  Like the highly desensitizing model (α >> 
ρ), the moderately desensitizing model (α > ρ) exhibited RPI at all stimulation 
frequencies.  However, the rate and extent of RPI were always less in that case, 
supporting the idea that macroscopic desensitization dictated the maximum possible rate 
and extent of RPI.  Interestingly, the non-desensitizing model actually exhibited 
enhancement of current amplitudes (repeated pulse enhancement, RPE) with repetitive 
activation, despite the occupancy of the D state increasing with each successive pulse.   
RPE was also observed with the moderately desensitizing model (α > ρ) at 30 and 100 
Hz, though this was followed by RPI. 
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Figure 4. Lack of macroscopic desensitization precludes repeated pulse inhibition, even 
in the presence of high occupancy desensitized states. 
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The simulations performed to demonstrate this fundamental relationship between 
macroscopic desensitization and RPI, however, required the use of kinetic models that 
differed by more than one parameter (i.e., to keep relative equilibrium occupancies of O
and D states constant, multiple rate constants had to be altered).  To illustrate this 
relationship in an even more direct manner, simulations were performed using a single 
model activated using different GABA concentrations.  Indeed, decreasing the GABA 
concentration is known to decrease the rate and extent of macroscopic desensitization, as 
this prevents the synchronous activation of receptors needed to resolve the true peak 
current (Jones and Westbrook, 1996; Bianchi and Macdonald, 2002; Bianchi et al., 2007).  
However, decreasing the GABA concentration does not prevent receptors from 
occupying microscopic D states, and in fact, preserves the relative occupancies of O and 
D states (so long as all O and D states are located distal to the GABA binding step; 
Appendix I).  In other words, GABA concentrations that fail to induce macroscopic 
desensitization can still drive the vast majority of GABA-bound receptors into the D 
state.  To illustrate this phenomenon, currents were evoked by repetitive stimulation 
using the highly desensitizing (α >> ρ) branched model over a wide range of GABA 
concentrations (Figure 5).  In the left column, the model was activated by brief (1 ms) 
pulses of saturating (10 mM) GABA at frequencies of 10, 30, and 100 Hz, and also by 
continuous application.  In the middle and right columns, the same protocols were 
applied but with sub-saturating GABA concentrations (10 μM and 10 nM, respectively). 
Consistent with the results from Figure 4, the activation patterns clearly supported 
the hypothesis that macroscopic desensitization, and not microscopic D state kinetics per 
se, was the driving force behind the phenomenon of RPI.  For example, application of a
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Figure 5. Decreasing the GABA concentration decreased the amount of repeated pulse 
inhibition by decreasing the extent of macroscopic desensitization, and not by preventing 
receptor entry into desensitized states. 
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continuous pulse of 10 nM GABA yielded a non-desensitizing macroscopic current 
(despite causing accumulation of receptors in the D state), and pulse trains applying this 
same concentration failed to elicit RPI, even at the highest stimulation frequencies.  In 
contrast, the GABA concentrations supporting macroscopic desensitization (10 mM and 
10 µM) always yielded currents that exhibited RPI, though lower concentrations required 
use of higher stimulation frequencies.  This effect was not dependent on the size or 
complexity of the kinetic model used for the simulations, as both the 4-state linear model 
and comprehensive models of the α1β3γ2L and α4β3γ2L isoforms (Haas and Macdonald, 
1999; Lagrange et al., 2007) behaved similarly when activated by concentrations of 
GABA sufficiently low to avoid macroscopic desensitization (data not shown).  Of note, 
the phenomenon of RPE was again present in several conditions despite the concurrent 
accumulation of receptors in the D state, including the 10 µM condition, which ultimately 
underwent RPI. 
 
Faster deactivation shifts the time course of repeated pulse inhibition away from the 
limit imposed by macroscopic desensitization 
 
 The results in the previous section demonstrated that macroscopic desensitization 
was both necessary and sufficient to cause RPI, and importantly, that the time course of 
macroscopic desensitization represented a boundary condition for maximal rate and 
extent of RPI.  But what determined the difference between the time course of RPI at any 
given frequency and the limit set by macroscopic desensitization?  We hypothesized that 
this difference was related to the time course of deactivation (the return of macroscopic 
current to baseline upon termination of an agonist pulse), which determines the rate at 
which receptors become available for subsequent activation.  For example, if deactivation
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Figure 6. Faster deactivation shifts the time course of repeated pulse inhibition away 
from the time course of macroscopic desensitization. 
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is significantly faster than the inter-pulse interval, then the vast majority of receptors 
should be available for reactivation by subsequent pulses, thus reducing the rate and 
extent of RPI.  In contrast, if deactivation is extremely slow, meaning that nearly all 
receptors remain GABA-bound at the time of reactivation, then near-maximal RPI would 
be expected (that is, within the limit imposed by macroscopic desensitization). 
To test this hypothesis, currents were evoked by repetitive stimulation using the 
highly desensitizing (α >> ρ) branched model over a wide range of unbinding rates (Koff) 
(Figure 6).  For each value of Koff, the model was again activated by brief (1 ms) pulses 
of saturating (10 mM) GABA at frequencies of 10, 30, and 100 Hz, and also by 
continuous application.  Note that varying the unbinding rate in the setting of a saturating 
GABA concentration has minimal effect on macroscopic current kinetics during GABA 
exposure, as the fractional occupancy of the unbound state is effectively zero under these 
conditions (Bianchi et al., 2007).  However, because the unbinding rate is an important 
determinant of the mean time receptors are GABA-bound (though not the only 
determinant; see Appendix II), it significantly influences the deactivation time course, 
when the GABA concentration is zero (Bianchi et al., 2007).  Thus, varying Koff in the 
setting of saturating GABA allows for the effect of deactivation to be evaluated 
independent of macroscopic desensitization. 
Consistent with our hypothesis, the results demonstrated that deactivation was an 
important determinant of RPI kinetics, with faster deactivation decreasing and slower 
deactivation increasing the rate and extent of RPI.  For example, compared to the slowest 
unbinding rate (Koff = 1 s
-1
), increasing the unbinding rate by two orders of magnitude 
(Koff = 100 s
-1
) nearly eliminated RPI at 10 Hz and significantly decreased the amount of 
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RPI observed at 30 and 100 Hz.  In fact, the rate and extent of RPI observed at 30 and 
100 Hz for the slowest unbinding rate (Koff = 1 s
-1
) was comparable to that observed at 10 
and 30 Hz, respectively, for the fastest unbinding rate (Koff = 100 s
-1
).  Thus, changes in 
the deactivation time course changed the frequency response properties of model, such 
that slower deactivation shifted the shape of RPI towards the limit imposed by 
macroscopic desensitization, while faster deactivation shifted it away (i.e., towards a non-
desensitizing macroscopic current).  Of note, however, the change in frequency response 
was not due to D state accessibility or occupancy, as equilibrium p(D) remained at ~0.9 
for all values of Koff in the setting of a continuous application of saturating GABA. 
 
Changes in the kinetics of repeated pulse inhibition could not be used to infer either 
the magnitude or the direction of change in D state occupancy 
 
The results in the previous sections demonstrated that, in contrast to leading 
hypotheses in the literature, RPI was in fact a poor predictor of receptor occupancy in D 
states.  This is consistent with previous studies of other macroscopic phenomena, whose 
kinetic properties are determined by a complex interplay between multiple rate constants 
in the underlying gating scheme (Bianchi et al., 2007).  However, it has been argued that 
despite this complex relationship between microscopic and macroscopic receptor 
properties, experimental increases in the rate and/or extent of RPI (due to disease-causing 
mutations or allosteric modulators) are nevertheless indicative of overall increases in the 
fractional occupancy of D states.  To test this hypothesis, rate constants in the branched 
and linear models were systematically varied either alone or in combination over several 
orders of magnitude, and the response of each model to pulse trains of increasing 
frequency was evaluated (the results of this extremely large data set are not shown). 
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Figure 7. Increased repeated pulse inhibition can occur despite decreased desensitized 
state occupancy.  * indicates modified rate constants, see text. 
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Consistent with our hypothesis, the simulations showed that no single rate 
constant in either model could cause the extent of RPI to change in a direction opposite 
that of D state occupancy (i.e., increased or decreased RPI was always associated with 
increased or decreased D state occupancy, respectively).  For example, in the branched 
model, either increasing β or decreasing α led to dereased RPI (because these changes 
decreased the extent of macroscopic desensitization; Bianchi et al., 2007) and D state 
occupancy (increasing efficacy (β/α) in the branched model increased O state occupancy 
at the expense of occupancy in all other states; Appendix I).  In the linear model, either 
increasing β or decreasing α led to increased RPI (because these changes increased the 
extent of macroscopic desensitization; Bianchi et al., 2007) and D state occupancy 
(increasing efficacy in the linear model increases occupancy of both O and D states; 
Appendix I).  In both models, increasing δ or decreasing ρ always increased RPI (because 
these changes increased the extent of macroscopic desensitization; Bianchi et al., 2007) 
and increased D state occupancy (Appendix I). 
However, changes in RPI extent did not necessarily parallel those of D state 
occupancy when multiple rate constants were changed, a scenario often encountered with 
disease-causing mutations and allosteric modulators.  An example is shown in Figure 7, 
where the response of the branched model to pulse trains of 10, 30, and 100 Hz or to 
continuous application in the setting of increased channel efficacy (β/α) mediated by a 
simultaneous increase in both the channel opening (β) and closing (α) rate.  The “wild 
type” condition (Kon = 7x10
6
, Koff = 3000, β = 1000, α = 30, δ = 6000, and ρ = 20 s
-1
) is 
shown in the left column, while conditions of increased efficacy are shown in the middle 
(β = 6000 and α = 60 s-1) and right (β = 3x104 and α = 120 s-1) columns.  As in previous 
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figures, p(D) was shown as an upward trace, while the resulting currents were shown as 
downward traces (note that currents were scaled to peak p(O) to facilitate comparison of 
RPI extent).  The results demonstrate that so long as the channel opening rate (β) 
increases more than the channel closing rate (α), the extent of RPI increases despite p(D) 
decreasing.  This reflects the fact that increased efficacy in branched models necessarily 
decreases p(D) (Appendix I).  However, when increases in efficacy are accompanied by 
an increase in the channel closing rate (α), the extent of macroscopic desensitization 
increases, reflecting the increased disparity between the channel closing rate (α) and the 
resensitization rate (ρ) (Appendix V).  This same effect was observed in the branched 
model with decreases in D state stability (δ/ρ) that were mediated by greater reductions in 
the desensitization rate (δ) than the resensitization rate (ρ) – the reduction in D state 
stability (δ/ρ) necessarily reduced D state occupancy, but because of the increased 
disparity between the channel closing rate (α) and the resensitization rate (ρ), the extent 
of desensitization actually increased (data not shown). 
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DISCUSSION 
 
The phenomenon of repeated pulse inhibition depends on the relationships among 
macroscopic, and not microscopic, GABAA receptor properties 
 
Simulations using simple Markov models of GABAA receptor function 
demonstrated that the extent and rate of RPI, like all other macroscopic current properties 
(e.g., activation, desensitization, deactivation), could not be attributed to individual 
microscopic kinetic parameters such as the lifetime or fractional occupancy of 
desensitized states.  Indeed, for any given desensitized state occupancy, a wide range of 
RPI profiles were possible, including the absence of RPI or even the phenomenon of RPE 
(Figure 4).  Even relative changes in D state occupancy could not be inferred from 
changes in RPI kinetics, as illustrated by the example of increasing channel efficacy, 
which increased RPI extent while decreasing D state occupancy (Figure 7).  Despite these 
complexities, our simulations definitively demonstrated that RPI could not occur in the 
absence of desensitized states (i.e., C-C-O models do not exhibit RPI at any stimulation 
frequency; data not shown).  In other words, D states were necessary (though they did not 
necessarily need to be long-lived) but not sufficient for RPI to be observed. 
Interestingly, despite the emphasis on microscopic “mechanisms” throughout the 
literature of ion channel biophysics, we have demonstrated that in fact macroscopic 
desensitization was critical, being both necessary and sufficient for RPI to be observed.  
This fundamental relationship was demonstrated using a variety of modeling approaches, 
and appeared to be independent of model size or connectivity (though we limited our 
simulations to non-cyclic gating schemes).  Thus, the relationship between macroscopic 
desensitization and RPI may generalize not only to other ligand-gated channels, but also 
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to voltage-gated channels (where the analogous phenomenon to macroscopic 
desensitization is termed “inactivation”).  Interestingly, the time course of macroscopic 
desensitization was found to impose a limit on RPI kinetics, such that the rate and extent 
of RPI could approach but never exceed that of macroscopic desensitization, regardless 
of the underlying D state kinetics.  Given that firing frequencies considerably higher than 
those tested in this study have been documented throughout the brain in both normal and 
abnormal conditions, the results suggest that macroscopic desensitization may have broad 
physiological significance, despite the fact that experimental visualization of this 
phenomenon requires application of agonist for physiologically irrelevant durations (a 
prominent criticism of early desensitization studies). 
However, the results demonstrated that RPI kinetics were influenced not only by 
the time course macroscopic desensitization, but also by the time course of deactivation.  
This extends the physiological significance of deactivation, which is already thought to 
be the primary determinant of IPSC decay rate (Jones and Westbrook, 1995; Galarreta 
and Hestrin, 1997).  Indeed, while macroscopic desensitization facilitated RPI, 
deactivation attenuated RPI by promoting receptor availability for reactivation.  In other 
words, deactivation determined the position of RPI between two boundaries – that of 
macroscopic desensitization and that of full recovery (i.e., no RPI).  The functional 
consequence of changes in deactivation time course was a shift in the frequency response 
profile of the receptor.  Compared to slowly deactivating currents, those with rapid 
deactivation required higher stimulation frequencies to exhibit RPI, and higher 
frequencies to reach the limit imposed by macroscopic desensitization.  Thus, the low-
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pass frequency filter imposed by RPI on GABAA receptor responses is determined, at 
least in part, by deactivation. 
Of note, the sensitivity of RPI to both macroscopic desensitization and 
deactivation implied that the phenomenon would be exquisitely sensitive to changes in 
certain rate constants and relatively insensitive to changes in others, reflecting the fact 
that these current properties can be differentially sensitive to changes in certain rate 
constants, a phenomenon termed desensitization-deactivation uncoupling (Bianchi et al., 
2007).  For example, in the linear model, increasing the channel opening rate (β) not only 
increased the rate and extent of macroscopic desensitization (Bianchi et al., 2007), but 
also prolonged deactivation (by increasing the mean bound time; Appendix II), the 
combination of which markedly increased the rate and extent of RPI (data not shown).  
Conversely, in the branched model, increasing the channel opening rate (β) decreased the 
rate and extent of macroscopic desensitization (Bianchi et al., 2007) but prolonged 
deactivation (by increasing the mean bound time; Appendix II), the result being offsetting 
effects on RPI kinetics (data not shown). 
Unexpectedly, understanding how desensitization and deactivation shaped RPI 
provided an intuitive kinetic explanation for the phenomenon of repeated pulse 
enhancement (RPE), which in addition to being observed in many of our simulations, has 
also been observed in a variety of experimental settings (Nathan and Lambert, 1991; 
Lambert and Wilson, 1994; Wilcox and Dichter, 1994; Fleidervish and Gutnick, 1995).  
Simply, both phenomena reflect a system attempting to reach equilibrium.  What differs 
is the manner in which the underlying system accomplishes this task.  In the case of 
currents that exhibit macroscopic desensitization, equilibrium occupancy of the O state is 
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less than the transient peak occupancy (i.e., currents overshoot their equilibrium value).  
Thus, if the first pulse is of sufficient duration to achieve peak O state occupancy, then 
subsequent activation can only cause O state occupancy to decrease, as this drives the 
system closer to its equilibrium value.  The only way that subsequent activation can 
achieve the same O state occupancy is if all receptors have returned to the unbound state, 
meaning that deactivation is shorter than the inter-pulse interval.  But in the case of 
currents that fail to exhibit macroscopic desensitization, peak and equilibrium O state 
occupancy are one and the same (i.e., currents do not overshoot their equilibrium values).  
Thus, only if the first pulse is of infinite duration will peak O state occupancy ever be 
achieved.  For any shorter pulse length, O state occupancy will be less than maximal, and 
subsequent activation will drive the system closer to equilibrium, giving the appearance 
of current enhancement. 
 
The physiological significance of macroscopic desensitization 
 
Macroscopic desensitization has been observed for nearly all ligand-gated ion 
channels (Jones and Westbrook, 1996; Bianchi and Macdonald, 2002; Mohammadi et al., 
2003; Robert and Howe, 2003; Schorge and Colquhoun, 2003; Tsuneki et al., 2007).  In 
the case of GABAA receptors, desensitization can be extensive and multi-phasic, with as 
many as four components having been identified (time constants ranging from ~10 ms to 
~10 s) (Celentano and Wong, 1994; Haas and Macdonald, 1999; Bianchi and Macdonald, 
2002; Lagrange et al., 2007).  Desensitization kinetics are highly dependent on subunit 
composition (Bianchi et al., 2002; Fisher, 2007; Lagrange et al., 2007).  For example, 
while  subunit-containing isoforms give rise to macroscopic currents that desensitize 
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rapidly and extensively, those containing  subunits desensitize slowly and to a much 
lesser extent (Haas and Macdonald, 1999; Bianchi and Macdonald, 2002).  The subunit-
dependence of desensitization is of particular interest given the subunit-dependence of 
receptor subcellular localization.  Receptor isoforms containing  subunits are found 
primarily in synapses, where they are transiently activated by nearly-saturating 
concentrations of GABA (“phasic” inhibition).  In contrast, those containing  subunits 
are targeted extrasynaptically, where they are persistently activated by sub-saturating 
concentrations of ambient GABA (“tonic” inhibition) (Farrant and Nusser, 2005).  
Desensitization has therefore been suggested to represent an important mechanism for 
tuning receptor responses to specific contexts of activation (Jones and Westbrook, 1995, 
1996; Bianchi and Macdonald, 2002; Overstreet et al., 2002; Lagrange et al., 2007). 
However, the physiological relevance of desensitization has remained a matter of 
some debate.  Even the fastest phase of desensitization occurs with a time constant over 
an order of magnitude longer than the presumed duration of the synaptic transient (~10 
ms vs. <1 ms, respectively; Clements, 1996; Bianchi and Macdonald, 2002; Mozrzymas, 
2004), prompting some investigators to call desensitization “more of an experimental 
nuisance than a physiologically interesting phenomenon” (Colquhoun and Sakmann, 
1998).  Others have disagreed, arguing that the underlying D state provides an additional 
agonist-bound conformation from which channels can re-open, extending the duration of 
synaptic currents (Jones and Westbrook, 1995, 1996).  While true, it should be 
emphasized that addition of D states to kinetic models necessarily decreases open 
probability, meaning that regardless of deactivation time course, net charge transfer must 
decrease.  Moreover, it was recently demonstrated fast desensitization actually 
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accelerates early phases of IPSC decay, suggesting that desensitization serves to reshape 
rather than to enhance IPSCs (Bianchi et al., 2007).  Unfortunately, such a role appears to 
be reserved for fast desensitization, as elimination of intermediate and slow desensitized 
states from comprehensive kinetic models had minimal predicted effects on either the 
amplitude or decay of individual IPSCs (Haas and Macdonald, 1999). 
The results of this and one other study (Bianchi and Macdonald, 2002), however, 
suggest that the unique property conferred by macroscopic desensitization is the ability to 
modulate signal intensity in the setting of repetitive activation.  In the case of receptor 
isoforms that exhibit multi-phasic macroscopic desensitization, this finding implies that 
all phases will have relevance in the setting of high frequency stimulation, not just the 
slow phases.  The difference is that slow phases can only influence RPI kinetics after 
prolonged repetitive activation, whereas fast phases can manifest themselves after even 
short bursts.  
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CHAPTER VIII 
 
 
 
CONCLUSION 
 
 
 
Emmanuel J. Botzolakis and Robert L. Macdonald 
 
 
The relationship microscopic and macroscopic kinetic phenomena 
 
The primary goals of this dissertation were to determine the microscopic kinetic 
factors that shape GABAA receptor macroscopic currents, to use this information to 
develop an algorithm for interpreting the effects of mutations and modulators, and to 
apply this algorithm to answer long-standing questions in the field of GABAA receptor 
research.  These goals were accomplished through a combination of theoretical studies 
using Markov models of GABAA receptor function, which systematically evaluated the 
relationship between microscopic rate constants and macroscopic current properties, and 
electrophysiological studies of recombinant GABAA receptors expressed in HEK293T 
cells, which tested the hypotheses generated by the theoretical studies and illustrated the 
utility of the algorithmic approach. 
Both the theoretical and electrophysiological studies demonstrated that 
macroscopic current properties depended on a complex interplay among all rate constants 
in the gating scheme, and consequently, that changes in individual macroscopic current 
properties could not be attributed with any degree of certainty to changes in individual 
rate constants.  For example, while delaying agonist unbinding could prolong the time 
course of deactivation, so could increasing the stability of open and/or desensitized states 
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(Chapter II).  This reflected the fact that stabilizing fully liganded states increased the 
mean time receptors were GABA-bound (since unbinding can only occur from a subset 
of all states), which allowed channel activity to persist for an extended period of time 
(Appendix II).  The relationship between macroscopic desensitization and the stability of 
open and desensitized states was more complex, depending not only on every rate 
constant in the gating scheme, but also on the arrangement of states in the model (i.e., 
“branched” vs. “linear” desensitized states; Chapter II).  In the linear model, macroscopic 
desensitization was increased when either open or desensitized states were stabilized.  
However, in the branched model, macroscopic desensitization was increased only when 
desensitized states were stabilized; stabilizing open states actually decreased macroscopic 
desensitization (Chapter II).  This reflected the fact that stabilizing the open state in the 
branched model shifted its behavior towards that of the C-C-O arrangement, which could 
not undergo macroscopic desensitization (Appendix IV).  Interestingly, while all rate 
constants influenced the extent and time course of macroscopic desensitization, only a 
subset of rate constants determined whether macroscopic desensitization could actually 
occur.  For example, the linear model could only desensitize when the channel opening 
rate (β) was larger than the resensitization rate (ρ).  In contrast, the branched model could 
only desensitize when the channel closing rate (α) was larger than the resensitization rate 
(ρ) (Appendix IV).  Like desensitization and deactivation, every other macroscopic 
current property (rise time, amplitude, EC50, paired pulse recovery, etc.) was also found 
to have a complex dependence on microscopic rate constants (Botzolakis, Bianchi, Smith, 
and Macdonald, unpublished observations). 
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Admittedly, these findings were somewhat discouraging, as they suggested that 
the relationships between macroscopic currents and microscopic rate constants were 
possibly too complex to allow mechanistic insight to be obtained from macroscopic 
observations alone.  However, it was soon realized that combining macroscopic 
observations could impose tremendous constraints on the possible explanations for the 
macroscopic effects of a given mutation or modulator.  Indeed, while the time course of 
desensitization and deactivation were both influenced by all rate constants in the gating 
scheme, their differential sensitivities to changes in certain rate constants could be 
exploited to include or exclude rate constants from consideration.  For example, 
deactivation was prolonged whenever changing a rate constant increased receptor mean 
bound time; however, only a subset of rate constants increased mean bound time and yet 
decreased the extent of macroscopic desensitization (Chapter II; Appendix II).  In fact, 
such an observation could only be explained with increases in single channel efficacy 
(i.e., increased channel opening rate or decreased channel closing rate) and only with 
kinetic models that contained a branched desensitized state.  Thus, by asking just two 
macroscopic “questions” (Is the extent of macroscopic desensitization increased or 
decreased?  Is deactivation accelerated or prolonged?) the microscopic transition targeted 
by certain mutations and modulators could be exposed (Chapter II).  Moreover, with only 
one additional “question” (Is peak current increased or decreased?), every state transition 
in simple 4-state models of GABAA receptor function could be identified as the target of 
a mutation or modulator.  These questions, combined with a few basic single channel 
experiments, were used to generate the first experimental algorithm for interpreting 
changes in macroscopic currents in terms of microscopic mechanisms.  Preliminary 
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studies indicate that adding a fourth “question” (Is current rise time faster or slower?) will 
allow the algorithm to be extended further, such that the actual rate constant, and not just 
the reversible state transition, could be identified (Botzolakis, Smith, and Macdonald, 
unpublished observations).  This suggested that microscopic transitions in even larger 
kinetic schemes could eventually be identified, the caveat simply being that more 
“questions” will be required as the number of states is increased. 
Our preliminary “four-question” algorithm, however, was sufficient to identify 
the rate constant targeted by the most widely prescribed class of GABAA receptor 
modulator, the benzodiazepines.  Up to this point, there has been considerable 
disagreement regarding the mechanism of action of these drugs.  While single channel 
studies have made compelling arguments that benzodiazepines increase receptor affinity 
for GABA (Twyman et al., 1989; Rogers et al., 1994), other studies have suggested that 
benzodiazepines act by increasing efficacy (Rusch and Forman, 1005; Campo-Soria et 
al., 2006).  By applying the algorithm to whole cell currents evoked from recombinant 
α1β3γ2 GABAA receptors, however, we demonstrated not only that benzodiazepines act 
by increasing GABA affinity, but also that this increase was specifically mediated by a 
slower unbinding rate, as this was the only mechanism by which macroscopic 
desensitization could appear unchanged (when evoked by saturating concentrations of 
GABA) in the context of prolonged deactivation (Chapter III).  In fact, this pattern of 
desensitization and deactivation appeared to be the macroscopic “fingerprint” of changes 
in the microscopic unbinding rate, as it was independent of the connectivity or number of 
states in the gating scheme (Chapter II).  Interestingly, this pattern was also observed 
when currents were evoked by different agonists (GABA, muscimol, and THIP), 
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suggesting they differed not in terms of their mode of channel gating, but rather, in terms 
of their microscopic affinity for the receptor (Chapter II). 
In addition to allowing the experimental algorithm to be generated, understanding 
the kinetic determinants of desensitization and deactivation provided simple explanations 
for several unresolved issues in the field of GABAA receptor biophysics.  First, while fast 
desensitization has been shown to prolong deactivation, a phenomenon referred to as 
desensitization-deactivation “coupling”, numerous examples of desensitization-
deactivation “uncoupling” have been reported (Bianchi et al., 2001; Scheller and Forman, 
2002; Fisher, 2004; Mercik et al., 2006; Barberis et al., 2007; Chapter II).  The kinetic 
basis for uncoupling, however, was not entirely clear.  If macroscopic desensitization 
required the presence of microscopic desensitized states, and the presence of those states 
delayed agonist unbinding, then how could increased macroscopic desensitization ever be 
associated with faster deactivation (or vice versa)?  The answer was provided by our 
simulations, which as discussed above, demonstrated that the macroscopic phenomenon 
of desensitization was as intimately linked to the process of channel opening and closing 
as it was to the process of entering and exiting desensitized states.  Even the rates of 
binding and unbinding could influence the time course of macroscopic desensitization.  
Changing many of these rate constants, however, had opposite effects on desensitization 
and deactivation, thus giving the appearance of uncoupling (Chapter II).  In fact, our 
simulations indicated that coupling was as likely to be observed as uncoupling: of the 12 
microscopic transitions systematically evaluated for their ability to modulate macroscopic 
desensitization and deactivation, 6 could were found to promote coupling (linear model: 
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α, β, δ, and ρ; branched model: δ and ρ) and 6 were found to promote uncoupling (linear 
model: Kon and Koff; branched model: Kon, Koff, α, β). 
Second, the arrangement of desensitized states in kinetic models of GABAA 
receptor function has thus far been somewhat arbitrary.  Granted, branched arrangements 
have typically provided the best fits of macroscopic and microscopic data (Chapter VI), 
but optimized mathematical fitting is by no means adequate proof for such an 
arrangement, as it assumes the core gating scheme to which desensitized states are being 
added is already correct.  However, the fact that desensitization-deactivation uncoupling 
has been observed with several mutations and pharmacological agents that altered 
channel efficacy (e.g., the TM2 9’ leucine mutation and the anticonvulsant barbiturates, 
respectively; Chapter II; Twyman et al., 1989; Feng et al., 2004) strongly suggested the 
existence of a branch point in the underlying channel gating scheme.  Indeed, purely 
linear state arrangements could not cause desensitization and deactivation to appear 
uncoupled, except in the special case of altered agonist binding or unbinding rates, as 
discussed above (Chapter II, III).  That being said, the possibility that receptors have 
access to both types of desensitized states cannot be excluded.  In fact, it is worth 
mentioning that existing comprehensive models technically already include both types of 
states, as the distal closed states responsible for channel bursting have an arrangement 
with respect to the open states identical to that of linear desensitized states.  While some 
might argue that these states do not have sufficiently long lifetimes to warrant 
classification as “desensitized” states, it should be emphasized that in linear 
arrangements, the requirements for macroscopic desensitization are such that the open 
state can actually have a longer lifetime than that of the desensitized state, and yet, still 
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support substantial macroscopic desensitization (i.e., desensitization requires that β > ρ, 
but dwell time in the open state is equal to 1/(α + δ)). 
Third, the minimal macroscopic desensitization observed with currents from δ-
subunit containing receptors has long seemed at odds with the known ability of these 
isoforms to enter closed states with lifetimes and proportions similar to (if not greater 
than) those of γ-subunit containing isoforms, which undergo rapid and extensive 
macroscopic desensitization (Fisher and Macdonald, 1997; Haas and Macdonald, 1999).  
While somewhat counterintuitive, the fact that macroscopic desensitization has specific 
microscopic requirements provides a simple explanation for this phenomenon.  Consider, 
for example, the branched arrangement where exit rates from open and desensitized states 
are equal (i.e., α = ρ).  So long as this kinetic relationship is maintained, macroscopic 
desensitization will never be observed (Appendix IV), even if the entry rate into the 
desensitized state (δ) is increased by several orders of magnitude such that the vast 
majority of receptors are found in the desensitized state at equilibrium (Appendix I).  
Thus, the absence of macroscopic desensitization should never be taken to indicate the 
absence of microscopic desensitized states.  The converse, however, is not true – 
macroscopic desensitization necessitates the existence of microscopic desensitized states, 
as C-C-O arrangements were proven to always generate “flat” currents (Appendix IV).  
Even then, however, neither the rate nor the extent of macroscopic desensitization was 
found to correspond to the entry/exit rates or fractional occupancy of the desensitized 
state (Chapter II). 
Fourth, while it has been known for some time that simple open channel block 
can have unusual effects on macroscopic currents (Ascher, et al., 1978; Marty, 1978; 
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Lipton, 2005, 2006), the kinetic bases for these effects remain unclear.  The ability of an 
open channel blocker to decrease the extent of macroscopic desensitization is perhaps 
most counterintuitive (Chapter IV), as blocked states were expected to provide channels 
with an additional route for closure (besides that already provided by existing 
desensitized states), and therefore, to increase current desensitization.  The simulations, 
however, demonstrated that open channel block was no different than adding a linear 
desensitized state to the gating scheme, which as discussed above, can only cause 
macroscopic desensitization under certain conditions (β > ρ).  By analogy, when the exit 
rate from the blocked state (k+) was equal to or greater than the channel opening rate (β), 
a macroscopically non-desensitizing (i.e., flat) current was favored.  Consequently, 
stabilizing non-desensitizing blocked states (by increasing the concentration of blocker) 
necessarily gave the appearance of attenuated macroscopic desensitization, as this 
decreased the contribution of the existing desensitized states (which supported 
macroscopic desensitization) to the macroscopic current. 
 
The physiological significance of macroscopic desensitization and deactivation 
 
Having exposed the microscopic determinants of desensitization and deactivation, 
the next goal of this dissertation was to determine the possible physiological relevance of 
these macroscopic phenomena.  While it is generally agreed that the time course of 
deactivation determines the rate of IPSC decay, this only pertains to deactivation 
following brief GABA pulses (~1 ms), which are intended to mimic the synaptic GABA 
transient.  But what of deactivation following longer pulses of GABA, which typically 
has a much longer time course?  Is this process only of interest to kineticists, who apply it 
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as a constraint during fitting of microscopic rate constants to putative gating schemes?  
And what about macroscopic desensitization, which by definition, is the loss of current in 
the continued presence of agonist?  Does the fact that receptors are exposed to GABA in 
vivo for 1 millisecond or less (Clements, 1996; Mozrzymas, 2004), and not for 100s to 
1000s of milliseconds, automatically make this phenomenon physiologically irrelevant?  
To gain insight into the possible biological significance of desensitization and 
deactivation, we explored how changes in these macroscopic properties affected receptor 
currents evoked under three distinct physiological contexts.  This included the classic 
synaptic context, where receptors are transiently activated by nearly saturating 
concentrations of GABA; the perisynaptic context, where receptors are also transiently 
activated, but by lower concentrations of GABA and likely in the context of baseline 
GABA exposure; and the extrasynaptic context, where receptors are persistently activated 
by extremely low concentrations of ambient GABA. 
From the synaptic standpoint, investigators have argued that desensitization is an 
important determinant of IPSC decay, as the underlying desensitized state provides 
receptors with additional opportunities to re-open, thus enhancing GABAergic synaptic 
transmission by prolonging receptor deactivation (Jones and Westbrook, 1995, 1996).  
This explanation, however, has long left something to be desired.  Although our 
simulations clearly supported the idea that stabilizing desensitized states prolongs current 
deactivation, to conclude that desensitized states enhance charge transfer ignores their 
known ability to decrease peak current amplitudes (Haas and Macdonald, 1999).  Indeed, 
our simulations indicate that it is impossible to increase IPSC charge transfer by adding a 
non-conducting state to the gating scheme (Botzolakis and Macdonald, unpublished 
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observations).  Moreover, both the simulations (Chapters II and IV) and the experimental 
results (Chapter IV) demonstrated that stabilizing desensitized states had mixed effects 
on deactivation time course; while fast phases were accelerated, slow phases were 
markedly prolonged.  This suggested that the role of desensitized states was not to 
enhance charge transfer, but rather, to redistribute it.  In other words, compared to 
receptors that lack desensitized states, those with access to desensitized states gave rise to 
IPSCs that delivered less charge initially but more charge later on.  Interestingly, the limit 
of this effect was an IPSC that actually resembled a “tonic” current, as receptors with 
extremely high desensitized state stability had low open probability and high mean 
GABA bound times (Appendix I, II), the combination of which was predicted to yield 
small but sustained currents. 
Despite the clear ability of desensitized states to influence IPSC shape, the 
physiological relevance of their macroscopic manifestation was less clear.  In fact, some 
investigators have gone so far as to call macroscopic desensitization more of an 
experimental nuisance than a biologically interesting phenomenon.  Our simulations, 
however, revealed that the time course of macroscopic desensitization represents an 
important boundary condition for IPSC decay, as the time course of current deactivation 
can never be slower than that of macroscopic desensitization (Chapter II).  This was 
demonstrated by decreasing the GABA unbinding rate in the context of receptor 
activation by a saturating concentration of GABA, which caused the deactivation time 
course to approach that of macroscopic desensitization.  Indeed, the magnitude of the 
unbinding rate appeared to determine the position of deactivation between two limits, the 
slow limit being determined by desensitization and the fast limit being determined by 
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channel mean open time (or burst/cluster length, depending on the gating scheme).  
While the existence of a slow limit imparted by macroscopic desensitization was 
somewhat counterintuitive, this occurred simply because receptors that cannot unbind 
GABA are functionally no different from those that unbind but are immediately re-bound 
with GABA (i.e., receptors are fully liganded in both cases).  Thus, receptors that give 
rise to rapidly desensitizing currents will necessarily evoke IPSCs with fast decay 
components, while those that give rise to slowly desensitizing currents will evoke IPSCs 
whose time course depends highly on agonist affinity.  Interestingly, this suggests that 
allosteric modulators that act primarily by increasing GABA affinity (such as 
benzodiazepines) will have the greatest effects on the shape of IPSCs mediated by non-
desensitizing receptors. 
The simulations also demonstrated that the time course of macroscopic 
desensitization represented an important boundary condition for the pattern of current 
responses evoked by high frequency stimulation, a phenomenon termed “repeated pulse 
inhibition” (Chapter V, VII).  Specifically, we found that the rate and extent of repeated 
pulse inhibition could never be faster or greater, respectively, than the rate and extent of 
macroscopic desensitization.  The existence of this kinetic boundary reflected the simple 
fact that for any pulse duration, there was a stimulation frequency that effectively 
exposed receptors to agonist continuously, which represented the maximal amount of 
current that could be lost.  Consequently, receptors that yielded macroscopically non-
desensitizing currents did not exhibit repeated pulse inhibition, no matter how high the 
stimulation frequency (Chapter VII).  Conversely, receptors that yielded macroscopically 
desensitizing currents necessarily exhibited repeated pulse inhibition, provided of course 
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that the stimulation frequency was high enough to prevent complete receptor unbinding 
between successive pulses.  Given the lack of any clear relationship between macroscopic 
desensitization and the occupancy of open, closed, or desensitized states (except that 
observing the macroscopic phenomenon necessitates the existence of a desensitized state; 
see above), it should be emphasized that kinetic data obtained from experimental 
protocols involving pulse trains should not under any circumstances be used to extract 
microscopic kinetic information.  This includes the commonly employed experimental 
paradigm of paired-pulse recovery, often used as an index of receptor recovery from 
desensitized states. 
However, the dependence of repeated pulse inhibition on the phenomenon of 
macroscopic desensitization did provide valuable information regarding the frequency 
domain within which different receptor isoforms could respond (Chapter V, VII).  
Desensitization served as a low-pass filter for receptor responses, decreasing the 
amplitude of successive IPSCs, and the multi-phasic nature of desensitization allowed the 
amount of filtering to be modulated with time, such that longer exposures to high 
frequency stimulation yielded progressively more filtering.  Indeed, while fast 
desensitization was most relevant during short bursts of repetitive stimulation, slow 
desensitization was most relevant during sustained repetitive stimulation.  This finding 
was consistent with the results of previous studies that showed that receptors lacking fast 
desensitization could still exhibit repeated pulse inhibition, but only in the context of long 
pulse trains or short pulse trains involving longer pulse durations (Bianchi and 
Macdonald, 2002).  The idea that slow desensitization was primarily relevant under 
conditions of sustained exposure to agonist was further supported by the observation that 
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the kinetic properties of a single IPSC (evoked by brief exposure to GABA) were 
virtually identical when slow desensitized states were removed from comprehensive 
models of GABAA receptor function, but not when fast desensitized states were removed 
(Haas and Macdonald, 1999).  Notably, the time course of deactivation also played an 
important role in filtering receptor responses to high frequency stimulation, as it 
determined the rate of receptor recovery between successive pulses.  Specifically, slower 
deactivation caused the amount of repeated pulse inhibition to increase for any given 
amount of macroscopic desensitization and any given stimulation frequency, thus left-
shifting the frequency response profile.  Interestingly, considering the context of high 
frequency stimulation exposed a role for the longer deactivation time course observed 
with longer GABA exposures in vitro.  This reflected the increasing occupancy of slow 
desensitized states with sustained receptor activation, which caused IPSCs later in the 
pulse train to have slower decay than those occurring earlier in the train (Chapter VII). 
Our simulations suggested that desensitization and deactivation may also have 
physiological significance for receptors activated under nonsynaptic conditions.  In the 
perisynaptic context, our simulations demonstrated that isoforms with more 
desensitization and slower deactivation were substantially less responsive to test pulses of 
saturating GABA following pre-application of sub-saturating GABA (Chapter V).  It 
should be noted, however, that we did not independently evaluate the role of 
desensitization and deactivation in this context of receptor activation, and so it was 
difficult to know which macroscopic property was more relevant, or if differences in 
these particular macroscopic properties were even responsible for the phenomenon.  
Indeed, among other kinetic differences, the less responsive isoform also had a lower 
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steady-state GABA EC50, meaning that pre-exposure to any given GABA concentration 
would have driven more receptors into fully liganded states.  However, it should be noted 
that even if this were the case, a non-desensitizing receptor would have responded in 
exactly the same manner with or without pre-application, as the lack of macroscopic 
desensitization precludes any loss of current amplitude due to repeated exposure (see 
above).  This suggested that enhanced macroscopic desensitization was at least partly 
responsible for this phenomenon, and consequently, that desensitization might be of 
physiological relevance to receptors that mediate nonsynaptic forms of GABAergic 
transmission (Overstreet et al., 2000).  Interestingly, our studies of open channel block 
suggested that desensitized states may also buffer open state occupancy from fluctuations 
in the GABA concentration or exposure to negative modulators, thus ensuring stability of 
the tonic current.  For example, open channel block was found to have decreasing effects 
on channel opening probability with increasing desensitized state occupancy (Chapter IV, 
Appendix II).  While we can only speculate as to the evolutionary significance of this 
finding, it should be noted that tonic currents are thought to be responsible for three times 
as much charge transfer as phasic currents, and consequently, protecting this current from 
environmental toxins may have been a high priority in the development of GABAergic 
systems. 
 
Future Directions 
 
The kinetic studies presented in this dissertation have raised more questions than 
they have answered.  In hopes that some brave soul will continue this work where we left 
off, the following is a long list of possible future directions. 
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Chapter II:  While the studies in this chapter demonstrated the complex 
relationship between microscopic rate constants and macroscopic current properties, our 
focus was on understanding the kinetic determinants of macroscopic desensitization and 
deactivation.  Consequently, the relationship between affinity, efficacy, desensitized state 
stability, and other macroscopic current properties such as current rise time, peak current 
EC50 (note that the solutions presented in Appendix II refer to equilibrium EC50), paired-
pulse recovery, and current rebound (which, incidentally, can occur with blockade of any 
fully liganded state) remains unclear.  In addition, our studies involved gross 
measurements of macroscopic current properties (i.e., extent of desensitization; weighted 
deactivation time course); the relationships between microscopic rate constants and 
different phases of desensitization and deactivation were not systematically evaluated.  
Once available, however this information should allow for generation of a substantially 
more comprehensive algorithm for interpreting the effects of mutations and modulators, 
and may even expose conditions where microscopic information can actually be extracted 
from macroscopic observations.  The data shown in Appendix V, for example, illustrate 
how simply varying the concentration of agonist can expose the microscopic exit rate 
from the desensitized state, at least for models containing only a single open state. 
Chapter III:  Applying our preliminary algorithm to benzodiazepines illustrated 
the potential power of combining macroscopic observations to constrain mechanistic 
hypotheses.  It would therefore be of interest to apply the algorithm (or, better still, an 
expanded version of the algorithm; see above) to other modulators and mutations.  
Indeed, the mechanism of action of many clinically relevant compounds and disease-
causing mutations remains controversial, reflecting the general lack of appreciation for 
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the complex relationship between microscopic and macroscopic currents.  Macro-micro 
issues aside, this chapter also touches on the issue of context-dependent modulation, a 
topic only starting to be explored in the literature.  Specifically, we found that 
benzodiazepines had distinct effects on macroscopic current shape and microscopic 
channel opening frequency depending on the mode of receptor activation.  This suggests 
that disorders characterized by deficits in phasic or tonic inhibition could be treated not 
by compounds that selectively modulate synaptic or extrasynaptic receptor isoforms, but 
rather, by drugs that modulate receptors selectively under certain contexts of activation. 
Chapter IV:  This chapter addressed issues similar to those addressed in Chapter 
III, namely the macro-micro relationship and the idea of context-dependent modulation.  
As for the former, the idea that open channel block is analogous to addition of a linear 
desensitized state offers a unique method for systematically evaluating the relationship 
between microscopic and macroscopic desensitization in an actual experimental context.  
Indeed, using single channel analysis, the entry and exit rates from the blocked state can 
be determined, and by simply varying the concentration of blocker, precise control can be 
gained over the entry rate into the blocked (i.e., linear desensitized) state.  It is worth 
noting that there are few experimental approaches that allow for the magnitude of a single 
rate constant in the gating scheme to be controlled.  The most well known is changing the 
concentration of agonist, which changes the effective binding rate, the other being 
receptor activation in the presence of benzodiazepines, which as demonstrated in Chapter 
III, lowers the unbinding rate.  As for the demonstration that open channel blockers also 
modulate receptors in a context-dependent manner (reflecting the dependence of open 
channel block on channel open probability), it would be of interest to explore whether 
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other negative modulators are similarly dependent upon GABA concentration.  Based on 
the mathematical analysis shown in Appendix II, it seems likely that this would be the 
case not only for negative modulators, but also for positive modulators.  If so, then the 
validity of using pharmacological agents to determine which receptor isoforms mediate 
phasic and tonic currents would need to be re-examined. 
Chapter V:  Increasing evidence suggests that most GABAA receptor isoforms 
access similar numbers of open and closed states and have similar bursting structure (i.e., 
one type of opening per burst), but have very different open, closed, burst, and cluster 
durations.  This suggests that GABAA receptor isoforms operate according to the same 
core gating scheme, but that subunit composition determines the magnitude of the rate 
constants governing the state transitions.  Although the feasibility of using a common 
core gating structure to describe the behavior of different receptor isoforms was presented 
in this chapter, this needs to be tested with other isoforms.  One of the greatest challenges 
would be to explain the behavior of αβ receptors in terms of a limited αβγ receptor 
gating scheme and to apply such an “embedded” model to explain the effects of 
neurosteroids, which convert αβ currents into αβγ-like currents, possibly by granting 
αβ receptors access to a previously restricted portion of the gating scheme (Bianchi and 
Macdonald, 2003).  In addition, it is worth noting that different receptor isoforms tend to 
undergo macroscopic desensitization according to a time course with similar time 
constants but very different relative contributions (at saturating concentrations of 
GABA).  This raises the intriguing possibility that differences in current shape reflect 
differences in the manner that receptors access the fully liganded gating scheme, and not 
the actual gating scheme itself.  Indeed, for the time constants of a macroscopic time 
340 
 
course to be similar, the underlying model connectivity and rate constants must be 
similar.  But by accessing the gating scheme from different starting positions (i.e., after 
binding GABA, receptors might enter a fast desensitized state as opposed to the 
traditional pre-open state), the relative contributions of each component would be very 
different, despite the time constants themselves being unchanged (Appendix III, IV). 
Chapter VI:  The microfluidic system presented in this chapter represents a major 
advance in solution exchange, as we can now activate GABAA receptors in vitro under 
physiologically relevant conditions.  The full potential of this approach, however, has yet 
to be achieved.  For example, while our system can exchange solutions in <100 s, there 
is no reason that faster times cannot be achieved.  The simplest way to do this would be 
to translate the devices with a faster motor, many of which are commercially available.  
In addition, the septal thickness could conceivably be reduced further, perhaps to as little 
as 1-5 m.  Since solution exchange time is linearly related to both septal thickness and 
translational velocity, even a two-fold improvement in both aspects would decrease 
exchange times to only ~25 s, more than enough to synchronously activate even the 
most rapidly activating GABAA receptors.  Similarly, there is no reason that pulse 
durations even shorter than 400 s could not be achieved.  This would only require 
increasing translational velocity and/or decreasing the width of the central channel.  
Moreover, there is no reason that the shape of the pulse must be square.  PDMS 
microfabrication is already being used to generate concentration gradients, which if used 
to replace the existing central stream (which delivers a single concentration of GABA), 
would allow for even more physiologically relevant GABA pulses to be generated.  For 
example, while a GABA transient with a rapid rise but multi-exponential decay could be 
341 
 
used to mimic the synaptic transient, one with a relatively slow rise and slow decay could 
be used to mimic the perisynaptic environment.  The shape of the waveform could even 
be modified to replicate disease states, where GABA reuptake is either enhanced or 
impaired. 
Chapter VII:  The results from this chapter and those before it argue strongly 
against the idea that macroscopic desensitization and deactivation are physiologically 
irrelevant phenomena.  However, all of the included studies involved either theoretical 
modeling or electrophysiological studies using recombinant receptors expressed in 
heterologous cells.  Convincing the scientific community will undoubtedly require work 
in primary culture, where both pre- and postsynaptic factors are in play.  Indeed, it is 
possible that changes in presynaptic factors, such as the concentration of GABA in the 
cleft or the rate of clearance due to reuptake, are more important in the physiological 
setting than postsynaptic receptor properties.  One of the simplest experiments for testing 
this hypothesis is to study the phenomenon of repeated pulse inhibition in neuronal slice 
preparations under conditions that selectively modulate postsynaptic receptor 
desensitization or deactivation.  For example, as shown in Chapter II, desensitization can 
be targeted selectively by reducing the GABA concentration, and as shown in Chapter 
III, deactivation can be targeted selectively by adding benzodiazepines.  If the importance 
of postsynaptic receptor properties is confirmed, it will be of enormous interest to 
determine how clinically relevant drugs such as benzodiazepines and barbiturates 
influence the time course of repeated pulse inhibition. 
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APPENDIX I 
 
ANALYTIC SOLUTIONS OF EQUILIBRIUM FRACTIONAL OCCUPANCY 
FOR MARKOV MODELS OF GABAA RECEPTOR FUNCTION 
 
 
 
Emmanuel J. Botzolakis, Matt T. Bianchi, Farid Hekmat, and Robert L. Macdonald 
 
 
 
I. Solution of equilibrium fractional occupancy for states in the 𝒞 
       𝛼        
       
       𝛽        
        𝒪  reaction 
scheme, which is represented by the following system of first-order differential 
equations: 
   𝒞´ = −𝒞𝛽 + 𝒪𝛼 (1) 
   𝒪´ = 𝒞𝛽 − 𝒪𝛼 (2) 
 
 A. Macroscopic Solution 
  i. 
𝒪(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠
 = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪  + (# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞)
 
     = 
𝒪
𝒪 +𝒞 
 = 
1
1 + 
𝒞
𝒪
 (3) 
   as t → ∞,   𝒞´ =  𝒪´ = 0 
   from (1) and (2), 𝒞𝛽 = 𝒪𝛼, or alternatively, 
   
𝒞
𝒪
=  
𝛼
𝛽
  (4) 
   substituting (4) into (3) 
    𝒪(𝑡)𝑡 → ∞ =
1
1 + 
𝛼
𝛽
  (5) 
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  ii. 
𝒞(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠
 = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞  + (# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪)
 
     = 
𝒞
𝒞 + 𝒪 
 = 
1
1 + 
𝒪
𝒞
  (6) 
   substituting (4) into (6)  
    𝒞(𝑡)𝑡 → ∞ =
1
1 + 
𝛽
𝛼
  (7) 
 
 B. Microscopic Solution 
  i. 𝑝 𝒪  = 
𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑜𝑝𝑒𝑛 −𝑐𝑙𝑜𝑠𝑒𝑑  𝑐𝑦𝑐𝑙𝑒
 
    = 
(𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒪)
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒪  + (𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒞)
 (8) 
   if the mean dwell time in state 𝒩 equals the reciprocal sum of  
   the exit rates from state 𝒩, then 
 
   mean dwell time in 𝒪 = 
1
𝛼
 (9) 
 
   mean dwell time in 𝒞 = 
1
𝛽
 (10) 
    
   substituting (9) and (10) into (8) 
 
   𝑝(𝒪) = 
1
𝛼
 
1
𝛼
 + 
1
𝛽
 
 , or alternatively, 
    𝑝 𝒪 =
1
1 + 
𝛼
𝛽
  (note that this is identical to (5)) 
  ii. 𝑝(𝒞) = 
𝑚𝑒𝑎𝑛  𝑐𝑙𝑜𝑠𝑒𝑑  𝑡𝑖𝑚𝑒
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑜𝑝𝑒𝑛 −𝑐𝑙𝑜𝑠𝑒𝑑  𝑐𝑦𝑐𝑙𝑒
 
    = 
(𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒞)
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒪  + (𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒞)
 (11) 
   substituting (9) and (10) into (11) 
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   𝑝(𝒞) = 
1
𝛽
 
1
𝛼
 + 
1
𝛽
 
 , or alternatively,  
    𝑝(𝒞)  =
1
1 + 
𝛽
𝛼
  (note that this is identical to (8)) 
 
II.  Solution of equilibrium fractional occupancy for states in the 
𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪  reaction scheme, which is represented by the following 
system of first-order differential equations: 
   𝒞1´ = −𝒞1𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴] + 𝒞2𝐾𝑜𝑓𝑓  (12) 
   𝒞2´ = 𝒞1𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 − 𝒞2 𝐾𝑜𝑓𝑓 + 𝛽 + 𝒪𝛼 (13) 
   𝒪´ = 𝒞2𝛽 − 𝒪𝛼 (14) 
 
 A. Macroscopic Solution 
  i. 
𝒪(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠
 
     = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1  + (# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2)
 
     = 
𝒪
𝒪 + 𝒞1  + 𝒞2
 = 
1
1 + 
𝒞1
𝒪
 + 
𝒞2
𝒪
 (15) 
   as t → ∞,   𝒞1´ =  𝒞2´ = 𝒪´ = 0 
   from (14), 𝒞2𝛽 = 𝒪𝛼, or alternatively, 
   
𝒞2
𝒪
=  
𝛼
𝛽
  (16) 
   from (12), 𝒞1𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴] = 𝒞2𝐾𝑜𝑓𝑓 , or alternatively, 
   
𝒞2
𝒞1
=  
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝐾𝑜𝑓𝑓
 (17) 
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   solving (16) for 𝒞2 and substituting into (17) 
   
𝒞1
𝒪
=  
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴]
 (18) 
   substituting (16) and (18) into (15) 
    𝒪(𝑡)𝑡 → ∞ =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (19) 
  ii. 
𝒞1(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1  
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠
 
     = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1  + (# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2)
  
     = 
𝒞1
𝒪 + 𝒞1  + 𝒞2
 = 
1
1 + 
𝒪
𝒞1
 + 
𝒞2
𝒞1
 (20) 
   substituting (17) and (18) into (20) 
   
𝒞1(𝑡)
𝑡 → ∞
=
1
1 + 
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝐾𝑜𝑓𝑓
 + 
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝛼𝐾𝑜𝑓𝑓
  (21) 
  iii. 
𝒞2(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  
 
     = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1  +(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2)
  
     = 
𝒞2
𝒪 + 𝒞1  + 𝒞2
 = 
1
1 + 
𝒪
𝒞2
 + 
𝒞1
𝒞2
 (22) 
   substituting (16) and (17) into (22) 
    
𝒞2(𝑡)
𝑡 → ∞
=
1
1 + 
𝐾𝑜𝑓𝑓
 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛽
𝛼
  (23) 
 
 B. Microscopic Solution 
  i. 𝑝(𝒪) = 
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒪 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒪 𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚 𝒞2)
   𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒩 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒩𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚 𝑛𝑒𝑖𝑔𝑕𝑏𝑜𝑟𝑠)
 (24) 
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   if the mean dwell time in state 𝒩 equals the reciprocal sum of  
   the exit rates from state 𝒩, then 
 
   mean dwell time in 𝒪 = 
1
𝛼
 (25) 
   mean dwell time in 𝒞1 = 
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 (26) 
   mean dwell time in 𝒞2 = 
1
𝛽  + 𝐾𝑜𝑓𝑓
 (27) 
   probability of 𝒞1  →  𝒞2 transition = 1 (no other option once in 𝒞1) (28) 
   probability of 𝒞2  →  𝒞1transition = 
𝐾𝑜𝑓𝑓
𝛽  + 𝐾𝑜𝑓𝑓
 (29) 
   probability of 𝒞2  →  𝒪 transition = 
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
 (30) 
   probability of 𝒪 →  𝒞2 transition = 1 (no other option once in 𝒪) (31) 
   substituting (25 – 31) into (24) 
   𝑝(𝒪) = 
  
1
𝛼
   
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
  
 
1
𝛼
   
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
 +   
1
𝛽  + 𝐾𝑜𝑓𝑓
   +  
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
   
𝐾𝑜𝑓𝑓
𝛽  + 𝐾𝑜𝑓𝑓
 
 
   or alternatively, 
    𝑝(𝒪) =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (note that this is identical to (19)) 
  ii. 𝑝(𝒞1) = 
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒞1 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒞1 𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛 𝑓𝑟𝑜𝑚 𝒞2)
  𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒩 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒩𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚 𝑛𝑒𝑖𝑔𝑕𝑏𝑜𝑟𝑠)
 (32) 
   substituting (25 – 31) into (32) 
   𝑝(𝒞1) = 
 
1
𝐾𝑜𝑛[𝐺𝐴𝐵𝐴]
   
𝐾𝑜𝑓𝑓
𝛽 + 𝐾𝑜𝑓𝑓
 
 
1
𝛼
   
𝛽
𝛽 + 𝐾𝑜𝑓𝑓
  +   
1
𝛽 + 𝐾𝑜𝑓𝑓
  +  
1
𝐾𝑜𝑛[𝐺𝐴𝐵𝐴]
   
𝐾𝑜𝑓𝑓
𝛽 + 𝐾𝑜𝑓𝑓
 
 
   or alternatively, 
    𝑝(𝒞1) =
1
1 + 
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝐾𝑜𝑓𝑓
 + 
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝛼𝐾𝑜𝑓𝑓
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   (note that this is identical to (22)) 
  iii. 𝑝(𝒞2) = 
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒞2 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒞2 𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛 𝑓𝑟𝑜𝑚 𝒞1  𝑎𝑛𝑑  𝒪)
  𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒩 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒩𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚 𝑛𝑒𝑖𝑔𝑕𝑏𝑜𝑟𝑠)
 (33) 
   substituting (25 – 31) into (33) 
   𝑝(𝒞2) = 
  
1
𝛽 + 𝐾𝑜𝑓𝑓
 
 
1
𝛼
   
𝛽
𝛽 + 𝐾𝑜𝑓𝑓
  +   
1
𝛽 + 𝐾𝑜𝑓𝑓
  +  
1
𝐾𝑜𝑛[𝐺𝐴𝐵𝐴]
   
𝐾𝑜𝑓𝑓
𝛽 + 𝐾𝑜𝑓𝑓
 
 
    𝑝 𝒞2 =
1
1 + 
𝐾𝑜𝑓𝑓
 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛽
𝛼
  (note that this is identical to (24)) 
 
III.  Solution of equilibrium fractional occupancy for states in the 
𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟  reaction scheme, which is represented by 
the following system of first-order differential equations: 
   𝒞1´ = −𝒞1𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴] + 𝒞2𝐾𝑜𝑓𝑓  (34) 
   𝒞2´ = 𝒞1𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 − 𝒞2 𝐾𝑜𝑓𝑓 + 𝛽 + 𝒪𝛼 (35) 
   𝒪´ = 𝒞2𝛽 − 𝒪(𝛼 + 𝛿) + 𝒟𝜌 (36) 
   𝒟´ = 𝒪𝛿 − 𝒟𝜌  (37) 
 
 A. Macroscopic Solution 
  i. 
𝒪(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑜𝑝𝑒𝑛  
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠
 
    = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2  + (# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒟)
 
    = 
𝒪
𝒪 + 𝒞1  + 𝒞2+ 𝒟
 = 
1
1 + 
𝒞1
𝒪
 + 
𝒞2
𝒪
 + 
𝒟
𝒪
 (38) 
   as t → ∞,   𝒞1´ =  𝒞2´ = 𝒪´ = 𝒟´ = 0 
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   from (37), 𝒪𝛿 = 𝒟𝜌, or alternatively, 
   
𝒟
𝒪
=  
𝛿
𝜌
  (39) 
   from (36), 𝒪 𝛼 + 𝛿 = 𝒞2𝛽 + 𝒟𝜌 (40) 
   solving (39) for 𝒟 and substituting into (40) 
   
𝒞2
𝒪
=  
𝛼
𝛽
  (41) 
   from (34), 𝒞1𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 = 𝒞2𝐾𝑜𝑓𝑓 , or alternatively 
   
𝒞2
𝒞1
=  
𝐾𝑜𝑛
𝐾𝑜𝑓𝑓
 (42) 
   solving (41) for 𝒞2 and substituting into (42) 
   
𝒞1
𝒪
=  
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
 (43) 
   substituting (39), (41), and (43) into (38) 
    𝒪(𝑡)𝑡 → ∞ =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
  (44) 
  ii. 
𝒞1(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  
 
    = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2  + (# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒟)
 
    = 
𝒞1
𝒪 + 𝒞1  + 𝒞2+ 𝒟
 = 
1
1 + 
𝒪
𝒞1
 + 
𝒞2
𝒞1
 + 
𝒟
𝒞1
 (45) 
   solving (39) for 𝒪 and substituting into (43) 
   
𝒟
𝒞1
=  
𝛽𝛿𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝛼𝜌𝐾𝑜𝑓𝑓
 (46) 
   substituting (42), (43), and (46) into (45) 
    
𝒞1(𝑡)
𝑡 → ∞
=
1
1+ 
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝐾𝑜𝑓𝑓
 + 
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝛼𝐾𝑜𝑓𝑓
 + 
𝛽𝛿 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝛼𝜌 𝐾𝑜𝑓𝑓
  (47) 
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  iii. 
𝒞2(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠
 
    = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2  + (# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒟)
 
    = 
𝒞2
𝒪 + 𝒞1  + 𝒞2+ 𝒟
 = 
1
1 + 
𝒞1
𝒞2
 + 
𝒪
𝒞2
 + 
𝒟
𝒞2
 (48) 
   solving (39) for 𝒪 and substituting into (41) 
   
𝒟
𝒞2
=  
𝛽𝛿
𝛼𝜌
 (49) 
   substituting (41), (42), and (49) into (48) 
    
𝒞2(𝑡)
𝑡 → ∞
=
1
1 + 
𝐾𝑜𝑓𝑓
 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛽
𝛼
 + 
𝛽𝛿
𝛼𝜌
  (50) 
  iv. 
𝒟(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒟
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠
 
    = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒟)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2  + (# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒟)
 
    = 
𝒟
𝒪 + 𝒞1  + 𝒞2+ 𝒟
 = 
1
1 + 
𝒞1
𝒟
 + 
𝒞2
𝒟
 + 
𝒪 
𝒟
 (51) 
   substituting (39), (46), and (49) into (51) 
    𝒟(𝑡)𝑡 → ∞ =
1
1 + 
𝛼𝜌 𝐾𝑜𝑓𝑓
 𝛽𝛿 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝜌
𝛽𝛿
 + 
𝜌
𝛿
  (52) 
 
B. Microscopic Solution 
  i. 𝑝(𝒪) = 
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒪 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒪 𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝒞2  𝑎𝑛𝑑  𝒟)
   𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒩 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒩𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝑛𝑒𝑖𝑔 𝑕𝑏𝑜𝑟𝑠 )
 (53) 
   if the mean dwell time in state 𝒩 equals the reciprocal sum of  
   the exit rates from state 𝒩, then 
 
   mean dwell time in 𝒪 = 
1
𝛼  + 𝛿
 (54) 
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   mean dwell time in 𝒞1 = 
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 (55) 
   mean dwell time in 𝒞2 = 
1
𝛽  + 𝐾𝑜𝑓𝑓
 (56) 
   mean dwell time in 𝒟 = 
1
𝜌
 (57) 
   probability of 𝒞1  →  𝒞2 transition = 1 (no other option once in 𝒞1) (58) 
   probability of 𝒞2  →  𝒞1transition = 
𝐾𝑜𝑓𝑓
𝛽  + 𝐾𝑜𝑓𝑓
 (59) 
   probability of 𝒞2  →  𝒪 transition = 
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
 (60) 
   probability of 𝒪 →  𝒞2 transition = 
𝛼
𝛼  + 𝛿
  (61) 
   probability of 𝒪 →  𝒟 transition = 
𝛿
𝛼  + 𝛿
  (62) 
   probability of 𝒟 →  𝒪 transition = 1 (no other option once in 𝒟) (63) 
   substituting (54 – 63) into (53) 
   𝑝(𝒪) = 
 
1
𝛼  + 𝛿
   
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
 
 
1
𝛼  + 𝛿
   
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
  +   
1
𝛽  + 𝐾𝑜𝑓𝑓
   
𝛼
𝛼  + 𝛿
  +  
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
   
𝐾𝑜𝑓𝑓
𝛽  + 𝐾𝑜𝑓𝑓
   
𝛼
𝛼  + 𝛿
  +  
1
𝜌
   
𝛿
𝛼  + 𝛿
   
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
 
 
   or alternatively,  
   𝑝(𝒪) =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾 𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
  (note that this is identical to (44)) 
  ii. 𝑝(𝒞1) = 
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒞1 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒞1  𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝒞2)
  𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒩 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒩𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝑛𝑒𝑖𝑔 𝑕𝑏𝑜𝑟𝑠 )
 (64) 
   substituting (54 – 63) into (64) 
   𝑝(𝒞1) = 
  
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
   
𝐾𝑜𝑓𝑓
𝛽  + 𝐾𝑜𝑓𝑓
   
𝛼
𝛼  + 𝛿
 
 
1
𝛼  + 𝛿
   
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
  +   
1
𝛽  + 𝐾𝑜𝑓𝑓
   
𝛼
𝛼  + 𝛿
  +  
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
   
𝐾𝑜𝑓𝑓
𝛽  + 𝐾𝑜𝑓𝑓
   
𝛼
𝛼  + 𝛿
  +  
1
𝜌
   
𝛿
𝛼  + 𝛿
   
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
 
 
   or alternatively, 
    𝑝(𝒞1) =
1
1+ 
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝐾𝑜𝑓𝑓
 + 
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝛼𝐾𝑜𝑓𝑓
 + 
𝛽𝛿 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝛼𝜌 𝐾𝑜𝑓𝑓
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   (note that this is identical to (47)) 
  iii. 𝑝(𝒞2) = 
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒞2 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒞2  𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝒞1  𝑎𝑛𝑑  𝒪)
  𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒩 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒩𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝑛𝑒𝑖𝑔 𝑕𝑏𝑜𝑟𝑠 )
 (65) 
   substituting (54 – 63) into (65) 
   𝑝(𝒞2) = 
  
1
𝛽  + 𝐾𝑜𝑓𝑓
   
𝛼
𝛼  + 𝛿
 
 
1
𝛼  + 𝛿
   
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
  +   
1
𝛽  + 𝐾𝑜𝑓𝑓
   
𝛼
𝛼  + 𝛿
  +  
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
   
𝐾𝑜𝑓𝑓
𝛽  + 𝐾𝑜𝑓𝑓
   
𝛼
𝛼  + 𝛿
  +  
1
𝜌
   
𝛿
𝛼  + 𝛿
   
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
 
 
   or alternatively, 
    𝑝(𝒞2) =
1
1 + 
𝐾𝑜𝑓𝑓
 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛽
𝛼
 + 
𝛽𝛿
𝛼𝜌
   (note that this is identical to (50)) 
  iv. 𝑝(𝒟) = 
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒟 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒟 𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝒪)
  𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒩 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒩𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝑛𝑒𝑖𝑔 𝑕𝑏𝑜𝑟𝑠 )
 (66) 
   substituting (54 – 63) into (66) 
   𝑝(𝒟) = 
  
1
𝜌
   
𝛿
𝛼  + 𝛿
   
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
 
 
1
𝛼  + 𝛿
   
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
  +   
1
𝛽  + 𝐾𝑜𝑓𝑓
   
𝛼
𝛼  + 𝛿
  +  
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
   
𝐾𝑜𝑓𝑓
𝛽  + 𝐾𝑜𝑓𝑓
   
𝛼
𝛼  + 𝛿
  +  
1
𝜌
   
𝛿
𝛼  + 𝛿
   
𝛽
𝛽  + 𝐾𝑜𝑓𝑓
 
 
   or alternatively, 
    𝑝(𝒟) =
1
1 + 
𝛼𝜌 𝐾𝑜𝑓𝑓
 𝛽𝛿 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝜌
𝛽𝛿
 + 
𝜌
𝛿
   (note that this is identical to (52)) 
 
IV.   Solution of equilibrium fractional occupancy for the 
  
 reaction scheme, which is represented by the following system of first-order 
differential equations: 
   𝒞1´ = −𝒞1𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴] + 𝒞2𝐾𝑜𝑓𝑓  (67) 
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   𝒞2´ = 𝒞1𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 − 𝒞2 𝐾𝑜𝑓𝑓 + 𝛽 +  𝛿 + 𝒪𝛼 + 𝒟𝜌 (68) 
   𝒪´ = 𝒞2𝛽 − 𝒪𝛼 (69) 
   𝒟´ = 𝒞2𝛿 − 𝒟𝜌  (70) 
 
 A. Macroscopic Solution 
  i. 
𝒪(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑜𝑝𝑒𝑛  
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠
 
     = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2  + (# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒟)
 
     = 
𝒪
𝒪 + 𝒞1  + 𝒞2+ 𝒟
 = 
1
1 + 
𝒞1
𝒪
 + 
𝒞2
𝒪
 + 
𝒟
𝒪
 (71) 
   as t → ∞,   𝒞1´ =  𝒞2´ = 𝒪´ = 𝒟´ = 0 
   from (69), 𝒪𝛼 = 𝒞2𝛽, or alternatively, 
   
𝒞2
𝒪
=  
𝛼
𝛽
  (72) 
   from (67), 𝒞1𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 = 𝒞2𝐾𝑜𝑓𝑓 , or alternatively, 
   
𝒞2
𝒞1
=  
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝐾𝑜𝑓𝑓
 (73) 
   solving (73) for 𝒞2 and substituting into (72) 
   
𝒞1
𝒪
=  
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴]
 (74) 
   from (53), 𝒟𝜌 = 𝒞2𝛿, or alternatively, 
   
𝒞2
𝒟
=  
𝜌
𝛿
  (75) 
   solving (75) for 𝒞2 and substituting into (72) 
   
𝒟
𝒪
=  
𝛼𝛿
𝛽𝜌
 (76) 
   substituting (72), (74), and (76) into (71) 
356 
 
    𝒪(𝑡)𝑡 → ∞ =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
  (77) 
  ii. 
𝒞1(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  
 
     = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2  +(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒟)
 
     = 
𝒞1
𝒪 + 𝒞1  + 𝒞2+ 𝒟
 = 
1
1 + 
𝒪
𝒞1
 + 
𝒞2
𝒞1
 + 
𝒟
𝒞1
 (78) 
   solving (74) for 𝒪 and substituting into (76) 
   
𝒟
𝒞1
=  
𝛿𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝜌𝐾𝑜𝑓𝑓
 (79) 
   substituting (73), (74), and (79) into (78) 
    
𝒞1(𝑡)
𝑡 → ∞
=
1
1+ 
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝐾𝑜𝑓𝑓
 + 
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝛼𝐾𝑜𝑓𝑓
 + 
𝛿𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝜌𝐾𝑜𝑓𝑓
  (80) 
  iii. 
𝒞2(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠
 
     = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2  + (# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒟)
 
     = 
𝒞2
𝒪 + 𝒞1  + 𝒞2+ 𝒟
 = 
1
1 + 
𝒞1
𝒞2
 + 
𝒪
𝒞2
 + 
𝒟
𝒞2
 (81) 
   substituting (72), (73), and (75) into (81) 
    
𝒞2(𝑡)
𝑡 → ∞
=
1
1 + 
𝐾𝑜𝑓𝑓
 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛽
𝛼
 + 
𝛿
𝜌
  (82) 
  iv. 
𝒟(𝑡)
𝑡  → ∞  = 
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒟
# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠
 
     = 
(# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒟)
 # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒪  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞1  +  # 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒞2  + (# 𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟𝑠  𝑖𝑛  𝒟)
 
     = 
𝒟
𝒪 + 𝒞1  + 𝒞2+ 𝒟
 = 
1
1 + 
𝒞1
𝒟
 + 
𝒞2
𝒟
 + 
𝒪 
𝒟
 (83) 
   substituting (75), (76), and (79) into (83) 
357 
 
    𝒟(𝑡)𝑡 → ∞ =
1
1 + 
𝜌𝐾𝑜𝑓𝑓
 𝛿𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛽𝜌
𝛼𝛿
 + 
𝜌
𝛿
  (84) 
 
 B. Microscopic Solution 
  i. 𝑝(𝒪) = 
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒪 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒪 𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝒞2)
   𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒩 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒩𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝑛𝑒𝑖𝑔 𝑕𝑏𝑜𝑟𝑠 )
 (85) 
   if the mean dwell time in state 𝒩 equals the reciprocal sum of  
   the exit rates from state 𝒩, then 
 
   mean dwell time in 𝒪 = 
1
𝛼
 (86) 
   mean dwell time in 𝒞1 = 
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 (87) 
   mean dwell time in 𝒞2 = 
1
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
 (88) 
   mean dwell time in 𝒟 = 
1
𝜌
 (89) 
   probability of 𝒞1  →  𝒞2 transition = 1 (no other option once in 𝒞1) (90) 
   probability of 𝒞2  →  𝒞1transition = 
𝐾𝑜𝑓𝑓
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
 (91) 
   probability of 𝒞2  →  𝒪 transition = 
𝛽
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
 (92) 
   probability of 𝒪 →  𝒞2 transition = 1 (no other option once in 𝒪) (93) 
   probability of 𝒞2  →  𝒟 transition = 
𝛿
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
 (94) 
   probability of 𝒟 →  𝒞2 transition = 1 (no other option once in 𝒟) (95) 
   substituting (86 – 95) into (85) 
   𝑝(𝒪) = 
 
1
𝛼
   
𝛽
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
 
 
1
𝛼
   
𝛽
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
  +   
1
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
  +  
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
   
𝐾𝑜𝑓𝑓
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
  +  
1
𝜌
   
𝛿
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
 
 
   or alternatively,  
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   𝑝(𝒪) =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾 𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
  
   (note that this is identical to (77)) 
  ii. 𝑝(𝒞1) = 
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒞1 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒞1  𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝒞2)
  𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒩 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒩𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝑛𝑒𝑖𝑔 𝑕𝑏𝑜𝑟𝑠 )
 (96) 
   substituting (86 – 95) into (96) 
   𝑝(𝒞1) = 
  
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
   
𝐾𝑜𝑓𝑓
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
 
 
1
𝛼
   
𝛽
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
  +   
1
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
  +  
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
   
𝐾𝑜𝑓𝑓
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
  +  
1
𝜌
   
𝛿
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
 
 
   or alternatively, 
    𝑝(𝒞1) =
1
1+ 
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝐾𝑜𝑓𝑓
 + 
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝛼𝐾𝑜𝑓𝑓
 + 
𝛿𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝜌𝐾𝑜𝑓𝑓
  
   (note that this is identical to (80)) 
  iii. 𝑝(𝒞2) = 
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒞2 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒞2  𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝒞1 ,   𝒪,   𝒟)
  𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒩 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒩𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝑛𝑒𝑖𝑔 𝑕𝑏𝑜𝑟𝑠 )
 (97) 
   substituting (86 – 95) into (97) 
   𝑝(𝒞2) = 
  
1
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
 
 
1
𝛼
   
𝛽
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
  +   
1
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
  +  
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
   
𝐾𝑜𝑓𝑓
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
  +  
1
𝜌
   
𝛿
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
 
 
   or alternatively, 
    𝑝(𝒞2) =
1
1 + 
𝐾𝑜𝑓𝑓
 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛽
𝛼
 + 
𝛿
𝜌
   
   (note that this is identical to (82)) 
  iv. 𝑝(𝒟) = 
 𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒟 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒟 𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝒞2)
  𝑚𝑒𝑎𝑛  𝑑𝑤𝑒𝑙𝑙  𝑡𝑖𝑚𝑒  𝑖𝑛  𝒩 (𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝒩𝑡𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛  𝑓𝑟𝑜𝑚  𝑛𝑒𝑖𝑔 𝑕𝑏𝑜𝑟𝑠 )
 (98) 
   substituting (86 – 95) into (98) 
   𝑝(𝒟) = 
  
1
𝜌
   
𝛿
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
 
 
1
𝛼
   
𝛽
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
  +   
1
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
  +  
1
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
   
𝐾𝑜𝑓𝑓
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
  +  
1
𝜌
   
𝛿
𝛽  + 𝛿  + 𝐾𝑜𝑓𝑓
 
 
   or alternatively, 
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    𝑝(𝒟) =
1
1 + 
𝜌𝐾𝑜𝑓𝑓
 𝛿𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛽𝜌
𝛼𝛿
 + 
𝜌
𝛿
   
   (note that this is identical to (84)) 
 
V.   Shortcut for solving the equilibrium fractional occupancy of state 𝒩 in any non-
cyclic Markov model, independent of the number of states (the “round trip” formula) 
A. Setup an equation in the following form 
𝒩(𝑡)
𝑡  → ∞
 =
1
1 + 
𝑟𝑎𝑡𝑒𝑠
𝑟𝑎𝑡𝑒𝑠
 +  …  + 
𝑟𝑎𝑡𝑒𝑠
𝑟𝑎𝑡𝑒𝑠
 
 B. Increase the number of rate-constant-ratio-terms in the denominator until 
it equals the number of states in the gating scheme minus 1. 
 C. Assign each term in the denominator (other than the term that equals 1) to 
a different state in the gating scheme (other than state 𝒩). 
 D. For each term, the numerator is equal to the product of rate constants that 
permit the shortest possible transition from the assigned state to 𝒩, and the denominator 
is the product of rate constants that permit the shortest possible transition from 𝒩 to the 
assigned state. 
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I. Mean closed time (MCT) 
 A. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪   
  𝑝(𝒪) = 1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 19) (1) 
  however, it is also true that 
  𝑝(𝒪) =
𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑜𝑝𝑒𝑛 −𝑐𝑙𝑜𝑠𝑒𝑑  𝑐𝑦𝑐𝑙𝑒
 
    =
(𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒 )
 𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒   +  𝑚𝑒𝑎𝑛  𝑐𝑙𝑜𝑠𝑒𝑑  𝑡𝑖𝑚𝑒  
 (2) 
  since there is a single 𝒪 state, 
 
  mean open time = mean dwell time in 𝒪 = 
1
𝛼
 (3) 
 
  substituting (3) into (2) 
 
  𝑝(𝒪) =  
1
𝛼
 
1
𝛼
 +  𝑀𝐶𝑇 
  =  
1
1 + 𝛼(𝑀𝐶𝑇)
 (4) 
 
  setting (1) equal to (4) 
  
1
1 + 𝛼(𝑀𝐶𝑇)
=  
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 
  MCT =  
1
𝛽  
 1 +
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
  (5) 
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 B. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟  
  𝑝(𝒪) = 1
1 + 
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 44) (6) 
  however, it is also true that 
  𝑝(𝒪) =
𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑜𝑝𝑒𝑛 −𝑐𝑙𝑜𝑠𝑒𝑑  𝑐𝑦𝑐𝑙𝑒
 
    =
(𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒 )
 𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒   +  𝑚𝑒𝑎𝑛  𝑐𝑙𝑜𝑠𝑒𝑑  𝑡𝑖𝑚𝑒  
 (7) 
  since there is a single 𝒪 state, 
 
  mean open time = mean dwell time in 𝒪 =
1
𝛼+ 𝛿
 (8) 
 
  substituting (8) into (7) 
 
  𝑝(𝒪) =
 
1
𝑎+𝛿
 
 
1
𝑎+𝛿  
  +  𝑀𝐶𝑇  
=  
1
1 +  𝑎+𝛿  𝑀𝐶𝑇 
 (9) 
 
  setting (6) equal to (9) 
   
  
1
1 +  𝛼+𝛿  𝑀𝐶𝑇 
=
1
1 + 
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 
  𝑀𝐶𝑇 =
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝛼+𝛿
 (10) 
 
 C.   
    
  
 
  𝑝(𝒪) = 1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴   
 + 
𝛼𝛿
𝛽𝜌
 
  (Appendix I, eq. 77) (11) 
  however, it is also true that 
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  𝑝(𝒪) =
𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑜𝑝𝑒𝑛 −𝑐𝑙𝑜𝑠𝑒𝑑  𝑐𝑦𝑐𝑙𝑒
 
    =
(𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒 )
 𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒   +  𝑚𝑒𝑎𝑛  𝑐𝑙𝑜𝑠𝑒𝑑  𝑡𝑖𝑚𝑒  
 (12) 
  since there is a single 𝒪 state, 
 
  mean open time = mean dwell time in 𝒪 =
1
𝛼
 (13) 
 
  substituting (13) into (12) 
 
  𝑝(𝒪) =
 
1
𝑎
 
 
1
𝑎  
  +  𝑀𝐶𝑇  
=  
1
1 + 𝑎 𝑀𝐶𝑇 
 (14) 
 
  setting (12) equal to (14) 
   
  
1
1 + 𝑎 𝑀𝐶𝑇 
=
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴   
 + 
𝛼𝛿
𝛽𝜌
 
  𝑀𝐶𝑇 =
1
𝛽  
 1 +
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
+
𝛿
𝜌
  (15) 
 
 D. Shortcut to solving MCT for any non-cyclic Markov model, independent 
of the number of 𝒞 states (assuming the presence of a single 𝒪 state) 
  i.  Using the “round trip” formula outlined in Appendix I, Section V, 
solve for 𝑝(𝒪). 
  ii.  Take the inverse of 𝑝(𝒪) and subtract 1. 
  iii. Solve for the mean open time (inverse sum of the exit rates from 
the 𝒪 state). 
  iv. MCT = the product of (ii) and (iii) 
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II. Mean bound time (MBT) 
 A. 𝒞1 
        𝐾𝑜𝑓𝑓      
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
         𝛼            
         
           𝛽            
          𝒪  
  𝑝(𝒞1)  =
1
1 + 
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝐾𝑜𝑓𝑓
 + 
𝛽𝐾 𝑜𝑛  𝐺𝐴𝐵𝐴  
𝛼𝐾𝑜𝑓𝑓
 
  (Appendix I, eq. 21) (16) 
  however, it is also true that 
  𝑝(𝒞1)  =
𝑚𝑒𝑎𝑛  𝑢𝑛𝑏𝑜𝑢𝑛𝑑  𝑡𝑖𝑚𝑒
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑢𝑛𝑏𝑜𝑢𝑛𝑑 −𝑏𝑜𝑢𝑛𝑑  𝑐𝑦𝑐𝑙𝑒
 
    =
 𝑚𝑒𝑎𝑛  𝑢𝑛𝑏𝑜𝑢𝑛𝑑  𝑡𝑖𝑚𝑒  
 𝑚𝑒𝑎𝑛  𝑢𝑛𝑏𝑜𝑢𝑛𝑑  𝑡𝑖𝑚𝑒   +  𝑚𝑒𝑎𝑛  𝑏𝑜𝑢𝑛𝑑  𝑡𝑖𝑚𝑒  
 (17) 
  since there is a single unbound state, 
  mean unbound time = mean dwell time in 𝒞1 =
1
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
 (18) 
  substituting (18) into (17) 
  𝑝(𝒞1)  =
 
1
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 
 
1
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
  +(𝑀𝐵𝑇)
=  
1
1+ (𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 )(𝑀𝐵𝑇)
 (19) 
  setting (16) equal to (19) 
  
1
1+ (𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 )(𝑀𝐵𝑇)
=
1
1 + 
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝐾𝑜𝑓𝑓
 + 
𝛽𝐾 𝑜𝑛  𝐺𝐴𝐵𝐴  
𝛼𝐾𝑜𝑓𝑓
 
 
  𝑀𝐵𝑇 =
1
𝐾𝑜𝑓𝑓
  1 +  
𝛽
𝛼
   (20) 
 
  B. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟 
  𝑝(𝒞1)  =
1
1+ 
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝐾𝑜𝑓𝑓
 + 
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝛼𝐾 𝑜𝑓𝑓
 + 
𝛽𝛿 𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝛼𝜌𝐾 𝑜𝑓𝑓
  (Appendix I, eq. 47) (21) 
  however, it is also true that 
  𝑝(𝒞1)  =
𝑚𝑒𝑎𝑛  𝑢𝑛𝑏𝑜𝑢𝑛𝑑  𝑡𝑖𝑚𝑒
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑢𝑛𝑏𝑜𝑢𝑛𝑑 −𝑏𝑜𝑢𝑛𝑑  𝑐𝑦𝑐𝑙𝑒
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    =
 𝑚𝑒𝑎𝑛  𝑢𝑛𝑏𝑜𝑢𝑛𝑑  𝑡𝑖𝑚𝑒  
 𝑚𝑒𝑎𝑛  𝑢𝑛𝑏𝑜𝑢𝑛𝑑  𝑡𝑖𝑚𝑒   +  𝑚𝑒𝑎𝑛  𝑏𝑜𝑢𝑛𝑑  𝑡𝑖𝑚𝑒  
 (22) 
  since there is a single unbound state, 
  mean unbound time = mean dwell time in 𝒞1 =
1
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
 (23) 
  substituting (23) into (22) 
  𝑝(𝒞1)  =
 
1
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 
 
1
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
  +(𝑀𝐵𝑇)
=  
1
1+ (𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 )(𝑀𝐵𝑇)
 (24) 
  setting (21) equal to (24) 
  
1
1+ (𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 )(𝑀𝐵𝑇)
=
1
1+ 
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝐾𝑜𝑓𝑓
 + 
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝛼𝐾 𝑜𝑓𝑓
 + 
𝛽𝛿 𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝛼𝜌𝐾 𝑜𝑓𝑓
 
  𝑀𝐵𝑇 =
1
𝐾𝑜𝑓𝑓
  1 +  
𝛽
𝛼
+  
𝛽𝛿
𝛼𝜌
   (25) 
  
 C. 
   
 
 
  𝑝(𝒞1)  =
1
1+ 
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝐾𝑜𝑓𝑓
 + 
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝛼𝐾 𝑜𝑓𝑓
 + 
𝛿𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝜌𝐾 𝑜𝑓𝑓
  (Appendix I, eq. 80) (26) 
  however, it is also true that 
  𝑝(𝒞1)  =
𝑚𝑒𝑎𝑛  𝑢𝑛𝑏𝑜𝑢𝑛𝑑  𝑡𝑖𝑚𝑒
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑢𝑛𝑏𝑜𝑢𝑛𝑑 −𝑏𝑜𝑢𝑛𝑑  𝑐𝑦𝑐𝑙𝑒
 
    =
 𝑚𝑒𝑎𝑛  𝑢𝑛𝑏𝑜𝑢𝑛𝑑  𝑡𝑖𝑚𝑒  
 𝑚𝑒𝑎𝑛  𝑢𝑛𝑏𝑜𝑢𝑛𝑑  𝑡𝑖𝑚𝑒   +  𝑚𝑒𝑎𝑛  𝑏𝑜𝑢𝑛𝑑  𝑡𝑖𝑚𝑒  
 (27) 
  since there is a single unbound state, 
  mean unbound time = mean dwell time in 𝒞1 =
1
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
 (28) 
  substituting (28) into (27) 
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  𝑝(𝒞1)  =
 
1
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 
 
1
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
  +(𝑀𝐵𝑇)
=  
1
1+ (𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 )(𝑀𝐵𝑇)
 (29) 
  setting (26) equal to (29) 
  
1
1+ (𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 )(𝑀𝐵𝑇)
=
1
1+ 
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝐾𝑜𝑓𝑓
 + 
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝛼𝐾 𝑜𝑓𝑓
 + 
𝛿𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝜌𝐾 𝑜𝑓𝑓
 
  𝑀𝐵𝑇 =
1
𝐾𝑜𝑓𝑓
  1 +  
𝛽
𝛼
+  
𝛿
𝜌
   (30) 
 
D. Shortcut to solving MBT for any non-cyclic Markov model, independent of the 
number of bound states (assuming the presence of a single unbound 𝒞 state) 
  i.  Using the “round trip” formula outlined in Appendix I, Section V, 
solve for 𝑝(𝒞1).   
  ii.  Take the inverse of 𝑝(𝒞1) and subtract 1. 
  iii. Divide this by 𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 . 
 
III.  Opening frequency (𝓕) 
 A.  𝒞 
       𝛼        
       
       𝛽        
        𝒪 
  𝒡 =
𝑛𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑜𝑝𝑒𝑛𝑖𝑛𝑔𝑠
𝑡𝑖𝑚𝑒
 =
1 𝑜𝑝𝑒𝑛𝑖𝑛𝑔
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑜𝑝𝑒𝑛 −𝑐𝑙𝑜𝑠𝑒𝑑  𝑐𝑦𝑐𝑙𝑒
 
   =
1 𝑜𝑝𝑒𝑛𝑖𝑛𝑔
 𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒   + (𝑚𝑒𝑎𝑛  𝑐𝑙𝑜𝑠𝑒𝑑  𝑡𝑖𝑚𝑒 )
  (31) 
  mean open time = mean dwell time in 𝒪 =
1
𝛼
 (32) 
  mean closed time = mean dwell time in 𝒞 =
1
𝛽
 (33) 
  substituting (33) and (32) into (31) 
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  𝒡 =
1
1
𝛼
 + 
1
𝛽  
=
𝛼
1 + 
𝛼
𝛽  
=
𝛽
1 + 
𝛽
𝛼  
 (34) 
  since  𝑝 𝒪 =
1
1 + 
𝛼
𝛽
  (Appendix I, eq. 5) 
  𝒡 = 𝑝 𝒪 ∗ 𝛼  (35) 
  since 𝑝(𝒞) =
1
1 + 
𝛽
𝛼
  (Appendix I, eq. 7) 
  𝒡 = 𝑝(𝒞) ∗ 𝛽  (36) 
 
 B.  𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
  𝒡 =
𝑛𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑜𝑝𝑒𝑛𝑖𝑛𝑔𝑠
𝑡𝑖𝑚𝑒
 =
1 𝑜𝑝𝑒𝑛𝑖𝑛𝑔
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑜𝑝𝑒𝑛 −𝑐𝑙𝑜𝑠𝑒𝑑  𝑐𝑦𝑐𝑙𝑒
 
   =
1 𝑜𝑝𝑒𝑛𝑖𝑛𝑔
 𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒   + (𝑚𝑒𝑎𝑛  𝑐𝑙𝑜𝑠𝑒𝑑  𝑡𝑖𝑚𝑒 )
  (37) 
  mean open time = mean dwell time in 𝒪 =
1
𝛼
 (38) 
  mean closed time =
1
𝛽  
 1 +
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
   (Appendix II, eq. 5) 
  substituting (38) and (5) into (37) 
  𝒡 =
1
1
𝛼
 + 
1
𝛽  
 1+
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 
=
𝛼
1 + 
𝛼
𝛽  
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾 𝑜𝑛  𝐺𝐴𝐵𝐴  
=
𝛽
1+ 
𝛽
𝛼
 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 (39) 
  since  𝑝 𝒪 =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 19) 
  𝒡 = 𝑝 𝒪 ∗ 𝛼  (40) 
  since  𝑝(𝒞2)  =
1
1 + 
𝛽
𝛼
 + 
𝐾𝑜𝑓𝑓
 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 23) 
  𝒡 = 𝑝(𝒞2) ∗ 𝛽  (41) 
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 C. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟 
  𝒡 =
𝑛𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑜𝑝𝑒𝑛𝑖𝑛𝑔𝑠
𝑡𝑖𝑚𝑒
 =
1 𝑜𝑝𝑒𝑛𝑖𝑛𝑔
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑜𝑝𝑒𝑛 −𝑐𝑙𝑜𝑠𝑒𝑑  𝑐𝑦𝑐𝑙𝑒
 
   =
1 𝑜𝑝𝑒𝑛𝑖𝑛𝑔
 𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒   + (𝑚𝑒𝑎𝑛  𝑐𝑙𝑜𝑠𝑒𝑑  𝑡𝑖𝑚𝑒 )
  (42) 
  mean open time = mean dwell time in 𝒪 =
1
𝛼  + 𝛿
 (43) 
  mean closed time =
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝛼+𝛿
  (Appendix II, eq. 10) 
  substituting (43) and (10) into (42) 
  𝒡 =
1
 
1
𝛼  + 𝛿
  + 
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
𝛼+𝛿
 
=
𝛼  + 𝛿
1 + 
𝛼
𝛽  
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾 𝑜𝑛  𝐺𝐴𝐵𝐴  
 (44) 
  since  𝑝 𝒪 =
1
1 + 
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 44) 
  𝒡 = 𝑝 𝒪 ∗ (𝛼 + 𝛿)  (45) 
  rearranging (44) 
  𝒡 =
𝛼
1 + 
𝛼
𝛽  
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾 𝑜𝑛  𝐺𝐴𝐵𝐴  
+
𝛿
1 + 
𝛼
𝛽  
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾 𝑜𝑛  𝐺𝐴𝐵𝐴  
 (46) 
   =
𝛽
1 + 
𝛽
𝛼  
 + 
𝛽𝛿
𝛼𝜌
 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
+
𝜌
1 + 
𝛼𝜌
𝛽𝛿  
 + 
𝜌
𝛿
 + 
𝛼𝜌𝐾 𝑜𝑓𝑓
𝛽𝛿𝐾 𝑜𝑛  𝐺𝐴𝐵𝐴  
 
  since  𝑝(𝒞2) =
1
1 + 
𝛽
𝛼
 + 
𝛽𝛿
𝛼𝜌
 + 
𝐾𝑜𝑓𝑓
 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 50) 
  and 𝑝(𝒟) =
1
1 + 
𝛼𝜌
𝛽𝛿
 + 
𝜌
𝛿
 + 
𝛼𝜌 𝐾𝑜𝑓𝑓
 𝛽𝛿 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 52) 
  𝒡 = 𝑝 𝒞2 ∗ 𝛽 + 𝑝 𝒟 ∗ 𝜌  (47) 
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 D. 
   
  F = 
𝑛𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑜𝑝𝑒𝑛𝑖𝑛𝑔𝑠
𝑡𝑖𝑚𝑒
=  
1
 𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒  +  𝑚𝑒𝑎𝑛  𝑐𝑙𝑜𝑠𝑒𝑑  𝑡𝑖𝑚𝑒  
 
  𝒡 =
𝑛𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑜𝑝𝑒𝑛𝑖𝑛𝑔𝑠
𝑡𝑖𝑚𝑒
 =
1 𝑜𝑝𝑒𝑛𝑖𝑛𝑔
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑜𝑝𝑒𝑛 −𝑐𝑙𝑜𝑠𝑒𝑑  𝑐𝑦𝑐𝑙𝑒
 
   =
1 𝑜𝑝𝑒𝑛𝑖𝑛𝑔
 𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒   + (𝑚𝑒𝑎𝑛  𝑐𝑙𝑜𝑠𝑒𝑑  𝑡𝑖𝑚𝑒 )
  (48) 
  mean open time = mean dwell time in 𝒪 =
1
𝛼
 (49) 
  mean closed time =
1
𝛽  
 1 +
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
+
𝛿
𝜌
  (Appendix II, eq. 15) 
  substituting (49) and (15) into (48) 
  𝒡 =
1
1
𝛼
 + 
1
𝛽  
 1+
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
+
𝛿
𝜌
 
=
𝛼
1 + 
𝛼
𝛽  
 + 
𝛼𝛿
𝛽𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾 𝑜𝑛  𝐺𝐴𝐵𝐴  
=
𝛽
1 + 
𝛽
𝛼  
 + 
𝛿
𝜌
 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 (50) 
  since  𝑝 𝒪 =
1
1 + 
𝛼
𝛽
 + 
𝛼𝛿
𝛽𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 77) 
  𝒡 = 𝑝 𝒪 ∗ 𝛼  (51) 
  since  𝑝(𝒞2) =
1
1 + 
𝛽
𝛼
 + 
𝛿
𝜌
 + 
𝐾𝑜𝑓𝑓
 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 82) 
  𝒡 = 𝑝 𝒞2 ∗ 𝛽  (52) 
 
 E. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼1           
           
           𝛽1           
              𝒪1
           𝛼2           
           
           𝛽2           
             𝒪2 
  𝒡 =
𝑛𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑜𝑝𝑒𝑛𝑖𝑛𝑔𝑠
𝑡𝑖𝑚𝑒
 =
1 𝑜𝑝𝑒𝑛𝑖𝑛𝑔
𝑚𝑒𝑎𝑛  𝑙𝑒𝑛𝑔𝑡 𝑕  𝑜𝑓  𝑜𝑝𝑒𝑛 −𝑐𝑙𝑜𝑠 𝑒𝑑  𝑐𝑦𝑐𝑙𝑒
 
   =
1 𝑜𝑝𝑒𝑛𝑖𝑛𝑔
 𝑚𝑒𝑎𝑛  𝑜𝑝𝑒𝑛  𝑡𝑖𝑚𝑒   + (𝑚𝑒𝑎𝑛  𝑐𝑙𝑜𝑠𝑒𝑑  𝑡𝑖𝑚𝑒 )
  (53) 
  mean open time =
1
𝛼1
 1 +  
𝛽2
𝛼2
   (by analogy to Appendix II, eq. 5) (54) 
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  mean closed time =
1
𝛽1
 1 +
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴   
  (Appendix II, eq. 5) (55) 
  substituting (54) and (55) into (53) 
  𝒡 =
1
1
𝛼1
 1+ 
𝛽2
𝛼2
  + 
1
𝛽1
 1+
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴    
 
=
𝛼1
1 + 
𝛽2
𝛼2
 + 
𝛼1
𝛽1
 + 
𝛼1𝐾𝑜𝑓𝑓
𝛽1𝐾𝑜𝑛  𝐺𝐴𝐵𝐴   
 (56) 
  since  𝑝 𝒪1 =
1
1 + 
𝛽2
𝛼2
 + 
𝛼1
𝛽1
 + 
𝛼1𝐾𝑜𝑓𝑓
𝛽1𝐾𝑜𝑛  𝐺𝐴𝐵𝐴   
  (Appendix I, Section V) (57) 
  𝒡 = 𝑝 𝒪1 ∗ 𝛼1  (58) 
  since  𝑝(𝒞2) =
1
1 + 
𝛽
𝛼
 + 
𝛿
𝜌
 + 
𝐾𝑜𝑓𝑓
 𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, Section V) (59) 
  𝒡 = 𝑝 𝒞2 ∗ 𝛽1  (60) 
 
 F. Shortcut for solving opening frequency for any non-cyclic Markov model, 
independent of the number of 𝒞 and 𝒪 states 
  i.  Identify every transition between 𝒞 and 𝒪 states. 
 ii.  Determine the equilibrium fractional occupancies (using the 
“round trip” approach described in Appendix I, Section V) of EITHER the 𝒞 or 𝒪 
states involved in those transitions. 
 iii. Multiply each of the equilibrium fractional occupancies by the sum 
of the rate constants that permit transition to the other conductance level. 
 iv. Opening frequency = the sum of those terms. 
 
IV. GABA EC50 
 A. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
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  𝑝(𝒪) =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 19) 
  or alternatively, 
  𝑝(𝒪) =
𝛽
𝛼
1 + 
𝛽
𝛼
 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 (61) 
  let 𝒠 =
𝛽
𝛼
 (classical definition of “efficacy”) (62) 
 let 𝒦𝑎  =
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛
 (classical definition of “affinity”) (63) 
 substituting (62) and (63) into (61) 
 𝑝(𝒪) =
𝒠
1 + 𝒠 + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 (64) 
  𝑝(𝒪)𝑚𝑎𝑥 = lim GABA  → ∞ 𝑝 𝒪 = lim GABA  → ∞  
𝒠
1 + 𝒠 + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 =
𝒠
1 + 𝒠
 (65) 
  EC50 is, by definition, the [GABA] yielding ½  𝑝(𝒪)𝑚𝑎𝑥  
  ½  𝑝(𝒪)𝑚𝑎𝑥  =  
1
2
  
𝒠
1 + 𝒠
 =
𝒠
2 + 2𝒠
 (66) 
  setting (66) equal to (64) 
  
𝒠
2 + 2𝒠
=
𝒠
1 + 𝒠 + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 
  solving for [𝐺𝐴𝐵𝐴] 
  [𝐺𝐴𝐵𝐴]𝐸𝐶50 = 
𝒦𝑎
1 + 𝒠
 (67) 
  (note that the above matches the solution shown in Colquhoun, 1998) 
 
 B. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟 
  𝑝(𝒪) =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
  (Appendix I, eq. 44) 
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  or alternatively, 
  𝑝(𝒪) =
𝛽
𝛼
1 + 
𝛽
𝛼
 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛽𝛿
𝛼𝜌
 (68) 
  let 𝒠 =
𝛽
𝛼
 (classical definition of “efficacy”) (69) 
 let 𝒦𝑎  =
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛
 (classical definition of “affinity”) (70) 
 let ∆ =
𝛿
𝜌
  (Bianchi et al., 2007, definition of 𝒟 state “stability”) (71) 
 substituting (69), (70), and (71) into (68) 
 𝑝(𝒪) =
𝒠
1 + 𝒠 + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 + 𝒠∆
 (72) 
  𝑝(𝒪)𝑚𝑎𝑥 = lim GABA  → ∞ 𝑝 𝒪 = lim GABA  → ∞  
𝒠
1 + 𝒠 + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 + 𝒠∆
  
  𝑝(𝒪)𝑚𝑎𝑥 =
𝒠
1 + 𝒠 + 𝒠∆
 (73) 
  EC50 is, by definition, the [GABA] yielding ½  𝑝(𝒪)𝑚𝑎𝑥  
  ½  𝑝(𝒪)𝑚𝑎𝑥  =  
1
2
  
𝒠
1 + 𝒠 + 𝒠∆
 =
𝒠
2 + 2𝒠 + 2𝒠∆
 (74) 
  setting (74) equal to (72) 
  
𝒠
2 + 2𝒠 + 2𝒠∆
=
𝒠
1 + 𝒠 + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 + 𝒠∆
 
  solving for [𝐺𝐴𝐵𝐴] 
  [𝐺𝐴𝐵𝐴]𝐸𝐶50 = 
𝒦𝑎
1 + 𝒠 + 𝒠∆
 (75) 
 
 C.    
  𝒪(∞) =
1
1 + 
𝛼
𝛽
 + 
𝛼
𝛽
𝛿
𝜌
  
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
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  𝑝(𝒪) =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
  (Appendix I, eq. 77) 
  or alternatively, 
  𝑝(𝒪) =
𝛽
𝛼
1 + 
𝛽
𝛼
 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 (76) 
  let 𝒠 =
𝛽
𝛼
 (classical definition of “efficacy”) (77) 
 let 𝒦𝑎  =
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛
 (classical definition of “affinity”) (78) 
 let ∆ =
𝛿
𝜌
  (Bianchi et al., 2007, definition of 𝒟 state “stability”) (79) 
 substituting (77), (78), and (79) into (76) 
 𝑝(𝒪) =
𝒠
1 + 𝒠 + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 + ∆
 (80) 
  𝑝(𝒪)𝑚𝑎𝑥 = lim GABA  → ∞ 𝑝 𝒪 = lim GABA  → ∞  
𝒠
1 + 𝒠 + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 + ∆
  
  𝑝(𝒪)𝑚𝑎𝑥 =
𝒠
1 + 𝒠 + ∆
 (81) 
  EC50 is, by definition, the [GABA] yielding ½  𝑝(𝒪)𝑚𝑎𝑥  
  ½  𝑝(𝒪)𝑚𝑎𝑥  =  
1
2
  
𝒠
1 + 𝒠 + ∆
 =
𝒠
2 + 2𝒠 + 2∆
 (82) 
  setting (74) equal to (72) 
  
𝒠
2 + 2𝒠 + 2∆
=
𝒠
1 + 𝒠 + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 + ∆
 
  solving for [𝐺𝐴𝐵𝐴] 
  [𝐺𝐴𝐵𝐴]𝐸𝐶50 = 
𝒦𝑎
1 + 𝒠 + ∆
 (83)  
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I. Open probability 
 A. 𝒞 
           𝛼           
          
           𝛽           
           𝒪 
  𝑝(𝒪)𝐶𝒪 =
1
1 + 
𝛼
𝛽
 
  (Appendix I, eq. 5) (1) 
  𝒞 
           𝛼            
          
           𝛽            
           𝒪 
          𝐾−        
          
      𝐾+[𝐵]      
           ℬ  
  𝑝(𝒪)𝐶𝒪ℬ =
1
1 + 
𝛼
𝛽
 +  
𝐾+[𝐵 ]
𝐾−
 
  (Appendix I, Section V) (2) 
  
𝑝(𝒪)𝐶𝒪
 𝑝(𝒪)𝐶𝒪ℬ
=  
1 + 
𝛼
𝛽
 + 
𝐾+[𝐵]
𝐾−
1 + 
𝛼
𝛽
= 1 +
𝐾+[𝐵]
𝐾−
1 + 
𝛼
𝛽
 
 
  
𝑝(𝒪)𝐶𝒪
 𝑝(𝒪)𝐶𝒪ℬ
= 1 +  
1
1 + 
𝛼
𝛽
 
  
𝐾+[𝐵]
𝐾−
  
  
𝑝(𝒪)𝐶𝒪
 𝑝(𝒪)𝐶𝒪ℬ
=  1 +  p(𝒪)𝐶𝒪  
𝐾+[𝐵]
𝐾−
   (3) 
 
 B. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
  𝑝(𝒪)𝐶𝐶𝒪 =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 19) (4) 
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  𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
          𝐾−        
          
      𝐾+ 𝐵      
           ℬ  
  𝑝(𝒪)𝐶𝐶𝒪ℬ =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝐾+[𝐵]
𝐾−
 
  (Appendix I, Section V) (5) 
  
𝑝(𝒪)𝐶𝐶𝒪
 𝑝(𝒪)𝐶𝐶𝒪ℬ
=  
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝐾+[𝐵]
𝐾−
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
= 1 +
𝐾+[𝐵]
𝐾−
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 
  
𝑝(𝒪)𝐶𝐶𝒪
 𝑝(𝒪)𝐶𝐶𝒪ℬ
= 1 +  
1
1+ 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  
𝐾+[𝐵]
𝐾−
  
  
𝑝(𝒪)𝐶𝐶𝒪
 𝑝(𝒪)𝐶𝐶𝒪ℬ
=  1 +  p(𝒪)𝐶𝐶𝒪  
𝐾+[𝐵]
𝐾−
   (6) 
 
 C. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟  
  𝑝(𝒪)𝐶𝐶𝒪𝒟 =
1
1 + 
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 44) (7) 
    
  𝑝(𝒪)𝐶𝐶𝒪𝒟ℬ =
1
1 + 
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝐾+[𝐵]
𝐾−
 
  (Appendix I, Section V) (8) 
  
𝑝(𝒪)𝐶𝐶𝒪𝒟
 𝑝(𝒪)𝐶𝐶𝒪𝒟ℬ
=  
1 + 
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝐾+[𝐵 ]
𝐾−
1 + 
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
= 1 +
𝐾+[𝐵]
𝐾−
1 + 
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 
  
𝑝(𝒪)𝐶𝐶𝒪𝒟
 𝑝(𝒪)𝐶𝐶𝒪𝒟ℬ
= 1 +  
1
1 + 
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  
𝐾+[𝐵]
𝐾−
  
  
𝑝(𝒪)𝐶𝐶𝒪𝒟
 𝑝(𝒪)𝐶𝐶𝒪𝒟ℬ
=  1 +  p(𝒪)𝐶𝐶𝒪𝒟  
𝐾+[𝐵]
𝐾−
   (9) 
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 D.  
    
  
 
 
  𝑝(𝒪)𝐶𝐶𝒟𝒪 =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴   
 + 
𝛼𝛿
𝛽𝜌
 
  (Appendix I, eq. 77) (10) 
    
  𝑝(𝒪)𝐶𝐶𝒟𝒪ℬ =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴   
 + 
𝛼𝛿
𝛽𝜌
 + 
𝐾+[𝐵]
𝐾−
 
  (Appendix I, Section V) (11) 
  
𝑝(𝒪)𝐶𝐶𝒟𝒪
 𝑝(𝒪)𝐶𝐶𝒟𝒪ℬ
=  
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴   
 + 
𝛼𝛿
𝛽𝜌
 + 
𝐾+[𝐵]
𝐾−
 
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴   
 + 
𝛼𝛿
𝛽𝜌
= 1 +
𝐾+[𝐵]
𝐾−
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴   
 + 
𝛼𝛿
𝛽𝜌
 
  
𝑝(𝒪)𝐶𝐶𝒟𝒪
 𝑝(𝒪)𝐶𝐶𝒟𝒪ℬ
= 1 +  
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴   
 + 
𝛼𝛿
𝛽𝜌
  
𝐾+[𝐵]
𝐾−
  
  
𝑝(𝒪)𝐶𝐶𝒟𝒪
 𝑝(𝒪)𝐶𝐶𝒟𝒪ℬ
=  1 +  p(𝒪)𝐶𝐶𝒟𝒪  
𝐾+[𝐵]
𝐾−
   (12) 
 
II. Mean closed time (MCT) 
 A. 𝒞 
           𝛼           
          
           𝛽           
           𝒪 
  since there is only 1 closed state, 
  𝑀𝐶𝑇𝒞𝒪 = mean dwell time in 𝒞 =
1
𝛽
  (13) 
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  𝒞 
           𝛼            
          
           𝛽            
           𝒪 
          𝐾−        
          
      𝐾+[𝐵]      
           ℬ 
  𝑀𝐶𝑇𝒞𝒪ℬ =
𝛼
𝛽
 + 
 𝐾+[𝐵]
𝐾−
𝛼  +  𝐾+[𝐵]   
 (Appendix II, Section I.D) (14) 
  
𝑀𝐶𝑇𝒞𝒪ℬ
𝑀𝐶𝑇𝒞𝒪
=
𝛼  + 
 𝛽𝐾 +[𝐵]
𝐾−
𝛼  +  𝐾+[𝐵]   
 (15) 
  thus, 
  
𝑀𝐶𝑇𝒞𝒪ℬ
𝑀𝐶𝑇𝒞𝒪
> 1 if 
𝛽
𝐾−
> 1  
  or alternatively, 
  
𝑀𝐶𝑇𝒞𝒪ℬ
𝑀𝐶𝑇𝒞𝒪
> 1 if 
1
𝐾−
>
1
𝛽
 (16) 
  (i.e., if mean dwell time in ℬ > mean dwell time in 𝒞)  
 
 B. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
  𝑀𝐶𝑇𝒞𝒞𝒪 =
1
𝛽  
 1 +
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
   (Appendix II, eq. 5) (17) 
  𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
          𝐾−        
          
      𝐾+ 𝐵      
           ℬ 
  𝑀𝐶𝑇𝒞𝒞𝒪ℬ =
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
 𝐾+[𝐵]
𝐾−
𝛼  +  𝐾+[𝐵]   
 (Appendix II, Section I.D) (18) 
  
𝑀𝐶𝑇𝒞𝒞𝒪ℬ
𝑀𝐶𝑇𝒞𝒞𝒪
=
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
 𝐾+ 𝐵 
𝐾−
𝛼  +  𝐾+ 𝐵    
1
𝛽  
 1+
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 
=
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
 𝐾+ 𝐵 
𝐾−
 
𝛼
𝛽  
 + 
 𝐾+ 𝐵 
𝛽
   1 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 
 
  
𝑀𝐶𝑇𝒞𝒞𝒪ℬ
𝑀𝐶𝑇𝒞𝒞𝒪
=
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
 𝐾+ 𝐵 
𝐾−
𝛼
𝛽  
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾 𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
 𝐾+ 𝐵 
𝛽
 + 
𝐾𝑜𝑓𝑓  𝐾+ 𝐵 
𝛽𝐾 𝑜𝑛  𝐺𝐴𝐵𝐴  
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𝑀𝐶𝑇𝒞𝒞𝒪ℬ
𝑀𝐶𝑇𝒞𝒞𝒪
=
𝛼
 𝐾+ 𝐵 
 + 
𝛼𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  𝐾+ 𝐵 
 + 
𝛽
𝐾−
𝛼
 𝐾+ 𝐵  
 + 
𝛼𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  𝐾+ 𝐵 
 + 1 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 (19) 
  thus, 
  
𝑀𝐶𝑇𝒞𝒞𝒪ℬ
𝑀𝐶𝑇𝒞𝒞𝒪
> 1  if  
𝛽
𝐾−
>  1 +  
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
  
  or alternatively, 
  
𝑀𝐶𝑇𝒞𝒞𝒪ℬ
𝑀𝐶𝑇𝒞𝒞𝒪
> 1  if  
1
𝐾−
>
1
𝛽
 1 +  
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
  (20) 
  (i.e., if mean dwell time in ℬ > 𝑀𝐶𝑇𝒞𝒞𝒪) 
 
 C. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟 
  𝑀𝐶𝑇𝒞𝒞𝒪𝒟 =
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
𝛼  + 𝛿
  (Appendix II, eq. 10) (21) 
   
  𝑀𝐶𝑇𝒞𝒞𝒪𝒟ℬ =
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 + 
 𝐾+[𝐵]
𝐾−
𝛼  + 𝛿  +   𝐾+[𝐵]   
 (Appendix II, Section I.D) (22) 
  
𝑀𝐶𝑇𝒞𝒞𝒪𝒟ℬ
𝑀𝐶𝑇𝒞𝒞𝒪𝒟
=
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 + 
 𝐾+[𝐵]
𝐾−
𝛼  + 𝛿  +   𝐾+[𝐵]   
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
𝛼  + 𝛿
=
 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 + 
 𝐾+[𝐵]
𝐾−
  𝛼  + 𝛿 
 𝛼  + 𝛿  +   𝐾+[𝐵]   
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 
 
  
𝑀𝐶𝑇𝒞𝒞𝒪𝒟ℬ
𝑀𝐶𝑇𝒞𝒞𝒪𝒟
=
𝛼2
𝛽
 + 
𝛼2𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝜌
 + 
𝛼𝛿
𝛽
 + 
𝛼𝛿𝐾 𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿2
𝜌
 + 
 𝛼𝐾+[𝐵]
𝐾−
 + 
 𝛿𝐾+[𝐵]
𝐾−
𝛼2
𝛽
+
𝛼2𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
+
𝛼𝛿
𝜌
+
𝛼𝛿
𝛽
+
𝛼𝛿𝐾 𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
+
𝛿2
𝜌
+
𝛼𝐾+[𝐵]
𝛽
+
𝛼𝐾𝑜𝑓𝑓 𝐾+[𝐵]
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
+
𝛿𝐾+[𝐵]
𝜌
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  let X = 
𝛼2
𝛽
 +  
𝛼2𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 +  
𝛼𝛿
𝜌
 + 
𝛼𝛿
𝛽
 +  
𝛼𝛿𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴]
 +  
𝛿2
𝜌
 
  
𝑀𝐶𝑇𝒞𝒞𝒪𝒟ℬ
𝑀𝐶𝑇𝒞𝒞𝒪𝒟
=
𝑋  + 
 𝛼𝐾+[𝐵]
𝐾−
 + 
 𝛿𝐾+[𝐵]
𝐾−
𝑋 + 
𝛼𝐾+[𝐵]
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓 𝐾+[𝐵]
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿𝐾+[𝐵]
𝜌
 
=
𝑋
𝐾+[𝐵]
 + 
𝛼
𝐾−
 + 
𝛿
𝐾−
𝑋
𝐾+[𝐵 ]
 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 
 
  
𝑀𝐶𝑇𝒞𝒞𝒪𝒟ℬ
𝑀𝐶𝑇𝒞𝒞𝒪𝒟
=
𝑋
𝐾+[𝐵]
 + 
𝛼
𝐾−
 + 
𝛿
𝐾−
𝑋
𝐾+[𝐵]
 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 
 (23) 
  thus, 
  
𝑀𝐶𝑇𝒞𝒞𝒪𝒟ℬ
𝑀𝐶𝑇𝒞𝒞𝒪𝒟
> 1  if   
𝛼  +𝛿  
𝐾−
 >  
𝛼
𝛽
 +  
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴]
 +  
𝛿
𝜌
  
  or alternatively, 
 
  
𝑀𝐶𝑇𝒞𝒞𝒪𝒟ℬ
𝑀𝐶𝑇𝒞𝒞𝒪𝒟
> 1  if  
1
𝐾−
>
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
𝛼  +𝛿  
 (24) 
  (i.e., if mean dwell time in ℬ > 𝑀𝐶𝑇𝒞𝒞𝒪𝒟) 
 
 D.  
   
 
 
  𝑀𝐶𝑇𝒞𝒞𝒟𝒪 =
1
𝛽  
 1 +
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
+
𝛿
𝜌
   (Appendix II, eq. 15) (25) 
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  𝑀𝐶𝑇𝒞𝒞𝒟𝒪ℬ =
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
 + 
 𝐾+[𝐵]
𝐾−
𝛼  +   𝐾+[𝐵]   
 (Appendix II, Section I.D) (26) 
  
𝑀𝐶𝑇𝒞𝒞𝒟𝒪ℬ
𝑀𝐶𝑇𝒞𝒞𝒟𝒪
=
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
 + 
 𝐾+[𝐵]
𝐾−
𝛼  +   𝐾+[𝐵]   
1
𝛽  
 1 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿
𝜌
 
=
𝛼  + 
𝛼𝐾𝑜𝑓𝑓
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝜌
 + 
 𝛽𝐾 +[𝐵]
𝐾−
 𝛼  +   𝐾+[𝐵]   1 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿
𝜌
 
 
  
𝑀𝐶𝑇𝒞𝒞𝒟𝒪ℬ
𝑀𝐶𝑇𝒞𝒞𝒟𝒪
=
𝛼  + 
𝛼𝐾𝑜𝑓𝑓
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝜌
 + 
 𝛽𝐾 +[𝐵]
𝐾−
𝛼  + 
𝛼𝐾𝑜𝑓𝑓
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝜌
 + 𝐾+ 𝐵  + 
𝐾𝑜𝑓𝑓 𝐾+ 𝐵 
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿𝐾+ 𝐵 
𝜌
 
  let X = 𝛼 +  
𝛼𝐾𝑜𝑓𝑓
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴]
 + 
𝛼𝛿
𝜌
 
  
𝑀𝐶𝑇𝒞𝒞𝒟𝒪ℬ
𝑀𝐶𝑇𝒞𝒞𝒟𝒪
=
𝑋  + 
 𝛽𝐾 +[𝐵]
𝐾−
𝑋 + 𝐾+ 𝐵  + 
𝐾𝑜𝑓𝑓 𝐾+ 𝐵 
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿𝐾+ 𝐵 
𝜌
 
  
𝑀𝐶𝑇𝒞𝒞𝒟𝒪ℬ
𝑀𝐶𝑇𝒞𝒞𝒟𝒪
=
𝑋
𝐾+ 𝐵 
 + 
𝛽
𝐾−
𝑋
𝐾+ 𝐵 
 + 1 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿
𝜌
 (27) 
  thus, 
  
𝑀𝐶𝑇𝒞𝒞𝒟𝒪ℬ
𝑀𝐶𝑇𝒞𝒞𝒟𝒪
> 1  if  
𝛽
𝐾−
>  1 +  
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
 +  
𝛿
𝜌
  
  or alternatively, 
  
𝑀𝐶𝑇𝒞𝒞𝒟𝒪ℬ
𝑀𝐶𝑇𝒞𝒞𝒟𝒪
> 1  if  
1
𝐾−
>
1
𝛽
 1 +  
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
 + 
𝛿
𝜌
  (28) 
  (i.e., if mean dwell time in ℬ > 𝑀𝐶𝑇𝒞𝒞𝒟𝒪) 
 
III. Mean bound time (MBT) 
 A. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
  𝑀𝐵𝑇𝐶𝐶𝒪 =
1
𝐾𝑜𝑓𝑓
 1 +
𝛽
𝛼
   (Appendix II, eq. 20) (29) 
  𝒞1
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
          𝐾−        
          
      𝐾+ 𝐵      
           ℬ 
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  𝑀𝐵𝑇𝐶𝐶𝒪𝐵 =
1
𝐾𝑜𝑓𝑓
 1 +
𝛽
𝛼
+
𝛽𝐾+[𝐵]
𝛼𝐾−
   (Appendix II, Section II.D) (30) 
  
𝑀𝐵𝑇𝐶𝐶𝒪𝐵
𝑀𝐵𝑇𝐶𝐶𝒪 
=
1
𝐾𝑜𝑓𝑓
 1 + 
𝛽
𝛼
 + 
𝛽𝐾 +[𝐵]
𝛼𝐾−
 
1
𝐾𝑜𝑓𝑓
 1 + 
𝛽
𝛼
 
=
1 + 
𝛽
𝛼
 + 
𝛽𝐾 +[𝐵]
𝛼𝐾−
1 + 
𝛽
𝛼
= 1 +
𝐾+[𝐵]
𝐾−
1 + 
𝛼
𝛽
 (31) 
  since 𝑝(𝒪)𝒞𝒞𝒪 =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix  I, eq. 19) 
  and 𝑝(𝒪)𝒞𝒞𝒪𝑚𝑎𝑥 = lim GABA  → ∞ 𝑝(𝒪)𝒞𝒞𝒪 =
1
1 + 
𝛼
𝛽
 
 
  
𝑀𝐵𝑇𝐶𝐶𝒪𝐵
𝑀𝐵𝑇𝐶𝐶𝒪 
= 1 +  𝑝(𝒪)𝒞𝒞𝒪𝑚𝑎𝑥   
𝐾+[𝐵]
𝐾−
  (32) 
 
 B. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟 
  𝑀𝐵𝑇𝐶𝐶𝒪𝒟 =
1
𝐾𝑜𝑓𝑓
 1 +
𝛽
𝛼
+
𝛽𝛿
𝛼𝜌
   (Appendix II, eq. 25) (33) 
   
  𝑀𝐵𝑇𝐶𝐶𝒪𝒟𝐵 =
1
𝐾𝑜𝑓𝑓
 1 +
𝛽
𝛼
+
𝛽𝛿
𝛼𝜌
+
𝛽𝐾+[𝐵]
𝛼𝐾−
  (Appendix II, Section II.D) (34) 
  
𝑀𝐵𝑇𝐶𝐶𝒪𝒟𝐵
𝑀𝐵𝑇𝐶𝐶𝒪𝒟 
=
1
𝐾𝑜𝑓𝑓
 1 + 
𝛽
𝛼
 + 
𝛽𝛿
𝛼𝜌
 + 
𝛽𝐾 +[𝐵]
𝛼𝐾−
 
1
𝐾𝑜𝑓𝑓
 1 + 
𝛽
𝛼
 + 
𝛽𝛿
𝛼𝜌
 
=
1 + 
𝛽
𝛼
 + 
𝛽𝛿
𝛼𝜌
 + 
𝛽𝐾 +[𝐵]
𝛼𝐾−
1 + 
𝛽
𝛼
 + 
𝛽𝛿
𝛼𝜌
= 1 +
𝐾+[𝐵]
𝐾−
1 + 
𝛼
𝛽
 + 
𝛿
𝜌
 (35) 
  since 𝑝(𝒪)𝒞𝒞𝒪𝒟 =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
  (Appendix  I, eq. 44) 
  and 𝑝(𝒪)𝒞𝒞𝒪𝒟𝑚𝑎𝑥 = lim GABA  → ∞ 𝑝(𝒪)𝒞𝒞𝒪𝒟 =
1
1 + 
𝛼
𝛽
 + 
𝛿
𝜌
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𝑀𝐵𝑇𝐶𝐶𝒪𝒟𝐵
𝑀𝐵𝑇𝐶𝐶𝒪𝒟 
= 1 +  𝑝(𝒪)𝒞𝒞𝒪𝒟𝑚𝑎𝑥   
𝐾+[𝐵]
𝐾−
  (36) 
 
 C.  
 
 
 
  𝑀𝐵𝑇𝐶𝐶𝒟𝒪 =
1
𝐾𝑜𝑓𝑓
 1 +
𝛽
𝛼
+
𝛿
𝜌
   (Appendix II, eq. 30) (37) 
   
  𝑀𝐵𝑇𝐶𝐶𝒟𝒪𝐵 =
1
𝐾𝑜𝑓𝑓
 1 +
𝛽
𝛼
+
𝛿
𝜌
+
𝛽𝐾+[𝐵]
𝛼𝐾−
   (Appendix II, Section II.D) (38) 
  
𝑀𝐵𝑇𝐶𝐶𝒟𝒪𝐵
𝑀𝐵𝑇𝐶𝐶𝒟𝒪 
=
1
𝐾𝑜𝑓𝑓
 1 + 
𝛽
𝛼
 + 
𝛿
𝜌
 + 
𝛽𝐾 +[𝐵]
𝛼𝐾−
 
1
𝐾𝑜𝑓𝑓
 1 + 
𝛽
𝛼
 + 
𝛿
𝜌
 
=
1 + 
𝛽
𝛼
 + 
𝛿
𝜌
 + 
𝛽𝐾 +[𝐵]
𝛼𝐾−
1 + 
𝛽
𝛼
 + 
𝛿
𝜌
= 1 +
𝐾+[𝐵]
𝐾−
1 + 
𝛼
𝛽
 + 
𝛼𝛿
𝛽𝜌
 (39) 
  since 𝑝(𝒪)𝒞𝒞𝒟𝒪 =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
  (Appendix  I, eq. 77) 
  and 𝑝(𝒪)𝒞𝒞𝒟𝒪𝑚𝑎𝑥 = lim GABA  → ∞ 𝑝(𝒪)𝒞𝒞𝒟𝒪 =
1
1 + 
𝛼
𝛽
 + 
𝛼𝛿
𝛽𝜌
 
 
  
𝑀𝐵𝑇𝐶𝐶𝒟𝒪𝐵
𝑀𝐵𝑇𝐶𝐶𝒟𝒪 
= 1 +  𝑝(𝒪)𝒞𝒞𝒟𝒪𝑚𝑎𝑥   
𝐾+[𝐵]
𝐾−
  (40) 
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IV. Opening frequency (𝓕) 
 A. 𝒞 
           𝛼           
          
           𝛽           
           𝒪 
  𝒡𝒞𝒪 = 𝑝 𝒪 𝒞𝒪 ∗ 𝛼  (Appendix II, eq. 35) (41) 
  𝑝 𝒪 𝒞𝒪 =
1
1 + 
𝛼
𝛽
  (Appendix I, eq. 5) (42) 
  substituting (42) into (41) 
  𝒡𝒞𝒪 =
𝛼
1 + 
𝛼
𝛽
  (43) 
  𝒞 
           𝛼            
          
           𝛽            
           𝒪 
          𝐾−        
          
      𝐾+[𝐵]      
           ℬ 
  𝒡𝒞𝒪ℬ = 𝑝 𝒪 𝒞𝒪ℬ ∗ (𝛼 +  𝐾+ 𝐵 )  (Appendix II, Section III.F) (44) 
  𝑝 𝒪 𝒞𝒪ℬ =
1
1 + 
𝛼
𝛽
 + 
 𝐾+[𝐵]
𝐾−
  (Appendix I, Section V) (45) 
  substituting (45) into (44) 
  𝒡𝒞𝒪ℬ =
𝛼  + 𝐾+ 𝐵 
1 + 
𝛼
𝛽
 + 
 𝐾+[𝐵]
𝐾−
 (46) 
  
𝒡𝒞𝒪ℬ
𝒡𝒞𝒪
=
𝛼  + 𝐾+ 𝐵 
1 + 
𝛼
𝛽
 + 
 𝐾+[𝐵]
𝐾−
𝛼
1 + 
𝛼
𝛽
=
 𝛼  + 𝐾+ 𝐵   1 + 
𝛼
𝛽
 
𝛼 1 + 
𝛼
𝛽
 + 
 𝐾+[𝐵]
𝐾−
 
=
𝛼  + 𝐾+ 𝐵  + 
𝛼2
𝛽
 + 
 𝛼𝐾 +[𝐵]
𝛽
𝛼  + 
𝛼2
𝛽
 + 
 𝛼𝐾 +[𝐵]
𝐾−
 
  
𝒡𝒞𝒪ℬ
𝒡𝒞𝒪
=
1 +
 𝐾+ 𝐵 
𝛼
 + 
𝛼
𝛽
 + 
 𝐾+[𝐵]
𝛽
1 + 
𝛼
𝛽
 + 
 𝐾+[𝐵]
𝐾−
=
1 + 
𝛼
𝛽
 + 𝐾+ 𝐵  
1
𝛼
 + 
1
𝛽
 
1 + 
𝛼
𝛽
 + 
 𝐾+[𝐵]
𝐾−
 
  thus, 
  
𝒡𝒞𝒪ℬ
𝒡𝒞𝒪
> 1  if  
1
𝐾−
<  
1
𝛼
+
1
𝛽
  
  or alternatively, 
  
𝒡𝒞𝒪ℬ
𝒡𝒞𝒪
> 1  if  𝐾− >
𝛼  
1 + 
𝛼
𝛽
 (47) 
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  (i.e., if the unblocking rate is greater than 𝒡𝒞𝒪) 
 
 B. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
  𝒡𝒞𝒞𝒪 = 𝑝 𝒪 𝒞𝒞𝒪 ∗ 𝛼  (Appendix II, eq. 40) (48) 
  𝑝 𝒪 𝒞𝒞𝒪 =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
  (Appendix I, eq. 19) (49) 
  substituting (49) into (48) 
  𝒡𝒞𝒞𝒪 =
𝛼
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 (50) 
  𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
          𝐾−        
          
      𝐾+ 𝐵      
           ℬ 
  𝒡𝒞𝒞𝒪ℬ = 𝑝 𝒪 𝒞𝒞𝒪ℬ ∗ (𝛼 +  𝐾+ 𝐵 )  (Appendix II, Section III.F) (51) 
  𝑝 𝒪 𝒞𝒞𝒪ℬ =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
 𝐾+[𝐵]
𝐾−
  (Appendix I, Section V) (52) 
  substituting (52) into (51) 
  𝒡𝒞𝒞𝒪ℬ =
𝛼  + 𝐾+ 𝐵 
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
 𝐾+[𝐵]
𝐾−
 (53) 
  
𝒡𝒞𝒞𝒪ℬ
𝒡𝒞𝒞𝒪
=
𝛼  + 𝐾+ 𝐵 
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
 𝐾+ 𝐵 
𝐾−
𝛼
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
=
 𝛼  + 𝐾+ 𝐵   1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 
𝛼 1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
 𝐾+ 𝐵 
𝐾−
 
 
  
𝒡𝒞𝒞𝒪ℬ
𝒡𝒞𝒞𝒪
=
𝛼  + 𝐾+ 𝐵  + 
𝛼2
𝛽
 + 
 𝛼𝐾 +[𝐵]
𝛽
 + 
𝛼2𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛼𝐾𝑜𝑓𝑓 𝐾+ 𝐵 
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
𝛼  + 
𝛼2
𝛽
 + 
𝛼2𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
 𝛼𝐾 +[𝐵]
𝐾−
 
  
𝒡𝒞𝒞𝒪ℬ
𝒡𝒞𝒞𝒪
=
1 +
 𝐾+ 𝐵 
𝛼
 + 
𝛼
𝛽
 + 
 𝐾+[𝐵]
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝐾𝑜𝑓𝑓 𝐾+ 𝐵 
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
 𝐾+[𝐵]
𝐾−
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𝒡𝒞𝒞𝒪ℬ
𝒡𝒞𝒞𝒪
=
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 𝐾+ 𝐵  
1
𝛼
 + 
1
𝛽
 + 
𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
+ 
 𝐾+[𝐵]
𝐾−
 
  thus, 
  
𝒡𝒞𝒞𝒪ℬ
𝒡𝒞𝒞𝒪
> 1  if  
1
𝐾−
<  
1
𝛼
+
1
𝛽
+
𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
  
  or alternatively, 
  
𝒡𝒞𝒞𝒪ℬ
𝒡𝒞𝒞𝒪
> 1  if  𝐾− >
𝛼  
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 (54) 
  (i.e., if the unblocking rate is greater than 𝒡𝒞𝒞𝒪) 
 
 C. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟 
  𝒡𝒞𝒞𝒪𝒟 = 𝑝 𝒪 𝒞𝒞𝒪𝒟 ∗ (𝛼 + 𝛿)  (Appendix II, eq. 45) (55) 
  𝑝 𝒪 𝒞𝒞𝒪𝒟 =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
  (Appendix I, eq. 44) (56) 
  substituting (56) into (55) 
  𝒡𝒞𝒞𝒪𝒟 =
𝛼  + 𝛿
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 (57) 
   
  𝒡𝒞𝒞𝒪𝒟ℬ = 𝑝 𝒪 𝒞𝒞𝒪𝒟ℬ ∗ (𝛼 + 𝛿 + 𝐾+ 𝐵 ) (Appendix II, Section III.F) (58) 
  𝑝 𝒪 𝒞𝒞𝒪𝒟ℬ =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 + 
 𝐾+[𝐵]
𝐾−
  (Appendix I, Section V) (59) 
  substituting (59) into (58) 
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  𝒡𝒞𝒞𝒪𝒟ℬ =
𝛼  + 𝛿  + 𝐾+ 𝐵 
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 + 
 𝐾+[𝐵 ]
𝐾−
 (60) 
  
𝒡𝒞𝒞𝒪𝒟ℬ
𝒡𝒞𝒞𝒪𝒟
=
𝛼  + 𝛿  + 𝐾+ 𝐵 
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌  + 
 𝐾+[𝐵]
𝐾−
𝛼  + 𝛿
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 
  
𝒡𝒞𝒞𝒪𝒟ℬ
𝒡𝒞𝒞𝒪𝒟
=
 𝛼  + 𝛿  + 𝐾+ 𝐵   1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 
 𝛼  + 𝛿  1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿
𝜌
 + 
 𝐾+[𝐵]
𝐾−
 
 
  
𝒡𝒞𝒞𝒪𝒟ℬ
𝒡𝒞𝒞𝒪𝒟
=
𝛼  + 𝛿  + 𝐾+ 𝐵  + 
𝛼2
𝛽
 + 
𝛼𝛿
𝛽
 + 
 𝛼𝐾 +[𝐵]
𝛽
 + 
𝛼2𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛼𝛿𝐾 𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 +
𝛼𝐾𝑜𝑓𝑓 𝐾+ 𝐵 
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛼𝛿
𝜌
 + 
𝛿2
𝜌
 + 
𝛿𝐾+[𝐵]
𝜌
𝛼  + 
𝛼2
𝛽
 + 
𝛼2𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛼𝛿
𝜌
 + 
 𝛼𝐾 +[𝐵]
𝐾−
 + 𝛿  + 
𝛼𝛿
𝛽
 + 
𝛼𝛿 𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿2
𝜌
 + 
 𝛿𝐾 +[𝐵]
𝐾−
 
  
𝒡𝒞𝒞𝒪𝒟ℬ
𝒡𝒞𝒞𝒪𝒟
=
1 + 
𝛿
𝛼
 + 
𝐾+[𝐵]
𝛼
 + 
𝛼
𝛽
 + 
𝛿
𝛽
 + 
 𝐾+[𝐵]
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿𝐾 𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 +
𝐾𝑜𝑓𝑓 𝐾+ 𝐵 
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿
𝜌
 + 
𝛿2
𝛼𝜌
 + 
𝛿𝐾+[𝐵]
𝛼𝜌
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿
𝜌
 + 
 𝐾+[𝐵]
𝐾−
 + 
𝛿
𝛼
 + 
𝛿
𝛽
 + 
𝛿𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛿2
𝛼𝜌
 + 
 𝛿𝐾 +[𝐵]
𝛼𝐾 −
 
  
𝒡𝒞𝒞𝒪𝒟ℬ
𝒡𝒞𝒞𝒪𝒟
=
1 + 
𝛿
𝛼
 + 
𝛼
𝛽
 + 
𝛿
𝛽
 + 
𝛿
𝜌
 + 
𝛿2
𝛼𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿𝐾 𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 𝐾+ 𝐵  
1
𝛼
 + 
1
𝛽
 + 
𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿
𝛼𝜌
 
1 + 
𝛿
𝛼
 + 
𝛼
𝛽
 + 
𝛿
𝛽
 + 
𝛿
𝜌
 + 
𝛿2
𝛼𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 +  𝐾+ 𝐵  
1
𝐾−
 + 
𝛿
𝛼𝐾 −
 
 
  thus, 
  
𝒡𝒞𝒞𝒪𝒟ℬ
𝒡𝒞𝒞𝒪𝒟
> 1  if  
1
𝐾−
 1 +
𝛿
𝛼
 <  
1
𝛼
 + 
1
𝛽
 +  
𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
 +  
𝛿
𝛼𝜌
  
  or alternatively, 
  
𝒡𝒞𝒞𝒪𝒟ℬ
𝒡𝒞𝒞𝒪𝒟
> 1  if  𝐾− >
1 + 
𝛿
𝛼
 
1
𝛼
 + 
1
𝛽
 + 
𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿
𝛼𝜌
 
  
𝒡𝒞𝒞𝒪𝒟ℬ
𝒡𝒞𝒞𝒪𝒟
> 1  if  𝐾− >
𝛼  + 𝛿  
1 + 
𝛼
𝛽
 + 
𝛼𝐾 𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿
𝜌
 (61) 
  (i.e., if the unblocking rate is greater than 𝒡𝒞𝒞𝒪𝒟) 
 
 D.  
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  𝒡𝒞𝒞𝒟𝒪 = 𝑝 𝒪 𝒞𝒞𝒟𝒪 ∗ (𝛼)  (Appendix II, eq. 51) (62) 
  𝑝 𝒪 𝒞𝒞𝒟𝒪 =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
  (Appendix I, eq. 77) (63) 
  substituting (63) into (62) 
  𝒡𝒞𝒞𝒟𝒪 =
𝛼
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
 (64) 
   
  𝒡𝒞𝒞𝒟𝒪ℬ = 𝑝 𝒪 𝒞𝒞𝒟𝒪ℬ ∗ (𝛼 + 𝐾+ 𝐵 ) (Appendix II, Section III.F) (65) 
  𝑝 𝒪 𝒞𝒞𝒟𝒪ℬ =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
 + 
 𝐾+[𝐵]
𝐾−
  (Appendix I, Section V) (66) 
  substituting (66) into (65) 
  𝒡𝒞𝒞𝒟𝒪ℬ =
𝛼  + 𝐾+ 𝐵 
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
 + 
 𝐾+[𝐵]
𝐾−
 (67) 
  
𝒡𝒞𝒞𝒟𝒪ℬ
𝒡𝒞𝒞𝒟𝒪
=
𝛼  + 𝐾+ 𝐵 
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
 + 
 𝐾+[𝐵]
𝐾−
𝛼
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
 
  
𝒡𝒞𝒞𝒟𝒪ℬ
𝒡𝒞𝒞𝒟𝒪
=
 𝛼  + 𝐾+ 𝐵   1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
 
 𝛼  1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
 + 
 𝐾+[𝐵]
𝐾−
 
 
  
𝒡𝒞𝒞𝒟𝒪ℬ
𝒡𝒞𝒞𝒟𝒪
=
𝛼  + 𝐾+ 𝐵  + 
𝛼2
𝛽
 + 
 𝛼𝐾 +[𝐵]
𝛽
 + 
𝛼2𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 +
𝛼𝐾𝑜𝑓𝑓 𝐾+ 𝐵 
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛼2𝛿
𝛽𝜌
 + 
𝛼𝛿 𝐾+[𝐵]
𝛽𝜌
 𝛼  1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
 + 
 𝐾+[𝐵]
𝐾−
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𝒡𝒞𝒞𝒟𝒪ℬ
𝒡𝒞𝒞𝒟𝒪
=
1 + 
𝐾+[𝐵]
𝛼
 + 
𝛼
𝛽
 + 
 𝐾+[𝐵]
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 +
𝐾𝑜𝑓𝑓 𝐾+ 𝐵 
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛼𝛿
𝛽𝜌
 + 
𝛿𝐾+[𝐵]
𝛽𝜌
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
 + 
 𝐾+[𝐵]
𝐾−
 
  
𝒡𝒞𝒞𝒟𝒪ℬ
𝒡𝒞𝒞𝒟𝒪
=
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛼𝛿
𝛽𝜌
 + 𝐾+ 𝐵  
1
𝛼
 + 
1
𝛽
 + 
𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛿
𝛽𝜌
 
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝛼𝛿
𝛽𝜌
 + 
 𝐾+[𝐵]
𝐾−
 
  thus, 
  
𝒡𝒞𝒞𝒟𝒪ℬ
𝒡𝒞𝒞𝒟𝒪
> 1  if  
1
𝐾−
<  
1
𝛼
 +  
1
𝛽
 +  
𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
 +  
𝛿
𝛽𝜌
  
  or alternatively, 
  
𝒡𝒞𝒞𝒟𝒪ℬ
𝒡𝒞𝒞𝒟𝒪
> 1  if  𝐾− >
𝛼
1 + 
𝛼
𝛽
 + 
𝛼𝐾 𝑜𝑓𝑓
𝛽𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
 + 
𝛼𝛿
𝛽𝜌
 (68) 
  (i.e., if the unblocking rate is greater than 𝒡𝒞𝒞𝒟𝒪) 
   
V. GABA EC50 
 A. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
  let 𝒠 =
𝛽
𝛼
 (classical definition of “efficacy”) (69) 
 let 𝒦𝑎 =
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛
 (classical definition of GABA “affinity”) (70) 
  [𝐺𝐴𝐵𝐴]𝐸𝐶50 = 
𝒦𝑎
1 + 𝒠
  (Appendix II, eq. 67) 
  𝒞1
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
          𝐾−        
          
      𝐾+ 𝐵      
           ℬ 
 let 𝒦𝑏 =
𝐾−
𝐾+
 (classical definition of blocker “affinity”) (71) 
  𝑝 𝒪 𝒞𝒞𝒪ℬ =
1
1 + 
𝛼
𝛽
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
 𝐾+[𝐵]
𝐾−
  (Appendix III, eq. 5) 
  or alternatively, 
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  𝑝 𝒪 𝒞𝒞𝒪ℬ =
𝛽
𝛼
1 + 
𝛽
𝛼
 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
 𝛽𝐾 +[𝐵]
𝛼𝐾−
 (72) 
 substituting (69), (70), and (71) into (72) 
 𝑝 𝒪 𝒞𝒞𝒪ℬ =
𝒠
1 + 𝒠 + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 + 
𝒠[𝐵]
𝒦𝑏
 (73) 
  𝑝 𝒪 𝒞𝒞𝒪ℬ𝑚𝑎𝑥 = lim GABA  → ∞ 𝑝 𝒪 𝒞𝒞𝒪ℬ 
  𝑝 𝒪 𝒞𝒞𝒪ℬ𝑚𝑎𝑥 =
𝒠
1 + 𝒠 + 
𝒠[𝐵]
𝒦𝑏
 (74) 
  EC50 is, by definition, the [GABA] yielding ½ 𝑝 𝒪 𝒞𝒞𝒪ℬ𝑚𝑎𝑥  
   
1
2
  𝑝 𝒪 𝒞𝒞𝒪ℬ𝑚𝑎𝑥   =  
1
2
  
𝒠
1 + 𝒠 + 
𝒠[𝐵]
𝒦𝑏
 =
𝒠
2 + 2𝒠 + 
2𝒠[𝐵]
𝒦𝑏
 (75) 
  setting (75) equal to (74) 
  
𝒠
2 + 2𝒠 + 
2𝒠[𝐵]
𝒦𝑏
=
𝒠
1 + 𝒠 + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]𝐸𝐶50
 + 
𝒠[𝐵]
𝒦𝑏
 
  [𝐺𝐴𝐵𝐴]𝐸𝐶50 = 
𝒦𝑎
1 + 𝒠 + 
𝒠[𝐵 ]
𝒦𝑏
 (76) 
  
𝐸𝐶50𝒞𝒞𝒪
𝐸𝐶50𝒞𝒞𝒪ℬ
=
𝒦𝑎
1 + 𝒠
𝒦𝑎
1 + 𝒠 + 
𝒠[𝐵]
𝒦𝑏
=
1 + 𝒠 + 
𝒠[𝐵]
𝒦𝑏
1 + 𝒠
= 1 +
𝒠[𝐵]
𝒦𝑏
1 + 𝒠
 
  since 𝑝 𝒪 𝒞𝒞𝒪𝑚𝑎𝑥 =
𝒠
1 + 𝒠
  (Appendix II, eq. 65) 
  
𝐸𝐶50𝒞𝒞𝒪
𝐸𝐶50𝒞𝒞𝒪ℬ
= 1 +  𝑝 𝒪 𝒞𝒞𝒪𝑚𝑎𝑥  
[𝐵]
𝒦𝑏
 (77) 
 
 B. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟 
  let 𝒠 =
𝛽
𝛼
 (classical definition of “efficacy”) (78) 
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 let 𝒦𝑎 =
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛
 (classical definition of GABA “affinity”) (79) 
 let ∆ =
𝛿
𝜌
  (Bianchi et al., 2007, definition of 𝒟 state “stability”) (80) 
  [𝐺𝐴𝐵𝐴]𝐸𝐶50 = 
𝒦𝑎
1 + 𝒠 + 𝒠∆
  (Appendix II, eq. 75) 
   
 let 𝒦𝑏 =
𝐾−
𝐾+
 (classical definition of blocker “affinity”) (81) 
  𝑝 𝒪 𝒞𝒞𝒪𝒟ℬ =
1
1 + 
𝛼
𝛽
 + 
𝛿
𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝐾+[𝐵]
𝐾−
 
  (Appendix III, eq. 8) 
  or alternatively, 
  𝑝 𝒪 𝒞𝒞𝒪𝒟ℬ =
𝛽
𝛼
1 + 
𝛽
𝛼
 + 
𝛽𝛿
𝛼𝜌
 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
 𝛽𝐾 +[𝐵]
𝛼𝐾−
 (82) 
 substituting (78), (79), (80), and (81) into (82) 
 𝑝 𝒪 𝒞𝒞𝒪𝒟ℬ =
𝒠
1 + 𝒠 + 𝒠∆ + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 + 
𝒠[𝐵]
𝒦𝑏
 (83) 
  𝑝 𝒪 𝒞𝒞𝒪𝒟ℬ𝑚𝑎𝑥 = lim GABA  → ∞ 𝑝 𝒪 𝒞𝒞𝒪𝒟ℬ 
  𝑝 𝒪 𝒞𝒞𝒪𝒟ℬ𝑚𝑎𝑥 =
𝒠
1 + 𝒠 + 𝒠∆ + 
𝒠[𝐵]
𝒦𝑏
 (84) 
  EC50 is, by definition, the [GABA] yielding ½ 𝑝 𝒪 𝒞𝒞𝒪𝒟ℬ𝑚𝑎𝑥  
   
1
2
  𝑝 𝒪 𝒞𝒞𝒪𝒟ℬ𝑚𝑎𝑥   =  
1
2
  
𝒠
1 + 𝒠 + 𝒠∆ + 
𝒠[𝐵]
𝒦𝑏
 =
𝒠
2 + 2𝒠 + 2𝒠∆ + 
2𝒠[𝐵]
𝒦𝑏
 (85) 
  setting (85) equal to (84) 
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𝒠
2 + 2𝒠 + 2𝒠∆ + 
2𝒠[𝐵]
𝒦𝑏
=
𝒠
1 + 𝒠 + 𝒠∆ + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 + 
𝒠[𝐵]
𝒦𝑏
 
  [𝐺𝐴𝐵𝐴]𝐸𝐶50 = 
𝒦𝑎
1 + 𝒠 + 𝒠∆ + 
𝒠[𝐵]
𝒦𝑏
 (86) 
  
𝐸𝐶50𝒞𝒞𝒪𝒟
𝐸𝐶50𝒞𝒞𝒪𝒟ℬ
=
𝒦𝑎
1 + 𝒠 + 𝒠∆
𝒦𝑎
1 + 𝒠 + 𝒠∆ + 
𝒠[𝐵 ]
𝒦𝑏
=
1 + 𝒠 + 𝒠∆ + 
𝒠[𝐵]
𝒦𝑏
1 + 𝒠 + 𝒠∆
= 1 +
𝒠[𝐵]
𝒦𝑏
1 + 𝒠 + 𝒠∆
 
  since 𝑝 𝒪 𝒞𝒞𝒪𝒟𝑚𝑎𝑥 =
𝒠
1 + 𝒠 + 𝒠∆
  (Appendix II, eq. 73) 
  
𝐸𝐶50𝒞𝒞𝒪𝒟
𝐸𝐶50𝒞𝒞𝒪𝒟ℬ
= 1 +  𝑝 𝒪 𝒞𝒞𝒪𝒟𝑚𝑎𝑥  
[𝐵]
𝒦𝑏
 (87) 
 
 C.  
 
 
 
  let 𝒠 =
𝛽
𝛼
 (classical definition of “efficacy”) (88) 
 let 𝒦𝑎 =
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛
 (classical definition of GABA “affinity”) (89) 
 let ∆ =
𝛿
𝜌
  (Bianchi et al., 2007, definition of 𝒟 state “stability”) (90) 
  [𝐺𝐴𝐵𝐴]𝐸𝐶50 = 
𝒦𝑎
1 + 𝒠 + ∆
  (Appendix II, eq. 83) 
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 let 𝒦𝑏 =
𝐾−
𝐾+
 (classical definition of blocker “affinity”) (91) 
  𝑝 𝒪 𝒞𝒞𝒟𝒪ℬ =
1
1 + 
𝛼
𝛽
 + 
𝛼𝛿
𝛽𝜌
 + 
𝛼𝐾𝑜𝑓𝑓
𝛽𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
𝐾+[𝐵]
𝐾−
 
  (Appendix III, eq. 11) 
  or alternatively, 
  𝑝 𝒪 𝒞𝒞𝒟𝒪ℬ =
𝛽
𝛼
1 + 
𝛽
𝛼
 + 
𝛿
𝜌
 + 
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛 [𝐺𝐴𝐵𝐴 ]
 + 
 𝛽𝐾 +[𝐵]
𝛼𝐾 −
 (92) 
 substituting (88), (89), (90), and (91) into (92) 
 𝑝 𝒪 𝒞𝒞𝒟𝒪ℬ =
𝒠
1 + 𝒠 + ∆ + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 + 
𝒠[𝐵]
𝒦𝑏
 (93) 
  𝑝 𝒪 𝒞𝒞𝒟𝒪ℬ𝑚𝑎𝑥 = lim GABA  → ∞ 𝑝 𝒪 𝒞𝒞𝒟𝒪ℬ 
  𝑝 𝒪 𝒞𝒞𝒟𝒪ℬ𝑚𝑎𝑥 =
𝒠
1 + 𝒠 + ∆ + 
𝒠[𝐵]
𝒦𝑏
 (94) 
  EC50 is, by definition, the [GABA] yielding ½ 𝑝 𝒪 𝒞𝒞𝒟𝒪ℬ𝑚𝑎𝑥  
   
1
2
  𝑝 𝒪 𝒞𝒞𝒟𝒪ℬ𝑚𝑎𝑥   =  
1
2
  
𝒠
1 + 𝒠 + ∆ + 
𝒠[𝐵]
𝒦𝑏
 =
𝒠
2 + 2𝒠 + 2∆ + 
2𝒠[𝐵]
𝒦𝑏
 (95) 
  setting (95) equal to (94) 
  
𝒠
2 + 2𝒠 + 2∆ + 
2𝒠[𝐵]
𝒦𝑏
=
𝒠
1 + 𝒠 + ∆ + 
𝒦𝑎
[𝐺𝐴𝐵𝐴 ]
 + 
𝒠[𝐵]
𝒦𝑏
 
  [𝐺𝐴𝐵𝐴]𝐸𝐶50 = 
𝒦𝑎
1 + 𝒠 + ∆ + 
𝒠[𝐵]
𝒦𝑏
 (96) 
  
𝐸𝐶50𝒞𝒞𝒟𝒪
𝐸𝐶50𝒞𝒞𝒟𝒪ℬ
=
𝒦𝑎
1 + 𝒠 + ∆
𝒦𝑎
1 + 𝒠 + ∆ + 
𝒠[𝐵]
𝒦𝑏
=
1 + 𝒠 + ∆ + 
𝒠[𝐵]
𝒦𝑏
1 + 𝒠 + ∆
= 1 +
𝒠[𝐵]
𝒦𝑏
1 + 𝒠 + ∆
 
  since 𝑝 𝒪 𝒞𝒞𝒟𝒪𝑚𝑎𝑥 =
𝒠
1 + 𝒠 + ∆
  (Appendix II, eq. 81) 
  
𝐸𝐶50𝒞𝒞𝒟𝒪
𝐸𝐶50𝒞𝒞𝒟𝒪ℬ
= 1 +  𝑝 𝒪 𝒞𝒞𝒟𝒪𝑚𝑎𝑥  
[𝐵]
𝒦𝑏
 (97) 
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I. Analytic solution of fractional occupancy as a function of time for states in the 
𝒞 
       𝛼        
       
       𝛽        
        𝒪  reaction scheme, which is represented by the following system of first-
order differential equations: 
  𝒞´ = −𝒞𝛽 + 𝒪𝛼 (1) 
  𝒪´ = 𝒞𝛽 − 𝒪𝛼 (2) 
 At t = 0, all receptors occupy either 𝒞 or 𝒪.  Thus,   
  𝒞∘ + 𝒪∘ = 1  (3) 
 This system can be represented as the matrix equation 
  𝒩´ =  𝒬𝒩, where (4) 
   𝒩´ =  
𝒞´
𝒪´
  (5) 
   𝒬 =  
−𝛽 𝛼
𝛽 −𝛼
  (6) 
   𝒩 =  
𝒞
𝒪
  (7) 
 which has the general solution 
  𝒩 𝑡 = 𝑐𝑣𝑒𝜆𝑡  (8) 
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where 𝑣 and 𝜆 are eigenvectors and eigenvalues of 𝒬, respectively, and 𝑐 
is an integration constant 
 To obtain the eigenvalues, we set 
  𝒬𝑣 = 𝜆𝑣 
  𝒬𝑣 − 𝜆𝐼𝑣 = 0 
  (𝒬 − 𝜆𝐼)𝑣 = 0 
   
−𝛽 − 𝜆 𝛼
𝛽 −𝛼 − 𝜆
 𝑣 = 0 (9) 
This system has a non-trivial solution only when 
 det⁡(𝒬 − 𝜆𝐼) = 0 
  −𝛽 − 𝜆  −𝛼 − 𝜆 −  𝛼  𝛽 = 0 
 𝜆2 +  𝜆 𝛼 + 𝛽 = 0 
 𝜆 𝜆 + 𝛼 + 𝛽 = 0 
Solving for the eigenvalues 
 𝜆1 = 0   (10) 
 𝜆2 = −(𝛼 + 𝛽) (11) 
Substituting (10) and (11) into (9) and solving the homogenous equation 
 𝑣1 =  
1
𝛽 𝛼 
   (12) 
 𝑣2 =  
1
−1
   (13) 
 Substituting (7) and (10 – 13) into (8) 
   
𝒞(𝑡)
𝒪(𝑡)
 =  𝑐1  
1
𝛽 𝛼 
 +  𝑐2  
1
−1
 𝑒−(𝛼+𝛽)𝑡  (14) 
 Solving for the integration constants when 𝒞∘ = 1 and 𝒪∘ = 0 
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  𝑐1 =
𝛼
𝛽+ 𝛼
  (15) 
  𝑐2 =
𝛽
𝛽+ 𝛼
  (16) 
 Substituting (15) and (16) into (14) 
  𝒞(𝑡) =
𝛼
𝛽+ 𝛼
+  
𝛽
𝛽+ 𝛼
 𝑒− 𝛽+ 𝛼 𝑡      (17) 
  𝒪(𝑡) =
𝛽
𝛽+ 𝛼
−  
𝛽
𝛽+ 𝛼
 𝑒− 𝛽+ 𝛼 𝑡    (18) 
 
II. Analytic solution of fractional occupancy as a function of time for states in the 
 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 reaction scheme, which is represented by the following 
system of first-order differential equations: 
  𝒞1′ = −𝒞1𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 + 𝒞2𝐾𝑜𝑓𝑓  (19) 
  𝒞2′ = 𝒞1𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 − 𝒞2 𝐾𝑜𝑓𝑓 + 𝛽 + 𝒪𝛼 (20) 
  𝒪′ = 𝒞2𝛽 − 𝒪𝛼       (21)                                                      (21) 
 At t = 0, all receptors occupy either 𝒞1 or 𝒞2 or 𝒪.  Thus,   
  𝒞1𝑜 + 𝒞2𝑜 + 𝒪𝑜 = 1 (22) 
 This system can be represented as the matrix equation 
  𝒩´ =  𝒬𝒩, where (4) 
   𝒩´ =  
𝒞1′
𝒞2′
𝒪′
  (23) 
   𝒬 =  
−𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝐾𝑜𝑓𝑓 0
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 − 𝐾𝑜𝑓𝑓 +  𝛽  𝛼
0 𝛽 −𝛼
  (24) 
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   𝒩 =  
𝒞1
𝒞2
𝒪
  (25) 
 This system has the general solution 
  𝒩 𝑡 = 𝑐𝑣𝑒𝜆𝑡  (8) 
where 𝑣 and 𝜆 are eigenvectors and eigenvalues of 𝒬, respectively, and 𝑐 
is an integration constant 
 To obtain the eigenvalues, we set 
  𝒬𝑣 = 𝜆𝑣 
  𝒬𝑣 − 𝜆𝐼𝑣 = 0 
  (𝒬 − 𝜆𝐼)𝑣 = 0 
   
−𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 − 𝜆 𝐾𝑜𝑓𝑓 0
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 − 𝐾𝑜𝑓𝑓 + 𝛽  − 𝜆 𝛼
0 𝛽 −𝛼 − 𝜆
 𝑣 = 0         (26) 
This system has a non-trivial solution only when  
          det( 𝒬 − 𝜆𝐼) = 0 
             𝜆3 + 𝜆2 𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 + 𝐾𝑜𝑓𝑓 + 𝛽 + 𝛼 + 𝜆 𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽 + 𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛼 + 𝐾𝑜𝑓𝑓𝛼 = 0 
             𝜆  𝜆2 + 𝜆 𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 + 𝐾𝑜𝑓𝑓 + 𝛽 + 𝛼 +  𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽 + 𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛼 + 𝐾𝑜𝑓𝑓𝛼  = 0 
To simplify, let 
 𝑝 = 𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 + 𝐾𝑜𝑓𝑓 + 𝛽 + 𝛼 (27) 
 𝑞 =  𝑝2 − 4 𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽 + 𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛼 + 𝐾𝑜𝑓𝑓𝛼  
½
 (28) 
Solving the eigenvalues 
 𝜆1 = 0   (29) 
 𝜆2 =
−𝑝  − 𝑞
2
  (30) 
396 
 
 𝜆3 =
−𝑝  + 𝑞
2
  (31) 
Substituting (29 – 31) into (26) and solving the homogenous equation 
  𝑣1 =
 
 
 
  
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
 
1
 
𝛽
𝛼
  
 
 
 
 (32) 
  𝑣2 =
 
 
 
  
− 𝜆2+𝛽+𝛼 
𝛽
 
 
 𝜆2+𝛼 
𝛽
 
1  
 
 
 
 (33) 
  𝑣3 =
 
 
 
  
− 𝜆3+𝛽+𝛼 
𝛽
 
 
 𝜆3+𝛼 
𝛽
 
1  
 
 
 
 (34) 
 Substituting (25) and (29 – 34) into (8) 
   
𝒞1(𝑡)
𝒞2(𝑡)
𝒪(𝑡)
 = 𝑐1
 
 
 
  
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 
 
1
 
𝛽
𝛼
  
 
 
 
+ 𝑐2
 
 
 
  
− 𝜆2+𝛽+𝛼 
𝛽
 
 
 𝜆2+𝛼 
𝛽
 
1  
 
 
 
𝑒𝜆2𝑡 + 𝑐3
 
 
 
  
− 𝜆3+𝛽+𝛼 
𝛽
 
 
 𝜆3+𝛼 
𝛽
 
1  
 
 
 
𝑒𝜆3𝑡  (35) 
 Solving for the integration constants when 𝒞1𝑜 = 1, 𝒞2𝑜 = 0, and 𝒪𝑜 = 0 
  𝑐1 =
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛼
𝜆2𝜆3
  (36) 
  𝑐2 = −
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽
𝜆2𝑞
  (37) 
  𝑐3 =
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽
𝜆3𝑞
 (38) 
 Substituting (36 – 38) into (35) 
  𝒞1(𝑡) =
𝐾𝑜𝑓𝑓 𝛼
𝜆2𝜆3
+
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  𝜆2+𝛽+𝛼 
𝜆2𝑞
𝑒𝜆2𝑡 −
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  𝜆3+𝛽+𝛼 
𝜆3𝑞
𝑒𝜆3𝑡  (39) 
  𝒞2(𝑡) =
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛼
𝜆2𝜆3
−
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  𝜆2+𝛼 
𝜆2𝑞
𝑒𝜆2𝑡 +
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  𝜆3+𝛼 
𝜆3𝑞
𝑒𝜆3𝑡  (40) 
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  𝒪 𝑡 =
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽
𝜆2𝜆3
−
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽
𝜆2𝑞
𝑒𝜆2𝑡 +
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽
𝜆3𝑞
𝑒𝜆3𝑡  (41) 
 
III. Analytic solution of fractional occupancy as a function of time for states in the 
𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟 reaction scheme, which collapses to the 
𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟 reaction scheme as  GABA → ∞.  This is represented by 
the following system of first-order differential equations: 
  𝒞2′ = −𝒞2𝛽 + 𝒪𝛼 (42) 
  𝒪′ = 𝒞2𝛽 − 𝒪 𝛼 + 𝛿 + 𝒟𝜌 (43) 
  𝒟′ = 𝒪𝛿 − 𝒟𝜌       (44)                                                      (21) 
 At t = 0, all receptors occupy either 𝒞2 or 𝒪 or 𝒟.  Thus,   
  𝒞2𝑜 + 𝒪𝑜 + 𝒟𝑜 = 1 (45) 
 This system can be represented as the matrix equation 
  𝒩´ =  𝒬𝒩, where (4) 
   𝒩´ =  
𝒞2′
𝒪′
𝒟′
  (46) 
   𝒬 =  
−𝛽 𝛼 0
𝛽 − 𝛼 +  𝛿  𝜌
0 𝛿 −𝜌
  (47) 
   𝒩 =  
𝒞2
𝒪
𝒟
  (48) 
 This system has the general solution 
  𝒩 𝑡 = 𝑐𝑣𝑒𝜆𝑡  (8) 
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where 𝑣 and 𝜆 are eigenvectors and eigenvalues of 𝒬, respectively, and 𝑐 
is an integration constant 
 To obtain the eigenvalues, we set 
  𝒬𝑣 = 𝜆𝑣 
  𝒬𝑣 − 𝜆𝐼𝑣 = 0 
  (𝒬 − 𝜆𝐼)𝑣 = 0 
   
−𝛽 − 𝜆 𝛼 0
𝛽 − 𝛼 +  𝛿  − 𝜆 𝜌
0 𝛿 −𝜌 − 𝜆
 𝑣 = 0         (49) 
This system has a non-trivial solution only when  
          det( 𝒬 − 𝜆𝐼) = 0 
             𝜆3 + 𝜆2 𝛽 + 𝛼 + 𝛿 + 𝜌 + 𝜆 𝛽𝛿 + 𝛽𝜌 + 𝛼𝜌 = 0 
             𝜆 𝜆2 + 𝜆 𝛽 + 𝛼 + 𝛿 + 𝜌 +  𝛽𝛿 + 𝛽𝜌 + 𝛼𝜌  = 0 
To simplify, let 
 𝑝 = 𝛽 + 𝛼 + 𝛿 + 𝜌 (50) 
 𝑞 =  𝑝2 − 4 𝛽𝛿 + 𝛽𝜌 + 𝛼𝜌  ½ (51) 
Solving the eigenvalues 
 𝜆1 = 0   (52) 
 𝜆2 =
−𝑝  − 𝑞
2
  (53) 
 𝜆3 =
−𝑝  + 𝑞
2
  (54) 
Substituting (52 – 54) into (49) and solving the homogenous equation 
  𝑣1 =
 
 
 
  
𝛼
𝛽
 
1
 
𝛿
𝜌
  
 
 
 
  (55) 
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  𝑣2 =  
 
− 𝜆2+𝛿+𝜌 
𝛿
 
 
 𝜆2+𝜌 
𝛿
 
1
  (56) 
  𝑣3 =  
 
− 𝜆3+𝛿+𝜌 
𝛿
 
 
 𝜆3+𝜌 
𝛿
 
1
  (57) 
 Substituting (48) and (52 – 57) into (8) 
   
𝒞2(𝑡)
𝒪(𝑡)
𝒟(𝑡)
 = 𝑐1
 
 
 
  
𝛼
𝛽
 
1
 
𝛿
𝜌
  
 
 
 
+ 𝑐2  
 
− 𝜆2+𝛿+𝜌 
𝛿
 
 
 𝜆2+𝜌 
𝛿
 
1
 𝑒𝜆2𝑡 + 𝑐3  
 
− 𝜆3+𝛿+𝜌 
𝛿
 
 
 𝜆3+𝜌 
𝛿
 
1
 𝑒𝜆3𝑡  (58) 
 Solving for the integration constants when 𝒞2𝑜 = 1, 𝒪𝑜 = 0, and 𝒟𝑜 = 0 
  𝑐1 =
𝛽𝜌
𝜆2𝜆3
   (59) 
  𝑐2 = −
𝛽𝛿
𝜆2𝑞
   (60) 
  𝑐3 =
𝛽𝛿
𝜆3𝑞
  (61)  
 Substituting (59 – 61) into (58) 
  𝒞2(𝑡) =
𝛼𝜌
𝜆2𝜆3
+
𝛽 𝜆2+𝛿+𝜌 
𝜆2𝑞
𝑒𝜆2𝑡 −
𝛽 𝜆3+𝛿+𝜌 
𝜆3𝑞
𝑒𝜆3𝑡  (62) 
  𝒪(𝑡) =
𝛽𝜌
𝜆2𝜆3
−
𝛽 𝜆2+𝜌 
𝜆2𝑞
𝑒𝜆2𝑡 +
𝛽 𝜆3+𝜌 
𝜆3𝑞
𝑒𝜆3𝑡  (63) 
  𝒟(𝑡) =
𝛽𝛿
𝜆2𝜆3
−
𝛽𝛿
𝜆2𝑞
𝑒𝜆2𝑡 +
𝛽𝛿
𝜆3𝑞
𝑒𝜆3𝑡  (64) 
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IV. Analytic solution of fractional occupancy as a function of time for states in the 
  
reaction scheme, which collapses to the 
 
reaction scheme as  GABA → ∞.  This is represented by the following system of 
first-order differential equations: 
  𝒪′ = −𝒪𝛼 + 𝒞2𝛽 (65) 
  𝒞2′ = 𝒪𝛼 − 𝒞2(𝛽 + 𝛿) + 𝒟𝜌 (66) 
  𝒟′ = 𝒞2𝛿 − 𝒟𝜌       (67)                                                      (21) 
 At t = 0, all receptors occupy either 𝒪 or 𝒞2 or 𝒟.  Thus,   
  𝒪𝑜 + 𝒞2𝑜 + 𝒟𝑜 = 1 (68) 
 This system can be represented as the matrix equation 
  𝒩´ =  𝒬𝒩, where (4) 
   𝒩´ =  
𝒪′
𝒞2′
𝒟′
  (69) 
   𝒬 =  
−𝛼 𝛽 0
𝛼 −(𝛽 + 𝛿) 𝜌
0 𝛿 −𝜌
  (70) 
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   𝒩 =  
𝒪
𝒞2
𝒟
  (71) 
 This system has the general solution 
  𝒩 𝑡 = 𝑐𝑣𝑒𝜆𝑡  (8) 
where 𝑣 and 𝜆 are eigenvectors and eigenvalues of 𝒬, respectively, and 𝑐 
is an integration constant 
 To obtain the eigenvalues, we set 
  𝒬𝑣 = 𝜆𝑣 
  𝒬𝑣 − 𝜆𝐼𝑣 = 0 
  (𝒬 − 𝜆𝐼)𝑣 = 0 
   
−𝛼 − 𝜆 𝛽 0
𝛼 −(𝛽 + 𝛿) − 𝜆 𝜌
0 𝛿 −𝜌 − 𝜆
 𝑣 = 0         (72) 
This system has a non-trivial solution only when  
          det( 𝒬 − 𝜆𝐼) = 0 
             𝜆3 + 𝜆2 𝛽 + 𝛼 + 𝛿 + 𝜌 + 𝜆 𝛼𝛿 + 𝛼𝜌 + 𝛽𝜌 = 0 
             𝜆 𝜆2 + 𝜆 𝛽 + 𝛼 + 𝛿 + 𝜌 +  𝛼𝛿 + 𝛼𝜌 + 𝛽𝜌  = 0 
To simplify, let 
 𝑝 = 𝛽 + 𝛼 + 𝛿 + 𝜌 (73) 
 𝑞 =  𝑝2 − 4 𝛼𝛿 + 𝛼𝜌 + 𝛽𝜌  ½ (74) 
Solving the eigenvalues 
 𝜆1 = 0   (75) 
 𝜆2 =
−𝑝  − 𝑞
2
  (76) 
 𝜆3 =
−𝑝  + 𝑞
2
  (77) 
402 
 
Substituting (75 – 77) into (72) and solving the homogenous equation 
  𝑣1 =
 
 
 
  
𝛽
𝛼
 
1
 
𝛿
𝜌
  
 
 
 
  (78) 
  𝑣2 =  
 
− 𝜆2+𝛿+𝜌 
𝛿
 
 
 𝜆2+𝜌 
𝛿
 
1
  (79) 
  𝑣3 =  
 
− 𝜆3+𝛿+𝜌 
𝛿
 
 
 𝜆3+𝜌 
𝛿
 
1
  (80) 
 Substituting (71) and (75 – 80) into (8) 
   
𝒪(𝑡)
𝒞2(𝑡)
𝒟(𝑡)
 = 𝑐1
 
 
 
  
𝛽
𝛼
 
1
 
𝛿
𝜌
  
 
 
 
+ 𝑐2  
 
− 𝜆2+𝛿+𝜌 
𝛿
 
 
 𝜆2+𝜌 
𝛿
 
1
 𝑒𝜆2𝑡 + 𝑐3  
 
− 𝜆3+𝛿+𝜌 
𝛿
 
 
 𝜆3+𝜌 
𝛿
 
1
 𝑒𝜆3𝑡  (81) 
 Solving for the integration constants when 𝒪𝑜 = 0, 𝒞2𝑜 = 1, and 𝒟𝑜 = 0 
  𝑐1 =
𝛼𝜌
𝜆2𝜆3
   (82) 
  𝑐2 = −
𝛿(𝜆2+𝛼)
𝜆2𝑞
  (83) 
  𝑐3 =
𝛿(𝜆3+𝛼)
𝜆3𝑞
  (84) 
 Substituting (82 – 84) into (81) 
  𝒪(𝑡) =
𝛽𝜌
𝜆2𝜆3
+
 𝜆2+𝛼  𝜆2+𝛿+𝜌 
𝜆2𝑞
𝑒𝜆2𝑡 −
 𝜆3+𝛼  𝜆3+𝛿+𝜌 
𝜆3𝑞
𝑒𝜆3𝑡  (85) 
  𝒞2(𝑡) =
𝛼𝜌
𝜆2𝜆3
−
 𝜆2+𝛼  𝜆2+𝜌 
𝜆2𝑞
𝑒𝜆2𝑡 +
 𝜆3+𝛼  𝜆3+𝜌 
𝜆3𝑞
𝑒𝜆3𝑡  (86) 
  𝒟(𝑡) =
𝛼𝛿
𝜆2𝜆3
−
𝛿 𝜆2+𝛼 
𝜆2𝑞
𝑒𝜆2𝑡 +
𝛿 𝜆3+𝛼 
𝜆3𝑞
𝑒𝜆3𝑡  (87) 
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APPENDIX V 
 
THE MICROSCOPIC KINETIC DETERMINANTS OF 
MACROSCOPIC DESENSITIZATION FOR TWO- AND THREE-STATE 
MARKOV MODELS OF GABAA RECEPTOR FUNCTION 
 
 
 
Emmanuel J. Botzolakis, Matt T. Bianchi, Farid Hekmat, and Robert L. Macdonald 
 
 
 
I. 𝒞 
       𝛼        
       
       𝛽        
        𝒪   
 𝒪(𝑡) =
𝛽
𝛽+ 𝛼
−  
𝛽
𝛽+ 𝛼
 𝑒− 𝛽+ 𝛼 𝑡   (Appendix IV, eq. 18) (1) 
 For macroscopic desensitization to occur, 𝒪(t) must have a local maximum where 
𝒪′ 𝑡 = 0   (2) 
 𝒪′(𝑡) = 𝛽𝑒− 𝛽+ 𝛼 𝑡   (3) 
 Setting (2) equal to (3) 
 0 = 𝛽𝑒− 𝛽+ 𝛼 𝑡   (4) 
Since no solution exists for (4), 𝒪(𝑡) has no local maxima, and consequently, 
cannot undergo macroscopic desensitization. 
 
II. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
 𝒪(𝑡) =
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽
𝜆2𝜆3
−
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽
𝜆2(𝜆3−𝜆2)
𝑒𝜆2𝑡 +
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽
𝜆3(𝜆3−𝜆2)
𝑒𝜆3𝑡   (Appendix IV, eq. 41) (5) 
 For macroscopic desensitization to occur, 𝒪(t) must have a local maximum where 
𝒪′ 𝑡 = 0   (2) 
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 𝒪′(𝑡) = −
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽
(𝜆3−𝜆2)
𝑒𝜆2𝑡 +
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽
(𝜆3−𝜆2)
𝑒𝜆3𝑡  (6) 
 Setting (2) equal to (6) 
 0 = −
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽
(𝜆3−𝜆2)
𝑒𝜆2𝑡 +
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴 𝛽
(𝜆3−𝜆2)
𝑒𝜆3𝑡  
 𝑒𝜆2𝑡 = 𝑒𝜆3𝑡  
 𝜆2 = 𝜆3   (7) 
 However, when 𝜆2 = 𝜆3, the denominator in (1) is zero. 
Thus, 𝒪(𝑡) has no local maxima, and consequently, cannot undergo macroscopic 
desensitization. 
 
III. 𝒞1 
       𝐾𝑜𝑓𝑓       
          
𝐾𝑜𝑛  𝐺𝐴𝐵𝐴  
           𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟, which reduces to the 
 𝒞2 
           𝛼            
          
           𝛽            
           𝒪 
           𝜌            
          
           𝛿             
            𝒟 reaction scheme as  GABA → ∞. 
 𝒪(𝑡) =
𝛽𝜌
𝜆2𝜆3
−
𝛽 𝜆2+𝜌 
𝜆2(𝜆3−𝜆2)
𝑒𝜆2𝑡 +
𝛽 𝜆3+𝜌 
𝜆3(𝜆3−𝜆2)
𝑒𝜆3𝑡   (Appendix IV, eq. 63) (8) 
 For macroscopic desensitization to occur, 𝒪(𝑡) must have a local maximum 
where 𝒪′ 𝑡 = 0  (2) 
 𝒪′(𝑡) = −
𝛽 𝜆2+𝜌 
(𝜆3−𝜆2)
𝑒𝜆2𝑡 +
𝛽 𝜆3+𝜌 
(𝜆3−𝜆2)
𝑒𝜆3𝑡  (9) 
 Setting (2) equal to (9) 
 0 = −
𝛽 𝜆2+𝜌 
(𝜆3−𝜆2)
𝑒𝜆2𝑡 +
𝛽 𝜆3+𝜌 
(𝜆3−𝜆2)
𝑒𝜆3𝑡  
  𝜆2 + 𝜌 𝑒
𝜆2𝑡 =  𝜆3 + 𝜌 𝑒
𝜆3𝑡  
 𝑒(𝜆3−𝜆2)𝑡 =
 𝜆2+𝜌 
 𝜆3+𝜌 
 
 𝑡 =
ln
 𝜆2+𝜌 
 𝜆3+𝜌 
(𝜆3−𝜆2)
   (10) 
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𝜆2 =
−𝑝  − 𝑞
2
  (Appendix IV, eq. 53) (11) 
𝜆3 =
−𝑝  + 𝑞
2
  (Appendix IV, eq. 54) (12) 
𝑝 = 𝛽 + 𝛼 + 𝛿 + 𝜌  (Appendix IV, eq. 50) (13) 
𝑞 =  𝑝2 − 4 𝛽𝛿 + 𝛽𝜌 + 𝛼𝜌  ½  (Appendix IV, eq. 51) (14) 
 Substituting (11 – 14) into (10) 
 𝑡 =
ln 
 
−𝑝−𝑞
2
+𝜌 
 
−𝑝+𝑞
2
+𝜌 
     
 
−𝑝+𝑞
2
  −   
−𝑝−𝑞
2
 
=
ln 
 −𝑝−𝑞+2𝜌 
 −𝑝+𝑞+2𝜌 
     
𝑞
=
ln 
𝛽+𝛼+𝛿−𝜌+𝑞
𝛽+𝛼+𝛿−𝜌−𝑞
 
𝑞
 (15) 
 Let 𝑋 = 𝛽 + 𝛼 + 𝛿 − 𝜌 (16) 
 Substituting (16) into (15) 
 𝑡 =
ln 
𝑋+𝑞
𝑋−𝑞
 
𝑞
   (17) 
 Substituting (13) into (14) and rearranging  
 𝑞 =   𝛽 + 𝛼 + 𝛿 + 𝜌 2 − 4 𝛽𝛿 + 𝛽𝜌 + 𝛼𝜌  ½ =   𝛽 + 𝛼 − 𝛿 − 𝜌 2 + 4𝛼𝛿 ½ 
 Since all rate constants are positive, 𝑞 must also be positive. 
 Thus, there is a positive solution for 𝑡 only when  
𝑋+𝑞
𝑋−𝑞
 > 0 
 Multiplying the numerator and denominator by  𝑋 − 𝑞  
 
 𝑋+𝑞  𝑋−𝑞 
 𝑋−𝑞  𝑋−𝑞 
> 0 
 
𝑋2−𝑞2
 𝑋−𝑞 2
> 0   (18) 
 Since the denominator in (18) must be positive, there is a positive solution for 𝑡 
only when the numerator in (18) is also positive 
 𝑋2 − 𝑞2 > 0   (19) 
 Substituting (14) and (16) into (19) 
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  𝛽 + 𝛼 + 𝛿 − 𝜌 2 −  𝛽 + 𝛼 + 𝛿 + 𝜌 2 –  𝛽𝛿 + 𝛼𝜌 + 𝛽𝜌  > 0 
 −4𝛿𝜌 +  𝛽𝛿 > 0 
 𝛽 > 𝜌    (20) 
 Thus, 𝒪(𝑡) has a local maximum, meaning that it can undergo macroscopic 
desensitization, but only when 𝛽 >  𝜌. 
 
III.  
reaction scheme, which reduces to the 
 
 
reaction scheme as  GABA → ∞.   
 
 
 𝒪(𝑡) =
𝛽𝜌
𝜆2𝜆3
+
 𝜆2+𝛼  𝜆2+𝛿+𝜌 
𝜆2(𝜆3−𝜆2)
𝑒𝜆2𝑡 −
 𝜆3+𝛼  𝜆3+𝛿+𝜌 
𝜆3(𝜆3−𝜆2)
𝑒𝜆3𝑡   (Appendix IV, eq. 85) (21) 
 For macroscopic desensitization to occur, 𝒪(𝑡) must have a local maximum 
where 𝒪′ 𝑡 = 0  (2) 
 𝒪′(𝑡) =
 𝜆2+𝛼  𝜆2+𝛿+𝜌 
(𝜆3−𝜆2)
𝑒𝜆2𝑡 −
 𝜆3+𝛼  𝜆3+𝛿+𝜌 
(𝜆3−𝜆2)
𝑒𝜆3𝑡  (22) 
 Setting (2) equal to (22) 
 0 =
 𝜆2+𝛼  𝜆2+𝛿+𝜌 
(𝜆3−𝜆2)
𝑒𝜆2𝑡 −
 𝜆3+𝛼  𝜆3+𝛿+𝜌 
(𝜆3−𝜆2)
𝑒𝜆3𝑡  
  𝜆2 + 𝛼  𝜆2 + 𝛿 + 𝜌 𝑒
𝜆2𝑡 =  𝜆3 + 𝛼  𝜆3 + 𝛿 + 𝜌 𝑒
𝜆3𝑡  
 𝑒(𝜆3−𝜆2)𝑡 =
 𝜆2+𝛼  𝜆2+𝛿+𝜌 
 𝜆3+𝛼  𝜆3+𝛿+𝜌 
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 𝑡 =
ln 
 𝜆2+𝛼  𝜆2+𝛿+𝜌 
 𝜆3+𝛼  𝜆3+𝛿+𝜌 
 
(𝜆3−𝜆2)
  (23) 
𝜆2 =
−𝑝  − 𝑞
2
  (Appendix IV, eq. 76) (24) 
𝜆3 =
−𝑝  + 𝑞
2
  (Appendix IV, eq. 77) (25) 
𝑝 = 𝛽 + 𝛼 + 𝛿 + 𝜌  (Appendix IV, eq. 73) (26) 
𝑞 =  𝑝2 − 4 𝛼𝛿 + 𝛼𝜌 + 𝛽𝜌  ½  (Appendix IV, eq. 74) (27) 
 Substituting (24 – 27) into (23) 
 𝑡 =
ln 
  
−𝑝−𝑞
2
 +𝛼   
−𝑝−𝑞
2
 +𝛿+𝜌 
  
−𝑝+𝑞
2
 +𝛼   
−𝑝+𝑞
2
 +𝛿+𝜌 
     
 
−𝑝+𝑞
2
  −   
−𝑝−𝑞
2
 
=
ln 
 −𝑝−𝑞+2𝛼  −𝑝−𝑞+2𝛿+2𝜌  
 −𝑝+𝑞+2𝛼  −𝑝+𝑞+2𝛿+2𝜌  
     
𝑞
 
 𝑡 =
ln 
 −𝑞+𝛼−𝛽−𝛿−𝜌  −𝑞−𝛼−𝛽+𝛿+𝜌 
 𝑞+𝛼−𝛽−𝛿−𝜌  𝑞−𝛼−𝛽+𝛿+𝜌 
 
𝑞
 
 𝑡 =
ln 
𝑞2−𝛼2+2𝛼𝛿+2𝛼𝜌+𝛽2−𝛿2−2𝛿𝜌 −𝜌2+2𝛽𝑞
𝑞2−𝛼2+2𝛼𝛿+2𝛼𝜌+𝛽2−𝛿2−2𝛿𝜌 −𝜌2−2𝛽𝑞
 
𝑞
 (28) 
 Let 𝑋 = 𝑞2 − 𝛼2 + 2𝛼𝛿 + 2𝛼𝜌 + 𝛽2 − 𝛿2 − 2𝛿𝜌 − 𝜌2 (29) 
 Substituting (29) into (28) 
 𝑡 =
ln 
𝑋+2𝛽𝑞
𝑋−2𝛽𝑞
 
𝑞
   (30) 
 Substituting (26) into (27) and rearranging  
 𝑞 =   𝛽 + 𝛼 + 𝛿 + 𝜌 2 − 4 𝛼𝛿 + 𝛼𝜌 + 𝛽𝜌  ½ =   𝛽 + 𝛼 − 𝛿 − 𝜌 2 + 4𝛽𝛿 ½ 
 Since all rate constants are positive, 𝑞 must also be positive. 
 Thus, there is a positive solution for 𝑡 only when  
𝑋+2𝛽𝑞
𝑋−2𝛽𝑞
 > 0 
 Multiplying the numerator and denominator by  𝑋 − 2𝛽𝑞  
 
 𝑋+2𝛽𝑞   𝑋−2𝛽𝑞  
 𝑋−2𝛽𝑞   𝑋−2𝛽𝑞  
> 0 
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𝑋2−4𝛽2𝑞2
 𝑋−2𝛽𝑞  2
> 0   (31) 
 Since the denominator in (31) must be positive, there is a positive solution for 𝑡 
only when the numerator in (31) is also positive 
 𝑋2 − 4𝛽2𝑞2 > 0  (32) 
 Substituting (27) and (29) into (32) and simplifying 
 16𝛽2𝛿(𝛼 − 𝜌) > 0 
  𝛼 − 𝜌 > 0 
 𝛼 > 𝜌    (33) 
 Thus, 𝒪(𝑡) has a local maximum, meaning that it can undergo macroscopic 
desensitization, but only when 𝛼 >  𝜌. 
 
